Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
gsea,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.6850308245064757,-3.1174886691886776,0.0,0.0,0.0,99/181,17.52%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;GNL3;NOP10;RPL27;RPS28;RPL30;RPL8;NOP58;RPL37;RPS15;RPL5;NOP56;RPL3;RPS17;RPL10A;THUMPD1;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;UTP3;RIOK3;LAS1L;RPS20;RPS19;FAU;UTP11;EXOSC9;RPS16;RPL26;KRR1;DKC1;EBNA1BP2;XRN2;SNU13;RPL23A;WDR12;RPS14;NOP14;RPL36AL;DIS3;UTP20;TRMT112;MTREX;RIOK1;RPP14;RPS27L;RRP1B;DCAF13;RPS4X;RPL7;RPP30;RPL11;WDR18;RPS5;RRP36;NOC4L;RPP38
gsea,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.6939371938183793,-3.108627864504396,0.0,0.0,0.0,95/171,17.52%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;GNL3;RPL27;RPS28;RPL30;RPL8;NOP58;RPL37;RPS15;RPL5;NOP56;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;UTP3;RIOK3;LAS1L;RPS20;RPS19;FAU;UTP11;EXOSC9;RPS16;RPL26;KRR1;EBNA1BP2;XRN2;SNU13;RPL23A;WDR12;RPS14;NOP14;RPL36AL;DIS3;UTP20;MTREX;RIOK1;RPP14;RPS27L;RRP1B;DCAF13;RPS4X;RPL7;RPP30;RPL11;WDR18;RPS5;RRP36;NOC4L;RPP38
gsea,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.7864286695736104,-3.1011521919655776,0.0,0.0,0.0,65/106,7.52%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;UPF2;RPL8;RPL37;RPS15;RPL5;PPP2R1A;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;GSPT2;FAU;RPS16;RPL26;UPF3A
gsea,rRNA Processing R-HSA-72312,-0.6763689719007383,-3.1011068185222364,0.0,0.0,0.0,100/191,17.52%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;GNL3;NOP10;RPL27;RPS28;RPL30;RPL8;NOP58;RPL37;RPS15;RPL5;NOP56;RPL3;RPS17;RPL10A;THUMPD1;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;UTP3;RIOK3;LAS1L;RPS20;RPS19;FAU;UTP11;EXOSC9;RPS16;RPL26;KRR1;DKC1;EBNA1BP2;XRN2;SNU13;RPL23A;WDR12;RPS14;NOP14;MRM2;RPL36AL;DIS3;UTP20;TRMT112;MTREX;RIOK1;RPP14;RPS27L;RRP1B;DCAF13;RPS4X;RPL7;RPP30;RPL11;WDR18;RPS5;RRP36;NOC4L;RPP38
gsea,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.798154383824448,-3.0879396992166614,0.0,0.0,0.0,67/101,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;EIF3A;RPS8;RPL35;RPL22L1;RPL28;EIF5B;RPS25;RPL6;EIF5;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;EIF4A2;RPL18;RPL27;RPS28;RPL30;RPL8;EIF2S2;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;EIF4A1;RPS16;RPL26
gsea,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.7920108618210115,-3.0794356844419886,0.0,0.0,0.0,65/100,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;EIF3A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;EIF4A2;RPL18;RPL27;RPS28;RPL30;RPL8;EIF2S2;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;EIF4A1;RPS16;RPL26
gsea,Cellular Response To Starvation R-HSA-9711097,-0.7322516393932933,-3.079216196158918,0.0,0.0,0.0,74/139,8.11%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;ATP6V0C;RPL14;RPL9;RPL15;ATP6V1D;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;ATP6V1G1;RPL7A;RPS12;RPL34;RPL36A;RPLP2;CEBPG;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;ATP6V0E2;RPL8;EIF2S2;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;ATP6V1F;RPS2;RPL39;RPL41;RPL32;IMPACT;RPS13;RPL31;RPL18A;ATP6V1E1;RPS20;RPS19;FAU;ATP6V1H;CEBPB;RPS16;RPL26;ATP6V1A;LAMTOR3
gsea,Cap-dependent Translation Initiation R-HSA-72737,-0.7823877821546098,-3.0769554256765526,0.0,0.0,0.0,67/108,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;EIF3A;RPS8;RPL35;RPL22L1;RPL28;EIF5B;RPS25;RPL6;EIF5;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;EIF4A2;RPL18;RPL27;RPS28;RPL30;RPL8;EIF2S2;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;EIF4A1;RPS16;RPL26
gsea,Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.7333457798408268,-3.0698295958956106,0.0,0.0,0.0,68/127,7.42%,HSP90AA1;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;TPR;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;GNL3;RPL27;RPS28;RPL30;RPL8;RPL37;POLR2G;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RANBP2;RPL18A;PBRM1;POLR2E;RPS20;RPS19;FAU;RPS16;RPL26
gsea,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.8119494979035226,-3.0687155500576786,0.0,0.0,0.0,62/91,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;EIF3A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;RPS16;RPL26
gsea,Eukaryotic Translation Termination R-HSA-72764,-0.8320944323201599,-3.057447008717017,0.0,0.0,0.0,62/84,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;GSPT2;FAU;RPS16;RPL26
gsea,Selenoamino Acid Metabolism R-HSA-2408522,-0.788478779613414,-3.0547278924608046,0.0,0.0,0.0,61/97,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;RPS16;RPL26
gsea,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.8218007225223045,-3.0542422541454615,0.0,0.0,0.0,65/89,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;CEBPG;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;EIF2S2;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;IMPACT;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;CEBPB;RPS16;RPL26
gsea,Influenza Infection R-HSA-168255,-0.7119922931442343,-3.0532846396357636,0.0,0.0,0.0,72/144,7.79%,HSP90AA1;PABPN1;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;TPR;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;GNL3;RPL27;RPS28;RPL30;RPL8;RPL37;POLR2G;RPS15;RPL5;RPL3;RPS17;RPL10A;CANX;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RANBP2;RPL18A;PBRM1;POLR2E;RPS20;CLTC;RPS19;FAU;RPS16;RPL26;XPO1
gsea,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.825794728768261,-3.050207313107794,0.0,0.0,0.0,62/86,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;GSPT2;FAU;RPS16;RPL26
gsea,Viral mRNA Translation R-HSA-192823,-0.8298767217424016,-3.0387485797850333,0.0,0.0,0.0,63/84,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;GNL3;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;PBRM1;RPS20;RPS19;FAU;RPS16;RPL26
gsea,Selenocysteine Synthesis R-HSA-2408557,-0.8243903078783499,-3.0333758678224427,0.0,0.0,0.0,61/83,7.42%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;RPS16;RPL26
gsea,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.6990139185388577,-3.0217965398797118,0.0,0.0,0.0,95/156,16.86%,UBB;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;PSMD2;RPL18;ELOC;RPL27;RPS28;RPL30;UPF2;RPL8;ELOB;RPL37;RPS15;RPL5;RPL3;PSMA4;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;USP33;RPS20;RPS19;GSPT2;PSMC2;FAU;RPS16;PSMB3;RPL26;UPF3A;PSMD14;SEM1;PSMC6;MSI1;RPL23A;UBC;PSMC1;RPS14;PSME2;PSMB11;PSME4;RPL36AL;RBX1;EIF4G1;RPS27L;PSMD6;PSMB6;RPS4X;RPL7;RPL11;RNPS1;PSMA7;RPS5
gsea,Translation R-HSA-72766,-0.641406947192197,-3.019580355155939,0.0,0.0,0.0,150/255,22.15%,EEF1A1;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;EIF3A;RPS8;RPL35;RPL22L1;RPL28;EIF5B;RPS25;RPL6;EIF5;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;EIF4A2;RPL18;MRPL47;RPL27;RPS28;RPL30;RPL8;EIF2S2;RPL37;RPS15;RPL5;MRPL46;MRPS17;RPL3;SSR3;RPS17;RPL10A;AURKAIP1;SRP14;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;MRPS26;RPL18A;MRPL17;YARS2;MRPL53;RPS20;RPS19;GSPT2;FAU;SEC61B;EIF4A1;MRPL49;RPS16;RPL26;MRPL52;MRPS9;MRPS15;MRPL12;MRPS14;RPN2;EIF4B;PTCD3;EEF1G;MARS2;RPL23A;SEC11A;EEF1B2;MRPL41;MRPS2;SPCS2;LARS2;MRPL23;AIMP1;MARS1;MRPL36;RPS14;EIF3C;RPL36AL;MRPL11;TRMT112;EIF2B4;EIF4G1;SPCS3;MRPL38;SPCS1;RPS27L;DDOST;RPN1;RPS4X;MRPL3;MRPS18B;MRPS33;MRPL34;EEF2;SRP19;MRPL16;EIF1AX;MRPS16;RPL7;RPL11;RPS5;MRPS31;MRPS30;FARS2;MRPS18A;RPL22;MRPL24;DTD1;MTRF1L;GFM1;MRPS10;RARS2;RPLP0;MRPL57;EIF3M;GADD45GIP1;OXA1L;MRPL43;SSR1;DARS2;ERAL1;MRPL48;MRPL51
gsea,Signaling By ROBO Receptors R-HSA-376176,-0.6592552867993722,-3.007541999089954,0.0,0.0,0.0,106/195,16.86%,UBB;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;PPP3CB;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;PFN1;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;PSMD2;RPL18;ELOC;PKN2;RPL27;RPS28;RPL30;UPF2;RPL8;ELOB;RPL37;RPS15;RPL5;RPL3;PSMA4;RPS17;SOS1;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;USP33;RPS20;RPS19;GSPT2;PSMC2;FAU;RPS16;PSMB3;AKAP5;RPL26;UPF3A;CAP1;PRKACB;PSMD14;SEM1;PSMC6;MSI1;SRGAP2;RPL23A;UBC;FLRT3;PSMC1;PFN2;RPS14;PSME2;PSMB11;PSME4;RPL36AL;RBX1;EIF4G1;RPS27L;PSMD6;PSMB6;RPS4X;ENAH;RPL7;RPL11;RNPS1;PSMA7;RPS5
gsea,Peptide Chain Elongation R-HSA-156902,-0.8408462331228932,-3.0017362103579117,0.0,0.0,0.0,62/80,7.42%,EEF1A1;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;RPS16;RPL26
gsea,Eukaryotic Translation Elongation R-HSA-156842,-0.8232201829771627,-2.9792415312236376,0.0,0.0,0.0,62/84,7.42%,EEF1A1;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;RPS16;RPL26
gsea,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.7728049992440273,-2.9559093644511516,0.0,0.0,0.0,80/100,16.86%,RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;SSR3;RPS17;RPL10A;SRP14;RPS2;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;RPS20;RPS19;FAU;SEC61B;RPS16;RPL26;RPN2;RPL23A;SEC11A;SPCS2;RPS14;RPL36AL;SPCS3;SPCS1;RPS27L;DDOST;RPN1;RPS4X;SRP19;RPL7;RPL11;RPS5
gsea,mRNA Splicing - Major Pathway R-HSA-72163,-0.6031059699616402,-2.8237125305412327,0.0,0.0,0.0,96/180,22.74%,PABPN1;HNRNPA2B1;HNRNPH1;SRSF1;HSPA8;DDX5;SNRNP70;HNRNPU;SRRM2;HNRNPA0;FUS;PRPF40A;PCBP1;SRSF2;HNRNPD;U2SURP;SRSF7;HNRNPK;HNRNPA1;HNRNPA3;PCBP2;TRA2B;PCF11;PAPOLA;DDX42;SRSF10;POLR2G;SRSF5;HNRNPM;CDC40;DNAJC8;CWC27;BCAS2;CPSF6;DHX15;POLR2E;DDX46;SF1;EFTUD2;CWC15;HNRNPH2;WBP11;ALYREF;SRSF6;SRSF9;PRPF19;SNRPG;DHX9;SNU13;SF3B5;CWC22;SLU7;DDX23;SF3B1;SRSF11;SART1;FIP1L1;GTF2F1;CHERP;LSM8;LSM4;CSTF2T;GCFC2;SNRNP200;SMNDC1;SRRM1;HNRNPL;LSM7;MTREX;POLR2K;PUF60;SNRPB2;U2AF1;SNRPE;SNRNP27;SNRPD2;POLR2A;SF3B3;CSTF2;RNPS1;DHX38;CCAR1;SF3B6;CSTF3;CDC5L;PRPF8;LSM2;POLR2L;PPIL4;POLR2D;BUD31;HNRNPR;DHX16;WBP4;LSM6;POLR2B
gsea,mRNA Splicing R-HSA-72172,-0.5938537505094557,-2.794500541428385,0.0,0.0,0.0,92/188,20.66%,PABPN1;HNRNPA2B1;HNRNPH1;SRSF1;RNPC3;HSPA8;DDX5;SNRNP70;HNRNPU;SRRM2;HNRNPA0;FUS;PRPF40A;PCBP1;SRSF2;HNRNPD;U2SURP;SRSF7;HNRNPK;HNRNPA1;HNRNPA3;PCBP2;TRA2B;PCF11;PAPOLA;DDX42;SRSF10;POLR2G;SRSF5;HNRNPM;CDC40;DNAJC8;CWC27;BCAS2;CPSF6;DHX15;POLR2E;DDX46;SF1;EFTUD2;CWC15;HNRNPH2;WBP11;ALYREF;SRSF6;SRSF9;PRPF19;SNRPG;DHX9;SNU13;SF3B5;CWC22;SLU7;DDX23;SF3B1;SRSF11;SART1;FIP1L1;GTF2F1;CHERP;LSM8;LSM4;CSTF2T;GCFC2;SNRNP200;SMNDC1;SRRM1;HNRNPL;LSM7;MTREX;POLR2K;PUF60;SNRPB2;U2AF1;SNRPE;SNRNP27;SNRPD2;POLR2A;SF3B3;CSTF2;RNPS1;DHX38;CCAR1;SF3B6;CSTF3;CDC5L;PRPF8;LSM2;POLR2L;PPIL4;POLR2D;BUD31
gsea,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.6737270800625662,-2.786417199174019,0.0,0.0,0.0,52/95,15.77%,COX7C;COX8A;COX6C;COX4I1;UQCRC2;COX6A1;NDUFC2;COX5B;NDUFB3;NDUFA5;NDUFC1;NDUFB6;CYCS;NDUFB1;ATP5PB;UQCRB;LRPPRC;NDUFA1;UQCRFS1;COX6B1;NDUFAF4;UQCRQ;NDUFS5;UQCR10;NDUFB10;NDUFB8;COX5A;NDUFAF7;COX19;NDUFS2;NDUFA6;NDUFA7;NDUFA3;NDUFB7;COX14;COX7B;UQCR11;TMEM186;NDUFB9;SURF1;TMEM126B;NDUFA2;NDUFS8;COX7A2L;NDUFS6;COX20;SCO1;NDUFA13;NDUFB11;NDUFAB1;NDUFV1;NDUFA12
gsea,Respiratory Electron Transport R-HSA-611105,-0.6826911931934323,-2.779272380237755,0.0,0.0,0.0,51/89,15.77%,COX7C;COX8A;COX6C;COX4I1;UQCRC2;COX6A1;NDUFC2;COX5B;NDUFB3;NDUFA5;NDUFC1;NDUFB6;CYCS;NDUFB1;UQCRB;LRPPRC;NDUFA1;UQCRFS1;COX6B1;NDUFAF4;UQCRQ;NDUFS5;UQCR10;NDUFB10;NDUFB8;COX5A;NDUFAF7;COX19;NDUFS2;NDUFA6;NDUFA7;NDUFA3;NDUFB7;COX14;COX7B;UQCR11;TMEM186;NDUFB9;SURF1;TMEM126B;NDUFA2;NDUFS8;COX7A2L;NDUFS6;COX20;SCO1;NDUFA13;NDUFB11;NDUFAB1;NDUFV1;NDUFA12
gsea,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.5633369855397518,-2.7516898125374207,0.0,0.0,0.0,113/236,22.74%,PABPN1;HNRNPA2B1;HNRNPH1;SRSF1;RNPC3;HSPA8;DDX5;TPR;SNRNP70;HNRNPU;SRRM2;HNRNPA0;FUS;PRPF40A;PCBP1;SRSF2;HNRNPD;U2SURP;SRSF7;HNRNPK;HNRNPA1;HNRNPA3;PCBP2;FYTTD1;TRA2B;PCF11;PAPOLA;DDX42;SRSF10;THOC2;POLR2G;SRSF5;HNRNPM;CDC40;DNAJC8;CWC27;SARNP;RANBP2;BCAS2;METTL14;CPSF6;DHX15;POLR2E;DDX46;SF1;EFTUD2;CWC15;HNRNPH2;WBP11;ALYREF;SRSF6;SRSF9;PRPF19;SNRPG;DHX9;SNU13;SF3B5;CWC22;SLU7;DDX23;SF3B1;SRSF11;SART1;FIP1L1;GTF2F1;ZC3H11A;CHERP;LSM8;LSM4;CSTF2T;GCFC2;NUP98;NUP88;SNRNP200;SMNDC1;SRRM1;HNRNPL;LSM7;MTREX;GLE1;POLR2K;PUF60;NUP153;SNRPB2;U2AF1;NUP155;SNRPE;SNRNP27;SNRPD2;POLR2A;SF3B3;CSTF2;RNPS1;DHX38;CCAR1;SF3B6;NDC1;NUP37;NUP54;CSTF3;CDC5L;PRPF8;LSM2;POLR2L;PPIL4;POLR2D;BUD31;HNRNPR;DHX16;WBP4;SEH1L;LSM6;POLR2B
gsea,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.6082378164360792,-2.7359385879834512,0.0,0.0,0.0,65/141,15.77%,COX7C;COX8A;COX6C;COX4I1;LDHB;BSG;UQCRC2;MDH2;COX6A1;IDH3B;NDUFC2;COX5B;NDUFB3;NDUFA5;NDUFC1;NDUFB6;CYCS;NDUFB1;ATP5PB;UQCRB;LRPPRC;NDUFA1;UQCRFS1;COX6B1;NDUFAF4;UQCRQ;NDUFS5;UQCR10;NDUFB10;NDUFB8;COX5A;NDUFAF7;PCDHB16;COX19;NDUFS2;NDUFA6;NDUFA7;NDUFA3;NDUFB7;COX14;HAGH;COX7B;UQCR11;TMEM186;NDUFB9;PDHX;SURF1;TMEM126B;NDUFA2;NDUFS8;COX7A2L;PDHB;MPC2;ADHFE1;NDUFS6;COX20;GSTZ1;SCO1;NDUFA13;NDUFB11;PLPP6;NDUFAB1;NDUFV1;FAHD1;NDUFA12
gsea,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.7479996764800546,-2.7284715046340233,0.0,0.0,0.0,36/52,15.67%,RPS27;RPS29;RPS27A;RPS21;RPS7;RPS6;RPS23;RPS24;RPS15A;EIF3A;RPS8;RPS25;EIF5;RPS12;RPS9;RPS3;RPS10;EIF4A2;RPS28;EIF2S2;RPS15;RPS17;RPS2;RPS13;RPS20;RPS19;FAU;EIF4A1;RPS16;EIF4B;RPS14;EIF3C;EIF4G1;RPS27L;RPS4X;EIF1AX
gsea,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.7378695575817769,-2.724876717373068,0.0,0.0,0.0,35/53,15.67%,RPS27;RPS29;RPS27A;RPS21;RPS7;RPS6;RPS23;RPS24;RPS15A;EIF3A;RPS8;RPS25;RPS12;RPS9;RPS3;RPS10;EIF4A2;RPS28;EIF2S2;RPS15;RPS17;RPS2;RPS13;RPS20;RPS19;FAU;EIF4A1;RPS16;EIF4B;RPS14;EIF3C;EIF4G1;RPS27L;RPS4X;EIF1AX
gsea,Translation Initiation Complex Formation R-HSA-72649,-0.7396291053970713,-2.7021287267664365,0.0,0.0,0.0,35/52,15.67%,RPS27;RPS29;RPS27A;RPS21;RPS7;RPS6;RPS23;RPS24;RPS15A;EIF3A;RPS8;RPS25;RPS12;RPS9;RPS3;RPS10;EIF4A2;RPS28;EIF2S2;RPS15;RPS17;RPS2;RPS13;RPS20;RPS19;FAU;EIF4A1;RPS16;EIF4B;RPS14;EIF3C;EIF4G1;RPS27L;RPS4X;EIF1AX
gsea,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.5373554458925542,-2.696850544022734,0.0,0.0,0.0,105/313,15.10%,SERINC1;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;RPL35A;RPS21;CKB;RPS7;RPL21;RPS6;RPS23;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;RPS24;RPS15A;RPS8;RPL35;RPL22L1;RPL28;RPS25;RPL6;RPL13A;RPL7A;RPS12;RPL34;RPL36A;RPLP2;RPS9;RPS3;RPL36;RPL12;RPS10;RPL23;ALDH6A1;PSMD2;OAZ1;RPL18;RPL27;RPS28;RPL30;RPL8;RPL37;RPS15;RPL5;RPL3;PSMA4;RPS17;RPL10A;RPS2;RPL39;RPL41;RPL32;RPS13;HECA;RPL31;RPL18A;GLUL;RPS20;RPS19;PSMC2;FAU;PSPH;RPS16;PSMB3;RPL26;AMT;OAT;PSMD14;SEM1;ADO;PSMC6;GATM;PDHX;RPL23A;NMRAL1;SEPHS2;DDO;PDHB;PSMC1;TDO2;AIMP1;MARS1;RPS14;SLC36A4;PSME2;PSMB11;PSME4;RPL36AL;GRHPR;HNMT;GSTZ1;TYR;RPS27L;PSMD6;PSMB6;RPS4X;NDUFAB1;GLDC
gsea,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.7622639880437622,-2.69089458231176,0.0,0.0,0.0,26/45,7.36%,RPS27;RPS29;RPS27A;RPS21;RPS7;RPS6;RPS23;RPS24;RPS15A;EIF3A;RPS8;RPS25;RPS12;RPS9;RPS3;RPS10;RPS28;EIF2S2;RPS15;RPS17;RPS2;RPS13;RPS20;RPS19;FAU;RPS16
gsea,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.771386750561986,-2.6869415042479723,0.0,0.0,0.0,33/43,16.86%,RPS27;RPS29;RPS27A;RPS21;RPS7;RPS6;RPS23;RPS24;RPS15A;RPS8;RPS25;RPS12;RPS9;RPS3;RPS10;RPS28;RPS15;RPS17;RPS2;RPS13;RPS20;RPS19;FAU;RPS16;SNRPG;GEMIN6;RPS14;RPS27L;SNRPE;RPS4X;SNRPD2;GEMIN5;RPS5
gsea,Axon Guidance R-HSA-422475,-0.5165723033804942,-2.6326574137362657,0.0,0.0,0.0,162/481,16.86%,HSP90AA1;UBB;ACTG1;RPLP1;RPL38;RPS27;RPS29;RPS27A;RPL27A;HSPA8;RPL35A;CDK5R1;HSP90AB1;PPP3CB;RPS21;RPS7;RPL21;RPS6;RPS23;PRNP;RPL14;RPL9;RPL15;RPL37A;RPL4;RPL19;SEMA5A;RPS24;RPS15A;SCN2A;PFN1;RPS8;MYL6;RPL35;RPL22L1;RPL28;DSCAML1;RPS25;RPL6;RPL13A;RPL7A;EPHA7;RPS12;RPL34;RPL36A;RPLP2;AP2M1;SEMA6D;RPS9;PTK2;RPS3;RPL36;RPL12;RPS10;RPL23;PSMD2;ACTR2;RPL18;CNTN1;ELOC;EFNB3;PKN2;RPL27;RPS28;MYL12B;RPL30;UPF2;RPL8;ELOB;RPL37;RPS15;ROCK2;CACNA1H;RPL5;RPL3;PSMA4;SCN3B;EZR;RPS17;SOS1;RPL10A;RHOB;RPS2;DOK6;RPL39;RPL41;RPL32;RPS13;RPL31;RPL18A;USP33;PLXNC1;ST8SIA4;TIAM1;SPTBN1;RPS20;CLTC;RPS19;GSPT2;PSMC2;FAU;ROCK1;RPS16;PSMB3;ARPC5;AKAP5;RPL26;UPF3A;ARPC2;CAP1;PRKACB;COL4A2;PSMD14;SCN3A;SEM1;RNMT;CDK5;PSMC6;MSI1;ARHGEF12;SRGAP2;RPL23A;UBC;FLRT3;APH1B;MAPK1;PSMC1;PFN2;RPS14;PSME2;PSMB11;PSME4;RPL36AL;RBX1;MYH10;SH3KBP1;LIMK2;EIF4G1;COL4A1;PLXNA2;LAMA1;MAPK3;CNTNAP1;RPS27L;PSMD6;PSMB6;CSNK2B;RPS4X;ENAH;RPL7;MAPK8;SCN1A;AGRN;RPL11;ABLIM3;FGFR1;TRPC1;ITGA9;RNPS1;PSMA7;RELN;RPS5
gsea,SARS-CoV-2 Infection R-HSA-9694516,-0.5317723396205353,-2.61759089774278,0.0,0.0,0.0,97/239,19.97%,HSP90AA1;UBB;RPS27;YWHAH;RPS29;RPS27A;DDX5;HSP90AB1;TPR;RPS21;GJA1;RPS7;RPS6;RPS23;YWHAZ;YWHAE;RPS24;RPS15A;RPS8;RPS25;RPS12;RPS9;RPS3;YWHAB;SDC4;RPS10;CHMP2A;RPS28;UBE2N;RPS15;G3BP2;RPS17;CANX;RPS2;IRAK1;RPS13;RANBP2;RPS20;RPS19;SEC24A;FAU;PARP6;CNBP;RPS16;ST6GAL1;SNRPG;FUT8;SDC3;FURIN;RPN2;AKT1;GANAB;SIKE1;CTSL;GEMIN6;UBC;STT3A;ISCU;ST6GALNAC2;ZDHHC8;NUP98;NUP88;RPS14;PIK3C3;NUP153;RB1;CAV1;RPS27L;NUP155;DDOST;SNRPE;IRAK2;UVRAG;RPN1;RPS4X;VPS39;TAB3;CSNK1A1;SNRPD2;SEC23A;CHMP2B;AGRN;GEMIN5;RPS5;CREBBP;CHUK;ZDHHC2;MAGT1;G3BP1;IKBKG;NDC1;NUP37;NUP54;PARP16;TJP1;MASP1;UBE2I
gsea,SARS-CoV-2-host Interactions R-HSA-9705683,-0.5584953851753425,-2.6061618622853824,0.0,0.0,0.0,69/159,19.91%,HSP90AA1;RPS27;YWHAH;RPS29;RPS27A;HSP90AB1;TPR;RPS21;GJA1;RPS7;RPS6;RPS23;YWHAZ;YWHAE;RPS24;RPS15A;RPS8;RPS25;RPS12;RPS9;RPS3;YWHAB;RPS10;RPS28;UBE2N;RPS15;G3BP2;RPS17;RPS2;IRAK1;RPS13;RANBP2;RPS20;RPS19;SEC24A;FAU;CNBP;RPS16;SNRPG;AKT1;SIKE1;GEMIN6;NUP98;NUP88;RPS14;PIK3C3;NUP153;CAV1;RPS27L;NUP155;SNRPE;IRAK2;UVRAG;RPS4X;VPS39;TAB3;SNRPD2;SEC23A;GEMIN5;RPS5;CREBBP;CHUK;G3BP1;IKBKG;NDC1;NUP37;NUP54;TJP1;MASP1
gsea,SARS-CoV Infections R-HSA-9679506,-0.5118274658245014,-2.560945760705317,0.0,0.0,0.0,120/312,19.97%,HSP90AA1;ATP1B1;ATP1A2;UBB;RPS27;YWHAH;RPS29;RPS27A;DDX5;HSP90AB1;TPR;RPS21;GJA1;RPS7;RPS6;RPS23;YWHAZ;YWHAE;RPS24;RPS15A;RPS8;RPS25;RPS12;S1PR1;AP2M1;RPS9;RPS3;YWHAB;SDC4;RPS10;CHMP2A;RPS28;UBE2N;RPS15;ROCK2;G3BP2;ATP1B2;RPS17;SOS1;CANX;RPS2;IRAK1;ARID4B;RPS13;RANBP2;HDAC1;RPS20;RPS19;SEC24A;FAU;PARP6;CNBP;ROCK1;PHF21A;RPS16;COMT;ST6GAL1;SNRPG;CUL3;FUT8;SDC3;FURIN;RPN2;AKT1;GANAB;SIKE1;CTSL;GEMIN6;UBC;STT3A;ISCU;ST6GALNAC2;ZDHHC8;PTGES3;FXYD1;NUP98;NUP88;RPS14;RBX1;MTA3;SH3KBP1;PIK3C3;NUP153;RB1;CAV1;RPS27L;NUP155;DDOST;SNRPE;IRAK2;UVRAG;RPN1;RPS4X;VPS39;TAB3;CSNK1A1;SNRPD2;SEC23A;CHMP2B;AGRN;BRMS1L;GEMIN5;RPS5;ITGA4;CREBBP;CHUK;ZDHHC2;CHD4;CRBN;IL1R1;MAGT1;G3BP1;IKBKG;NDC1;NUP37;NUP54;PARP16;TJP1;MASP1;UBE2I
gsea,TP53 Regulates Metabolic Genes R-HSA-5628897,-0.6179416286940765,-2.545823662059108,0.0,0.0,0.0,45/77,24.96%,COX7C;YWHAH;COX8A;COX6C;YWHAZ;YWHAE;COX4I1;YWHAB;COX6A1;COX5B;PRDX2;CYCS;LRPPRC;COX6B1;TNRC6A;AGO3;COX5A;TNRC6C;COX19;UBL4A;COX14;LAMTOR3;COX7B;SURF1;AKT1;PRDX5;AGO4;PRKAG2;COX7A2L;COX20;SCO1;GNPDA1;PRDX1;RRAGB;MTOR;LAMTOR5;LAMTOR1;RRAGA;SCO2;YWHAG;LAMTOR4;LAMTOR2;RRM2B;REXO2;GLS2
gsea,Complex I Biogenesis R-HSA-6799198,-0.6641999596390519,-2.474466828271858,0.0,0.0,0.0,28/50,15.77%,NDUFC2;NDUFB3;NDUFA5;NDUFC1;NDUFB6;NDUFB1;NDUFA1;NDUFAF4;NDUFS5;NDUFB10;NDUFB8;NDUFAF7;NDUFS2;NDUFA6;NDUFA7;NDUFA3;NDUFB7;TMEM186;NDUFB9;TMEM126B;NDUFA2;NDUFS8;NDUFS6;NDUFA13;NDUFB11;NDUFAB1;NDUFV1;NDUFA12
gsea,Mitochondrial Protein Import R-HSA-1268020,-0.6153474833598671,-2.46984494460052,0.0,0.0,0.0,26/58,17.71%,SLC25A4;TOMM6;CHCHD2;TOMM22;TOMM7;TOMM20;HSPA9;TOMM5;NDUFB8;COX19;CHCHD10;HSPD1;TIMM9;CHCHD7;PMPCB;COX17;TIMM23;COA6;TIMM21;PMPCA;PITRM1;DNAJC19;COQ2;BCS1L;CS;TIMM13
gsea,Host Interactions Of HIV Factors R-HSA-162909,-0.536775278370445,-2.435670082181662,0.0,0.0,0.0,49/118,19.29%,UBB;RPS27A;PPIA;SLC25A4;TPR;SKP1;NPM1;PSIP1;AP2M1;PSMD2;ELOC;PKN2;SLC25A5;ELOB;RANBP1;CDK9;PSMA4;RANBP2;PSMC2;ATP6V1H;PSMB3;XPO1;PSMD14;CUL5;BANF1;SEM1;PSMC6;UBC;PSMC1;NUP98;NUP88;PSME2;PSMB11;PSME4;RBX1;RAN;NUP153;PSMD6;NUP155;PSMB6;AP1G1;AP1S1;PSMA7;PSMB2;PSMA2;NDC1;NUP37;PSMC5;NUP54
gsea,Orc1 Removal From Chromatin R-HSA-68949,-0.5856877877471752,-2.4255190232823773,0.0,0.0,0.0,34/65,23.30%,UBB;ORC4;RPS27A;SKP1;PSMD2;PSMA4;ORC6;PSMC2;PSMB3;SKP2;PSMD14;SEM1;PSMC6;UBC;PSMC1;CCNA1;MCM6;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;CUL1;MCM7;PSMA7;PSMB2;PSMA2;PSMC5;CCNA2;MCM4;PSMA1;ORC5;PSMC3
gsea,HIV Infection R-HSA-162906,-0.4885765083192396,-2.405126923788365,0.0,0.0,0.0,98/210,26.47%,UBB;RPS27A;PPIA;SLC25A4;TPR;SKP1;NPM1;PSIP1;AP2M1;PSMD2;CCNT2;ELOC;PKN2;SLC25A5;CHMP2A;ELOB;POLR2G;RANBP1;CDK9;PSMA4;RANBP2;POLR2E;TBP;PSMC2;TAF11;TCEA1;ATP6V1H;PSMB3;VPS28;XPO1;PSMD14;CCNH;CUL5;BANF1;NMT1;MNAT1;SEM1;RNMT;PSMC6;VPS4A;VTA1;FURIN;XRCC4;GTF2F1;UBC;PSMC1;NUP98;NUP88;PSME2;PSMB11;PSME4;RBX1;RAN;GTF2H5;POLR2K;NUP153;TSG101;FEN1;PSMD6;NUP155;PSMB6;AP1G1;GTF2H1;AP1S1;SSRP1;CDK7;POLR2A;CHMP2B;ERCC3;NELFB;PSMA7;PSMB2;VPS4B;PSMA2;TAF1;NDC1;NUP37;PSMC5;NUP54;POLR2L;POLR2D;TAF10;PSMA1;SEH1L;POLR2B;TAF5;RNGTT;SGIP1;GTF2A1;PSMC3;TAF7L;CCNK;CHMP5;SEC13;VPS37D;UBA52;PSME3;TAF15
gsea,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.5651246118354213,-2.397441621172484,0.0,0.0,0.0,36/81,20.18%,UBB;RPS27A;HSPA8;YWHAZ;HNRNPD;YWHAB;PSMD2;PSMA4;SET;ZFP36L1;PSMC2;EXOSC9;PSMB3;XPO1;PSMD14;ANP32A;SEM1;PSMC6;AKT1;UBC;PSMC1;KHSRP;PSME2;PSMB11;PSME4;DIS3;DCP2;EIF4G1;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5;DCP1A;PRKCD
gsea,G2/M Transition R-HSA-69275,-0.495815657258257,-2.3605510820384428,0.0,0.0,0.0,72/170,24.09%,HSP90AA1;UBB;DYNLL1;RPS27A;HSP90AB1;TUBA1A;YWHAE;SKP1;AKAP9;TUBA4A;PSMD2;CEP290;PPP2R1A;PSMA4;PCM1;ODF2;CETN2;PSMC2;CEP43;PHLDA1;PLK4;PRKAR2B;CKAP5;PSMB3;XPO1;PSMD14;CCNH;MNAT1;SEM1;PSMC6;FBXW11;SFI1;MZT1;SDCCAG8;UBC;TUBB4B;LIN52;PSMC1;BORA;CCNA1;PPME1;PSME2;PSMB11;PSME4;RBX1;ACTR1A;LIN54;CEP192;PSMD6;PSMB6;CUL1;HAUS3;CDK7;PSMA7;DCTN3;PSMB2;PPP1CB;PPP1R12B;PSMA2;FBXL18;PSMC5;OFD1;CCNA2;NME7;PSMA1;YWHAG;PPP2CA;CEP135;PSMC3;DYNC1I2;CENPF;PPP1R12A
gsea,ESR-mediated Signaling R-HSA-8939211,-0.503446240963187,-2.3601191673924053,0.0,0.0,0.0,59/149,23.75%,HSP90AA1;CALM1;DDX5;HSP90AB1;PPID;GNG3;GNB2;PTK2;FKBP5;H2AZ1;JUND;PGR;POLR2G;CDK9;ZDHHC21;TNRC6A;AGO3;SMC1A;JUN;IGF1R;KCTD6;TNRC6C;KAT2B;HDAC1;POLR2E;TBP;XPO1;UHMK1;AKT1;CBFB;AGO4;GTF2F1;GNG11;MAPK1;TGFA;PTGES3;GNG10;CDKN1B;POLR2K;CAV1;MAPK3;KANK1;POLR2A;CCND1;CREBBP;MBD4;GNG7;NCOA2;CHD1;GNB5;USF1;POLR2L;POLR2D;HRAS;KDM1A;POLR2B;GTF2A1;PIK3R3;H2AJ
gsea,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.5549598921585066,-2.3599390908173445,0.0,0.0,0.0,32/78,19.23%,CALM1;UBB;PPP3CA;RPS27A;PPIA;PPP3CB;SKP1;PPP3R1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;RASGRP1;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5
gsea,Late Phase Of HIV Life Cycle R-HSA-162599,-0.5102047087109737,-2.353874268499695,0.0,0.0,0.0,63/125,26.47%,UBB;RPS27A;PPIA;TPR;CCNT2;ELOC;CHMP2A;ELOB;POLR2G;RANBP1;CDK9;RANBP2;POLR2E;TBP;TAF11;TCEA1;VPS28;XPO1;CCNH;NMT1;MNAT1;RNMT;VPS4A;VTA1;FURIN;GTF2F1;UBC;NUP98;NUP88;RAN;GTF2H5;POLR2K;NUP153;TSG101;NUP155;GTF2H1;SSRP1;CDK7;POLR2A;CHMP2B;ERCC3;NELFB;VPS4B;TAF1;NDC1;NUP37;NUP54;POLR2L;POLR2D;TAF10;SEH1L;POLR2B;TAF5;RNGTT;SGIP1;GTF2A1;TAF7L;CCNK;CHMP5;SEC13;VPS37D;UBA52;TAF15
gsea,HIV Life Cycle R-HSA-162587,-0.5029001859747719,-2.3526037845754315,0.0,0.0,0.0,67/137,26.47%,UBB;RPS27A;PPIA;TPR;PSIP1;CCNT2;ELOC;CHMP2A;ELOB;POLR2G;RANBP1;CDK9;RANBP2;POLR2E;TBP;TAF11;TCEA1;VPS28;XPO1;CCNH;BANF1;NMT1;MNAT1;RNMT;VPS4A;VTA1;FURIN;XRCC4;GTF2F1;UBC;NUP98;NUP88;RAN;GTF2H5;POLR2K;NUP153;TSG101;FEN1;NUP155;GTF2H1;SSRP1;CDK7;POLR2A;CHMP2B;ERCC3;NELFB;VPS4B;TAF1;NDC1;NUP37;NUP54;POLR2L;POLR2D;TAF10;SEH1L;POLR2B;TAF5;RNGTT;SGIP1;GTF2A1;TAF7L;CCNK;CHMP5;SEC13;VPS37D;UBA52;TAF15
gsea,Cellular Response To Heat Stress R-HSA-3371556,-0.5449874438607771,-2.3461851202506496,0.0,0.0,0.0,40/88,23.80%,HSP90AA1;UBB;EEF1A1;HSPA8;HSP90AB1;TPR;HSPA4L;CAMK2B;YWHAE;HSPA9;CAMK2A;RANBP2;HSPA5;CRYAB;HSPA4;HSBP1;CCAR2;RPA3;MAPK1;PTGES3;NUP98;NUP88;BAG4;NUP153;MAPK3;NUP155;HSPA2;HSF1;DNAJB6;CREBBP;MTOR;NDC1;NUP37;NUP54;BAG1;HSPH1;SEH1L;CAMK2G;HIKESHI;HSPA12B
gsea,Mitotic G2-G2/M Phases R-HSA-453274,-0.4901682921192029,-2.340160915110709,0.0,0.0,0.0,72/172,24.09%,HSP90AA1;UBB;DYNLL1;RPS27A;HSP90AB1;TUBA1A;YWHAE;SKP1;AKAP9;TUBA4A;PSMD2;CEP290;PPP2R1A;PSMA4;PCM1;ODF2;CETN2;PSMC2;CEP43;PHLDA1;PLK4;PRKAR2B;CKAP5;PSMB3;XPO1;PSMD14;CCNH;MNAT1;SEM1;PSMC6;FBXW11;SFI1;MZT1;SDCCAG8;UBC;TUBB4B;LIN52;PSMC1;BORA;CCNA1;PPME1;PSME2;PSMB11;PSME4;RBX1;ACTR1A;LIN54;CEP192;PSMD6;PSMB6;CUL1;HAUS3;CDK7;PSMA7;DCTN3;PSMB2;PPP1CB;PPP1R12B;PSMA2;FBXL18;PSMC5;OFD1;CCNA2;NME7;PSMA1;YWHAG;PPP2CA;CEP135;PSMC3;DYNC1I2;CENPF;PPP1R12A
gsea,Iron Uptake And Transport R-HSA-917937,-0.6101419520372768,-2.3400258520188477,0.0,0.0,0.0,16/50,8.04%,FTH1;UBB;RPS27A;ATP6V0C;ATP6V1D;SKP1;SLC22A17;ATP6V1G1;IREB2;ATP6V0E2;ATP6V1F;ATP6V0A2;ATP6V1E1;FBXL5;ATP6V1H;ATP6V1A
gsea,Transcriptional Regulation By TP53 R-HSA-3700989,-0.45962813810703135,-2.3385320971285055,0.0,0.0,0.0,133/316,26.47%,UBB;COX7C;YWHAH;RPS27A;COX8A;CDK5R1;COX6C;YWHAZ;YWHAE;COX4I1;NPM1;YWHAB;COX6A1;CCNT2;COX5B;PRELID3A;ELOC;PRDX2;CNOT4;CYCS;ELOB;POLR2G;CDK9;LRPPRC;PPP2R1A;COX6B1;TNRC6A;PDZD2;AGO3;JUN;COX5A;TNRC6C;COX19;HDAC1;POLR2E;TBP;PCNA;TAF11;KMT5A;TCEA1;MAP2K6;RICTOR;CCNH;UBL4A;COX14;LAMTOR3;MNAT1;COX7B;RABGGTB;CDK5;RPA3;RGCC;BRD7;SURF1;AKT1;BLM;PRDX5;AGO4;GTF2F1;UBC;PRKAG2;COX7A2L;BCL6;CCNA1;CDKN1B;CCNG1;COX20;GTF2H5;SCO1;POLR2K;CNOT6L;GNPDA1;RAD17;CSNK2B;GTF2H1;SSRP1;CDK7;MDC1;POLR2A;ERCC3;CNOT1;CDK13;NELFB;CNOT2;CREBBP;PLK2;PRDX1;RRAGB;CHD4;PRELID1;CNOT7;TAF1;MTOR;LAMTOR5;BNIP3L;LAMTOR1;POLR2L;RRAGA;SCO2;WRN;RABGGTA;POLR2D;CCNA2;TAF10;MSH2;YWHAG;PPP2CA;EHMT1;POLR2B;TAF5;TOPBP1;TFDP2;ING3;RBBP7;LAMTOR4;RBL2;LAMTOR2;RRM2B;CNOT6;TAF7L;PPP1R13B;APAF1;CNOT11;REXO2;CCNK;CHD3;GLS2;MAPK11;TTC5;HDAC2;UBA52;BBC3;TAF15
gsea,Chaperone Mediated Autophagy R-HSA-9613829,-0.7826829459326868,-2.330459878057452,0.0,0.0,0.0,6/18,0.49%,HSP90AA1;UBB;EEF1A1;RPS27A;HSPA8;HSP90AB1
gsea,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.5503285795279796,-2.32954610359235,0.0,0.0,0.0,28/83,14.88%,HSP90AA1;UBB;DYNLL1;RPS27A;TUBA1A;YWHAE;SKP1;AKAP9;TUBA4A;CEP290;PPP2R1A;PCM1;ODF2;CETN2;CEP43;PLK4;PRKAR2B;CKAP5;FBXW11;SFI1;SDCCAG8;UBC;TUBB4B;BORA;ACTR1A;CEP192;CUL1;HAUS3
gsea,RHOBTB GTPase Cycle R-HSA-9706574,-0.6437403941858112,-2.329536537506745,0.0,0.0,0.0,14/35,12.62%,HSP90AA1;ACTG1;HSP90AB1;RNF20;PHIP;TRA2B;ROCK2;CCT7;ROCK1;MSI2;CUL3;RBM15;TXNL1;SRRM1
gsea,Cellular Response To Chemical Stress R-HSA-9711123,-0.49112033696178814,-2.3193176045706414,0.0,0.0,0.0,68/166,21.58%,UBB;COX7C;RPS27A;COX8A;COX6C;COX4I1;SKP1;MAFG;COX6A1;PSMD2;COX5B;PRDX2;CYCS;LRPPRC;PSMA4;COX6B1;CHD9;GSTP1;COX5A;GPX1;PCDHB16;COX19;PSMC2;PSMB3;SKP2;PSMD14;UBL4A;COX14;SEM1;COX7B;PSMC6;CUL3;SLC7A11;SURF1;AKT1;PRDX5;SRXN1;UBC;COX7A2L;NCOR1;PSMC1;PSME2;PSMB11;PSME4;RBX1;COX20;SCO1;PSMD6;PSMB6;CUL1;CSNK2B;PPARA;SQSTM1;PSMA7;CREBBP;HDAC3;MBD4;PRDX1;ATF4;PSMB2;NCOA2;PSMA2;PSMC5;PRKCD;SCO2;SOD1;PHGDH;PSMA1
gsea,RHO GTPase Effectors R-HSA-195258,-0.47966126477573273,-2.312254430393725,0.0,0.0,0.0,87/219,26.36%,CALM1;ACTG1;DYNLL1;RPS27;KTN1;YWHAH;DIAPH2;WIPF3;YWHAZ;YWHAE;CYFIP1;PFN1;MYL6;IQGAP2;PTK2;YWHAB;H2AZ1;TAOK1;ACTR2;KIF5B;DYNLL2;NCKAP1;PKN2;BAIAP2;MYL12B;ROCK2;PPP2R1A;PDZD2;RHOB;RANBP2;LIN7B;KDM4C;AHCTF1;ROCK1;CKAP5;WASF1;ARPC5;ARPC2;XPO1;ITGB3BP;KIF14;SRGAP2;KIF2A;MAPK1;PFN2;NUP98;CDKN1B;CENPE;RCC2;MYH10;LIMK2;ABI1;PIK3C3;MAPK3;KANSL1;FMNL2;CTNNB1;PPP1CB;NCOA2;PPP1R12B;ZWINT;NUP37;PRKCD;LLGL1;YWHAG;PPP2CA;SEH1L;KDM1A;ACTR3;DYNC1I2;ABI2;CENPF;H2AJ;CENPT;NCK1;PPP1R12A;IQGAP1;REXO2;DIAPH1;MAPK11;CYBA;H2BC4;PPP2R5D;ARPC1A;SEC13;MYH9;WASF3
gsea,mRNA 3-End Processing R-HSA-72187,-0.5751847750975576,-2.310387871988383,0.0,0.0,0.0,25/58,17.29%,PABPN1;SRSF1;SRSF2;SRSF7;FYTTD1;PCF11;PAPOLA;THOC2;SRSF5;CDC40;SARNP;CPSF6;ALYREF;SRSF6;SRSF9;SLU7;SRSF11;FIP1L1;ZC3H11A;CSTF2T;SRRM1;U2AF1;CSTF2;RNPS1;DHX38
gsea,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.6611631214489703,-2.2979681531064733,0.0,0.0,0.0,17/34,17.70%,HSP90AA1;DYNLL1;HSPA8;DNAJA1;HSP90AB1;CAPZA2;FKBP5;DYNLL2;PGR;CAPZB;PTGES3;NR3C2;ACTR1A;DCTN5;HSPA2;DCTN6;DCTN3
gsea,Mitochondrial Translation R-HSA-5368287,-0.5157257641811228,-2.2832157696123487,0.0,0.0,0.0,45/88,23.76%,MRPL47;MRPL46;MRPS17;AURKAIP1;MRPS26;MRPL17;MRPL53;MRPL49;MRPL52;MRPS9;MRPS15;MRPL12;MRPS14;PTCD3;MRPL41;MRPS2;MRPL23;MRPL36;MRPL11;MRPL38;MRPL3;MRPS18B;MRPS33;MRPL34;MRPL16;MRPS16;MRPS31;MRPS30;MRPS18A;MRPL24;MTRF1L;GFM1;MRPS10;MRPL57;GADD45GIP1;OXA1L;MRPL43;ERAL1;MRPL48;MRPL51;MRPS5;CHCHD1;TUFM;MRPS22;MRPL42
gsea,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.5696778710192504,-2.278562861468925,0.0,0.0,0.0,26/57,19.23%,UBB;RPS27A;SKP1;GLI3;PSMD2;PSMA4;PSMC2;PSMB3;PRKACB;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;CUL1;CSNK1A1;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Mitochondrial Translation Termination R-HSA-5419276,-0.5203509133370556,-2.27565320402453,0.0,2.97801928162625e-05,0.001,43/82,23.76%,MRPL47;MRPL46;MRPS17;AURKAIP1;MRPS26;MRPL17;MRPL53;MRPL49;MRPL52;MRPS9;MRPS15;MRPL12;MRPS14;PTCD3;MRPL41;MRPS2;MRPL23;MRPL36;MRPL11;MRPL38;MRPL3;MRPS18B;MRPS33;MRPL34;MRPL16;MRPS16;MRPS31;MRPS30;MRPS18A;MRPL24;MTRF1L;MRPS10;MRPL57;GADD45GIP1;OXA1L;MRPL43;ERAL1;MRPL48;MRPL51;MRPS5;CHCHD1;MRPS22;MRPL42
gsea,Mitochondrial Translation Elongation R-HSA-5389840,-0.524134916312623,-2.275319236987231,0.0,2.9328977773591857e-05,0.001,44/82,23.76%,MRPL47;MRPL46;MRPS17;AURKAIP1;MRPS26;MRPL17;MRPL53;MRPL49;MRPL52;MRPS9;MRPS15;MRPL12;MRPS14;PTCD3;MRPL41;MRPS2;MRPL23;MRPL36;MRPL11;MRPL38;MRPL3;MRPS18B;MRPS33;MRPL34;MRPL16;MRPS16;MRPS31;MRPS30;MRPS18A;MRPL24;GFM1;MRPS10;MRPL57;GADD45GIP1;OXA1L;MRPL43;ERAL1;MRPL48;MRPL51;MRPS5;CHCHD1;TUFM;MRPS22;MRPL42
gsea,Semaphorin Interactions R-HSA-373755,-0.5541568667768212,-2.273903600446152,0.0,2.8891231836672576e-05,0.001,18/61,13.64%,HSP90AA1;CDK5R1;HSP90AB1;SEMA5A;MYL6;SEMA6D;PKN2;MYL12B;ROCK2;RHOB;PLXNC1;ROCK1;RNMT;CDK5;ARHGEF12;MYH10;LIMK2;PLXNA2
gsea,Cytoprotection By HMOX1 R-HSA-9707564,-0.5797860420967748,-2.2688664244932135,0.0,5.6932721560501836e-05,0.002,24/51,18.22%,COX7C;COX8A;COX6C;COX4I1;COX6A1;COX5B;CYCS;LRPPRC;COX6B1;CHD9;COX5A;COX19;COX14;COX7B;SURF1;COX7A2L;NCOR1;COX20;SCO1;PPARA;CREBBP;HDAC3;MBD4;NCOA2
gsea,Mitochondrial Translation Initiation R-HSA-5368286,-0.5201496517319621,-2.2557973845759265,0.0,0.00014026902413456977,0.005,42/82,23.76%,MRPL47;MRPL46;MRPS17;AURKAIP1;MRPS26;MRPL17;MRPL53;MRPL49;MRPL52;MRPS9;MRPS15;MRPL12;MRPS14;PTCD3;MRPL41;MRPS2;MRPL23;MRPL36;MRPL11;MRPL38;MRPL3;MRPS18B;MRPS33;MRPL34;MRPL16;MRPS16;MRPS31;MRPS30;MRPS18A;MRPL24;MRPS10;MRPL57;GADD45GIP1;OXA1L;MRPL43;ERAL1;MRPL48;MRPL51;MRPS5;CHCHD1;MRPS22;MRPL42
gsea,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.5198261729930372,-2.2516230552370766,0.0,0.00013826518093264733,0.005,38/85,23.30%,UBB;ORC4;RPS27A;SKP1;PSMD2;PSMA4;ANAPC4;ORC6;PSMC2;UBE2E1;PSMB3;SKP2;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;CCNA1;MCM6;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;CUL1;MCM7;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;MCM4;PSMA1;ORC5;PSMC3
gsea,RNA Polymerase II Transcription Termination R-HSA-73856,-0.550562581538778,-2.251186507793772,0.0,0.00013631778401810302,0.005,27/66,17.29%,PABPN1;SRSF1;SRSF2;SRSF7;FYTTD1;PCF11;PAPOLA;THOC2;SRSF5;CDC40;SARNP;CPSF6;ALYREF;SRSF6;SRSF9;SNRPG;SLU7;SRSF11;FIP1L1;ZC3H11A;CSTF2T;SRRM1;U2AF1;SNRPE;CSTF2;RNPS1;DHX38
gsea,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.5755748728006422,-2.250800489769529,0.0,0.00013442448146229602,0.005,24/51,19.23%,UBB;RPS27A;PSMD2;ELOC;ELOB;PSMA4;PSMC2;PSMB3;PSMD14;CUL5;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Hedgehog Off State R-HSA-5610787,-0.5149118991745765,-2.249638133106228,0.0,0.00013258305020938786,0.005,46/93,26.34%,UBB;RPS27A;SKP1;GLI3;PSMD2;PRKAR1A;KIF3A;ADCY9;PSMA4;DYNC2H1;PSMC2;PRKAR2B;ADCY1;PSMB3;PRKACB;PSMD14;SEM1;PSMC6;PTCH1;UBC;GNAS;PSMC1;PSME2;PSMB11;PSME4;RBX1;GLI2;PSMD6;PSMB6;CUL1;CSNK1A1;ADCY2;PSMA7;PSMB2;PSMA2;ADCY5;PSMC5;OFD1;PSMA1;TTC21B;PRKAR2A;PSMC3;ADCY6;WDR35;UBA52;PSME3
gsea,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.5645151732086665,-2.2471355683165104,0.0,0.00013079138736872046,0.005,26/57,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PRKACB;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;GLI2;PSMD6;PSMB6;CUL1;CSNK1A1;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Interleukin-1 Signaling R-HSA-9020702,-0.5028329491441675,-2.245670654111563,0.0,0.0001290475022038042,0.005,42/104,20.07%,UBB;RPS27A;SKP1;PSMD2;UBE2N;PSMA4;PELI2;IRAK1;PSMC2;PSMB3;MAP2K6;PSMD14;PELI1;IL1RAP;SEM1;PSMC6;USP14;FBXW11;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;RBX1;PSMD6;IRAK2;PSMB6;CUL1;HMGB1;NKIRAS1;TAB3;SQSTM1;PSMA7;CHUK;PSMB2;IL1R1;PSMA2;IKBKG;S100B;PSMC5;MAP3K8
gsea,G1/S Transition R-HSA-69206,-0.48390936563635145,-2.241483635829256,0.0,0.00012734950875375412,0.005,49/119,23.70%,UBB;ORC4;RPS27A;SKP1;PSMD2;PPP2R1A;PSMA4;ORC6;HDAC1;CDK4;PSMC2;PCNA;PSMB3;SKP2;PSMD14;CCNH;MNAT1;SEM1;PSMC6;RPA3;AKT1;UBC;LIN52;PSMC1;CCNA1;MCM6;CDKN1B;PSME2;LIN54;RB1;PSMD6;PSMB6;CUL1;MCM7;CDK7;PSMA7;CCND1;PSMB2;PSMA2;PSMC5;CCNA2;MCM4;PSMA1;POLA1;PPP2CA;ORC5;PSMC3;TFDP2;RBL2
gsea,M Phase R-HSA-68886,-0.441743937930389,-2.234946382972034,0.0,0.0001256956190296794,0.005,116/322,23.82%,HSP90AA1;UBB;DYNLL1;RPS27;RPS27A;TUBA1A;TPR;YWHAE;PDS5B;AKAP9;TUBB2A;TUBA4A;NIPBL;H2AZ1;TAOK1;PSMD2;DYNLL2;HDAC8;CHMP2A;PDS5A;CEP290;PPP2R1A;PSMA4;SET;PCM1;SMC1A;RANBP2;ODF2;ANAPC4;CETN2;PSMC2;CEP43;AHCTF1;KMT5A;PLK4;PRKAR2B;UBE2E1;CKAP5;RAB1B;PSMB3;XPO1;PSMD14;BANF1;KIF23;SEM1;ITGB3BP;PSMC6;VPS4A;USO1;RAB2A;SFI1;MZT1;CDC26;SDCCAG8;KIF2A;UBC;TUBB4B;MAPK1;BLZF1;PSMC1;NUP98;NUP88;PSME2;CENPE;PSMB11;RCC2;PSME4;RAN;MAU2;TUBA1B;ACTR1A;VRK1;NUP153;RB1;WAPL;MAPK3;NCAPG2;CEP192;PSMD6;NUP155;NCAPH2;PSMB6;CSNK2B;HAUS3;ARPP19;CHMP2B;KANSL1;PSMA7;ANAPC1;DCTN3;PSMB2;PSMA2;MCPH1;ZWINT;NDC1;NUP37;PSMC5;NUP54;PHF8;UBE2I;OFD1;NCAPD2;NME7;PSMA1;NEK7;YWHAG;RAB33B;PPP2CA;SEH1L;CEP135;PSMC3;DYNC1I2;CENPF;H2AJ;CENPT;ENSA
gsea,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.5751116573780906,-2.2340323837603,0.0,0.0001240841367344271,0.005,24/52,19.23%,UBB;RPS27A;YWHAZ;SKP1;PSMD2;PSMA4;PSMC2;FBXW7;PSMB3;PSMD14;SEM1;PSMC6;AKT1;UBC;PSMC1;PSME2;RBX1;PSMD6;PSMB6;CUL1;PSMA7;PSMB2;PSMA2;PSMC5
gsea,mRNA Splicing - Minor Pathway R-HSA-72165,-0.5779926476298074,-2.230252138513844,0.0,0.00012251345145930777,0.005,34/49,31.22%,SRSF1;RNPC3;SRSF2;SRSF7;DDX42;POLR2G;POLR2E;EFTUD2;SRSF6;SNRPG;SF3B5;DDX23;SF3B1;GTF2F1;SNRNP200;POLR2K;SNRPE;SNRPD2;POLR2A;SF3B3;SF3B6;PRPF8;POLR2L;POLR2D;POLR2B;SNRPF;PDCD7;POLR2C;ZRSR2;NCBP2;SNRPD3;SNRNP48;POLR2H;SNRPB
gsea,"Cell Cycle, Mitotic R-HSA-69278",-0.4209728750567112,-2.2299629714781966,0.0,0.00012098203331606642,0.005,156/448,24.09%,HSP90AA1;UBB;DYNLL1;RPS27;ORC4;RPS27A;HSP90AB1;TUBA1A;TPR;YWHAE;SKP1;PDS5B;AKAP9;TUBB2A;TUBA4A;NIPBL;H2AZ1;TAOK1;PSMD2;DYNLL2;HDAC8;CHMP2A;PDS5A;CEP290;PPP2R1A;PSMA4;SET;PCM1;SMC1A;RANBP2;ODF2;ANAPC4;ORC6;HDAC1;CETN2;CDK4;PSMC2;PCNA;CEP43;PHLDA1;AHCTF1;KMT5A;PLK4;PRKAR2B;UBE2E1;CKAP5;ESCO1;RAB1B;PSMB3;SKP2;XPO1;PSMD14;CCNH;BANF1;MNAT1;KIF23;SEM1;ITGB3BP;PSMC6;VPS4A;USO1;RPA3;FBXW11;RAB2A;SFI1;MZT1;AKT1;CDC26;SDCCAG8;KIF2A;UBC;TUBB4B;MAPK1;LIN52;BLZF1;PSMC1;BORA;CCNA1;NUP98;MCM6;NUP88;CDKN1B;PPME1;PSME2;CENPE;PSMB11;RCC2;PSME4;RBX1;RAN;MAU2;TUBA1B;ACTR1A;VRK1;LIN54;NUP153;RB1;WAPL;MAPK3;NCAPG2;FEN1;CEP192;PSMD6;NUP155;NCAPH2;PSMB6;CUL1;CSNK2B;HAUS3;MCM7;POLD3;ARPP19;CDK7;CHMP2B;KANSL1;PSMA7;CCND1;ANAPC1;DCTN3;PSMB2;PPP1CB;PPP1R12B;PSMA2;MCPH1;FBXL18;ZWINT;NDC1;NUP37;PSMC5;NUP54;PHF8;UBE2I;OFD1;NCAPD2;CCNA2;MCM4;NME7;PSMA1;NEK7;POLA1;YWHAG;RAB33B;PPP2CA;SEH1L;CEP135;ORC5;PSMC3;TFDP2;DYNC1I2;CENPF;RBL2;H2AJ;CENPT;ENSA;CDKN2D;PPP1R12A
gsea,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.5674938446781163,-2.220471118518473,0.0,0.0001433861135597824,0.006,32/50,31.82%,UBB;RPS27A;POLR2G;POLR2E;COPS8;TCEA1;PRPF19;CUL4B;CCNH;MNAT1;UBC;COPS7A;RBX1;GTF2H5;POLR2K;GTF2H1;CDK7;POLR2A;ERCC3;POLR2L;POLR2D;POLR2B;UVSSA;UBA52;COPS6;COPS5;POLR2C;AQR;COPS2;POLR2H;XAB2;ERCC8
gsea,Signaling By Nuclear Receptors R-HSA-9006931,-0.4578235435202895,-2.2204216556974297,0.0,0.00014163750241880945,0.006,72/199,23.75%,HSP90AA1;CALM1;DDX5;HSP90AB1;APOE;PPID;GNG3;GNB2;PTK2;FKBP5;H2AZ1;JUND;PGR;POLR2G;CDK9;ZDHHC21;TNRC6A;AGO3;SMC1A;JUN;IGF1R;KCTD6;ABCA1;TNRC6C;KAT2B;APOD;HDAC1;POLR2E;TBP;XPO1;UHMK1;PDHX;AKT1;CBFB;AGO4;GTF2F1;GNG11;PDHB;NCOR1;MAPK1;TGFA;PTGES3;GNG10;CDKN1B;POLR2K;CAV1;MAPK3;RDH14;KANK1;POLR2A;CCND1;CREBBP;HDAC3;MBD4;CYP26B1;GNG7;NCOA2;CHD1;GNB5;USF1;POLR2L;POLR2D;PLTP;HRAS;RDH10;RDH5;ARL4C;KDM1A;POLR2B;GTF2A1;PIK3R3;H2AJ
gsea,Protein Localization R-HSA-9609507,-0.47147223063903665,-2.2199803291793034,0.0,0.0001399310264860527,0.006,50/148,19.73%,UBB;RPS27A;SLC25A4;PRNP;VAMP2;TOMM6;CHCHD2;TOMM22;TOMM7;TOMM20;AGPS;HSPA9;LONP2;TOMM5;NDUFB8;COX19;CHCHD10;ZFAND6;HSPD1;SEC61B;TIMM9;CHCHD7;PMPCB;COX17;UBL4A;TIMM23;PXMP4;MPV17;COA6;TIMM21;UBC;ABCD2;DDO;USP9X;PMPCA;PITRM1;SYCP2;DNAJC19;NUDT19;COQ2;UBE2D3;BCS1L;PEX2;ACOX1;CS;TIMM13;ATAD1;SLC25A13;GET4;PEX19
gsea,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.5476250186406372,-2.216055655957175,0.0,0.00013826518093264733,0.006,21/66,14.88%,HSP90AA1;DYNLL1;TUBA1A;YWHAE;AKAP9;TUBA4A;CEP290;PPP2R1A;PCM1;ODF2;CETN2;CEP43;PLK4;PRKAR2B;CKAP5;SFI1;SDCCAG8;TUBB4B;ACTR1A;CEP192;HAUS3
gsea,S Phase R-HSA-69242,-0.4636802481498291,-2.2140881114884587,0.0,0.00015941162036940516,0.006,60/152,23.70%,UBB;ORC4;RPS27A;SKP1;PDS5B;PSMD2;PDS5A;PSMA4;SMC1A;ANAPC4;ORC6;CDK4;PSMC2;PCNA;UBE2E1;ESCO1;PSMB3;SKP2;PSMD14;CCNH;MNAT1;SEM1;PSMC6;RPA3;AKT1;CDC26;UBC;LIN52;PSMC1;CCNA1;MCM6;CDKN1B;PSME2;PSMB11;PSME4;RBX1;LIN54;RB1;WAPL;FEN1;PSMD6;PSMB6;CUL1;MCM7;POLD3;CDK7;PSMA7;CCND1;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;MCM4;PSMA1;POLA1;ORC5;PSMC3;TFDP2;RBL2
gsea,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.5696956452307232,-2.213815575337919,0.0,0.00015755799687673766,0.006,23/51,19.23%,UBB;RPS27A;HSPA8;HNRNPD;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;EIF4G1;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.5117819060523722,-2.2108889863764607,0.0,0.00017799655476386783,0.006,37/79,23.70%,UBB;RPS27A;SKP1;PSMD2;PSMA4;CDK4;PSMC2;PSMB3;SKP2;PSMD14;CCNH;MNAT1;SEM1;PSMC6;AKT1;UBC;LIN52;PSMC1;CCNA1;CDKN1B;PSME2;LIN54;RB1;PSMD6;PSMB6;CUL1;CDK7;PSMA7;CCND1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1;PSMC3;TFDP2;RBL2
gsea,Regulation Of RAS By GAPs R-HSA-5658442,-0.5440596426172459,-2.2051168421504905,0.0,0.00021996733330193895,0.008,29/64,21.58%,UBB;RPS27A;NF1;PSMD2;KBTBD7;PSMA4;RASAL2;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;CUL3;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;SPRED3;PSMA7;PSMB2;RASA2;PSMA2;PSMC5;HRAS;PSMA1
gsea,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.5543679328242119,-2.202154047305791,0.0,0.00021749579023113064,0.008,24/56,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PRKACB;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;CUL1;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.5145708794002638,-2.1998303067512053,0.0,0.00021507917033967365,0.008,41/82,26.34%,UBB;RPS27A;SKP1;PSMD2;PPP2R1A;PSMA4;HDAC1;PSMC2;TLE4;PSMB3;PSMD14;SEM1;CTBP2;PSMC6;CTBP1;ZRANB1;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;CUL1;CSNK1A1;TLE5;PSMA7;PSMB2;CTNNB1;PSMA2;TLE1;PSMC5;FRAT1;PSMA1;PPP2CA;PSMC3;TCF7L2;PPP2R5D;UBA52;PSME3
gsea,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.541882824580975,-2.1993047661487637,0.0,0.0002127156629733036,0.008,25/61,19.23%,UBB;RPS27A;HIF1A;PSMD2;ELOC;ELOB;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;UBE2D3;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.5967551253203649,-2.1988782302498917,0.0,0.00021040353620185466,0.008,19/42,19.97%,UBB;RPS27A;UBE2N;PIAS1;SUMO2;CETN2;CUL4B;CCNH;MNAT1;RPA3;UBC;RBX1;GTF2H5;GTF2H1;RAD23B;CDK7;ERCC3;PARP2;UBE2I
gsea,Protein Ubiquitination R-HSA-8852135,-0.5398532633172664,-2.1988463734396504,0.0,0.00020814113258678095,0.008,31/62,28.34%,UBB;RPS27A;RNF20;UBE2N;WAC;PCNA;UBE2E1;SHPRH;RNF181;UBC;SELENOS;RTF1;USP9X;UBE2Q2;HLTF;UBE2D3;CTR9;PEX2;TMEM129;UBE2G2;RRAGA;USP5;UBA6;UBE2E3;UBE2A;H2BC4;UBA52;CDC73;RNF40;PEX5;UBE2G1
gsea,Aggrephagy R-HSA-9646399,-0.6757546005569574,-2.1949192785545577,0.0,0.00020592686521883648,0.008,6/23,3.34%,HSP90AA1;UBB;DYNLL1;RPS27A;DYNLL2;UBE2N
gsea,AURKA Activation By TPX2 R-HSA-8854518,-0.5370369711668482,-2.1934786792537095,0.0,0.0002037592140060066,0.008,21/68,14.88%,HSP90AA1;DYNLL1;TUBA1A;YWHAE;AKAP9;TUBA4A;CEP290;PPP2R1A;PCM1;ODF2;CETN2;CEP43;PLK4;PRKAR2B;CKAP5;SFI1;SDCCAG8;TUBB4B;ACTR1A;CEP192;HAUS3
gsea,Estrogen-dependent Gene Expression R-HSA-9018519,-0.5060591845004931,-2.1934501386840335,0.0,0.00020163672219344406,0.008,38/89,23.75%,HSP90AA1;DDX5;HSP90AB1;H2AZ1;JUND;PGR;POLR2G;CDK9;TNRC6A;AGO3;SMC1A;JUN;KCTD6;TNRC6C;KAT2B;HDAC1;POLR2E;TBP;CBFB;AGO4;GTF2F1;TGFA;PTGES3;POLR2K;KANK1;POLR2A;CCND1;CREBBP;MBD4;NCOA2;CHD1;USF1;POLR2L;POLR2D;KDM1A;POLR2B;GTF2A1;H2AJ
gsea,Cellular Response To Hypoxia R-HSA-1234174,-0.5303934209767461,-2.1926689208182184,0.0,0.00019955799309866626,0.008,34/68,26.45%,UBB;RPS27A;HIF1A;PSMD2;ELOC;ELOB;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;HIGD1A;PSME2;PSMB11;PSME4;RBX1;PSMD6;UBE2D3;PSMB6;MIA3;PSMA7;CREBBP;PSMB2;PSMA2;PSMC5;VEGFA;PSMA1;PSMC3;UBA52;PSME3;CITED2
gsea,Hedgehog On State R-HSA-5632684,-0.5096979256739899,-2.1914515120262195,0.0,0.00019752168704663907,0.008,34/80,21.58%,UBB;RPS27A;GLI3;PSMD2;KIF3A;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;CUL3;PTCH1;UBC;SPOPL;PSMC1;PSME2;PSMB11;PSME4;RBX1;GLI2;DZIP1;GRK2;PSMD6;PSMB6;EFCAB7;CSNK1A1;PSMA7;GAS8;PSMB2;PSMA2;PSMC5;SPOP;PSMA1
gsea,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.6475789233313547,-2.189955515324199,0.0,0.00021507917033967362,0.009,16/26,23.10%,POLR2G;POLR2E;CCNH;MNAT1;RNMT;GTF2F1;GTF2H5;POLR2K;GTF2H1;CDK7;POLR2A;ERCC3;POLR2L;POLR2D;POLR2B;RNGTT
gsea,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.5587550839034394,-2.187168410406948,0.0,0.00021292837863627685,0.009,24/53,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;CUL1;PSMA7;PSMB2;PSMA2;FBXL18;PSMC5
gsea,HIV Transcription Initiation R-HSA-167161,-0.5686110219634088,-2.185574409497241,0.0,0.00022998564749192823,0.009,31/45,34.89%,POLR2G;POLR2E;TBP;TAF11;CCNH;MNAT1;GTF2F1;GTF2H5;POLR2K;GTF2H1;CDK7;POLR2A;ERCC3;TAF1;POLR2L;POLR2D;TAF10;POLR2B;TAF5;GTF2A1;TAF7L;TAF15;POLR2C;GTF2A2;POLR2H;TAF2;GTF2B;TAF3;GTF2E1;TAF7;GTF2F2
gsea,Signaling By NOTCH4 R-HSA-9013694,-0.5232537514881248,-2.1848564195347238,0.0,0.00022773088624200734,0.009,36/77,23.36%,UBB;RPS27A;YWHAZ;MAML2;SKP1;PSMD2;PSMA4;KAT2B;PSMC2;FBXW7;PSMB3;PSMD14;HEY1;SEM1;PSMC6;AKT1;UBC;APH1B;PSMC1;SMAD3;PSME2;RBX1;PSMD6;PSMB6;CUL1;MAML3;PSMA7;CREBBP;PSMB2;HEY2;PSMA2;PSMC5;PSMA1;PSENEN;PSMC3;HES5
gsea,SARS-CoV-1 Infection R-HSA-9678108,-0.5653339101195256,-2.1837132521061613,0.0,0.00026310655789125125,0.011,18/48,19.97%,UBB;RPS27A;DDX5;CHMP2A;CANX;PARP6;ST6GAL1;GANAB;CTSL;UBC;ST6GALNAC2;PIK3C3;RB1;CAV1;UVRAG;CHMP2B;PARP16;UBE2I
gsea,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.544709377492038,-2.180916433130226,0.0,0.0002605766871422969,0.011,27/56,21.58%,UBB;RPS27A;SKP1;PSMD2;PSMA4;CDK4;PSMC2;PSMB3;SKP2;PSMD14;SEM1;PSMC6;UBC;PSMC1;CCNA1;CDKN1B;PSME2;PSMD6;PSMB6;CUL1;PSMA7;CCND1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1
gsea,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.576275664124051,-2.180000956284226,0.0,0.00025809500440760835,0.011,24/43,28.18%,UBB;RPS27A;RNF20;UBE2N;WAC;PCNA;UBE2E1;SHPRH;RNF181;UBC;SELENOS;RTF1;HLTF;UBE2D3;CTR9;PEX2;TMEM129;RRAGA;UBE2A;H2BC4;UBA52;CDC73;RNF40;PEX5
gsea,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.5381973105612433,-2.1746877835992033,0.0,0.0002921830238576698,0.013,24/57,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;PSMA7;CHUK;PSMB2;PSMA2;PSMC5
gsea,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.5470882931529458,-2.174415766510446,0.0,0.0002894523413917103,0.013,22/52,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.5398342041299826,-2.173980764599475,0.0,0.0002867722271195648,0.013,25/58,19.23%,UBB;RPS27A;PSMD2;ERLEC1;PSMA4;PSMC2;PSMB3;SEL1L;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;RNF5;PSMA7;ERLIN2;PSMB2;PSMA2;DERL2;PSMC5
gsea,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.5019954086538788,-2.169475215103693,0.0,0.0003374177809915981,0.016,27/94,14.88%,HSP90AA1;DYNLL1;TUBA1A;YWHAE;TTBK2;AKAP9;TUBA4A;AHI1;CEP290;PPP2R1A;PCM1;IQCB1;ODF2;CEP83;CETN2;CEP43;CEP162;PLK4;PRKAR2B;CKAP5;SFI1;SDCCAG8;TUBB4B;ACTR1A;CEP192;B9D1;HAUS3
gsea,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.500504404396248,-2.1675228398401516,0.0,0.0003343503466189472,0.016,45/102,26.34%,CALM1;UBB;PPP3CA;RPS27A;PPIA;PPP3CB;SKP1;PPP3R1;PSMD2;PSMA4;SOS1;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;RASGRP1;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;SH3KBP1;PSMD6;PSMB6;CUL1;TRPC1;PSMA7;CHUK;ORAI2;PSMB2;PSMA2;IKBKG;PSMC5;HRAS;PSMA1;AHCYL1;PSMC3;NCK1;IKBKB;NFATC1;UBA52;PSME3
gsea,Signaling By Hedgehog R-HSA-5358351,-0.4747139423399983,-2.1669140373071434,0.0,0.0003313381813340918,0.016,59/127,26.46%,UBB;RPS27A;SKP1;GLI3;PSMD2;PRKAR1A;ERLEC1;KIF3A;ADCY9;PSMA4;DYNC2H1;PSMC2;PRKAR2B;ADCY1;PSMB3;PRKACB;SEL1L;PSMD14;SEM1;PSMC6;CUL3;PTCH1;SYVN1;UBC;GNAS;SPOPL;PSMC1;PSME2;PSMB11;PSME4;RBX1;GLI2;DZIP1;GRK2;PSMD6;PSMB6;CUL1;EFCAB7;CSNK1A1;ADCY2;PSMA7;GAS8;PSMB2;PSMA2;ADCY5;DERL2;PSMC5;OFD1;SPOP;PSMA1;TTC21B;PRKAR2A;PSMC3;DISP2;ADCY6;WDR35;UBA52;PSME3;CDC73
gsea,Smooth Muscle Contraction R-HSA-445355,-0.6142139994213315,-2.165455629254432,0.0,0.00034566295233161835,0.017,8/34,8.41%,CALM1;MYL6;TPM1;PKN2;MYL12B;CACNA1H;VCL;PXDN
gsea,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.5502140113702151,-2.1640053394796848,0.0,0.00034260398815169255,0.017,24/54,19.23%,UBB;RPS27A;PSMD2;ERLEC1;PSMA4;PSMC2;PSMB3;SEL1L;PSMD14;SEM1;PSMC6;SYVN1;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;DERL2;PSMC5
gsea,MAPK6/MAPK4 Signaling R-HSA-5687128,-0.5072915152474023,-2.1623541440520606,0.0,0.000339598690010011,0.017,30/80,19.23%,UBB;RPS27A;SEPTIN7;PSMD2;PKN2;PSMA4;TNRC6A;AGO3;JUN;TNRC6C;PSMC2;PSMB3;PRKACB;XPO1;PSMD14;SEM1;PSMC6;AGO4;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;CDC42EP3;PSMB2;PSMA2;PSMC5
gsea,Protein Folding R-HSA-391251,-0.5140201590371775,-2.1615080143224685,0.0,0.0003534779408191158,0.017,33/83,18.87%,TUBA1A;GNG3;TUBB2A;GNB2;TUBA4A;AP3M1;GNAQ;NOP56;LONP2;CCT7;FBXL5;PFDN5;FBXW7;TCP1;PFDN6;XRN2;CCT5;GNG11;TUBB4B;CCT8;GNG10;TBCA;TUBA1B;CSNK2B;FBXW2;VBP1;CCT6A;HDAC3;ARL2;GNG7;SKIC2;TBCD;GNB5
gsea,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.6016486564006364,-2.1594327792632604,0.0,0.00035043071719136477,0.017,17/35,19.71%,UBB;RPS27A;CANX;SEL1L;SYVN1;GANAB;UBC;PSMC1;ENGASE;AMFR;UBXN1;MARCHF6;RAD23B;RNF5;DERL2;UGGT2;CALR
gsea,Centrosome Maturation R-HSA-380287,-0.5230435134090454,-2.1593781003038672,0.0,0.00034743558285639585,0.017,22/75,14.88%,HSP90AA1;DYNLL1;TUBA1A;YWHAE;AKAP9;TUBA4A;CEP290;PPP2R1A;PCM1;ODF2;CETN2;CEP43;PLK4;PRKAR2B;CKAP5;SFI1;MZT1;SDCCAG8;TUBB4B;ACTR1A;CEP192;HAUS3
gsea,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.5239148112327197,-2.156198369901275,0.0,0.0003444912135101552,0.017,29/70,23.21%,UBB;RPS27A;TPR;EIF4G2;EIF4A2;GNL3;ABCE1;FLNB;UBE2N;PDZD2;RANBP2;EIF4A1;UBE2E1;NEDD4;UBC;NUP98;NUP88;EIF4G1;NUP153;MAPK3;NUP155;ARIH1;EIF4G3;NDC1;NUP37;NUP54;PPM1B;SEH1L;SGIP1
gsea,ISG15 Antiviral Mechanism R-HSA-1169408,-0.5295751086523985,-2.1550125502703876,0.0,0.00034159632936301104,0.017,28/66,23.21%,UBB;RPS27A;TPR;EIF4G2;EIF4A2;GNL3;FLNB;UBE2N;PDZD2;RANBP2;EIF4A1;UBE2E1;NEDD4;UBC;NUP98;NUP88;EIF4G1;NUP153;MAPK3;NUP155;ARIH1;EIF4G3;NDC1;NUP37;NUP54;PPM1B;SEH1L;SGIP1
gsea,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.5426507499719805,-2.1545380326397074,0.0,0.00033874969328498596,0.017,22/55,19.23%,HSP90AA1;UBB;RPS27A;HSP90AB1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,RNA Polymerase I Transcription Termination R-HSA-73863,-0.6310749507795165,-2.153527981745096,0.0,0.00033595010904296125,0.017,14/29,15.87%,TAF1D;POLR2E;TBP;POLR1F;UBTF;CCNH;MNAT1;GTF2H5;POLR2K;POLR1H;GTF2H1;TTF1;CDK7;ERCC3
gsea,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.4901893899024452,-2.153221727525531,0.0,0.0003331964196245763,0.017,43/87,27.71%,UBB;RPS27A;UBQLN2;VAMP2;AP2M1;NECAP1;SNAP91;SH3GL1;CLTC;PICALM;COPS8;STAM;M6PR;ITSN2;TOR1A;UBC;TGFA;COPS7A;REPS1;SH3KBP1;GRK2;EPN2;VAMP3;STAM2;TACR1;FCHO2;NEDD8;CLTA;REPS2;EPS15;STON2;SYT12;TFRC;SGIP1;AGFG1;CLTB;ITSN1;UBA52;GRK3;UBQLN1;COPS6;COPS5;GRB2
gsea,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.5193558499476632,-2.1532066292143077,0.0,0.0003304875056438887,0.017,20/64,18.87%,HSP90AA1;CALM1;GNG3;GNB2;PTK2;ZDHHC21;IGF1R;XPO1;UHMK1;AKT1;GNG11;MAPK1;TGFA;GNG10;CDKN1B;CAV1;MAPK3;CCND1;GNG7;GNB5
gsea,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.5567961070363933,-2.1519956585017406,0.0,0.00034343286876818853,0.017,27/48,26.43%,DYNLL1;YWHAH;YWHAZ;YWHAE;PPP3R1;YWHAB;DYNLL2;CYCS;NMT1;UACA;AKT1;MAPK1;BCL2L1;BAK1;MAPK3;CASP3;MAPK8;APIP;C1QBP;YWHAG;DIABLO;TFDP2;PPP1R13B;APAF1;REXO2;CASP9;BBC3
gsea,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.5410284852173889,-2.1497425595716675,0.0,0.0003561711060824995,0.018,24/55,19.23%,UBB;RPS27A;PSMD2;ERLEC1;PSMA4;PSMC2;PSMB3;SEL1L;PSMD14;SEM1;PSMC6;SYVN1;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;DERL2;PSMC5
gsea,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.6676087450233222,-2.1496507784670937,0.0,0.000353344351272321,0.018,10/23,12.62%,HSP90AA1;ACTG1;HSP90AB1;PHIP;TRA2B;CCT7;MSI2;CUL3;TXNL1;SRRM1
gsea,Selective Autophagy R-HSA-9663891,-0.5381458231089005,-2.149303991993131,0.0,0.0003505621122859247,0.018,15/58,11.03%,HSP90AA1;UBB;DYNLL1;RPS27A;HSPA8;TOMM6;TOMM22;DYNLL2;TOMM7;TOMM20;UBE2N;TOMM5;MAP1LC3A;UBC;PRKAG2
gsea,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.6300306374509013,-2.147193633461643,0.001984126984126984,0.0003478233457836909,0.018,12/28,14.51%,UBB;RPS27A;HDAC1;TRIM33;SMAD4;UBC;NCOR1;MAPK1;USP9X;SMAD3;MAPK3;UBE2D3
gsea,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.49669632238561534,-2.146823158113532,0.0,0.00034512704077761585,0.018,37/81,23.70%,UBB;RPS27A;SKP1;PSMD2;PSMA4;CDK4;PSMC2;PSMB3;SKP2;PSMD14;CCNH;MNAT1;SEM1;PSMC6;AKT1;UBC;LIN52;PSMC1;CCNA1;CDKN1B;PSME2;LIN54;RB1;PSMD6;PSMB6;CUL1;CDK7;PSMA7;CCND1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1;PSMC3;TFDP2;RBL2
gsea,CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.49201834873399813,-2.1464789519681213,0.0,0.0003424722173870188,0.018,42/93,27.53%,CALM1;UBB;PPP3CA;RPS27A;PPP3CB;SKP1;PPP3R1;PSMD2;UBE2N;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;TAB3;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5;PRKCD;PSMA1;AHCYL1;PSMC3;IKBKB;NFATC1;UBA52;PSME3;UBE2M;TAB2
gsea,Signaling By WNT R-HSA-195721,-0.43575370443940004,-2.145018549687415,0.0,0.00035463435720129393,0.019,84/245,19.23%,CALM1;UBB;PPP3CA;RPS27A;PPP3CB;YWHAZ;SKP1;PFN1;PPP3R1;GNG3;AP2M1;GNB2;H2AZ1;PSMD2;USP34;VPS35;PPP2R1A;TNKS;PSMA4;PLCB1;TNRC6A;AGO3;CAMK2A;TNRC6C;FZD2;HDAC1;VPS29;CLTC;PSMC2;USP8;SOX9;TLE4;ZNRF3;WLS;PSMB3;XPO1;PSMD14;SEM1;CTBP2;PSMC6;CUL3;CCDC88C;AKT1;CTBP1;AGO4;ZRANB1;UBC;GNG11;WNT7B;PSMC1;GNG10;PIP5K1B;PSME2;PSMB11;PSME4;RYK;RBX1;PYGO1;GNAO1;CAV1;PYGO2;SOX4;PSMD6;PSMB6;CUL1;CSNK2B;CSNK1A1;TLE5;LRP6;FZD1;ASH2L;SOX6;PSMA7;CREBBP;RUVBL1;GNG7;CLTA;PSMB2;CTNNB1;PSMA2;TLE1;WNT4;GNB5;PSMC5
gsea,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.5258918154726137,-2.1430891764484694,0.0,0.0003519477332831023,0.019,24/58,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;PSMA7;CHUK;PSMB2;PSMA2;PSMC5
gsea,RHO GTPases Activate PKNs R-HSA-5625740,-0.5950032920761321,-2.140747946763542,0.0,0.00034930150972458274,0.019,21/35,26.22%,YWHAH;YWHAZ;YWHAE;MYL6;YWHAB;H2AZ1;PKN2;MYL12B;RHOB;KDM4C;MYH10;PPP1CB;NCOA2;PPP1R12B;YWHAG;KDM1A;H2AJ;PPP1R12A;REXO2;H2BC4;MYH9
gsea,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.5860761384618164,-2.1404369396706677,0.0,0.0003466947820400709,0.019,17/37,18.53%,UBB;RPS27A;YWHAZ;HDAC1;SOX9;TLE4;XPO1;AKT1;CTBP1;UBC;PYGO1;PYGO2;SOX4;ASH2L;SOX6;CTNNB1;TLE1
gsea,Ion Channel Transport R-HSA-983712,-0.46357262958021545,-2.1400849223666674,0.0,0.00034412667254347777,0.019,38/136,14.17%,ATP1B1;ATP1A2;CALM1;UBB;RPS27A;ATP6V0C;ATP6V1D;CAMK2B;ATP6V1G1;TTYH1;RYR2;ATP13A4;ATP6V0E2;ATP11B;ATP1B2;CLCN2;ATP6V1F;CAMK2A;ATP2B1;ATP13A5;ATP6V0A2;WWP1;ATP6V1E1;WNK3;ATP6V1H;ATP2C1;ATP6V1A;TRPM3;CLCN4;UBC;CLCN3;ATP2B4;FXYD1;CUTC;TRPC4AP;UNC80;TRDN;ATP2A2
gsea,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.5514236682322515,-2.138611300851105,0.0,0.00034159632936301104,0.019,21/48,19.23%,UBB;RPS27A;PSMD2;PKN2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Synthesis Of DNA R-HSA-69239,-0.46689292071170885,-2.137380815210481,0.0,0.0003391029254990475,0.019,43/114,23.30%,UBB;ORC4;RPS27A;SKP1;PSMD2;PSMA4;ANAPC4;ORC6;PSMC2;PCNA;UBE2E1;PSMB3;SKP2;PSMD14;SEM1;PSMC6;RPA3;CDC26;UBC;PSMC1;CCNA1;MCM6;PSME2;PSMB11;PSME4;RBX1;FEN1;PSMD6;PSMB6;CUL1;MCM7;POLD3;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;MCM4;PSMA1;POLA1;ORC5;PSMC3
gsea,Chaperonin-mediated Protein Folding R-HSA-390466,-0.5170977753010239,-2.136979327801058,0.0,0.0003366456579229674,0.019,30/77,18.87%,TUBA1A;GNG3;TUBB2A;GNB2;TUBA4A;AP3M1;GNAQ;NOP56;LONP2;CCT7;FBXL5;PFDN5;FBXW7;TCP1;PFDN6;XRN2;CCT5;GNG11;TUBB4B;CCT8;GNG10;TUBA1B;CSNK2B;FBXW2;VBP1;CCT6A;HDAC3;GNG7;SKIC2;GNB5
gsea,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.5719032727349236,-2.136694657413226,0.0,0.0003481497361613422,0.02,17/47,16.11%,CALM1;YWHAH;YWHAZ;YWHAE;VAMP2;YWHAB;MYO5A;RALGAPB;KIF3A;KIFAP3;RAB14;AKT1;PRKAG2;EXOC3;EXOC1;RALA;EXOC2
gsea,Potential Therapeutics For SARS R-HSA-9679191,-0.505499062722541,-2.1347480344301113,0.0,0.0003733159885181478,0.021,36/83,25.79%,HSP90AA1;ATP1B1;ATP1A2;HSP90AB1;S1PR1;AP2M1;ROCK2;ATP1B2;SOS1;ARID4B;HDAC1;ROCK1;PHF21A;COMT;CUL3;FURIN;PTGES3;FXYD1;RBX1;MTA3;SH3KBP1;BRMS1L;ITGA4;CHD4;CRBN;IL1R1;VEGFA;TYK2;FXYD7;KDM1A;SAP18;RBBP7;NCK1;CHD3;FXYD2;HDAC2
gsea,Apoptosis R-HSA-109581,-0.4586776680883813,-2.133829671403606,0.0,0.0003706683573939056,0.021,69/154,26.43%,UBB;DYNLL1;YWHAH;RPS27A;YWHAZ;YWHAE;PPP3R1;MAGED1;PTK2;YWHAB;PSMD2;DYNLL2;PKN2;CYCS;DNM1L;PSMA4;BIRC2;PSMC2;ROCK1;PSMB3;PSMD14;NMT1;SEM1;PSMC6;UACA;NDUFA2;AKT1;APPL1;UBC;DAPK1;MAPK1;PSMC1;PSME2;PSMB11;PSME4;ACIN1;BCL2L1;BAK1;MAPK3;PSMD6;PSMB6;HMGB1;CASP3;MAPK8;PSMA7;UNC5A;PSMB2;CTNNB1;PSMA2;APIP;PSMC5;TJP1;DSG2;PRKCD;MED12;C1QBP;PSMA1;YWHAG;PSMC3;DIABLO;TFDP2;HMGB2;PPP1R13B;APAF1;REXO2;CASP9;UBA52;PSME3;BBC3
gsea,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.5166119338684586,-2.132299324277655,0.0,0.00036805801684887813,0.021,22/75,14.88%,HSP90AA1;DYNLL1;TUBA1A;YWHAE;AKAP9;TUBA4A;CEP290;PPP2R1A;PCM1;ODF2;CETN2;CEP43;PLK4;PRKAR2B;CKAP5;SFI1;MZT1;SDCCAG8;TUBB4B;ACTR1A;CEP192;HAUS3
gsea,RNA Polymerase I Promoter Escape R-HSA-73772,-0.5875269210101982,-2.1319017720394573,0.0,0.00036548418456322165,0.021,16/37,15.87%,TAF1D;H2AZ1;POLR2E;TBP;POLR1F;UBTF;CCNH;MNAT1;CBX3;RRN3;GTF2H5;POLR2K;POLR1H;GTF2H1;CDK7;ERCC3
gsea,Opioid Signaling R-HSA-111885,-0.5048225513094745,-2.130324646293456,0.0,0.00037638854809442885,0.022,41/81,26.27%,CALM1;PPP3CA;PPP3CB;CAMK2B;PPP3R1;GNG3;GNB2;CAMKK1;PRKAR1A;ADCY9;GNAQ;GNAL;PPP2R1A;PLCB1;CAMK2A;PRKAR2B;PPP1CA;ADCY1;PRKACB;CDK5;GNG11;MAPK1;GNG10;GRK2;ADCY2;PPP1R1B;PDE1B;GNG7;ADCY5;GNB5;PRKCD;PLCB3;AHCYL1;PPP2CA;CAMK2G;PRKAR2A;PLCB2;PPP2R5D;GNG2;NBEA;ADCY6
gsea,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.513346677568134,-2.1273145679341936,0.0,0.0003871425066114125,0.022,26/65,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5
gsea,Programmed Cell Death R-HSA-5357801,-0.44277841702172366,-2.126308837999061,0.0,0.00039774915062816356,0.022,70/179,24.51%,HSP90AA1;UBB;DYNLL1;YWHAH;RPS27A;YWHAZ;YWHAE;PPP3R1;MAGED1;PTK2;YWHAB;PSMD2;DYNLL2;GNL3;PKN2;CYCS;DNM1L;CHMP2A;PSMA4;BIRC2;PSMC2;ROCK1;PSMB3;PSMD14;PELI1;NMT1;SEM1;PSMC6;UACA;NDUFA2;AKT1;APPL1;UBC;DAPK1;MAPK1;PSMC1;PSME2;PSMB11;PSME4;ACIN1;BCL2L1;BAK1;MAPK3;PSMD6;PSMB6;HMGB1;CHMP2B;CASP3;MAPK8;PSMA7;UNC5A;PSMB2;CTNNB1;PSMA2;APIP;PSMC5;TJP1;DSG2;PRKCD;MED12;C1QBP;PSMA1;YWHAG;PSMC3;DIABLO;TFDP2;HMGB2;PPP1R13B;APAF1;REXO2
gsea,MAP Kinase Activation R-HSA-450294,-0.5362375185529942,-2.125189337374685,0.0,0.0003950433740932781,0.022,33/59,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;IRAK1;JUN;MAP2K6;FBXW11;UBC;MAPK1;NFKB1;MAPK3;IRAK2;CUL1;TAB3;MAPK8;CHUK;IKBKG;MAP3K8;MAPK10;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,Transcription Of HIV Genome R-HSA-167172,-0.5143153158411969,-2.124621550306662,0.0,0.0003923741621061613,0.022,41/64,33.76%,CCNT2;ELOC;ELOB;POLR2G;CDK9;POLR2E;TBP;TAF11;TCEA1;CCNH;MNAT1;RNMT;GTF2F1;GTF2H5;POLR2K;GTF2H1;SSRP1;CDK7;POLR2A;ERCC3;NELFB;TAF1;POLR2L;POLR2D;TAF10;POLR2B;TAF5;RNGTT;GTF2A1;TAF7L;CCNK;TAF15;POLR2C;NCBP2;GTF2A2;POLR2H;TAF2;GTF2B;TAF3;GTF2E1;TAF7
gsea,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.49107796245084173,-2.1230989563381995,0.0,0.0003897407784678649,0.022,31/81,21.58%,UBB;RPS27A;SKP1;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;SKP2;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;CCNA1;PSME2;PSMB11;PSME4;RB1;PSMD6;PSMB6;CUL1;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1
gsea,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.5474256197929429,-2.121921189960307,0.0,0.000400047256831793,0.023,22/50,19.23%,UBB;RPS27A;PSMD2;PSMA4;CDK4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;CCND1;PSMB2;PSMA2;PSMC5
gsea,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.49852482534298304,-2.118558106256869,0.0,0.00044867509044368997,0.025,45/74,33.76%,CCNT2;ELOC;ELOB;POLR2G;CDK9;IWS1;POLR2E;TBP;TAF11;TCEA1;CCNH;MNAT1;GTF2F1;RTF1;MLLT3;GTF2H5;POLR2K;GTF2H1;CTR9;SSRP1;CDK7;POLR2A;ERCC3;NELFB;TAF1;POLR2L;POLR2D;TAF10;POLR2B;TAF5;GTF2A1;TAF7L;CCNK;CDC73;TAF15;POLR2C;NCBP2;GTF2A2;POLR2H;TAF2;GTF2B;TAF3;LEO1;GTF2E1;TAF7
gsea,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.4132979084984321,-2.117160401614845,0.0,0.0004457232806381394,0.025,147/383,26.34%,HSP90AA1;CALM1;UBB;RPS27A;TPR;RPS6;CAMK2B;MAML2;SKP1;NPM1;NF1;BRAF;AKAP9;QKI;GOLGB1;YWHAB;ERBIN;PSMD2;KIF5B;HDAC8;PRKAR1A;ERLEC1;POLR2G;PPP2R1A;NRG2;TNKS;PSMA4;SOS1;CAMK2A;TRIP11;RANBP2;BIRC6;TFG;CPSF6;KAT2B;HDAC1;POLR2E;SPTBN1;CLTC;VCL;PSMC2;CEP43;FBXW7;CEBPB;PSMB3;GCC2;ZMYM2;RICTOR;SEL1L;FAM114A2;PSMD14;HEY1;PEBP1;SEM1;CTBP2;RNMT;PSMC6;LMO7;AP3B1;SMAD4;AKT1;SYVN1;EEF1G;CTBP1;FIP1L1;GTF2F1;FXR1;RPS6KB2;UBC;ZFYVE9;APH1B;NCOR1;MAPK1;PSMC1;TGFA;CDKN1B;SMAD3;PSME2;PSMB11;PSME4;RBX1;BCL2L1;POLR2K;BAG4;MIB1;MAPK3;PSMD6;PSMB6;CUL1;RAP1A;CSNK1A1;KANK1;LRP6;POLR2A;RNF213;SPRED3;SQSTM1;FGFR1;MAML3;PSMA7;PDGFRA;CREBBP;HDAC3;ERLIN2;CHUK;CDK8;PSMB2;HEY2;CTNNB1;PPP1CB;AGGF1;PSMA2;MTOR;DERL2;PSMC5;KDM7A;POLR2L;POLR2D;JAG2;PPM1B;HRAS;RRBP1;PSMA1;DUSP6;PPP2CA;DUSP10;PSENEN;FGFR3;PTPN12;POLR2B;CAMK2G;PSMC3;HES5;AGK;PIK3R3;IQGAP1;MECP2;TBL1XR1;PPFIBP1;DUSP7;TCF7L2;PPP2R5D;CASP9;HDAC2;MYH9;UBA52;PSME3
gsea,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.6725797273435885,-2.1154007874525473,0.0,0.00046811348838634843,0.026,9/21,10.83%,UBB;RPS27A;TOMM6;TOMM22;TOMM7;TOMM20;TOMM5;MAP1LC3A;UBC
gsea,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.46266562513017356,-2.113620045561183,0.0,0.00047764335231278174,0.026,46/124,21.76%,CALM1;UBB;PPP3CA;RPS27A;PPP3CB;SKP1;PPP3R1;PSMD2;PKN2;MAP2K7;UBE2N;PSMA4;SOS1;JUN;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;RASGRP1;UBC;MAPK1;PSMC1;NFKB1;PSME2;PSMB11;PSME4;MAPK3;PSMD6;PSMB6;CUL1;TAB3;MAPK8;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5;MAPK10;VAV3;SPNS1;HRAS;PSMA1;AHCYL1
gsea,Ion Homeostasis R-HSA-5578775,-0.5763811888381278,-2.1133795646491222,0.0,0.0004745617822978606,0.026,18/43,22.80%,ATP1B1;ATP1A2;CALM1;CAMK2B;RYR2;ATP1B2;CAMK2A;ATP2B1;ATP2B4;FXYD1;TRDN;ATP2A2;TRPC1;FKBP1B;ORAI2;AHCYL1;FXYD7;CAMK2G
gsea,RNA Polymerase I Promoter Clearance R-HSA-73854,-0.5391182737790955,-2.1109064832245386,0.0,0.0004685164092749578,0.026,28/54,25.79%,TAF1D;H2AZ1;KAT2B;HDAC1;POLR2E;TBP;POLR1F;UBTF;CCNH;MNAT1;CBX3;MTA3;RRN3;GTF2H5;POLR2K;MAPK3;POLR1H;GTF2H1;TTF1;CDK7;ERCC3;CHD4;POLR2L;RBBP7;H2AJ;CHD3;H2BC4;HDAC2
gsea,RNA Polymerase I Transcription R-HSA-73864,-0.5391182737790955,-2.1109064832245386,0.0,0.0004685164092749578,0.026,28/54,25.79%,TAF1D;H2AZ1;KAT2B;HDAC1;POLR2E;TBP;POLR1F;UBTF;CCNH;MNAT1;CBX3;MTA3;RRN3;GTF2H5;POLR2K;MAPK3;POLR1H;GTF2H1;TTF1;CDK7;ERCC3;CHD4;POLR2L;RBBP7;H2AJ;CHD3;H2BC4;HDAC2
gsea,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.5448065212707883,-2.110341353605025,0.0,0.0004655511155453696,0.026,21/49,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Separation Of Sister Chromatids R-HSA-2467813,-0.44719358612111765,-2.1086113947571747,0.0,0.00047479741376871347,0.027,58/154,26.34%,UBB;DYNLL1;RPS27;RPS27A;PDS5B;TAOK1;PSMD2;DYNLL2;HDAC8;PDS5A;PPP2R1A;PSMA4;SMC1A;RANBP2;ANAPC4;PSMC2;AHCTF1;UBE2E1;CKAP5;PSMB3;XPO1;PSMD14;SEM1;ITGB3BP;PSMC6;CDC26;KIF2A;UBC;PSMC1;NUP98;PSME2;CENPE;PSMB11;RCC2;PSME4;WAPL;PSMD6;PSMB6;KANSL1;PSMA7;ANAPC1;PSMB2;PSMA2;ZWINT;NUP37;PSMC5;PSMA1;PPP2CA;SEH1L;PSMC3;DYNC1I2;CENPF;CENPT;ANAPC16;PPP2R5D;SEC13;UBA52;PSME3
gsea,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.5076376737196534,-2.108109414176397,0.0,0.0004839281332642657,0.028,20/59,17.18%,RPS7;RPS6;RPS9;NOP10;NOP58;NOP56;THUMPD1;RPS2;UTP3;UTP11;KRR1;DKC1;SNU13;RPS14;NOP14;UTP20;TRMT112;DCAF13;RRP36;NOC4L
gsea,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.48464724395088776,-2.1072343956362514,0.0,0.000480922368461382,0.028,39/97,21.58%,UBB;RPS27A;SKP1;MAFG;PSMD2;PSMA4;PCDHB16;PSMC2;PSMB3;SKP2;PSMD14;UBL4A;SEM1;PSMC6;CUL3;SLC7A11;AKT1;SRXN1;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;CUL1;CSNK2B;SQSTM1;PSMA7;CREBBP;PRDX1;ATF4;PSMB2;PSMA2;PSMC5;PRKCD;PHGDH;PSMA1
gsea,HSF1-dependent Transactivation R-HSA-3371571,-0.615232491333809,-2.105250150151615,0.0,0.0005018513974592384,0.03,16/30,22.80%,HSP90AA1;UBB;HSPA8;HSP90AB1;CAMK2B;CAMK2A;CRYAB;HSBP1;PTGES3;HSPA2;HSF1;DNAJB6;CREBBP;MTOR;HSPH1;CAMK2G
gsea,Gene Silencing By RNA R-HSA-211000,-0.4958292254666958,-2.1046349608468304,0.0,0.0005106480915426608,0.031,42/77,32.66%,HSP90AA1;TPR;H2AZ1;POLR2G;TNRC6A;AGO3;RANBP2;TNRC6C;POLR2E;AGO4;TSN;NUP98;NUP88;RAN;POLR2K;NUP153;NUP155;TSNAX;POLR2A;IPO8;HENMT1;NDC1;NUP37;NUP54;POLR2L;POLR2D;SEH1L;POLR2B;PRKRA;H2AJ;MYBL1;DICER1;H2BC4;SEC13;POLR2C;MOV10L1;TDRKH;POLR2H;BCDIN3D;NUP93;PIWIL2;NUP205
gsea,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.63112726014273,-2.1043254518459142,0.0,0.0005075343836674006,0.031,10/24,21.20%,HSP90AA1;CALM1;PKN2;RICTOR;AKT1;CAV1;CTNNB1;MTOR;VAV3;TRIB3
gsea,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.5105975338215465,-2.1017701818785413,0.0,0.00050445841770578,0.031,36/69,27.95%,SRSF1;TPR;SRSF2;SRSF7;FYTTD1;THOC2;SRSF5;CDC40;SARNP;RANBP2;ALYREF;SRSF6;SRSF9;SLU7;SRSF11;ZC3H11A;NUP98;NUP88;SRRM1;GLE1;NUP153;U2AF1;NUP155;RNPS1;DHX38;NDC1;NUP37;NUP54;SEH1L;SRSF4;SRSF3;SEC13;THOC1;UPF3B;THOC7;THOC5
gsea,Platelet Degranulation R-HSA-114608,-0.4755415477497259,-2.1014685121631307,0.0,0.0005014195115750223,0.031,21/94,8.26%,TMSB4X;CALM1;PPIA;PFN1;TUBA4A;CDC37L1;TGFB3;CLU;SELENOP;SOS1;HSPA5;MANF;RAB27B;CD9;TMX3;VCL;SERPING1;GTPBP2;CAP1;ABCC4;CYRIB
gsea,Transmission Across Chemical Synapses R-HSA-112315,-0.4496610586942869,-2.099291030521275,0.0,0.0005100080925419805,0.032,58/210,12.30%,NRGN;CALM1;SLC1A3;GRIA2;HSPA8;CAMK2B;TSPAN7;VAMP2;NEFL;GNG3;RAB3A;AP2M1;GNB2;SNAP25;CACNA2D2;EPB41L1;CAMKK1;PRKAR1A;GRIA3;ADCY9;GNAL;PLCB1;ARL6IP5;NSF;CAMK2A;SLC1A2;PPFIA2;SLC17A7;GLUL;LIN7B;PRKAR2B;ADCY1;CACNA1E;GABRA3;AKAP5;COMT;GABRG2;PRKACB;GAD1;ARHGEF9;GABRA1;PPM1F;PPM1E;KCNJ4;SLC32A1;LIN7C;SYN2;GAD2;GABRB3;PRKAG2;GNG11;GLRB;MAPK1;GNG10;KCNJ10;GABBR2;GABRA4;GABRB2
gsea,PTEN Regulation R-HSA-6807070,-0.4573220344168028,-2.0979602853199326,0.0,0.0005300165269084814,0.034,60/132,26.34%,UBB;RPS27A;CBX6;PSMD2;SCMH1;TNKS;PSMA4;TNRC6A;AGO3;JUN;TNRC6C;HDAC1;PSMC2;NEDD4;PSMB3;PSMD14;LAMTOR3;SEM1;PSMC6;SNAI2;AKT1;AGO4;UBC;MAPK1;PSMC1;PSME2;PSMB11;PSME4;MTA3;PREX2;CNOT6L;MAPK3;PSMD6;PSMB6;CSNK2B;PSMA7;HDAC3;RRAGB;CHD4;PSMB2;PSMA2;MTOR;PSMC5;LAMTOR5;LAMTOR1;RRAGA;PSMA1;MECOM;USP13;VAPA;KDM1A;PHC3;PSMC3;RBBP7;LAMTOR4;LAMTOR2;CHD3;HDAC2;UBA52;PSME3
gsea,Interleukin-17 Signaling R-HSA-448424,-0.5171105177004433,-2.097015340144365,0.0,0.0005268803344415673,0.034,33/63,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;IRAK1;JUN;MAP2K6;FBXW11;UBC;MAPK1;NFKB1;MAPK3;IRAK2;CUL1;TAB3;MAPK8;CHUK;IKBKG;MAP3K8;MAPK10;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.5294428971047666,-2.096227003634799,0.0,0.0005237810383566169,0.034,25/54,22.74%,CCNT2;ELOC;ELOB;POLR2G;CDK9;JUN;POLR2E;TCEA1;CCNH;MNAT1;GTF2F1;GTF2H5;POLR2K;GTF2H1;SSRP1;CDK7;MDC1;POLR2A;ERCC3;CDK13;NELFB;POLR2L;POLR2D;MSH2;POLR2B
gsea,Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.6766323327298625,-2.0927482650937552,0.0,0.0005773177730170187,0.036,8/22,5.34%,SLC1A3;VAMP2;RAB3A;SNAP25;ARL6IP5;SLC1A2;PPFIA2;SLC17A7
gsea,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.4866085234267905,-2.0910903462622956,0.0,0.0005852154169707399,0.037,36/83,26.34%,UBB;ORC4;RPS27A;H2AZ1;PSMD2;PSMA4;ANAPC4;ORC6;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;MCM6;PSME2;PSMD6;PSMB6;MCM7;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;MCM4;PSMA1;ORC5;PSMC3;H2AJ;ANAPC16;H2BC4;UBA52;PSME3
gsea,G2/M Checkpoints R-HSA-69481,-0.4575999799338478,-2.0909893074820496,0.0,0.0005818326688957645,0.037,48/123,26.34%,UBB;ORC4;YWHAH;RPS27A;YWHAZ;YWHAE;YWHAB;PSMD2;UBE2N;PSMA4;ORC6;PSMC2;HERC2;PSMB3;PSMD14;SEM1;PSMC6;RPA3;BLM;BRCC3;UBC;PSMC1;MCM6;PSME2;PSMB11;PSME4;PSMD6;PSMB6;RAD17;MCM7;MDC1;PSMA7;PSMB2;PSMA2;PSMC5;WRN;MCM4;PSMA1;YWHAG;ORC5;TOPBP1;BABAM2;PSMC3;NSD2;REXO2;H2BC4;UBA52;PSME3
gsea,mRNA Capping R-HSA-72086,-0.6074593138060119,-2.0909237211769724,0.0,0.0005784888029825705,0.037,19/28,30.63%,POLR2G;POLR2E;CCNH;MNAT1;RNMT;GTF2F1;GTF2H5;POLR2K;GTF2H1;CDK7;POLR2A;ERCC3;POLR2L;POLR2D;POLR2B;RNGTT;POLR2C;NCBP2;POLR2H
gsea,Signaling By FGFR2 R-HSA-5654738,-0.5088310713842159,-2.0892871303764387,0.0,0.0005973055816290365,0.038,23/62,22.74%,UBB;HNRNPH1;RPS27A;TIA1;BRAF;HNRNPA1;POLR2G;TIAL1;PPP2R1A;HNRNPM;SOS1;POLR2E;GTF2F1;UBC;MAPK1;POLR2K;MAPK3;POLR2A;POLR2L;POLR2D;HRAS;PPP2CA;POLR2B
gsea,Mitotic Prometaphase R-HSA-68877,-0.43653709552056363,-2.088800563329888,0.0,0.0005939117999152352,0.038,55/166,23.81%,HSP90AA1;DYNLL1;RPS27;TUBA1A;YWHAE;PDS5B;AKAP9;TUBA4A;TAOK1;DYNLL2;HDAC8;PDS5A;CEP290;PPP2R1A;PCM1;SMC1A;RANBP2;ODF2;CETN2;CEP43;AHCTF1;PLK4;PRKAR2B;CKAP5;XPO1;ITGB3BP;SFI1;MZT1;SDCCAG8;KIF2A;TUBB4B;NUP98;CENPE;RCC2;ACTR1A;WAPL;CEP192;CSNK2B;HAUS3;KANSL1;DCTN3;ZWINT;NUP37;OFD1;NCAPD2;NME7;NEK7;YWHAG;RAB33B;PPP2CA;SEH1L;CEP135;DYNC1I2;CENPF;CENPT
gsea,Cilium Assembly R-HSA-5617833,-0.44254737778259073,-2.0885485587392134,0.0,0.000590556366017409,0.038,61/177,23.56%,HSP90AA1;DYNLL1;TUBA1A;YWHAE;TTBK2;AKAP9;TUBA4A;DYNLL2;AHI1;KIF3A;KIFAP3;CEP290;PPP2R1A;PCM1;DYNC2H1;IQCB1;TRIP11;ODF2;CEP83;CETN2;CEP43;CEP162;PLK4;PRKAR2B;TTC30B;TCP1;CKAP5;IFT43;CCT5;SFI1;TTC8;LZTFL1;SDCCAG8;ARF4;TUBB4B;CCT8;EXOC3;NUDT19;ACTR1A;EXOC1;DYNLRB1;CEP192;B9D1;HAUS3;DYNLT2B;EXOC2;ARL3;BBS7;DCTN3;TMEM216;BBS5;EXOC6;OFD1;YWHAG;BBIP1;IFT20;CEP135;TTC21B;DYNC1I2;CCT2;IFT46
gsea,Neurotransmitter Release Cycle R-HSA-112310,-0.5562929914599799,-2.087471968060513,0.0,0.0005872386336240527,0.038,15/45,10.60%,SLC1A3;HSPA8;VAMP2;RAB3A;SNAP25;ARL6IP5;SLC1A2;PPFIA2;SLC17A7;LIN7B;GAD1;SLC32A1;LIN7C;SYN2;GAD2
gsea,Autophagy R-HSA-9612973,-0.46723423078374005,-2.083889747289327,0.0,0.0006055860438614274,0.039,55/122,28.57%,HSP90AA1;UBB;EEF1A1;DYNLL1;RPS27A;HSPA8;HSP90AB1;TOMM6;TOMM22;DYNLL2;TOMM7;TOMM20;CHMP2A;UBE2N;GABARAP;TOMM5;MAP1LC3A;VPS28;AMBRA1;LAMTOR3;GABARAPL2;WDR45;UBC;PRKAG2;PIK3C3;TSG101;UVRAG;CSNK2B;RB1CC1;CHMP2B;HSF1;SQSTM1;ATG9A;RRAGB;ATG16L1;ATG4D;MTOR;LAMTOR5;FUNDC1;LAMTOR1;RRAGA;PLIN2;DYNC1I2;LAMTOR4;LAMTOR2;ATG12;MFN1;ATG101;VPS37D;UBA52;ATG14;GFAP;PEX5;TOMM40;EPAS1
gsea,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.44344074797778443,-2.0828553687147195,0.0,0.0006237295939850535,0.041,50/134,23.92%,UBB;ORC4;RPS27A;SKP1;PSMD2;PPP2R1A;PSMA4;ORC6;HDAC1;CDK4;PSMC2;PCNA;PSMB3;SKP2;PSMD14;CCNH;MNAT1;SEM1;PSMC6;RPA3;AKT1;UBC;LIN52;PSMC1;CCNA1;MCM6;CDKN1B;PSME2;LIN54;RB1;PSMD6;PSMB6;CUL1;MCM7;CDK7;PSMA7;CCND1;PSMB2;PSMA2;PSMC5;CCNA2;MCM4;PSMA1;POLA1;PPP2CA;ORC5;PSMC3;TFDP2;RBL2;CDKN2D
gsea,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.5422249927836542,-2.079616210138014,0.0,0.0006523672072733747,0.042,21/46,18.53%,UBB;RPS27A;MAML2;SKP1;HIF1A;HDAC8;KAT2B;HDAC1;TLE4;FBXW7;HEY1;UBC;NCOR1;RBX1;CUL1;MAML3;CREBBP;HDAC3;CDK8;HEY2;TLE1
gsea,Regulation Of Apoptosis R-HSA-169911,-0.5294776159488476,-2.078023044307079,0.0,0.0006487827720685759,0.042,23/51,21.58%,UBB;RPS27A;PSMD2;PKN2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5;MED12;PSMA1
gsea,C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.4665294645096491,-2.0779742156519645,0.0,0.0006452375110190208,0.042,39/108,21.76%,CALM1;UBB;PPP3CA;RPS27A;PPP3CB;SKP1;PPP3R1;PSMD2;PKN2;UBE2N;PSMA4;PSMC2;PSMB3;PRKACB;PSMD14;SEM1;PSMC6;FBXW11;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;TAB3;PSMA7;CREBBP;CHUK;PSMB2;PSMA2;IKBKG;PSMC5;PRKCD;HRAS;PSMA1;AHCYL1
gsea,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.4882746881853154,-2.0772485716991893,0.0,0.0006522509622257493,0.043,33/76,26.34%,UBB;RPS27A;SKP1;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;CCNA1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1;PSMC3;ANAPC16;UBA52;PSME3
gsea,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.4886820779679827,-2.07569522651624,0.0,0.0006487252813488535,0.043,29/75,19.23%,UBB;RPS27A;SKP1;PSMD2;UBE2N;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;RASGRP1;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;TAB3;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5
gsea,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.49835099084719553,-2.0706829457054474,0.0,0.000676458680907038,0.046,30/70,23.80%,UBB;HSPA8;TPR;HSPA4L;YWHAE;HSPA9;RANBP2;HSPA5;HSPA4;HSBP1;CCAR2;RPA3;MAPK1;NUP98;NUP88;BAG4;NUP153;MAPK3;NUP155;HSPA2;HSF1;DNAJB6;NDC1;NUP37;NUP54;BAG1;HSPH1;SEH1L;HIKESHI;HSPA12B
gsea,Calnexin/calreticulin Cycle R-HSA-901042,-0.6157987820700366,-2.070242191604396,0.0,0.0006728412548059309,0.046,13/26,19.71%,UBB;RPS27A;CANX;SEL1L;SYVN1;GANAB;UBC;AMFR;MARCHF6;RNF5;DERL2;UGGT2;CALR
gsea,ABC Transporter Disorders R-HSA-5619084,-0.4913286021078402,-2.0700104889658615,0.0,0.0006692623119612186,0.046,27/72,19.23%,UBB;RPS27A;PSMD2;ERLEC1;PSMA4;ABCA1;PSMC2;LMBRD1;PSMB3;SEL1L;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;RNF5;PSMA7;ERLIN2;PSMB2;PSMA2;DERL2;PSMC5
gsea,Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.5008555478503605,-2.0692777198537793,0.0,0.0006759631067818313,0.046,28/66,23.30%,UBB;RPS27A;PSMD2;TNKS;PSMA4;PSMC2;NEDD4;PSMB3;PSMD14;SEM1;PSMC6;AKT1;UBC;PSMC1;PSME2;PSMB11;PSME4;PREX2;PSMD6;PSMB6;CSNK2B;PSMA7;PSMB2;PSMA2;PSMC5;PSMA1;USP13;PSMC3
gsea,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.5279906205614668,-2.0685850183155194,0.0,0.0006724054062198217,0.046,21/53,16.37%,TPR;RPS6;SKP1;NPM1;KIF5B;PRKAR1A;RANBP2;BIRC6;TFG;CLTC;VCL;CEBPB;GCC2;LMO7;EEF1G;MAPK1;RBX1;MAPK3;CUL1;RNF213;SQSTM1
gsea,DNA Replication R-HSA-69306,-0.4454807692616411,-2.0681419784971777,0.0,0.0006790195796587601,0.047,49/127,26.34%,UBB;ORC4;RPS27A;SKP1;H2AZ1;PSMD2;PSMA4;ANAPC4;ORC6;PSMC2;PCNA;UBE2E1;PSMB3;SKP2;PSMD14;SEM1;PSMC6;RPA3;CDC26;UBC;PSMC1;CCNA1;MCM6;PSME2;PSMB11;PSME4;RBX1;FEN1;PSMD6;PSMB6;CUL1;MCM7;POLD3;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;MCM4;PSMA1;POLA1;ORC5;PSMC3;H2AJ;ANAPC16;H2BC4;UBA52;PSME3
gsea,Oncogene Induced Senescence R-HSA-2559585,-0.5977484374034073,-2.067935007796682,0.0,0.0006754830193480374,0.047,11/29,14.10%,UBB;RPS27A;TNRC6A;AGO3;TNRC6C;CDK4;AGO4;UBC;MAPK1;RB1;MAPK3
gsea,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.49397829614220545,-2.0647356763381826,0.0,0.00072213110041507,0.051,26/69,19.23%,UBB;RPS27A;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;SKP2;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;PSME2;PSMB11;PSME4;RB1;PSMD6;PSMB6;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5
gsea,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.46244427152558637,-2.0634891375053606,0.0,0.0007283866748101318,0.052,21/98,8.26%,TMSB4X;CALM1;PPIA;PFN1;TUBA4A;CDC37L1;TGFB3;CLU;SELENOP;SOS1;HSPA5;MANF;RAB27B;CD9;TMX3;VCL;SERPING1;GTPBP2;CAP1;ABCC4;CYRIB
gsea,Macroautophagy R-HSA-1632852,-0.4671236482009487,-2.063029119096543,0.0,0.0007345780894678083,0.053,44/109,24.89%,HSP90AA1;UBB;DYNLL1;RPS27A;HSPA8;TOMM6;TOMM22;DYNLL2;TOMM7;TOMM20;CHMP2A;UBE2N;GABARAP;TOMM5;MAP1LC3A;AMBRA1;LAMTOR3;GABARAPL2;WDR45;UBC;PRKAG2;PIK3C3;UVRAG;CSNK2B;RB1CC1;CHMP2B;HSF1;SQSTM1;ATG9A;RRAGB;ATG16L1;ATG4D;MTOR;LAMTOR5;FUNDC1;LAMTOR1;RRAGA;PLIN2;DYNC1I2;LAMTOR4;LAMTOR2;ATG12;MFN1;ATG101
gsea,Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.45368769609079806,-2.0622304157196103,0.0,0.0007308302420725645,0.053,46/133,19.23%,CALM1;UBB;PPP3CA;RPS27A;PPP3CB;PFN1;PPP3R1;GNG3;AP2M1;GNB2;PSMD2;PSMA4;PLCB1;TNRC6A;AGO3;CAMK2A;TNRC6C;FZD2;CLTC;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;AGO4;UBC;GNG11;PSMC1;GNG10;PSME2;PSMB11;PSME4;RYK;GNAO1;PSMD6;PSMB6;FZD1;PSMA7;GNG7;CLTA;PSMB2;CTNNB1;PSMA2;WNT4;GNB5;PSMC5
gsea,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.42382982222184895,-2.061391986677668,0.0,0.0007467723477783592,0.053,76/205,26.74%,UBB;DYNLL1;RPS27;RPS27A;TUBA1A;PDS5B;TUBB2A;TUBA4A;TAOK1;PSMD2;DYNLL2;HDAC8;CHMP2A;PDS5A;PPP2R1A;PSMA4;SMC1A;RANBP2;ANAPC4;PSMC2;AHCTF1;UBE2E1;CKAP5;PSMB3;XPO1;PSMD14;BANF1;SEM1;ITGB3BP;PSMC6;VPS4A;CDC26;KIF2A;UBC;TUBB4B;PSMC1;NUP98;PSME2;CENPE;PSMB11;RCC2;PSME4;RAN;TUBA1B;VRK1;WAPL;PSMD6;NUP155;PSMB6;CHMP2B;KANSL1;PSMA7;ANAPC1;PSMB2;PSMA2;ZWINT;NDC1;NUP37;PSMC5;NUP54;UBE2I;PSMA1;PPP2CA;SEH1L;PSMC3;DYNC1I2;CENPF;CENPT;ANAPC16;TNPO1;PPP2R5D;SEC13;TMPO;UBA52;PSME3;TUBB4A
gsea,Cell Cycle Checkpoints R-HSA-69620,-0.41267255537873,-2.0611552511840507,0.0,0.0007430007702643271,0.053,80/230,26.34%,UBB;DYNLL1;RPS27;ORC4;YWHAH;RPS27A;YWHAZ;YWHAE;YWHAB;TAOK1;PSMD2;DYNLL2;UBE2N;PPP2R1A;PSMA4;RANBP2;ANAPC4;ORC6;PSMC2;AHCTF1;UBE2E1;CKAP5;HERC2;PSMB3;XPO1;PSMD14;SEM1;ITGB3BP;PSMC6;RPA3;BLM;CDC26;BRCC3;KIF2A;UBC;PSMC1;CCNA1;NUP98;MCM6;CDKN1B;PSME2;CENPE;PSMB11;RCC2;PSME4;PSMD6;PSMB6;RAD17;MCM7;MDC1;KANSL1;PSMA7;ANAPC1;PSMB2;PSMA2;ZWINT;NUP37;PSMC5;WRN;CCNA2;MCM4;PSMA1;YWHAG;PPP2CA;SEH1L;ORC5;TOPBP1;BABAM2;PSMC3;DYNC1I2;CENPF;NSD2;CENPT;REXO2;ANAPC16;H2BC4;PPP2R5D;SEC13;UBA52;PSME3
gsea,Oxidative Stress Induced Senescence R-HSA-2559580,-0.507133988997169,-2.060655869201244,0.0,0.0007392670980519436,0.053,32/66,28.40%,UBB;RPS27A;CBX6;H2AZ1;MAP2K7;TNIK;SCMH1;TNRC6A;AGO3;JUN;TNRC6C;CDK4;MAP2K6;AGO4;UBC;MAPK1;MAPK3;MINK1;KDM6B;MAPK8;MAPK10;PHC3;MAPK9;TFDP2;RBBP7;H2AJ;CDKN2D;MAPK11;H2BC4;UBA52;CBX8;E2F3
gsea,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.39861943170462105,-2.0588966987446065,0.0,0.0007742850132228251,0.055,142/443,22.74%,HSP90AA1;CALM1;UBB;HNRNPH1;RPS27A;CDK5R1;APOE;ATP6V0C;ATP6V1D;MEF2A;STMN1;CYFIP1;TIA1;PRKCE;ATP6V1G1;AP2M1;BRAF;HNRNPA1;PTK2;YWHAB;HIF1A;ERBIN;BCL11B;PTK2B;JUND;NCKAP1;PGR;PKN2;BAIAP2;ATP6V0E2;POLR2G;TIAL1;ROCK2;PPP2R1A;NRG2;HNRNPM;DOCK3;SH3GL1;SOS1;ATP6V1F;F3;IGF1R;PTPRZ1;ATP6V0A2;WWP1;ATP6V1E1;HDAC1;POLR2E;TIAM1;CLTC;USP8;VGF;STAM;ATP6V1H;ROCK1;NEDD4;WASF1;GABRG2;LAMA2;RICTOR;PRKACB;COL4A2;TCF12;CUL5;ATP6V1A;PXDN;RNMT;GABRA1;CDK5;ELMO2;MYCN;FURIN;AKT1;CD274;PTPRJ;GTF2F1;NTRK3;GABRB3;UBC;FLRT3;ID2;APH1B;NCOR1;MAPK1;TGFA;AAMP;GABRB2;NTRK2;SH3KBP1;DOCK7;POLR2K;COL4A1;THBS4;ABI1;PIK3C3;LAMA5;CAV1;LAMA1;MAPK3;PTN;RALA;RAP1A;STAM2;PDE3B;PTPRU;POLR2A;NAB2;FGFR1;NELFB;PDGFRA;YAP1;ID3;HDAC3;CHD4;CLTA;CTNNB1;SPRY1;GRIN2B;MTOR;S100B;ATP6V1G2;ATP6AP1;CXXC1;POLR2L;PRKCD;ADORA2A;EPS15;VAV3;POLR2D;TRIB3;VEGFA;HRAS;LLGL1;DUSP6;DOCK1;AHCYL1;PPP2CA;PSENEN;FGFR3;FLRT1;PTPN12;POLR2B
gsea,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.4937029422941909,-2.0583374900041935,0.0,0.0007762015602852578,0.055,31/68,26.34%,UBB;RPS27A;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;CCNA1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1;PSMC3;ANAPC16;UBA52;PSME3
gsea,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.4937029422941909,-2.0583374900041935,0.0,0.0007762015602852578,0.055,31/68,26.34%,UBB;RPS27A;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;CCNA1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1;PSMC3;ANAPC16;UBA52;PSME3
gsea,Amyloid Fiber Formation R-HSA-977225,-0.5272340144922429,-2.0571780608463155,0.0,0.0007819134369984194,0.056,13/44,11.70%,UBB;CST3;RPS27A;APOE;SORL1;H2AZ1;ITM2B;CALB1;MFGE8;FURIN;UBC;APH1B;USP9X
gsea,Activation Of BH3-only Proteins R-HSA-114452,-0.6234998379359584,-2.0565458724961396,0.0,0.0007780805279935251,0.056,7/25,2.40%,DYNLL1;YWHAH;YWHAZ;YWHAE;PPP3R1;YWHAB;DYNLL2
gsea,Signaling By NOTCH R-HSA-157118,-0.4347578856351923,-2.0554031455908937,0.0,0.000802612513706587,0.058,56/168,18.53%,UBB;RPS27A;YWHAZ;MAML2;SKP1;H2AZ1;HIF1A;PSMD2;CNTN1;HDAC8;PSMA4;TNRC6A;AGO3;JUN;FABP7;TNRC6C;KAT2B;HDAC1;PSMC2;TLE4;FBXW7;PSMB3;SEL1L;PSMD14;HEY1;SEM1;RAB6A;PSMC6;WWC1;FURIN;AKT1;AGO4;PRKCI;UBC;APH1B;NCOR1;PSMC1;SMAD3;PSME2;RBX1;MIB1;ATP2A2;PSMD6;PSMB6;CUL1;TMED2;MAML3;PSMA7;CCND1;CREBBP;HDAC3;CDK8;PSMB2;HEY2;PSMA2;TLE1
gsea,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.6194148782866861,-2.0551217345510873,0.0,0.0007987163364555841,0.058,10/28,9.75%,HSP90AA1;CALM1;HSP90AB1;VAMP2;SNAP25;MAP2K7;CD9;MAP2K6;STX1B;FURIN
gsea,Mitotic Anaphase R-HSA-68882,-0.4248959080026728,-2.0546628518602112,0.0,0.0008042090717048666,0.058,76/204,26.74%,UBB;DYNLL1;RPS27;RPS27A;TUBA1A;PDS5B;TUBB2A;TUBA4A;TAOK1;PSMD2;DYNLL2;HDAC8;CHMP2A;PDS5A;PPP2R1A;PSMA4;SMC1A;RANBP2;ANAPC4;PSMC2;AHCTF1;UBE2E1;CKAP5;PSMB3;XPO1;PSMD14;BANF1;SEM1;ITGB3BP;PSMC6;VPS4A;CDC26;KIF2A;UBC;TUBB4B;PSMC1;NUP98;PSME2;CENPE;PSMB11;RCC2;PSME4;RAN;TUBA1B;VRK1;WAPL;PSMD6;NUP155;PSMB6;CHMP2B;KANSL1;PSMA7;ANAPC1;PSMB2;PSMA2;ZWINT;NDC1;NUP37;PSMC5;NUP54;UBE2I;PSMA1;PPP2CA;SEH1L;PSMC3;DYNC1I2;CENPF;CENPT;ANAPC16;TNPO1;PPP2R5D;SEC13;TMPO;UBA52;PSME3;TUBB4A
gsea,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.5052823227539228,-2.0537039966626063,0.0,0.0008003426819370547,0.058,29/60,26.34%,UBB;RPS27A;PSMD2;ERLEC1;PSMA4;PSMC2;PSMB3;SEL1L;PSMD14;SEM1;PSMC6;SYVN1;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;DERL2;PSMC5;PSMA1;PSMC3;DISP2;UBA52;PSME3
gsea,FGFR2 Alternative Splicing R-HSA-6803529,-0.6232018552551167,-2.0534984712360496,0.0,0.0007965132911143894,0.058,13/25,22.74%,HNRNPH1;TIA1;HNRNPA1;POLR2G;TIAL1;HNRNPM;POLR2E;GTF2F1;POLR2K;POLR2A;POLR2L;POLR2D;POLR2B
gsea,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.5210948153051885,-2.0531172207355723,0.0,0.0008019380494093546,0.059,22/53,16.52%,CCNT2;ELOC;ELOB;POLR2G;CDK9;IWS1;POLR2E;TCEA1;CCNH;MNAT1;GTF2F1;RTF1;MLLT3;GTF2H5;POLR2K;GTF2H1;CTR9;SSRP1;CDK7;POLR2A;ERCC3;NELFB
gsea,Translation Of Structural Proteins R-HSA-9683701,-0.5846807756560493,-2.049146497517953,0.002036659877800407,0.0008440073603850699,0.064,8/29,11.22%,UBB;RPS27A;CANX;PARP6;ST6GAL1;GANAB;UBC;ST6GALNAC2
gsea,P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.47911515315057307,-2.048875099138778,0.0,0.000849156913086353,0.065,38/89,26.33%,UBB;RPS27A;YWHAE;MAGED1;FGD4;SOS1;BEX3;IRAK1;HDAC1;ARHGEF4;TIAM1;OMG;PRPF38B;ARHGEF9;ITGB3BP;ARHGEF12;PRKCI;UBC;PRDM4;APH1B;NFKB1;ABR;RTN4;AATF;PLEKHG5;CASP3;MAPK8;SQSTM1;HDAC3;ARHGEF26;VAV3;PSENEN;ARHGEF2;IKBKB;ITSN1;GNA13;HDAC2;UBA52
gsea,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.529636688533072,-2.0470496942385257,0.0,0.0008451702609122387,0.065,20/48,19.23%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.4860334039761086,-2.0461148142181425,0.0,0.0008412208671696581,0.065,34/71,26.91%,UBB;RPS27A;H2AZ1;PSMD2;PSMA4;PSMC2;PSMB3;TCF12;PSMD14;CCNH;MNAT1;SEM1;PSMC6;CBFB;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CDK7;PSMA7;YAP1;PSMB2;PSMA2;PSMC5;PSMA1;PSMC3;H2AJ;H2BC4;UBA52;PSME3;KMT2A
gsea,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.5904779403987707,-2.0458751112434497,0.004132231404958678,0.0008463115260807623,0.065,9/27,10.83%,HSP90AA1;UBB;RPS27A;ERBIN;NRG2;USP8;CUL5;AKT1;UBC
gsea,Insulin Receptor Recycling R-HSA-77387,-0.6620620510483131,-2.0455610109596125,0.0,0.000851355049261208,0.066,9/20,8.04%,ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0E2;ATP6V1F;ATP6V0A2;ATP6V1E1;ATP6V1H;ATP6V1A
gsea,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.4659194516199804,-2.044004301509525,0.0,0.0008652724226107608,0.067,28/82,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;BIRC2;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;EDARADD;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;TNFRSF12A;TNFRSF1A;PSMA7;CHUK;PSMB2;PSMA2;PSMC5
gsea,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.6524829980494519,-2.043052877233679,0.0,0.0008879415289252581,0.069,11/19,20.48%,UBB;RPS27A;SH3GL1;STAM;RNMT;CBLL1;UBC;SH3KBP1;STAM2;CTNNB1;EPS15
gsea,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.6248235700285034,-2.040355316940399,0.0,0.0009015647414238374,0.071,13/25,16.94%,TUBA1A;TUBB2A;TUBA4A;CCT7;PFDN5;TCP1;PFDN6;CCT5;TUBB4B;CCT8;TUBA1B;VBP1;CCT6A
gsea,Cardiac Conduction R-HSA-5576891,-0.471597979644412,-2.040040715237845,0.0,0.0008974667198719108,0.071,31/99,22.80%,ATP1B1;ATP1A2;CALM1;CAMK2B;SCN2A;AKAP9;CACNA2D2;RYR2;ATP1B2;SCN3B;CAMK2A;ATP2B1;KAT2B;SCN3A;KCNJ4;ATP2B4;KCND3;FXYD1;TRDN;ATP2A2;SCN1A;TRPC1;FKBP1B;ORAI2;KCNIP1;NPPA;AHCYL1;FXYD7;CACNG8;KCNIP2;CAMK2G
gsea,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.4884637903825597,-2.038794113499473,0.0,0.0008934057844878749,0.071,31/70,26.34%,UBB;RPS27A;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;CCNA1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1;PSMC3;ANAPC16;UBA52;PSME3
gsea,Transferrin Endocytosis And Recycling R-HSA-917977,-0.6136579639731329,-2.0378599465343665,0.0,0.0009068202857564618,0.071,9/25,8.04%,ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0E2;ATP6V1F;ATP6V0A2;ATP6V1E1;ATP6V1H;ATP6V1A
gsea,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.5428861109699439,-2.0372244611624506,0.0,0.0009114341523362851,0.071,22/41,24.56%,CCNT2;ELOC;ELOB;POLR2G;CDK9;POLR2E;TCEA1;CCNH;MNAT1;GTF2F1;GTF2H5;POLR2K;GTF2H1;SSRP1;CDK7;POLR2A;ERCC3;NELFB;POLR2L;POLR2D;POLR2B;CCNK
gsea,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.4562137553080338,-2.0358715040876976,0.0,0.0009332899712953695,0.072,42/101,19.23%,UBB;RPS27A;SKP1;GLI3;PSMD2;PSMA4;WWP1;CDK4;PSMC2;SOX9;FBXW7;PSMB3;SKP2;PSMD14;HEY1;SEM1;PSMC6;SMAD4;AKT1;CBFB;UBC;MAPK1;PSMC1;PSME2;PSMB11;PSME4;RBX1;GLI2;RB1;MAPK3;PSMD6;PSMB6;CUL1;PSMA7;YAP1;CCND1;HDAC3;PSMB2;HEY2;PSMA2;RUNX2;PSMC5
gsea,Interleukin-1 Family Signaling R-HSA-446652,-0.4396818757189835,-2.035492050685264,0.0,0.0009291420158673901,0.072,46/129,20.07%,UBB;RPS27A;SKP1;PSMD2;IL1RAPL1;UBE2N;PSMA4;PELI2;IRAK1;PSMC2;PSMB3;MAP2K6;PSMD14;PELI1;IL1RAP;SEM1;PSMC6;USP14;FBXW11;UBC;PSMC1;NFKB1;PTPN4;SMAD3;PSME2;PSMB11;PSME4;RBX1;PSMD6;IRAK2;PSMB6;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;SQSTM1;PSMA7;CHUK;PSMB2;IL1R1;PSMA2;IKBKG;S100B;PSMC5;MAP3K8
gsea,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.46620520879137983,-2.0342974100054514,0.0,0.0009250307680095699,0.072,43/95,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;PELI2;IRAK1;JUN;MAP2K6;EEA1;PELI1;USP14;FBXW11;NDUFA2;UBC;MAPK1;NFKB1;PIK3C3;MAPK3;IRAK2;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;RBSN;IKBKG;S100B;MAP3K8;MAPK10;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.6689504563777369,-2.03382156083045,0.0,0.000920955742599836,0.072,10/18,14.59%,RPS6;SKP1;NPM1;KIF5B;CLTC;CEBPB;MAPK1;RBX1;MAPK3;CUL1
gsea,Degradation Of DVL R-HSA-4641258,-0.5133805956855548,-2.03325013575341,0.0,0.0009254064302772799,0.073,22/54,19.23%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;CUL3;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.49314235204093254,-2.032363775576573,0.0,0.0009298182473199863,0.073,34/76,23.69%,UBB;RPS27A;SKP1;MAFG;PSMD2;PSMA4;PCDHB16;PSMC2;PSMB3;PSMD14;UBL4A;SEM1;PSMC6;SLC7A11;SRXN1;UBC;PSMC1;PSME2;RBX1;PSMD6;PSMB6;CUL1;SQSTM1;PSMA7;CREBBP;PRDX1;ATF4;PSMB2;PSMA2;PSMC5;PHGDH;PSMA1;PSMC3;TKT
gsea,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.5839029546708027,-2.0305173717826337,0.0,0.000951023983632383,0.075,13/28,18.12%,UBB;RPS27A;CHMP2A;STAM;VPS36;VPS28;VPS4A;VTA1;UBC;TSG101;STAM2;CHMP2B;VPS4B
gsea,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.4808035000490062,-2.0300281350597986,0.0,0.0009552867046255634,0.076,29/78,19.29%,SRSF1;TPR;SRSF2;SRSF7;FYTTD1;THOC2;SRSF5;CDC40;SARNP;RANBP2;ALYREF;SRSF6;SRSF9;SLU7;SRSF11;FIP1L1;ZC3H11A;NUP98;NUP88;SRRM1;GLE1;NUP153;U2AF1;NUP155;RNPS1;DHX38;NDC1;NUP37;NUP54
gsea,Degradation Of AXIN R-HSA-4641257,-0.5104266516689925,-2.0286318183917866,0.0,0.0009761998550330876,0.079,21/53,19.23%,UBB;RPS27A;PSMD2;TNKS;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Mitophagy R-HSA-5205647,-0.6063860737371443,-2.0273987614003373,0.0,0.0009886257143081134,0.081,16/27,28.35%,UBB;RPS27A;TOMM6;TOMM22;TOMM7;TOMM20;TOMM5;MAP1LC3A;UBC;CSNK2B;SQSTM1;FUNDC1;ATG12;MFN1;UBA52;TOMM40
gsea,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.5090864869207932,-2.026553213424104,0.0,0.0009844008180931218,0.081,19/55,19.97%,UBB;RPS27A;CANX;PARP6;ST6GAL1;FUT8;RPN2;GANAB;UBC;STT3A;ST6GALNAC2;ZDHHC8;DDOST;RPN1;CSNK1A1;ZDHHC2;MAGT1;PARP16;UBE2I
gsea,Ion Transport By P-type ATPases R-HSA-936837,-0.5350830895591528,-2.0252880963854274,0.0,0.000988448953050415,0.082,15/45,14.17%,ATP1B1;ATP1A2;CALM1;CAMK2B;ATP13A4;ATP11B;ATP1B2;CAMK2A;ATP2B1;ATP13A5;ATP2C1;ATP2B4;FXYD1;CUTC;ATP2A2
gsea,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.48316328039376716,-2.024501972762177,0.0,0.0009842606100290148,0.082,31/71,26.34%,UBB;RPS27A;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;CCNA1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1;PSMC3;ANAPC16;UBA52;PSME3
gsea,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.5426766759909893,-2.0229853779090674,0.0,0.0010046103019663237,0.085,20/39,22.74%,ELOC;ELOB;POLR2G;CDK9;POLR2E;TCEA1;CCNH;MNAT1;GTF2F1;GTF2H5;POLR2K;GTF2H1;SSRP1;CDK7;POLR2A;ERCC3;NELFB;POLR2L;POLR2D;POLR2B
gsea,Signaling By ERBB2 R-HSA-1227986,-0.5206283163244514,-2.02184766023072,0.0,0.0010166557421518187,0.087,11/46,10.83%,HSP90AA1;UBB;RPS27A;PRKCE;ERBIN;NRG2;SOS1;USP8;CUL5;AKT1;UBC
gsea,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.49079581861293614,-2.0216655832999737,0.0,0.0010124019524357022,0.087,24/64,19.23%,UBB;RPS27A;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5
gsea,Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.6943128030008853,-2.02010952732859,0.0,0.0010081836109672201,0.087,7/15,16.50%,HSP90AA1;CALM1;ZDHHC21;AKT1;CAV1;TACR1;DDAH1
gsea,HSF1 Activation R-HSA-3371511,-0.6384167706314318,-2.0191302442796064,0.002145922746781116,0.001028096283117444,0.089,10/23,16.63%,HSP90AA1;UBB;EEF1A1;HSP90AB1;YWHAE;HSBP1;RPA3;PTGES3;HSF1;DNAJB6
gsea,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.5951742118232336,-2.018943465650365,0.0,0.0010318467634890954,0.089,14/26,27.61%,ATRX;H2AZ1;POLR2G;POLR2E;TERF1;POLR2K;POLR2A;POLR2L;POLR2D;POLR2B;H2AJ;TERF2IP;H2BC4;POLR2C
gsea,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.6723552045795403,-2.018242555911261,0.0,0.001027600480511774,0.089,12/16,26.33%,UBB;RPS27A;SKP1;FBXW11;UBC;NFKB1;CUL1;CHUK;IKBKG;MAP3K8;IKBKB;UBA52
gsea,Death Receptor Signaling R-HSA-73887,-0.4471035625796946,-2.0157518976628825,0.0,0.001070988491650424,0.092,51/126,26.61%,UBB;RPS27A;YWHAE;MAGED1;FGD4;SHARPIN;SOS1;BEX3;IRAK1;BIRC2;HDAC1;ARHGEF4;TIAM1;OMG;PRPF38B;NSMAF;ARHGEF9;ITGB3BP;RACK1;ARHGEF12;PRKCI;UBC;PRDM4;APH1B;NFKB1;ABR;RTN4;BAG4;TAB3;AATF;PLEKHG5;CASP3;MAPK8;TNFRSF1A;SQSTM1;OTUD7B;HDAC3;CHUK;IKBKG;ARHGEF26;VAV3;PSENEN;ARHGEF2;IKBKB;ITSN1;GNA13;HDAC2;USP25;TAX1BP1;UBA52;CLIP3
gsea,Ub-specific Processing Proteases R-HSA-5689880,-0.4318722619864771,-2.012789281013466,0.0,0.0011219231824249097,0.097,52/155,22.19%,UBB;RPS27A;VDAC2;HIF1A;PSMD2;USP32;TOMM20;H2AC25;USP34;MAT2B;OTUB1;TNKS;PSMA4;BIRC2;USP33;PSMC2;USP8;PSMB3;SKP2;PSMD14;SEM1;PSMC6;USP14;USP24;SMAD4;UBC;USP19;PSMC1;USP9X;CCNA1;RHOT1;SMAD3;PSME2;PSMB11;PSME4;PSMD6;PSMB6;USP47;STAM2;PSMA7;RUVBL1;PSMB2;PSMA2;IKBKG;PSMC5;CCNA2;RCE1;TAF10;PSMA1;USP15;USP5;USP13
gsea,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.5182187909144047,-2.0120089165604176,0.0,0.001117362519081719,0.097,20/50,19.23%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Viral Messenger RNA Synthesis R-HSA-168325,-0.5312236528631286,-2.01200291390948,0.0,0.0011128387841866515,0.097,21/43,22.74%,TPR;GNL3;POLR2G;RANBP2;PBRM1;POLR2E;GTF2F1;NUP98;NUP88;POLR2K;NUP153;NUP155;POLR2A;NDC1;NUP37;NUP54;POLR2L;POLR2D;SEH1L;BLOC1S6;POLR2B
gsea,Clathrin-mediated Endocytosis R-HSA-8856828,-0.44275352739618,-2.0110342758032727,0.0,0.0011161568234966128,0.098,54/124,27.84%,UBB;RPS27A;HSPA8;UBQLN2;VAMP2;AP2M1;NECAP1;ACTR2;SNAP91;SH3GL1;CLTC;PICALM;COPS8;STAM;M6PR;SYNJ1;ARPC5;ARPC2;RAB5A;FNBP1L;ITSN2;TOR1A;UBC;TGFA;COPS7A;REPS1;SH3KBP1;GRK2;EPN2;VAMP3;STAM2;TACR1;FCHO2;NEDD8;CLTA;GAPVD1;REPS2;EPS15;STON2;SYT12;TFRC;ACTR3;SGIP1;AGFG1;CLTB;ITSN1;ARPC1A;UBA52;GRK3;UBQLN1;COPS6;COPS5;GRB2;WASL
gsea,ABC-family Proteins Mediated Transport R-HSA-382556,-0.4555457053878813,-2.0102782520284066,0.0,0.0011272221578043137,0.1,41/93,26.34%,UBB;RPS27A;PSMD2;ERLEC1;ABCB7;EIF2S2;PSMA4;PSMC2;PSMB3;SEL1L;ABCC4;PSMD14;SEM1;PSMC6;UBC;ABCD2;PSMC1;ABCA5;PSME2;PSMB11;PSME4;PSMD6;PSMB6;RNF5;PSMA7;ERLIN2;PSMB2;ABCG4;PSMA2;DERL2;PSMC5;PEX19;ABCD3;PSMA1;ABCB10;PEX3;PSMC3;ABCA2;EIF2S1;UBA52;PSME3
gsea,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.4706289052229423,-2.0079813459369347,0.0,0.0011691703699664659,0.102,39/86,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;PELI2;IRAK1;JUN;MAP2K6;PELI1;USP14;FBXW11;UBC;MAPK1;NFKB1;MAPK3;IRAK2;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;IKBKG;S100B;MAP3K8;MAPK10;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.5249619054641759,-2.0069493804708527,0.0,0.0011876483270549308,0.103,21/50,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;RBX1;PSMD6;PSMB6;CUL1;PSMA7;PSMB2;PSMA2;PSMC5
gsea,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.46469895636307856,-2.0068222848330812,0.0,0.0011982982347496101,0.105,40/90,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;PELI2;IRAK1;JUN;MAP2K6;PELI1;USP14;FBXW11;NDUFA2;UBC;MAPK1;NFKB1;MAPK3;IRAK2;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;IKBKG;S100B;MAP3K8;MAPK10;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.46341818014088854,-2.006217420380612,0.0,0.0012012129157705882,0.106,42/92,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;IRAK1;JUN;BIRC2;TLR3;MAP2K6;USP14;FBXW11;UBC;MAPK1;NFKB1;MAPK3;IRAK2;UBE2D3;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;IKBKG;S100B;MAP3K8;MAPK10;IKBKE;SARM1;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,Nucleotide Excision Repair R-HSA-5696398,-0.4513935985872567,-2.0049437992715697,0.0,0.0012117255620317834,0.107,52/105,34.54%,UBB;RPS27A;UBE2N;POLR2G;PIAS1;SUMO2;POLR2E;CETN2;PCNA;COPS8;TCEA1;PRPF19;CUL4B;CCNH;MNAT1;RPA3;UBC;COPS7A;RBX1;GTF2H5;POLR2K;GTF2H1;POLD3;RAD23B;CDK7;POLR2A;ERCC3;RUVBL1;PARP2;UBE2I;POLR2L;POLR2D;POLR2B;USP45;UVSSA;UBA52;COPS6;COPS5;POLR2C;AQR;COPS2;POLR2H;YY1;XAB2;ERCC8;RFC5;INO80E;ACTL6A;POLE3;COPS3;ACTR8;UBE2V2
gsea,Post-translational Protein Phosphorylation R-HSA-8957275,-0.46467057439746956,-2.004041357473066,0.0,0.0012145647266240394,0.108,26/79,25.07%,SPARCL1;KTN1;CST3;PPP3CA;HSP90B1;APOE;TMEM132A;DMTF1;CHGB;VGF;MFGE8;SCG2;WFS1;DNAJC3;FAM20A;MIA3;RCN1;EVA1A;MBTPS1;CXXC1;PCSK9;PDIA6;SERPIND1;CKAP4;CSF1;APLP2
gsea,Stabilization Of P53 R-HSA-69541,-0.5068772397703014,-2.0036004720309504,0.0,0.0012098203331606641,0.108,20/53,19.23%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.5324178179017973,-2.0029613296072504,0.0,0.0012051128610471988,0.108,17/54,14.10%,HSP90AA1;ACTG1;HSP90AB1;WIPF3;CYFIP1;PTK2;ACTR2;MYO5A;NCKAP1;BAIAP2;WASF1;ARPC5;ARPC2;ELMO2;MAPK1;ABI1;MAPK3
gsea,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.4225763497413622,-2.001311130694591,0.0,0.0012229501662337258,0.109,55/159,19.71%,UBB;RPS27A;CBX6;KMT2C;H2AZ1;PSMD2;SCMH1;PSMA4;TNRC6A;AGO3;KCTD6;TNRC6C;ACTL6B;SMARCC2;KAT2B;PBRM1;HDAC1;PSMC2;PSMB3;SMARCA2;TCF12;PSMD14;CCNH;MNAT1;SEM1;PSMC6;CBFB;AGO4;CTSL;UBC;PSMC1;KMT2E;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CSNK2B;CDK7;PRMT6;SMARCD2;ASH2L;PSMA7;YAP1;CCND1;SMARCE1;CREBBP;DPY30;ARID2;CLDN5;PSMB2;PSMA2;RUNX2;PSMC5;TJP1
gsea,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.4241088556719433,-2.0003313412812633,0.0,0.001225702144484009,0.11,88/159,35.99%,UBB;RPS27A;YWHAZ;H2AZ1;PSMD2;USP34;PPP2R1A;TNKS;PSMA4;FZD2;HDAC1;PSMC2;USP8;SOX9;TLE4;ZNRF3;PSMB3;XPO1;PSMD14;SEM1;PSMC6;CUL3;CCDC88C;AKT1;CTBP1;UBC;PSMC1;PIP5K1B;PSME2;PSMB11;PSME4;RYK;RBX1;PYGO1;CAV1;PYGO2;SOX4;PSMD6;PSMB6;CSNK2B;CSNK1A1;LRP6;FZD1;ASH2L;SOX6;PSMA7;CREBBP;RUVBL1;PSMB2;CTNNB1;PSMA2;TLE1;WNT4;PSMC5;FRAT1;PSMA1;PPP2CA;SFRP2;PSMC3;H2AJ;H2BC4;TCF7L2;PPP2R5D;UBA52;PSME3;CDC73;RSPO2;RNF146;TCF7;AXIN2;BTRC;CSNK1E;DACT1;PSMB10;CBY1;FZD4;CSNK1G2;LEO1;PSMD13;PSMD8;WNT5A;FZD6;H2AZ2;TCF7L1;DVL2;KREMEN1;PSMB7;AMER1
gsea,DNA Replication Pre-Initiation R-HSA-69002,-0.44598961709413265,-1.9988143925090434,0.0,0.0012358780018748938,0.111,38/99,26.34%,UBB;ORC4;RPS27A;H2AZ1;PSMD2;PSMA4;ANAPC4;ORC6;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;RPA3;CDC26;UBC;PSMC1;MCM6;PSME2;PSMD6;PSMB6;MCM7;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;MCM4;PSMA1;POLA1;ORC5;PSMC3;H2AJ;ANAPC16;H2BC4;UBA52;PSME3
gsea,Glucose Metabolism R-HSA-70326,-0.47832449843974395,-1.9985203504448095,0.0,0.0012311428371167526,0.111,32/74,25.80%,TPR;ALDOC;MDH2;MDH1;PGM2L1;PPP2R1A;SLC25A11;RANBP2;TPI1;PRKACB;MAP4K5;NUP98;NUP88;PKM;NUP153;NUP155;GNPDA1;ENO2;ENO1;PFKM;GOT2;NDC1;NUP37;NUP54;SLC25A13;PPP2CA;SEH1L;PCK2;HOOK3;PGP;PPP2R5D;SEC13
gsea,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.409981977311326,-1.9959182539380627,0.0,0.0012633848975296097,0.114,97/247,28.36%,HSP90AA1;CALM1;DYNLL1;TUBA1A;YWHAE;TTBK2;AKAP9;TUBA4A;DYNLL2;CYCS;AHI1;KIF3A;ATP5PB;KIFAP3;HSPA9;CEP290;PPP2R1A;CHD9;PCM1;DYNC2H1;IQCB1;TRIP11;ODF2;CEP83;CETN2;CEP43;CEP162;PLK4;PRKAR2B;TTC30B;TCP1;CKAP5;IFT43;MICOS10;CCT5;SFI1;TTC8;MICOS13;LZTFL1;SDCCAG8;ARF4;PRKAG2;CRTC2;TUBB4B;NCOR1;CCT8;DNAJC11;EXOC3;NUDT19;ACTR1A;EXOC1;DYNLRB1;CEP192;B9D1;HAUS3;DYNLT2B;EXOC2;PPARA;CREBBP;ARL3;HDAC3;BBS7;MBD4;DCTN3;TMEM216;BBS5;NCOA2;EXOC6;POLRMT;TFAM;OFD1;CRTC3;YWHAG;BBIP1;IFT20;CEP135;TTC21B;DYNC1I2;CCT2;GLUD1;IFT46;TBL1XR1;MAPK11;TNPO1;TMEM67;WDR35;TUBB4A;EXOC8;CHCHD3;RAB11A;SSBP1;APOOL;EXOC5;NDE1;NCOA1;TWNK;SIRT5
gsea,Metalloprotease DUBs R-HSA-5689901,-0.6008830568292359,-1.9946578263334749,0.0,0.0012880216474714294,0.116,8/23,10.83%,UBB;RPS27A;H2AC25;KAT2B;STAM;PSMD14;BRCC3;UBC
gsea,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.49703056275397667,-1.9939517930114088,0.0,0.0012831427775946435,0.116,23/52,26.33%,UBB;RPS27A;H2AZ1;JUN;ANAPC4;CDK4;UBE2E1;CEBPB;CDC26;UBC;MAPK1;CCNA1;NFKB1;CDKN1B;MAPK3;ANAPC1;CCNA2;EHMT1;H2AJ;CDKN2D;ANAPC16;H2BC4;UBA52
gsea,RNA Polymerase I Transcription Initiation R-HSA-73762,-0.5295158442470151,-1.9938135583083842,0.002105263157894737,0.0012783007293773053,0.116,23/45,25.79%,TAF1D;KAT2B;HDAC1;POLR2E;TBP;POLR1F;UBTF;CCNH;MNAT1;MTA3;RRN3;GTF2H5;POLR2K;POLR1H;GTF2H1;TTF1;CDK7;ERCC3;CHD4;POLR2L;RBBP7;CHD3;HDAC2
gsea,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.5580717737170346,-1.993064103514941,0.0,0.0012953264318953277,0.117,9/30,15.01%,UBB;RPS27A;PCNA;CUL4B;RPA3;UBC;USP1;RBX1;POLD3
gsea,Signaling By FGFR R-HSA-190236,-0.4739313574107217,-1.9918850745884378,0.0,0.001312224601061155,0.119,27/73,22.74%,UBB;HNRNPH1;RPS27A;TIA1;BRAF;HNRNPA1;POLR2G;TIAL1;PPP2R1A;HNRNPM;SOS1;POLR2E;GTF2F1;UBC;FLRT3;MAPK1;POLR2K;MAPK3;POLR2A;FGFR1;POLR2L;POLR2D;HRAS;PPP2CA;FGFR3;FLRT1;POLR2B
gsea,"TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",-0.6490858074028918,-1.9914214335699625,0.00211864406779661,0.0013145510485686022,0.12,11/17,26.33%,UBB;RPS27A;UBE2N;BIRC2;TLR3;UBC;UBE2D3;CHUK;IKBKG;IKBKB;UBA52
gsea,DARPP-32 Events R-HSA-180024,-0.6235531463617379,-1.9910838855678423,0.0,0.0013168601990685594,0.121,10/22,8.76%,CALM1;PPP3CA;PPP3CB;PPP3R1;PRKAR1A;PPP2R1A;PRKAR2B;PPP1CA;PRKACB;CDK5
gsea,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.5954157470248486,-1.9907390333334758,0.0,0.0013406601617839656,0.124,9/27,8.04%,ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0E2;ATP6V1F;ATP6V0A2;ATP6V1E1;ATP6V1H;ATP6V1A
gsea,Budding And Maturation Of HIV Virion R-HSA-162588,-0.574954625493764,-1.9890578421113723,0.0,0.0013714273296935647,0.128,15/27,26.33%,UBB;RPS27A;PPIA;CHMP2A;VPS28;VPS4A;VTA1;UBC;TSG101;CHMP2B;VPS4B;SGIP1;CHMP5;VPS37D;UBA52
gsea,Disorders Of Transmembrane Transporters R-HSA-5619115,-0.4201078795299631,-1.988403997502095,0.0,0.0013735019076471068,0.128,44/141,19.29%,UBB;SLC1A3;RPS27A;TPR;SLC4A4;BSG;PSMD2;ERLEC1;PSMA4;ABCA1;RANBP2;SLC9A7;PSMC2;LMBRD1;SLC35A1;PSMB3;SEL1L;PSMD14;SEM1;PSMC6;MAP4K5;UBC;PSMC1;NUP98;NUP88;PSME2;PSMB11;PSME4;NUP153;PSMD6;NUP155;PSMB6;SLC22A5;SLC35A3;RNF5;PSMA7;ERLIN2;PSMB2;PSMA2;DERL2;NDC1;NUP37;PSMC5;NUP54
gsea,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.45156776182385383,-1.9880771189076072,0.0,0.0013968328535246934,0.13,41/95,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;PELI2;IRAK1;JUN;MAP2K6;PELI1;USP14;FBXW11;NDUFA2;UBC;MAPK1;NFKB1;MAPK3;IRAK2;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;IKBKG;S100B;MAP3K8;MAPK10;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;S100A1;DUSP3;TAB2
gsea,Activation Of BAD And Translocation To Mitochondria R-HSA-111447,-0.6955916699306772,-1.9871718949415325,0.0,0.0014129288562460313,0.132,5/15,1.89%,YWHAH;YWHAZ;YWHAE;PPP3R1;YWHAB
gsea,Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.5070588559902691,-1.9865370773835371,0.002008032128514056,0.0014148298877980714,0.132,24/50,25.80%,TPR;H2AZ1;POLR2G;TNRC6A;RANBP2;POLR2E;NUP98;NUP88;RAN;POLR2K;NUP153;NUP155;POLR2A;IPO8;NDC1;NUP37;NUP54;POLR2L;POLR2D;SEH1L;POLR2B;H2AJ;H2BC4;SEC13
gsea,Basigin Interactions R-HSA-210991,-0.6130946577460099,-1.985234210228037,0.0,0.0014307440461726116,0.132,7/22,8.99%,ATP1B1;PPIA;BSG;SLC7A6;ATP1B2;SLC7A10;SLC7A11
gsea,Dual Incision In TC-NER R-HSA-6782135,-0.48693659298489467,-1.9845485553385676,0.0,0.0014255789052116995,0.132,20/63,15.87%,UBB;RPS27A;POLR2G;POLR2E;PCNA;TCEA1;PRPF19;CUL4B;CCNH;MNAT1;RPA3;UBC;RBX1;GTF2H5;POLR2K;GTF2H1;POLD3;CDK7;POLR2A;ERCC3
gsea,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.47182876001800356,-1.9836076669967895,0.0,0.0014622288918776374,0.134,31/70,26.34%,UBB;RPS27A;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;CCNA1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1;PSMC3;ANAPC16;UBA52;PSME3
gsea,Integration Of Energy Metabolism R-HSA-163685,-0.4610467052750511,-1.9830417873449129,0.0,0.0014708640036132517,0.134,47/95,26.27%,VAMP2;MARCKS;GNG3;GNB2;SNAP25;CACNA2D2;PRKAR1A;ADCY9;GNAQ;PPP2R1A;PLCB1;KCNG2;PRKAR2B;ADCY1;CACNA1E;ACSL3;AKAP5;PRKACB;PRKAG2;GNG11;GNAS;GNG10;ACACA;RAP1A;ADCY2;ADRA2A;KCNB1;ACSL4;GNG7;ADCY5;KCNS3;GNB5;PLCB3;SYT5;AHCYL1;PPP2CA;PRKAR2A;ACLY;TKT;IQGAP1;PLCB2;CACNA1C;PPP2R5D;GNG2;CACNB3;CHRM3;ADCY6
gsea,Regulated Necrosis R-HSA-5218859,-0.5176768234877852,-1.9821293756789395,0.0,0.0014794374359793263,0.136,13/46,15.84%,HSP90AA1;UBB;RPS27A;GNL3;CYCS;CHMP2A;BIRC2;PELI1;UBC;BAK1;HMGB1;CHMP2B;CASP3
gsea,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.6298835363736841,-1.9787765103542634,0.0019723865877712033,0.0015706137278897162,0.142,12/23,16.94%,TUBA1A;TUBB2A;TUBA4A;CCT7;PFDN5;TCP1;PFDN6;CCT5;TUBB4B;CCT8;VBP1;CCT6A
gsea,Transcriptional Regulation By MECP2 R-HSA-8986944,-0.4933844105276013,-1.9786633668423914,0.001851851851851852,0.0015719084045037848,0.143,18/58,12.29%,CALM1;GRIA2;CAMK2B;FKBP5;TNRC6A;AGO3;IRAK1;CAMK2A;TNRC6C;SST;HDAC1;GAD1;RNMT;AGO4;GAD2;NCOR1;PVALB;PTPN4
gsea,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.3987548353031581,-1.978502547294613,0.0,0.0015731939314598037,0.144,85/283,19.57%,UBE3A;UBB;RPS27A;KLHL9;SKP1;PJA2;WSB1;PSMD2;ELOC;KBTBD7;ELOB;UBE2N;DCAF1;HACE1;TRIP12;PSMA4;PJA1;HERC1;KCTD6;ANAPC4;HUWE1;UBE3C;UBR1;WWP1;PSMC2;FBXL5;UBE2E1;FBXW7;NEDD4;HERC2;PSMB3;SKP2;ASB12;PSMD14;CUL5;DZIP3;UFL1;SEM1;CBLB;PSMC6;LMO7;CUL3;KLHL22;FBXW11;CDC26;FBXO22;UBC;TRIM32;UBE2Q1;PSMC1;FBXL4;PSME2;PSMB11;PSME4;TPP2;UBE2Q2;RBX1;RNF19A;KLHL5;UBAC1;FBXO9;RNF130;PSMD6;UBE2D3;PSMB6;CUL1;FBXL16;BLMH;DET1;FBXW2;RNF25;RNF213;PSMA7;KLHL20;TRIM37;ANAPC1;PSMB2;UBE2G2;RNF126;PSMA2;LTN1;FBXL18;ZNRF2;PSMC5;HECTD2
gsea,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.4580387544900682,-1.9782999173656286,0.0,0.0015676545162081846,0.144,39/100,23.41%,DYNLL1;ARF5;KIF26B;CAPZA2;KIF5B;DYNLL2;KIF3A;KIFAP3;ARCN1;NSF;KIF21A;CAPZB;COPG2;RAB1B;NAPG;BICD1;KIF23;RAB6A;TMED7;KIF2A;ARF4;COPA;AGPAT3;CENPE;KIFC2;ACTR1A;DCTN5;NBAS;TMED2;ARF3;DCTN6;DCTN3;COPB2;KIF22;DCTN4;SEC22B;COPZ1;DYNC1I2;RAB3GAP1
gsea,RND3 GTPase Cycle R-HSA-9696264,-0.551459058282056,-1.9768629531782846,0.0,0.0015893218692468515,0.146,11/38,15.63%,CCDC88A;KTN1;CKB;ARHGAP5;RASAL2;PICALM;ROCK1;ARHGAP21;TXNL1;CAV1;PLEKHG5
gsea,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.48405176035730013,-1.976818898947631,0.0,0.0015837647997739603,0.146,20/62,15.87%,UBB;RPS27A;POLR2G;POLR2E;PCNA;TCEA1;PRPF19;CUL4B;CCNH;MNAT1;RPA3;UBC;RBX1;GTF2H5;POLR2K;GTF2H1;POLD3;CDK7;POLR2A;ERCC3
gsea,Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.6324117612382876,-1.976189372531179,0.002044989775051125,0.0015984803844408496,0.148,11/17,27.33%,PIGC;PIGW;PIGG;PIGB;PIGN;PIGL;PIGP;PIGH;PIGF;PIGO;DPM2
gsea,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.6062920464196788,-1.9749393167336378,0.00398406374501992,0.001613093777547552,0.149,9/23,12.62%,RNF20;TRA2B;ROCK2;CCT7;ROCK1;CUL3;RBM15;TXNL1;SRRM1
gsea,Signaling By EGFR In Cancer R-HSA-1643713,-0.6177796217188244,-1.9734705422981043,0.0019083969465648854,0.0016744918106029953,0.154,6/21,11.66%,HSP90AA1;UBB;RPS27A;SOS1;UBC;TGFA
gsea,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.45554489117831276,-1.9724450367037374,0.0,0.0016829390751320857,0.156,40/91,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;PELI2;IRAK1;JUN;MAP2K6;PELI1;USP14;FBXW11;NDUFA2;UBC;MAPK1;NFKB1;MAPK3;IRAK2;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;IKBKG;S100B;MAP3K8;MAPK10;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.45554489117831276,-1.9724450367037374,0.0,0.0016829390751320857,0.156,40/91,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;PELI2;IRAK1;JUN;MAP2K6;PELI1;USP14;FBXW11;NDUFA2;UBC;MAPK1;NFKB1;MAPK3;IRAK2;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;IKBKG;S100B;MAP3K8;MAPK10;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.484217380468826,-1.9721709100196154,0.0,0.0016771755851487564,0.156,24/61,21.58%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;CCNA1;CDKN1B;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1
gsea,ER-Phagosome Pathway R-HSA-1236974,-0.46117537707734313,-1.9665388701363804,0.0,0.0017771558750592146,0.164,34/74,26.76%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;SEC61B;PSMB3;PSMD14;SEM1;PSMC6;NDUFA2;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;HMGB1;VAMP3;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5;CALR;SEC22B;PSMA1;PSMC3;IKBKB;UBA52;PSME3;S100A1
gsea,MyD88-independent TLR4 Cascade R-HSA-166166,-0.4496927952482327,-1.9628711294466303,0.0,0.0018369516895337431,0.168,42/95,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;IRAK1;JUN;BIRC2;MAP2K6;USP14;FBXW11;NDUFA2;UBC;MAPK1;NFKB1;MAPK3;IRAK2;UBE2D3;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;IKBKG;S100B;MAP3K8;MAPK10;IKBKE;SARM1;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;DUSP3;TAB2
gsea,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.5021569718494505,-1.9615468429163818,0.0,0.0018569716842547416,0.17,21/52,22.77%,FTH1;HSPA8;VAMP2;GOLGB1;NECAP1;TBC1D8B;CLTC;PICALM;AP3B1;SH3D19;YIPF6;TXNDC5;AP1G1;AP1S1;BLOC1S1;CLTA;PUM1;TPD52L1;BLOC1S6;TFRC;SNAPIN
gsea,Neuronal System R-HSA-112316,-0.4084436405209251,-1.9606266273792052,0.0,0.0018703168393727023,0.17,104/334,18.87%,NRGN;CALM1;SLC1A3;KCNA1;GRIA2;HSPA8;KCNA2;CAMK2B;TSPAN7;VAMP2;NEFL;GNG3;RAB3A;AP2M1;GNB2;LRRTM1;GRM1;DLGAP1;SNAP25;CACNA2D2;RTN3;SLITRK4;EPB41L1;IL1RAPL1;CAMKK1;PRKAR1A;KCNN3;GRIA3;ADCY9;GNAL;SHARPIN;PLCB1;ARL6IP5;KCNAB2;NSF;CAMK2A;SLC1A2;KCNG2;PPFIA2;SLC17A7;GLUL;LIN7B;PRKAR2B;ADCY1;CACNA1E;SLITRK1;GABRA3;LRRTM2;AKAP5;COMT;GABRG2;PRKACB;IL1RAP;GAD1;DLGAP2;SYT7;ARHGEF9;GABRA1;KCNF1;PPM1F;PPM1E;KCNJ4;SLC32A1;LIN7C;SYN2;NTRK3;GAD2;GABRB3;KCNS1;PRKAG2;GNG11;GLRB;KCND3;MAPK1;GNG10;KCNJ10;GABBR2;GABRA4;GABRB2;SLITRK2;MAPK3;CASK;PDLIM5;SIPA1L1;EPB41L5;LRRC7;SLITRK6;KCNA3;GRIN2C;ADCY2;HCN3;GABRA5;EPB41;KCNB1;SLITRK5;NLGN3;GNG7;KCNA4;HOMER3;CPLX1;ADCY5;GRIN2B;KCNS3;GNB5
gsea,Sema4D In Semaphorin Signaling R-HSA-400685,-0.6123151568751949,-1.9592941226922216,0.0020325203252032522,0.00189660722935894,0.175,9/21,13.23%,MYL6;MYL12B;ROCK2;RHOB;ROCK1;RNMT;ARHGEF12;MYH10;LIMK2
gsea,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.4765611436997415,-1.9586249128490647,0.001937984496124031,0.0019227211737748002,0.178,21/68,16.37%,UBB;RPS27A;YWHAE;MAGED1;FGD4;SOS1;BEX3;ARHGEF4;TIAM1;PRPF38B;ARHGEF9;ITGB3BP;ARHGEF12;UBC;APH1B;ABR;AATF;PLEKHG5;CASP3;MAPK8;SQSTM1
gsea,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.5793596759868104,-1.9584291176098776,0.0022123893805309734,0.0019227646231369485,0.179,7/27,10.83%,HSP90AA1;UBB;RPS27A;GNL3;BIRC2;PELI1;UBC
gsea,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.5014075995132874,-1.9577054976982768,0.0019646365422396855,0.0019228077828366823,0.18,21/56,24.15%,CALM1;CAMK2B;BRAF;AKAP9;QKI;YWHAB;CAMK2A;VCL;FAM114A2;PEBP1;AP3B1;FXR1;MAPK1;MAPK3;RAP1A;AGGF1;KDM7A;HRAS;CAMK2G;AGK;IQGAP1
gsea,Downstream TCR Signaling R-HSA-202424,-0.4559172871125677,-1.9575889441001102,0.0,0.0019164197171129725,0.18,27/79,19.23%,UBB;RPS27A;SKP1;PSMD2;UBE2N;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5
gsea,tRNA Processing R-HSA-72306,-0.4449494907194638,-1.9568416290534854,0.0,0.0019228932447586716,0.182,45/96,31.63%,TPR;DDX1;RANBP2;RTCB;TRMT10A;TRNT1;NSUN6;CDKAL1;POP5;NUP98;ALKBH8;NUP88;THADA;RAN;TRMT112;TRMT6;RPP14;NUP153;NUP155;RPP30;LAGE3;CSTF2;RPP38;RPP25;RTRAF;NDC1;NUP37;QTRT2;NUP54;TRMT44;TRMT13;TYW5;FAM98B;SEH1L;PUS3;TRMT10C;TSEN15;SEC13;THG1L;CTU1;PUS7;TRDMT1;POP7;ADAT2;NUP93
gsea,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.48058453491553704,-1.9508692733369535,0.0,0.002044316866594918,0.19,27/61,26.34%,UBB;RPS27A;PSMD2;PSMA4;ANAPC4;PSMC2;UBE2E1;PSMB3;PSMD14;SEM1;PSMC6;CDC26;UBC;PSMC1;PSME2;PSMD6;PSMB6;PSMA7;ANAPC1;PSMB2;PSMA2;PSMC5;PSMA1;PSMC3;ANAPC16;UBA52;PSME3
gsea,Asparagine N-linked Glycosylation R-HSA-446203,-0.3978999971994998,-1.9500822862594234,0.0,0.0020439596154977536,0.19,112/261,29.51%,UBB;DYNLL1;RPS27A;ARF5;GOLGB1;CAPZA2;B4GALT6;DYNLL2;MAN1A2;CANX;ARCN1;NSF;TFG;NUS1;ST8SIA4;SPTBN1;SEC24A;CAPZB;SLC35A1;CNIH2;COPG2;RAB1B;ST6GAL1;NAPG;SEL1L;ALG2;MCFD2;USO1;FUT8;PREB;ST8SIA3;RPN2;TMED7;SYVN1;TRAPPC5;GANAB;ARF4;UBC;STT3A;ST6GALNAC2;GNPNAT1;COPA;PSMC1;TGFA;FUOM;LMAN1;ENGASE;AMFR;MANEA;YKT6;ACTR1A;SEC23IP;UBXN1;DCTN5;DDOST;RPN1;MARCHF6;MIA3;LMAN2;UAP1;RAD23B;SEC23A;TMED2;COG3;RNF5;ARF3;DCTN6;DCTN3;CTSA;COPB2;MAGT1;MAN2A2;DERL2;MPDU1;PMM1;UGGT2;CALR;DCTN4;B4GALT4;TRAPPC4;SEC22B;TRAPPC1;COPZ1;MAN1C1;ALG6;ST8SIA2;RFT1;ANKRD28;DYNC1I2;FPGT;GMPPA;TUSC3;CD55;COG6;SEC22A;ALG5;EDEM2;SEC13;UBA52;DPM2;SEC24D;NEU4;DOLK;GFPT1;NAPSA;KDELR1;COPB1;DCTN1;TRAPPC2L;NANP;SCFD1;TRAPPC6B
gsea,RAF Activation R-HSA-5673000,-0.5788749878590796,-1.949230362773135,0.001953125,0.0020499513054997743,0.19,6/30,4.85%,CALM1;CAMK2B;BRAF;YWHAB;PPP2R1A;CAMK2A
gsea,Glycogen Metabolism R-HSA-8982491,-0.6201039338431046,-1.9471671714108,0.0,0.002068555550031567,0.192,8/22,13.04%,CALM1;UBB;RPS27A;PHKA1;PPP1R3C;PHKG1;UBC;PHKB
gsea,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.4909502406032506,-1.9466617025121984,0.0,0.002074428089171901,0.193,31/50,36.33%,UBB;RPS27A;APOE;AP2M1;ABCA1;CLTC;MBTPS2;PRKACB;FURIN;UBC;ZDHHC8;NCEH1;LPL;MBTPS1;CLTA;PLTP;VLDLR;PCSK9;LCAT;NPC2;UBA52;SOAT1;AP2S1;APOA1;PCSK5;ABCG1;SAR1B;LDLRAP1;SCARB1;AP2B1;AP2A2
gsea,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.5801852851760962,-1.9446603667596385,0.004166666666666667,0.00210540161874713,0.196,20/33,27.84%,ACTG1;WIPF3;CYFIP1;PTK2;ACTR2;NCKAP1;BAIAP2;WASF1;ARPC5;ARPC2;MAPK1;ABI1;MAPK3;ACTR3;ABI2;NCK1;ARPC1A;WASF3;GRB2;WASL
gsea,Neddylation R-HSA-8951664,-0.3957757251114511,-1.9443977748125896,0.0,0.0021111169049845635,0.197,96/221,32.11%,UBB;RPS27A;KLHL9;SKP1;WSB1;HIF1A;PSMD2;COMMD3;ELOC;KBTBD7;DCAF6;ELOB;PSMA4;KCTD6;PUM2;PSMC2;FBXL5;DCUN1D5;COPS8;FBXW7;PSMB3;SKP2;ASB12;CUL4B;PSMD14;CUL5;SEM1;PSMC6;CUL9;LMO7;CUL3;KLHL22;FBXW11;COMMD8;DDA1;FBXO22;UBC;PSMC1;FBXL4;COPS7A;PSME2;PSMB11;PSME4;RBX1;KLHL5;FBXO9;PSMD6;DCAF13;UBE2D3;PSMB6;CUL1;FBXL16;FBXW2;SPSB3;SQSTM1;PSMA7;KLHL20;NEDD8;PSMB2;PSMA2;FBXL18;NAE1;PSMC5;DCAF17;BTBD1;PSMA1;FBXO7;PSMC3;COMMD5;RBBP7;ASB13;CCDC22;SOCS5;UBE2F;KLHL25;UBA52;PSME3;COPS6;COPS5;UBE2M;NEURL2;ASB11;FBXO15;EPAS1;FEM1B;COMMD1;BTRC;TULP4;COPS2;FBXL14;DCAF11;PSMB10;KLHL21;FBXO44;ERCC8;DCUN1D1
gsea,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.6054714941464956,-1.9423950273923278,0.0,0.002160504956250786,0.202,12/21,26.33%,UBB;RPS27A;SEL1L;SYVN1;UBC;AMFR;MARCHF6;RNF5;DERL2;UGGT2;EDEM2;UBA52
gsea,Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.5639840405361876,-1.9407403121030973,0.0,0.002184678775250897,0.205,7/29,8.09%,CALM1;CAMK2B;SCN2A;CACNA2D2;SCN3B;CAMK2A;SCN3A
gsea,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.6261793867126386,-1.940652625178961,0.0,0.0021776765996891954,0.205,10/20,17.62%,UBB;RPS27A;CORO1A;ATP6V1H;RAB5A;UBC;MAPK1;MAPK3;RNF213;ENO1
gsea,Aquaporin-mediated Transport R-HSA-445717,-0.5324344099623216,-1.940565023408643,0.0019801980198019802,0.0021769035515529903,0.205,17/35,18.87%,GNG3;GNB2;PRKAR1A;ADCY9;AQP4;PRKAR2B;ADCY1;RAB11FIP2;PRKACB;GNG11;GNAS;MYO5B;GNG10;ADCY2;GNG7;ADCY5;GNB5
gsea,G1/S DNA Damage Checkpoints R-HSA-69615,-0.47234917295837886,-1.9399726219772788,0.0,0.0021699707376945415,0.205,24/63,21.58%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;CCNA1;CDKN1B;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5;CCNA2;PSMA1
gsea,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.38215853415023043,-1.9390037323745697,0.0,0.0022122428949223573,0.209,98/335,19.71%,UBE3A;UBB;RPS27A;KLHL9;SKP1;PJA2;WSB1;PSMD2;ELOC;KBTBD7;ELOB;UBE2N;DCAF1;HACE1;TRIP12;PSMA4;CANX;PJA1;HERC1;KCTD6;ANAPC4;HSPA5;HUWE1;UBE3C;UBR1;WWP1;PSMC2;SEC24A;FBXL5;SEC61B;UBE2E1;FBXW7;NEDD4;HERC2;PSMB3;SKP2;ASB12;PSMD14;CUL5;DZIP3;UFL1;SEM1;CBLB;PSMC6;LMO7;CUL3;KLHL22;FBXW11;NDUFA2;CDC26;CTSL;FBXO22;UBC;TRIM32;UBE2Q1;PSMC1;FBXL4;PSME2;PSMB11;PSME4;TPP2;UBE2Q2;RBX1;RNF19A;PIK3C3;KLHL5;UBAC1;FBXO9;RNF130;PSMD6;UBE2D3;PSMB6;CUL1;FBXL16;HMGB1;BLMH;DET1;VAMP3;FBXW2;RNF25;SEC23A;RNF213;PSMA7;KLHL20;TRIM37;CHUK;ANAPC1;PSMB2;UBE2G2;RNF126;PSMA2;LTN1;FBXL18;ZNRF2;IKBKG;PSMC5;HECTD2;CALR
gsea,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.6088090780628831,-1.937690276094485,0.004219409282700422,0.002223619143986436,0.21,12/20,26.33%,UBB;RPS27A;UBE2N;BIRC2;NDUFA2;UBC;UBE2D3;CHUK;IKBKG;SARM1;IKBKB;UBA52
gsea,Attenuation Phase R-HSA-3371568,-0.6357258386274706,-1.9371368925055636,0.0,0.0022410299672931924,0.212,10/20,16.93%,HSP90AA1;UBB;HSPA8;HSP90AB1;HSBP1;PTGES3;HSPA2;HSF1;DNAJB6;CREBBP
gsea,Glycolysis R-HSA-70171,-0.4875550086768871,-1.9369052591353042,0.003952569169960474,0.002240069849575469,0.213,26/60,25.80%,TPR;ALDOC;PGM2L1;PPP2R1A;RANBP2;TPI1;PRKACB;MAP4K5;NUP98;NUP88;PKM;NUP153;NUP155;GNPDA1;ENO2;ENO1;PFKM;NDC1;NUP37;NUP54;PPP2CA;SEH1L;HOOK3;PGP;PPP2R5D;SEC13
gsea,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.6060457882361924,-1.934151335748032,0.0,0.0022755241376062646,0.216,10/23,17.62%,UBB;RPS27A;CORO1A;ATP6V1H;RAB5A;UBC;MAPK1;MAPK3;RNF213;ENO1
gsea,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.6127987197293236,-1.9339252073903594,0.0,0.0022684131246762454,0.216,8/21,15.83%,TUBA1A;TUBB2A;TUBA4A;CHMP2A;VPS4A;TUBB4B;TUBA1B;CHMP2B
gsea,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.5039366259259366,-1.9331229448984666,0.0,0.0022794371884597184,0.219,16/44,18.19%,UBB;RPS27A;TGFB3;PPP1R15A;PPP1CA;XPO1;FURIN;SMAD4;UBC;ZFYVE9;ITGB8;SMAD3;TGFB2;UCHL5;NEDD8;PPP1CB
gsea,UCH Proteinases R-HSA-5689603,-0.44636277228858534,-1.9322441459425452,0.0,0.0022843812501915643,0.22,29/85,21.68%,UBB;RPS27A;PSMD2;UCHL1;MBD5;H2AC25;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;ASXL2;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;UCHL5;PSMA7;RUVBL1;NEDD8;PSMB2;PSMA2;PSMC5;PSMA1;USP15
gsea,Regulation Of Insulin Secretion R-HSA-422356,-0.4740855145517534,-1.9322415815298326,0.0,0.0022773088624200733,0.22,37/71,26.27%,VAMP2;MARCKS;GNG3;GNB2;SNAP25;CACNA2D2;PRKAR1A;GNAQ;PLCB1;KCNG2;PRKAR2B;CACNA1E;ACSL3;AKAP5;PRKACB;GNG11;GNAS;GNG10;RAP1A;ADRA2A;KCNB1;ACSL4;GNG7;ADCY5;KCNS3;GNB5;PLCB3;SYT5;AHCYL1;PRKAR2A;IQGAP1;PLCB2;CACNA1C;GNG2;CACNB3;CHRM3;ADCY6
gsea,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.4877444999281497,-1.9321830689553376,0.0,0.0022702801313632215,0.22,26/55,26.33%,UBB;RPS27A;MAML2;SKP1;HDAC8;KAT2B;HDAC1;FBXW7;HEY1;UBC;APH1B;NCOR1;RBX1;MIB1;CUL1;MAML3;CREBBP;HDAC3;CDK8;HEY2;JAG2;PSENEN;HES5;TBL1XR1;HDAC2;UBA52
gsea,Amino Acids Regulate mTORC1 R-HSA-9639288,-0.49320951906121485,-1.9315884015154632,0.0,0.0022752067311624553,0.222,27/50,31.18%,ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0E2;ATP6V1F;ATP6V1E1;ATP6V1H;ATP6V1A;LAMTOR3;FNIP1;RRAGB;MTOR;LAMTOR5;ATP6V1G2;LAMTOR1;RRAGA;MIOS;SEH1L;LAMTOR4;LAMTOR2;SEC13;ATP6V1C2;ATP6V1B2;NPRL3;DEPDC5;FLCN;ITFG2
gsea,MAPK Family Signaling Cascades R-HSA-5683057,-0.3923565121211292,-1.9295483014625696,0.0,0.002345418559992453,0.228,83/266,23.30%,CALM1;UBB;RPS27A;CAMK2B;NEFL;NF1;BRAF;SEPTIN7;PTK2;YWHAB;PSMD2;KBTBD7;PKN2;PPP2R1A;NRG2;PSMA4;TNRC6A;SOS1;RAPGEF2;AGO3;RASAL2;JUN;CAMK2A;TNRC6C;SPTBN1;VCL;PSMC2;PSMB3;PRKACB;XPO1;PSMD14;LAMTOR3;PEBP1;SEM1;RNMT;PSMC6;CUL3;AGO4;RASGRP1;UBC;MAPK1;PSMC1;TGFA;PSME2;PSMB11;PSME4;RBX1;BCL2L1;MAPK3;PSMD6;LRRC7;PSMB6;RAP1A;SPRED3;FGFR1;PSMA7;PDGFRA;CDC42EP3;ARL2;PSMB2;PPP1CB;RASA2;ABHD17B;PSMA2;GRIN2B;PSMC5;IL5RA;SPNS1;RCE1;TYK2;HRAS;LLGL1;PSMA1;DUSP6;PPP2CA;DUSP10;CSF2RA;FGFR3;CAMK2G;MAPK4;IL6ST;PTPN3;PSMC3
gsea,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.6055855576827135,-1.9280916480856378,0.0,0.0023737636873268565,0.23,9/21,16.90%,PTK2;XPO1;UHMK1;AKT1;MAPK1;TGFA;CDKN1B;MAPK3;CCND1
gsea,G-protein Mediated Events R-HSA-112040,-0.513019105751115,-1.9242813923965707,0.0,0.0024668531671275984,0.236,25/49,26.27%,CALM1;CAMK2B;CAMKK1;PRKAR1A;ADCY9;GNAQ;GNAL;PLCB1;CAMK2A;PRKAR2B;ADCY1;PRKACB;MAPK1;GRK2;ADCY2;PDE1B;ADCY5;PRKCD;PLCB3;AHCYL1;CAMK2G;PRKAR2A;PLCB2;NBEA;ADCY6
gsea,Negative Regulation Of MET Activity R-HSA-6807004,-0.6051317630801925,-1.9206505783041476,0.0,0.002553493128713572,0.242,11/21,15.17%,UBB;RPS27A;SH3GL1;SOS1;USP8;STAM;RNMT;PTPRJ;UBC;SH3KBP1;STAM2
gsea,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.46102473441056574,-1.9188201473657336,0.0,0.0026102790218496754,0.248,28/68,19.23%,UBB;RPS27A;SKP1;PSMD2;PSMA4;WWP1;PSMC2;FBXW7;PSMB3;SKP2;PSMD14;SEM1;PSMC6;CBFB;UBC;PSMC1;PSME2;PSMB11;PSME4;RBX1;PSMD6;PSMB6;CUL1;PSMA7;PSMB2;PSMA2;RUNX2;PSMC5
gsea,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.4517242523477918,-1.9176855169604998,0.0,0.002655025649570714,0.251,38/75,34.29%,UBB;RPS27A;POLR2G;POLR2E;PCNA;COPS8;TCEA1;PRPF19;CUL4B;CCNH;MNAT1;RPA3;UBC;COPS7A;RBX1;GTF2H5;POLR2K;GTF2H1;POLD3;CDK7;POLR2A;ERCC3;POLR2L;POLR2D;POLR2B;UVSSA;UBA52;COPS6;COPS5;POLR2C;AQR;COPS2;POLR2H;XAB2;ERCC8;RFC5;POLE3;COPS3
gsea,Intracellular Signaling By Second Messengers R-HSA-9006925,-0.38510734400190494,-1.9166762336655758,0.0,0.0026936722598565146,0.254,102/274,26.34%,CALM1;UBB;RPS27A;CBX6;CAMK2B;PRKCE;PSMD2;CAMKK1;PRKAR1A;ADCY9;SCMH1;PPP2R1A;NRG2;TNKS;PSMA4;TNRC6A;SOS1;AGO3;IRAK1;JUN;CAMK2A;TNRC6C;HDAC1;PSMC2;PRKAR2B;ADCY1;NEDD4;PSMB3;RICTOR;PRKACB;PSMD14;LAMTOR3;IL1RAP;SEM1;RNMT;PSMC6;SNAI2;AKT1;PHLPP1;AGO4;RPS6KB2;UBC;MAPK1;PSMC1;TGFA;CDKN1B;PIP5K1B;PSME2;PSMB11;PSME4;MTA3;PREX2;GRK2;CNOT6L;MAPK3;PSMD6;PSMB6;CSNK2B;ADCY2;FGFR1;PSMA7;PDGFRA;IER3;PDE1B;HDAC3;CHUK;RRAGB;CHD4;PSMB2;PSMA2;ADCY5;MTOR;PSMC5;LAMTOR5;LAMTOR1;PRKCD;RRAGA;TRIB3;PSMA1;AHCYL1;PPP2CA;MECOM;USP13;VAPA;KDM1A;FGFR3;PHC3;CAMK2G;PRKAR2A;PSMC3;RBBP7;LAMTOR4;PIK3R3;LAMTOR2;CHD3;PPP2R5D;CASP9;HDAC2;NBEA;ADCY6;UBA52;PSME3
gsea,NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.4910177127128993,-1.91569761084357,0.002188183807439825,0.002703022005620223,0.257,23/51,25.79%,TAF1D;H2AZ1;ARID4B;HDAC1;POLR2E;TBP;POLR1F;UBTF;CCNH;MNAT1;GTF2H5;POLR2K;POLR1H;GTF2H1;TTF1;CDK7;ERCC3;SAP130;POLR2L;SAP18;H2AJ;H2BC4;HDAC2
gsea,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.6375814159811317,-1.9147965287440223,0.002053388090349076,0.0027123157648823513,0.259,10/19,16.94%,TUBA1A;TUBB2A;TUBA4A;CCT7;TCP1;CCT5;TUBB4B;CCT8;TUBA1B;CCT6A
gsea,COPI-mediated Anterograde Transport R-HSA-6807878,-0.4758677438474055,-1.9144492697528932,0.0,0.0027157757926472223,0.259,34/72,28.86%,DYNLL1;ARF5;GOLGB1;CAPZA2;DYNLL2;ARCN1;NSF;SPTBN1;CAPZB;COPG2;RAB1B;NAPG;USO1;TMED7;ARF4;COPA;YKT6;ACTR1A;DCTN5;TMED2;COG3;ARF3;DCTN6;DCTN3;COPB2;DCTN4;COPZ1;DYNC1I2;CD55;COG6;NAPSA;KDELR1;COPB1;DCTN1
gsea,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.533154288524007,-1.9139813272290582,0.0,0.0027249762742142577,0.26,15/33,26.61%,UBB;RPS27A;SHARPIN;BIRC2;RACK1;UBC;TNFRSF1A;OTUD7B;CHUK;IKBKG;IKBKB;USP25;TAX1BP1;UBA52;CLIP3
gsea,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.5327991592115027,-1.9131595074788823,0.0,0.002757097969932908,0.264,17/34,18.87%,GNG3;GNB2;PRKAR1A;ADCY9;AQP4;PRKAR2B;ADCY1;RAB11FIP2;PRKACB;GNG11;GNAS;MYO5B;GNG10;ADCY2;GNG7;ADCY5;GNB5
gsea,Oncogenic MAPK Signaling R-HSA-6802957,-0.46933215632548464,-1.911641618039085,0.0,0.0027775756761321754,0.266,27/70,25.35%,CALM1;CAMK2B;NF1;BRAF;AKAP9;QKI;YWHAB;CAMK2A;VCL;FAM114A2;PEBP1;AP3B1;FXR1;MAPK1;MAPK3;RAP1A;SPRED3;PPP1CB;AGGF1;KDM7A;HRAS;DUSP6;DUSP10;CAMK2G;AGK;IQGAP1;DUSP7
gsea,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.44722146776462646,-1.9106941919200635,0.0,0.0028093527028438784,0.27,23/81,18.31%,UBB;RPS27A;UBE2N;PIAS1;SUMO2;CETN2;PCNA;COPS8;CUL4B;CCNH;MNAT1;RPA3;UBC;COPS7A;RBX1;GTF2H5;GTF2H1;POLD3;RAD23B;CDK7;ERCC3;RUVBL1;PARP2
gsea,Telomere Maintenance R-HSA-157579,-0.4511760858066931,-1.9100988089120448,0.0,0.0028409428058690416,0.273,28/67,27.61%,ATRX;H2AZ1;NOP10;POLR2G;POLR2E;PCNA;DKC1;TERF1;RPA3;BLM;CCNA1;POLR2K;FEN1;POLD3;POLR2A;RUVBL1;POLR2L;WRN;POLR2D;CCNA2;POLA1;POLR2B;ANKRD28;H2AJ;TERF2IP;H2BC4;NHP2;POLR2C
gsea,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.534164833176691,-1.9088793035432472,0.004166666666666667,0.002866671053354301,0.274,10/35,15.07%,CALM1;CAMK2B;BRAF;YWHAB;CAMK2A;VCL;PEBP1;MAPK1;MAPK3;RAP1A
gsea,mTORC1-mediated Signaling R-HSA-166208,-0.5754433805631421,-1.9086962942874603,0.002079002079002079,0.002858288974250926,0.274,13/24,23.77%,RPS6;YWHAB;RPS6KB1;LAMTOR3;EIF4B;EIF4G1;RRAGB;MTOR;LAMTOR5;LAMTOR1;RRAGA;LAMTOR4;LAMTOR2
gsea,PLC Beta Mediated Events R-HSA-112043,-0.5236689821133201,-1.9080941625973824,0.0,0.0028781731541081693,0.277,24/45,26.27%,CALM1;CAMK2B;CAMKK1;PRKAR1A;ADCY9;GNAQ;PLCB1;CAMK2A;PRKAR2B;ADCY1;PRKACB;MAPK1;GRK2;ADCY2;PDE1B;ADCY5;PRKCD;PLCB3;AHCYL1;CAMK2G;PRKAR2A;PLCB2;NBEA;ADCY6
gsea,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.6321567969722516,-1.9080929002049294,0.0019047619047619048,0.002869806371683436,0.277,4/18,4.25%,HSP90AA1;UBB;RPS27A;SOS1
gsea,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.5624148555137298,-1.90647976172265,0.002012072434607646,0.00289515265813752,0.28,13/28,28.34%,UBB;RPS27A;UBE2E1;UBC;USP9X;UBE2Q2;UBE2G2;USP5;UBA6;UBE2E3;UBE2A;UBA52;UBE2G1
gsea,Chromatin Modifying Enzymes R-HSA-3247509,-0.40192413321205556,-1.9051337553533856,0.0,0.0029315415240517366,0.282,102/201,34.43%,KMT2C;KDM5A;MORF4L2;H2AZ1;H2AC25;HDAC8;CLOCK;RPS2;ARID4B;ACTL6B;SMARCC2;KAT2B;KDM4C;ZZZ3;PBRM1;HDAC1;CDK4;BRD8;NSD1;KMT5A;PHF21A;PRDM16;SMARCA2;MRGBP;KAT7;NCOR1;NFKB1;SETD2;KMT2E;MTA3;SETD3;KDM6B;MBIP;KAT6B;PRMT6;KANSL1;SMARCD2;ATXN7L3;BRMS1L;ASH2L;CCND1;SMARCE1;CREBBP;ASH1L;DOT1L;RUVBL1;HDAC3;DPY30;ARID2;CHD4;SAP130;NCOA2;SETD6;KDM7A;PHF8;KANSL3;TAF10;MECOM;ATF7IP;KDM1A;SAP18;EHMT1;SGF29;ING3;RBBP7;NSD2;H2AJ;HAT1;TADA1;CHD3;TBL1XR1;SMARCD1;H2BC4;MSL2;HDAC2;KDM4D;SUV39H1;KMT2A;ING4;SUPT7L;TADA2B;NCOA1;NSD3;RIOX2;EP400;COPRS;ELP2;SETD7;KAT6A;MORF4L1;EZH2;JADE3;WDR77;HCFC1;DR1;KDELR2;KANSL2;SUZ12;PRDM9;ACTL6A;KAT2A;H2AZ2
gsea,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.4834343012565919,-1.904852931126651,0.0022222222222222222,0.0029286716998701955,0.283,25/54,28.32%,TAF1D;H2AZ1;ARID4B;HDAC1;POLR2E;TBP;POLR1F;UBTF;CCNH;MNAT1;GTF2H5;POLR2K;POLR1H;GTF2H1;TTF1;CDK7;ERCC3;SAP130;POLR2L;SAP18;H2AJ;H2BC4;HDAC2;SUV39H1;TAF1B
gsea,Ca-dependent Events R-HSA-111996,-0.5535775798391008,-1.904729824659439,0.0,0.0029258183689310773,0.284,19/33,26.27%,CALM1;CAMK2B;CAMKK1;PRKAR1A;ADCY9;CAMK2A;PRKAR2B;ADCY1;PRKACB;MAPK1;GRK2;ADCY2;PDE1B;ADCY5;PRKCD;CAMK2G;PRKAR2A;NBEA;ADCY6
gsea,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.5098042305709053,-1.9039256026005944,0.002066115702479339,0.0029396207522070002,0.285,21/47,26.33%,UBB;RPS27A;CCNT2;CDK9;HDAC1;TRIM33;FURIN;SMAD4;UBC;NCOR1;MAPK1;USP9X;SMAD3;MAPK3;UBE2D3;CDK8;SKI;TFDP2;COL1A2;CCNK;UBA52
gsea,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.41533444601209457,-1.903074007209763,0.0,0.00293675244300943,0.285,55/159,21.94%,DYNLL1;ARF5;KIF26B;CAPZA2;SCOC;KIF5B;DYNLL2;KIF3A;KIFAP3;MAN1A2;ARCN1;NSF;TRIP11;KIF21A;CAPZB;RHOBTB3;M6PR;TMF1;COPG2;RAB1B;GCC2;NAPG;BICD1;KIF23;RAB6A;TMED7;KIF2A;ARF4;RIC1;COPA;AGPAT3;VPS53;CENPE;KIFC2;YKT6;ACTR1A;NAA38;DCTN5;VAMP3;NBAS;TMED2;RAB9B;COG3;ARF3;DCTN6;DCTN3;COPB2;MAN2A2;STX16;KIF22;DCTN4;SEC22B;COPZ1;RAB33B;MAN1C1
gsea,HIV Elongation Arrest And Recovery R-HSA-167287,-0.5432825818358868,-1.902515532135491,0.002061855670103093,0.00296147473006166,0.286,16/29,24.56%,CCNT2;ELOC;ELOB;POLR2G;CDK9;POLR2E;TCEA1;GTF2F1;POLR2K;SSRP1;POLR2A;NELFB;POLR2L;POLR2D;POLR2B;CCNK
gsea,Neutrophil Degranulation R-HSA-6798695,-0.3695071095824457,-1.9021380432582589,0.0,0.002958560632911079,0.286,106/339,25.72%,HSP90AA1;FTH1;EEF1A1;DYNLL1;CST3;HSPA8;PPIA;HSP90AB1;ITM2C;ATP6V0C;ATP6V1D;TMEM30A;CYFIP1;ALDOC;IQGAP2;RAB3A;PSMD2;SNAP25;ACTR2;ACTR1B;NDUFC2;COMMD3;PGRMC1;ILF2;ATP11B;CEP290;DEGS1;SRP14;ATP6AP2;KCNAB2;GSTP1;PDAP1;HUWE1;VCL;PSMC2;SCAMP1;SVIP;ROCK1;RAB14;ARPC5;CAP1;PSMD14;LAMTOR3;ERP44;RAB6A;ARL8A;NDUFA2;PRDX5;PTPRJ;CAB39;ARSA;TUBB4B;MAPK1;CCT8;NFKB1;RAP2B;PA2G4;LTA4H;PKM;DNAJC3;CD47;TXNDC5;PSMD6;GNPDA1;DDOST;LRRC7;CSNK2B;HMGB1;STK11IP;RAP1A;EEF2;ADGRE5;CDK13;RAB9B;CREG1;CTSB;PSMA2;CTSA;MAGT1;LAMTOR1;KRT1;PRKCD;DNAJC5;GM2A;GDI2;TRAPPC1;NME2;ATP11A;VAPA;TMBIM1;PSMC3;CCT2;ACLY;HOOK3;LAMTOR2;IQGAP1;TOM1;APAF1;CD55;NPC2;CKAP4;DIAPH1;ENPP4;PRDX4;CYBA;RAB24
gsea,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.4608575264774748,-1.9003270338807132,0.0,0.0030159827002305506,0.29,32/86,26.36%,HSP90AA1;CALM1;CYFIP1;PTK2;PTK2B;NCKAP1;PKN2;BAIAP2;ROCK2;ROCK1;WASF1;RICTOR;PRKACB;PXDN;ELMO2;AKT1;ABI1;CAV1;CTNNB1;MTOR;PRKCD;VAV3;TRIB3;VEGFA;HRAS;DOCK1;AHCYL1;ABI2;NCK1;MAPK11;CYBA;WASF3
gsea,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",-0.585779062716798,-1.8980213782493973,0.0,0.0030676122345904295,0.293,9/30,7.41%,GRIA2;CAMK2B;TSPAN7;AP2M1;EPB41L1;GRIA3;NSF;CAMK2A;AKAP5
gsea,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.4629754379987257,-1.8969523466667302,0.0,0.0031080454756127487,0.296,27/61,26.34%,UBB;RPS27A;PSMD2;PSMA4;FZD2;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;FZD1;PSMA7;PSMB2;PSMA2;PSMC5;PSMA1;PSMC3;PARD6A;UBA52;PSME3
gsea,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.42500991997337906,-1.8968200546476428,0.00199203187250996,0.0030993150107936117,0.296,46/154,15.21%,NRGN;CALM1;GRIA2;CAMK2B;TSPAN7;NEFL;GNG3;AP2M1;GNB2;EPB41L1;CAMKK1;PRKAR1A;GRIA3;ADCY9;GNAL;PLCB1;NSF;CAMK2A;LIN7B;PRKAR2B;ADCY1;GABRA3;AKAP5;GABRG2;PRKACB;ARHGEF9;GABRA1;PPM1F;PPM1E;KCNJ4;LIN7C;GABRB3;PRKAG2;GNG11;GLRB;MAPK1;GNG10;KCNJ10;GABBR2;GABRA4;GABRB2;MAPK3;CASK;LRRC7;GRIN2C;ADCY2
gsea,tRNA Processing In Nucleus R-HSA-6784531,-0.48360867909504746,-1.8908293744382056,0.0019342359767891683,0.003350897326132394,0.316,24/51,25.80%,TPR;DDX1;RANBP2;RTCB;TRNT1;POP5;NUP98;NUP88;RAN;RPP14;NUP153;NUP155;RPP30;CSTF2;RPP38;RPP25;RTRAF;NDC1;NUP37;NUP54;FAM98B;SEH1L;TSEN15;SEC13
gsea,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.6479788705227565,-1.8904684807357326,0.0020833333333333333,0.0033685723689791894,0.318,8/15,15.17%,UBB;RPS27A;SH3GL1;STAM;RNMT;UBC;SH3KBP1;STAM2
gsea,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.5451622220913243,-1.8899544296918727,0.004048582995951417,0.0033807569867041177,0.32,12/28,20.68%,HNRNPA2B1;PPIA;PKN2;HNRNPDL;HSPA9;AURKAIP1;TCP1;PSME2;RALA;GSTO1;SOD1;RPLP0
gsea,DAG And IP3 Signaling R-HSA-1489509,-0.5415925506394381,-1.8874958347424582,0.00398406374501992,0.0034681516217272374,0.328,20/37,26.27%,CALM1;CAMK2B;PRKCE;CAMKK1;PRKAR1A;ADCY9;CAMK2A;PRKAR2B;ADCY1;PRKACB;GRK2;ADCY2;PDE1B;ADCY5;PRKCD;AHCYL1;CAMK2G;PRKAR2A;NBEA;ADCY6
gsea,Deubiquitination R-HSA-5688426,-0.3851378368877385,-1.8872780109476734,0.0,0.003469268722681218,0.328,70/226,23.30%,UBB;RPS27A;VDAC2;HIF1A;PSMD2;USP32;UCHL1;MBD5;TOMM20;H2AC25;USP34;MAT2B;OTUB1;TNKS;PSMA4;BIRC2;USP33;KAT2B;PSMC2;USP8;STAM;PSMB3;SKP2;PSMD14;SEM1;ASXL2;PSMC6;USP14;USP24;OTUD7A;SMAD4;BRCC3;VCPIP1;ZRANB1;UBC;USP19;PSMC1;USP9X;CCNA1;RHOT1;SMAD3;PSME2;PSMB11;PSME4;ATXN3;PSMD6;PSMB6;USP47;STAM2;RAD23B;OTUD7B;UCHL5;PSMA7;RUVBL1;NEDD8;PSMB2;PSMA2;IKBKG;PSMC5;STAMBP;CCNA2;RCE1;TAF10;PSMA1;USP15;USP5;USP13;MYSM1;BABAM2;PSMC3
gsea,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.4852574263572948,-1.8863206880902692,0.0022471910112359553,0.0035024632849513146,0.331,17/42,26.33%,UBB;RPS27A;EYA1;BAZ1B;EYA4;UBE2N;HERC2;BRCC3;UBC;UBXN1;MDC1;MAPK8;UBE2I;BABAM2;NSD2;H2BC4;UBA52
gsea,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.5310936040917906,-1.8862041300938357,0.002127659574468085,0.003492814625764121,0.331,16/33,26.33%,UBB;RPS27A;CCNT2;CDK9;HDAC1;FURIN;SMAD4;UBC;MAPK1;SMAD3;MAPK3;CDK8;TFDP2;COL1A2;CCNK;UBA52
gsea,DNA Double Strand Break Response R-HSA-5693606,-0.4825980695065856,-1.8861376462239299,0.0022675736961451248,0.003483218981187846,0.331,17/43,26.33%,UBB;RPS27A;EYA1;BAZ1B;EYA4;UBE2N;HERC2;BRCC3;UBC;UBXN1;MDC1;MAPK8;UBE2I;BABAM2;NSD2;H2BC4;UBA52
gsea,MHC Class II Antigen Presentation R-HSA-2132295,-0.4462154942017863,-1.8858425447280205,0.0,0.0034789792374943372,0.332,29/80,20.83%,DYNLL1;AP2M1;CAPZA2;ACTR1B;KIF5B;DYNLL2;KIF3A;KIFAP3;CANX;CTSF;CLTC;SEC24A;CAPZB;KIF23;CTSL;KIF2A;CENPE;ACTR1A;DCTN5;AP1G1;AP1S1;SEC23A;DCTN6;CTSB;DCTN3;CLTA;CTSA;KIF22;DCTN4
gsea,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.4787868257603589,-1.8807184300636899,0.002079002079002079,0.0036598717838128066,0.346,19/52,19.23%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;CBFB;UBC;PSMC1;PSME2;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5
gsea,Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.5610949208315335,-1.878770728189362,0.0021551724137931034,0.0037395645393391214,0.352,12/25,23.68%,HSP90AA1;FTH1;HSP90B1;APOE;COL4A2;COL4A1;JCHAIN;CALR;MASP1;C1D;HSPH1;COL1A2
gsea,Pyruvate Metabolism R-HSA-70268,-0.5635343641827749,-1.8779443246254652,0.0040650406504065045,0.0037557031212031053,0.353,11/26,18.54%,LDHB;BSG;PCDHB16;HAGH;PDHX;PDHB;MPC2;GSTZ1;PLPP6;PDPR;GLO1
gsea,MAPK1/MAPK3 Signaling R-HSA-5684996,-0.384580172974306,-1.8771628787056835,0.0,0.003787491731347423,0.355,74/233,24.15%,CALM1;UBB;RPS27A;CAMK2B;NEFL;NF1;BRAF;PTK2;YWHAB;PSMD2;KBTBD7;PPP2R1A;NRG2;PSMA4;SOS1;RAPGEF2;RASAL2;CAMK2A;SPTBN1;VCL;PSMC2;PSMB3;PSMD14;LAMTOR3;PEBP1;SEM1;RNMT;PSMC6;CUL3;RASGRP1;UBC;MAPK1;PSMC1;TGFA;PSME2;PSMB11;PSME4;RBX1;BCL2L1;MAPK3;PSMD6;LRRC7;PSMB6;RAP1A;SPRED3;FGFR1;PSMA7;PDGFRA;ARL2;PSMB2;PPP1CB;RASA2;ABHD17B;PSMA2;GRIN2B;PSMC5;IL5RA;SPNS1;RCE1;TYK2;HRAS;LLGL1;PSMA1;DUSP6;PPP2CA;DUSP10;CSF2RA;FGFR3;CAMK2G;IL6ST;PTPN3;PSMC3;LAMTOR2;IQGAP1
gsea,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.5584104562690786,-1.8771570443949002,0.002178649237472767,0.0037772552672086465,0.355,6/25,10.83%,HSP90AA1;UBB;RPS27A;BIRC2;PELI1;UBC
gsea,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.4609092601260938,-1.8747733421552795,0.0019083969465648854,0.003881860174109042,0.364,24/66,22.77%,FTH1;HSPA8;VAMP2;GOLGB1;NECAP1;TBC1D8B;CHMP2A;CLTC;PICALM;M6PR;AP3B1;CLVS2;SH3D19;YIPF6;TXNDC5;AP1G1;AP1S1;BLOC1S1;CLTA;PUM1;TPD52L1;BLOC1S6;TFRC;SNAPIN
gsea,Long-term Potentiation R-HSA-9620244,-0.60495304017057,-1.8734731727717169,0.003898635477582846,0.003949477990834168,0.37,6/23,4.85%,NRGN;CALM1;GRIA2;CAMK2B;NEFL;CAMK2A
gsea,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.43822946426968495,-1.873300813653654,0.0,0.003938889577990109,0.37,31/86,20.01%,UBB;RPS27A;MAML2;PSMD2;PSMA4;KAT2B;PSMC2;PSMB3;PSMD14;BRD2;SEM1;PSMC6;SMAD4;CBFB;UBC;PSMC1;SMAD3;PSME2;PSMD6;PSMB6;MAML3;PSMA7;YAP1;ITGA4;CCND1;CREBBP;PSMB2;CTNNB1;PSMA2;PSMC5;CXXC1
gsea,Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.4397789023273036,-1.8732162914474928,0.0,0.0039335334896346726,0.37,32/87,24.56%,UBB;RPS27A;CCNT2;TGFB3;CDK9;PPP1R15A;HDAC1;TRIM33;PPP1CA;XPO1;FURIN;SMAD4;UBC;ZFYVE9;NCOR1;MAPK1;USP9X;ITGB8;SMAD3;TGFB2;MAPK3;UBE2D3;UCHL5;NEDD8;CDK8;PPP1CB;SKI;USP15;TFDP2;COL1A2;PARD6A;CCNK
gsea,Glutathione Conjugation R-HSA-156590,-0.5610498343993524,-1.8730192052139667,0.0020408163265306124,0.003928205967083799,0.37,11/26,21.02%,PRNP;MGST3;GSTM1;GSTP1;ESD;GSTM5;GSTZ1;GSTM4;AKR1A1;GSTO1;CHAC2
gsea,p75NTR Signals Via NF-kB R-HSA-193639,-0.6368085700329341,-1.8714951155323793,0.002105263157894737,0.003974388498723544,0.376,7/15,16.37%,UBB;RPS27A;IRAK1;PRKCI;UBC;NFKB1;SQSTM1
gsea,Spry Regulation Of FGF Signaling R-HSA-1295596,-0.6360413159604292,-1.8694041058675313,0.005905511811023622,0.004040864094206654,0.382,7/16,14.10%,UBB;RPS27A;BRAF;PPP2R1A;UBC;MAPK1;MAPK3
gsea,ER To Golgi Anterograde Transport R-HSA-199977,-0.42414341833610253,-1.8665869498210421,0.0,0.004122350764843745,0.387,56/122,29.51%,DYNLL1;ARF5;GOLGB1;CAPZA2;DYNLL2;ARCN1;NSF;TFG;SPTBN1;SEC24A;CAPZB;CNIH2;COPG2;RAB1B;NAPG;MCFD2;USO1;PREB;TMED7;TRAPPC5;ARF4;COPA;TGFA;LMAN1;YKT6;ACTR1A;SEC23IP;DCTN5;MIA3;LMAN2;SEC23A;TMED2;COG3;ARF3;DCTN6;DCTN3;COPB2;DCTN4;TRAPPC4;SEC22B;TRAPPC1;COPZ1;ANKRD28;DYNC1I2;CD55;COG6;SEC22A;SEC13;SEC24D;NAPSA;KDELR1;COPB1;DCTN1;TRAPPC2L;SCFD1;TRAPPC6B
gsea,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.5100350106848642,-1.8665567962453977,0.0037593984962406013,0.004111473849896927,0.387,16/37,23.64%,AP3M1;NOP56;LONP2;CCT7;FBXL5;FBXW7;TCP1;XRN2;CCT5;CCT8;FBXW2;CCT6A;HDAC3;SKIC2;CCT2;ARFGEF2
gsea,Antigen processing-Cross Presentation R-HSA-1236975,-0.4310974322606375,-1.8660100796957537,0.0022988505747126436,0.004121030103271483,0.389,36/85,26.76%,UBB;RPS27A;PSMD2;PSMA4;PSMC2;SEC61B;PSMB3;PSMD14;SEM1;PSMC6;NDUFA2;CTSL;UBC;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;HMGB1;VAMP3;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5;CALR;SEC22B;PSMA1;PSMC3;IKBKB;CYBA;UBA52;PSME3;S100A1
gsea,RAF/MAP Kinase Cascade R-HSA-5673001,-0.381938695346997,-1.8657352307059762,0.0,0.004125455582263346,0.389,72/230,24.15%,CALM1;UBB;RPS27A;CAMK2B;NEFL;NF1;BRAF;PTK2;YWHAB;PSMD2;KBTBD7;PPP2R1A;NRG2;PSMA4;SOS1;RAPGEF2;RASAL2;CAMK2A;SPTBN1;VCL;PSMC2;PSMB3;PSMD14;LAMTOR3;PEBP1;SEM1;RNMT;PSMC6;CUL3;RASGRP1;UBC;MAPK1;PSMC1;TGFA;PSME2;PSMB11;PSME4;RBX1;BCL2L1;MAPK3;PSMD6;LRRC7;PSMB6;RAP1A;SPRED3;FGFR1;PSMA7;PDGFRA;ARL2;PSMB2;PPP1CB;RASA2;ABHD17B;PSMA2;GRIN2B;PSMC5;IL5RA;SPNS1;RCE1;HRAS;LLGL1;PSMA1;DUSP6;PPP2CA;DUSP10;CSF2RA;FGFR3;CAMK2G;PTPN3;PSMC3;LAMTOR2;IQGAP1
gsea,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.46292728057831045,-1.8654254703896525,0.0020491803278688526,0.004139992511800052,0.391,32/79,28.54%,HSP90AA1;ACTG1;HSP90AB1;WIPF3;CYFIP1;PRKCE;PTK2;ACTR2;MYO5A;NCKAP1;BAIAP2;WASF1;ARPC5;ARPC2;ELMO2;MAPK1;ABI1;MAPK3;PRKCD;VAV3;DOCK1;AHCYL1;ACTR3;ABI2;NCK1;ARPC1A;MYH9;WASF3;GRB2;WASL;PIK3CB;MYO9B
gsea,CaM Pathway R-HSA-111997,-0.5486843469652609,-1.8650587857008436,0.001984126984126984,0.004134237211594457,0.391,18/31,26.27%,CALM1;CAMK2B;CAMKK1;PRKAR1A;ADCY9;CAMK2A;PRKAR2B;ADCY1;PRKACB;GRK2;ADCY2;PDE1B;ADCY5;PRKCD;CAMK2G;PRKAR2A;NBEA;ADCY6
gsea,Cyclin D Associated Events In G1 R-HSA-69231,-0.49985811761490306,-1.8649036961014223,0.0,0.004138593723020439,0.391,18/41,23.92%,UBB;RPS27A;SKP1;PPP2R1A;CDK4;SKP2;CCNH;MNAT1;UBC;CDKN1B;RB1;CUL1;CDK7;CCND1;PPP2CA;TFDP2;RBL2;CDKN2D
gsea,Regulation Of MECP2 Expression And Activity R-HSA-9022692,-0.5644975757353354,-1.864902575562336,0.001937984496124031,0.004127844128934671,0.391,9/29,11.34%,CALM1;CAMK2B;TNRC6A;AGO3;CAMK2A;TNRC6C;HDAC1;AGO4;NCOR1
gsea,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.5100997361990427,-1.8648741378574256,0.0020408163265306124,0.004117150232227587,0.391,20/36,34.52%,UBB;RPS27A;CETN2;COPS8;CUL4B;UBC;COPS7A;RBX1;RAD23B;RUVBL1;PARP2;UBA52;COPS6;COPS5;COPS2;YY1;INO80E;ACTL6A;COPS3;ACTR8
gsea,Ca2+ Pathway R-HSA-4086398,-0.47612635353893007,-1.8634903731328814,0.0,0.004161531854014151,0.394,16/56,13.03%,CALM1;PPP3CA;PPP3CB;PPP3R1;GNG3;GNB2;PLCB1;TNRC6A;AGO3;CAMK2A;TNRC6C;FZD2;AGO4;GNG11;GNG10;GNAO1
gsea,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.5365250658257689,-1.8616407165171522,0.004048582995951417,0.004250585253001591,0.404,14/27,22.74%,ELOC;ELOB;POLR2G;CDK9;POLR2E;TCEA1;GTF2F1;POLR2K;SSRP1;POLR2A;NELFB;POLR2L;POLR2D;POLR2B
gsea,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.5801464706797419,-1.8613925102577875,0.00205761316872428,0.004244634423387338,0.404,10/20,27.29%,UBB;RPS27A;CNTN1;UBC;APH1B;MIB1;JAG2;PSENEN;UBA52;NOTCH2
gsea,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.44660251908129817,-1.8609623817414813,0.0019880715705765406,0.004278421034603045,0.405,27/71,22.76%,TPR;SCMH1;PIAS1;SUMO2;SMC1A;RANBP2;CETN2;NSMCE3;SMC5;NSMCE4A;HERC2;SMC6;BLM;XRCC4;NUP98;NUP88;NUP153;NUP155;MDC1;NDC1;NUP37;NUP54;UBE2I;WRN;SEH1L;RAD52;PHC3
gsea,PCP/CE Pathway R-HSA-4086400,-0.43261678508874074,-1.8606196124989838,0.0,0.00427242945275766,0.405,28/83,19.23%,UBB;RPS27A;PFN1;AP2M1;PSMD2;PSMA4;FZD2;CLTC;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;UBC;PSMC1;PSME2;PSMB11;PSME4;RYK;PSMD6;PSMB6;FZD1;PSMA7;CLTA;PSMB2;PSMA2;WNT4;PSMC5
gsea,Deadenylation-dependent mRNA Decay R-HSA-429914,-0.4691621979522792,-1.86027581255769,0.0,0.004286220608912068,0.406,25/54,24.40%,SKIC3;EIF4A2;TUT4;CNOT4;EIF4A1;EXOSC9;EIF4B;EDC4;LSM4;DIS3;LSM7;DCP2;EIF4G1;CNOT6L;CNOT1;CNOT2;SKIC2;CNOT7;LSM2;DCP1A;PATL1;PAIP1;LSM6;CNOT6;CNOT11
gsea,Chromosome Maintenance R-HSA-73886,-0.41001459936027845,-1.8599473939542814,0.0,0.004290090626698987,0.407,34/92,26.23%,ATRX;NPM1;H2AZ1;NOP10;POLR2G;RSF1;POLR2E;PCNA;HJURP;DKC1;TERF1;ITGB3BP;RPA3;BLM;CCNA1;POLR2K;FEN1;POLD3;MIS18A;POLR2A;RUVBL1;POLR2L;WRN;POLR2D;CCNA2;POLA1;POLR2B;ANKRD28;RBBP7;H2AJ;CENPT;TERF2IP;H2BC4;NHP2
gsea,Interleukin-12 Signaling R-HSA-9020591,-0.5107900589157903,-1.858681106234011,0.004056795131845842,0.004333244807503374,0.41,13/33,21.28%,HNRNPA2B1;PPIA;PKN2;HNRNPDL;HSPA9;AURKAIP1;TCP1;PSME2;RALA;GSTO1;SOD1;RPLP0;TYK2
gsea,Dual Incision In GG-NER R-HSA-5696400,-0.4932306618802661,-1.8582575310214073,0.0,0.004341876719717867,0.412,12/41,18.31%,UBB;RPS27A;PCNA;CUL4B;RPA3;UBC;RBX1;GTF2H5;GTF2H1;POLD3;ERCC3;PARP2
gsea,PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,-0.5594571422946756,-1.8581313964024648,0.002257336343115124,0.004330912384567064,0.412,15/24,32.57%,HSP90AA1;POLR2G;POLR2E;POLR2K;POLR2A;HENMT1;POLR2L;POLR2D;POLR2B;MYBL1;POLR2C;MOV10L1;TDRKH;POLR2H;PIWIL2
gsea,Assembly Of HIV Virion R-HSA-175474,-0.6019245619696564,-1.8573866352525408,0.0020491803278688526,0.004373637637662935,0.415,7/17,14.10%,UBB;RPS27A;PPIA;VPS28;FURIN;UBC;TSG101
gsea,Toll-like Receptor Cascades R-HSA-168898,-0.4056025483300439,-1.8565949414986807,0.0,0.0043918301943480596,0.417,53/135,27.53%,UBB;RPS27A;HSP90B1;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;PELI2;IRAK1;JUN;BIRC2;TLR3;MAP2K6;EEA1;PELI1;USP14;FBXW11;NDUFA2;CTSL;UBC;MAPK1;NFKB1;PTPN4;PIK3C3;MAPK3;IRAK2;UBE2D3;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;CTSB;RBSN;IKBKG;S100B;MAP3K8;MAPK10;IKBKE;SARM1;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;S100A1;DUSP3;TAB2
gsea,GABA Receptor Activation R-HSA-977443,-0.5081620243458229,-1.8565086902843093,0.0020491803278688526,0.004390525920843713,0.418,27/48,26.27%,GNG3;GNB2;ADCY9;GNAL;ADCY1;GABRA3;GABRG2;ARHGEF9;GABRA1;KCNJ4;GABRB3;GNG11;GNG10;KCNJ10;GABBR2;GABRA4;GABRB2;ADCY2;GABRA5;GNG7;ADCY5;GNB5;GABRA2;KCNJ6;GNG2;GABRB1;ADCY6
gsea,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.45085664059979236,-1.8554381017073005,0.0,0.00440858529403746,0.42,21/59,26.33%,HSP90AA1;UBB;RPS27A;HSP90AB1;PCBP2;PDZD2;SIKE1;UBC;NFKB1;UBE2D3;HMGB1;NKIRAS1;CREBBP;CHUK;IKBKG;S100B;IKBKE;ATG12;IKBKB;TAX1BP1;UBA52
gsea,Unfolded Protein Response (UPR) R-HSA-381119,-0.431841146506463,-1.8550447460625534,0.0,0.004416900168945667,0.421,29/79,22.55%,HSP90B1;CEBPG;EIF2S2;HSPA5;HDGF;DNAJB9;CEBPB;MBTPS2;EXOSC9;PREB;SYVN1;KHSRP;DIS3;WFS1;DNAJC3;DCP2;ACADVL;MBTPS1;ATF4;CREB3L1;DNAJB11;TSPYL2;CALR;CXXC1;PDIA6;SSR1;NFYA;MYDGF;FKBP14
gsea,Signaling By VEGF R-HSA-194138,-0.44276248606894664,-1.8497880311032278,0.0,0.004588890656724827,0.432,34/94,26.36%,HSP90AA1;CALM1;CYFIP1;PTK2;PTK2B;NCKAP1;PKN2;BAIAP2;ROCK2;ROCK1;WASF1;RICTOR;PRKACB;PXDN;ELMO2;AKT1;AAMP;ABI1;CAV1;CTNNB1;MTOR;PRKCD;VAV3;TRIB3;VEGFA;HRAS;DOCK1;AHCYL1;ABI2;NCK1;FLT1;MAPK11;CYBA;WASF3
gsea,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.5365568346548941,-1.849029106133197,0.0019120458891013384,0.004625536400332385,0.435,14/33,23.41%,DYNLL1;CAPZA2;DYNLL2;CAPZB;BICD1;RAB6A;AGPAT3;ACTR1A;DCTN5;DCTN6;DCTN3;DCTN4;DYNC1I2;RAB3GAP1
gsea,Muscle Contraction R-HSA-397014,-0.39888990995985524,-1.8488425118734921,0.0,0.004618878420462892,0.435,40/151,22.80%,ATP1B1;ATP1A2;CALM1;CAMK2B;SCN2A;MYL6;AKAP9;CACNA2D2;TPM1;RYR2;PKN2;MYL12B;CACNA1H;ATP1B2;SCN3B;CAMK2A;ATP2B1;TMOD2;KAT2B;VCL;SCN3A;PXDN;KCNJ4;ATP2B4;KCND3;FXYD1;TRDN;ATP2A2;SCN1A;TRPC1;FKBP1B;ORAI2;KCNIP1;NPPA;GUCY1A2;AHCYL1;FXYD7;CACNG8;KCNIP2;CAMK2G
gsea,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.40869839260681623,-1.8471183693996036,0.0,0.004703064524760863,0.44,66/148,29.51%,DYNLL1;ARF5;GOLGB1;CAPZA2;B4GALT6;DYNLL2;MAN1A2;ARCN1;NSF;TFG;SPTBN1;SEC24A;CAPZB;CNIH2;COPG2;RAB1B;ST6GAL1;NAPG;MCFD2;USO1;FUT8;PREB;ST8SIA3;TMED7;TRAPPC5;ARF4;COPA;TGFA;LMAN1;MANEA;YKT6;ACTR1A;SEC23IP;DCTN5;MIA3;LMAN2;SEC23A;TMED2;COG3;ARF3;DCTN6;DCTN3;COPB2;MAN2A2;DCTN4;B4GALT4;TRAPPC4;SEC22B;TRAPPC1;COPZ1;MAN1C1;ST8SIA2;ANKRD28;DYNC1I2;CD55;COG6;SEC22A;SEC13;SEC24D;NAPSA;KDELR1;COPB1;DCTN1;TRAPPC2L;SCFD1;TRAPPC6B
gsea,Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,-0.6007249355414372,-1.8426506940789664,0.0,0.004882191216380375,0.445,8/18,13.23%,MYL6;MYL12B;ROCK2;RHOB;ROCK1;ARHGEF12;MYH10;LIMK2
gsea,FLT3 Signaling In Disease R-HSA-9682385,-0.5519226530056299,-1.8417343563697874,0.0019723865877712033,0.004913000114614117,0.446,9/26,13.20%,UBB;RPS27A;GOLGB1;SOS1;TRIP11;SPTBN1;ZMYM2;UBC;BCL2L1
gsea,NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.6304125096939166,-1.8408937953912206,0.006072874493927126,0.004915191628056658,0.447,7/15,16.37%,UBB;RPS27A;ITGB3BP;UBC;APH1B;MAPK8;SQSTM1
gsea,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.4903877367455453,-1.8352722147375222,0.004166666666666667,0.005201340033813477,0.46,26/54,28.54%,ACTG1;WIPF3;CYFIP1;PTK2;ACTR2;MYO5A;NCKAP1;BAIAP2;WASF1;ARPC5;ARPC2;ELMO2;MAPK1;ABI1;MAPK3;VAV3;DOCK1;ACTR3;ABI2;NCK1;ARPC1A;MYH9;WASF3;GRB2;WASL;MYO9B
gsea,Signaling By NOTCH1 R-HSA-1980143,-0.44199997459878226,-1.8338525508585481,0.0,0.005273636340060339,0.463,31/71,26.33%,UBB;RPS27A;MAML2;SKP1;HIF1A;CNTN1;HDAC8;KAT2B;HDAC1;TLE4;FBXW7;HEY1;UBC;APH1B;NCOR1;RBX1;MIB1;CUL1;MAML3;CREBBP;HDAC3;CDK8;HEY2;TLE1;JAG2;PSENEN;HES5;TBL1XR1;HDAC2;NBEA;UBA52
gsea,Signaling By ERBB4 R-HSA-1236394,-0.4611655914957205,-1.8332989509667634,0.0020242914979757085,0.005279644159506003,0.464,16/55,12.30%,UBB;RPS27A;APOE;STMN1;PGR;NRG2;SOS1;WWP1;NEDD4;GABRG2;GABRA1;GABRB3;UBC;APH1B;NCOR1;GABRB2
gsea,MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.5611297874500228,-1.8327636321005663,0.004158004158004158,0.0052903211461705155,0.465,15/24,31.12%,POLR2G;AGO3;POLR2E;AGO4;RAN;POLR2K;POLR2A;POLR2L;POLR2D;POLR2B;PRKRA;DICER1;POLR2C;POLR2H;BCDIN3D
gsea,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",-0.6028408043783644,-1.8322904213020812,0.003838771593090211,0.0053103203388708276,0.467,6/21,4.85%,CALM1;GRIA2;CAMK2B;NEFL;GRIA3;CAMK2A
gsea,Signaling By RAF1 Mutants R-HSA-9656223,-0.520693044801011,-1.8315272392597977,0.004123711340206186,0.005344249819527108,0.469,9/33,15.07%,CALM1;CAMK2B;BRAF;YWHAB;CAMK2A;VCL;MAPK1;MAPK3;RAP1A
gsea,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.5001824788731696,-1.8307018465875282,0.0,0.005392008887262564,0.471,14/38,19.21%,UBB;RPS27A;UBE2N;IRAK1;USP14;UBC;NFKB1;IRAK2;HMGB1;NKIRAS1;TAB3;CHUK;IKBKG;S100B
gsea,Condensation Of Prophase Chromosomes R-HSA-2299718,-0.5867120194203385,-1.830070051391404,0.0,0.005397659947947579,0.471,12/19,27.38%,H2AZ1;SET;KMT5A;RB1;NCAPG2;NCAPH2;MCPH1;PHF8;RAB33B;H2AJ;H2BC4;SMC4
gsea,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.46332450067543063,-1.829841356870162,0.001834862385321101,0.005407925901706182,0.472,22/69,15.21%,NRGN;CALM1;GRIA2;CAMK2B;NEFL;CAMKK1;PRKAR1A;GRIA3;CAMK2A;LIN7B;PRKAR2B;ADCY1;PRKACB;PPM1F;PPM1E;LIN7C;PRKAG2;MAPK1;MAPK3;CASK;LRRC7;GRIN2C
gsea,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,-0.6471950096715067,-1.8291649528251634,0.0,0.0054274045185236305,0.475,5/16,4.84%,GRIA2;TSPAN7;AP2M1;GRIA3;NSF
gsea,RHO GTPases Activate Formins R-HSA-5663220,-0.4087734344451117,-1.8288082677720348,0.0,0.005446790158649825,0.478,20/104,12.53%,ACTG1;DYNLL1;RPS27;DIAPH2;PFN1;TAOK1;DYNLL2;PPP2R1A;RHOB;RANBP2;AHCTF1;CKAP5;XPO1;ITGB3BP;SRGAP2;KIF2A;PFN2;NUP98;CENPE;RCC2
gsea,RHO GTPase Cycle R-HSA-9012999,-0.3650793952226677,-1.8286482891101927,0.0,0.005443039289381883,0.478,131/409,26.08%,HSP90AA1;CCDC88A;ACTG1;KTN1;DIAPH2;HSP90AB1;CKB;GJA1;WIPF3;CYFIP1;IQGAP2;FGD4;DOCK11;RNF20;PHIP;ERBIN;PTK2B;SYDE1;CDC42BPA;RALGAPA1;NCKAP1;NDUFA5;TRA2B;PKN2;BAIAP2;SLK;MYO9A;ROCK2;ARHGAP5;MACO1;ANKFY1;SLC4A7;DOCK3;SOS1;RHOB;RASAL2;FAM135A;CCT7;ARHGEF4;TIAM1;SPTBN1;CLTC;ARHGAP44;CAPZB;WDR11;PICALM;STAM;PRPF38B;ROCK1;ARHGAP12;WASF1;TMEM59;FNBP1L;TMEM87A;MSI2;ARHGEF9;DOCK10;ARHGAP32;ITSN2;CUL3;KIF14;ELMO2;ARHGAP21;UACA;ARHGEF12;SRGAP2;CCDC115;MTMR1;NHS;RRAS2;USP9X;RBM15;TXNL1;LMAN1;SRRM1;REPS1;ABR;DOCK7;YKT6;TUBA1B;ABI1;PREX2;CAV1;VAMP3;STAM2;PLEKHG5;LETM1;ARMCX3;FAM91A1;HSPE1;CDC42EP3;CCT6A;SLITRK5;DOCK4;CCDC187;FMNL2;SPATA13;STARD8;SOWAHC;ARHGEF26;ATP6AP1;PKP4;LAMTOR1;DSG2;SRGAP1;VAV3;OPHN1;C1QBP;ABCD3;KCTD13;DOCK1;RHOU;SH3PXD2A;TFRC;ARHGEF2;ABI2;CCT2;PIK3R3;PARD6A;NCK1;FILIP1;IQGAP1;ITSN1;CKAP4;DIAPH1;GNA13;CYBA;ACTN1;WDR91;TMPO;TOR1AIP1
gsea,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.5273127778429552,-1.8263371613729882,0.0038910505836575876,0.005554852790360433,0.485,15/31,22.34%,TPR;GNL3;RANBP2;PBRM1;XPO1;NUP98;NUP88;RAN;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;BLOC1S6
gsea,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.5273127778429552,-1.8263371613729882,0.0038910505836575876,0.005554852790360433,0.485,15/31,22.34%,TPR;GNL3;RANBP2;PBRM1;XPO1;NUP98;NUP88;RAN;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;BLOC1S6
gsea,Gluconeogenesis R-HSA-70263,-0.5443242791209665,-1.8258040759889202,0.006160164271047228,0.005578329971150258,0.485,11/24,22.87%,ALDOC;MDH2;MDH1;SLC25A11;TPI1;GNPDA1;ENO2;ENO1;GOT2;SLC25A13;PCK2
gsea,TNF Signaling R-HSA-75893,-0.48500060043931464,-1.8243393148687976,0.002066115702479339,0.005615392489764592,0.488,19/42,27.53%,UBB;RPS27A;SHARPIN;BIRC2;NSMAF;RACK1;UBC;BAG4;TAB3;TNFRSF1A;OTUD7B;CHUK;IKBKG;IKBKB;USP25;TAX1BP1;UBA52;CLIP3;TAB2
gsea,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.5200394277454923,-1.8200828350570564,0.0,0.005907339189117671,0.512,15/33,23.21%,SLC25A4;TPR;PSIP1;SLC25A5;RANBP2;BANF1;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;SGIP1
gsea,Interferon Signaling R-HSA-913531,-0.3999992327981419,-1.817226299887544,0.0,0.006047965684269837,0.519,40/128,23.28%,UBB;RPS27A;TPR;CAMK2B;EIF4G2;EIF4A2;BCL11B;GNL3;ABCE1;FLNB;UBE2N;PIAS1;PDZD2;CAMK2A;RANBP2;EIF4A1;UBE2E1;NEDD4;TRIM35;UBC;NUP98;NUP88;SAMHD1;EIF4G1;NUP153;IFIT2;MAPK3;NUP155;ARIH1;EIF4G3;NDC1;NUP37;NUP54;PRKCD;TYK2;PPM1B;SEH1L;CAMK2G;SGIP1;TRIM46
gsea,Signaling By TGFB Family Members R-HSA-9006936,-0.41192277268081295,-1.8151148859431556,0.0,0.006129000807243908,0.525,49/109,33.78%,UBB;RPS27A;CCNT2;TGFB3;CDK9;PPP1R15A;HDAC1;TRIM33;PPP1CA;XPO1;FURIN;SMAD4;ACVR2A;UBC;ZFYVE9;NCOR1;MAPK1;USP9X;ITGB8;SMAD3;TGFB2;MAPK3;UBE2D3;UCHL5;NEDD8;CDK8;PPP1CB;SKI;GREM2;USP15;BMPR1B;TFDP2;COL1A2;PARD6A;CCNK;INHBA;UBA52;UBE2M;SMAD1;BMPR1A;SNW1;BAMBI;TGIF2;BMPR2;CGN;STUB1;ARHGEF18;E2F4;BMP2
gsea,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.5143614825638279,-1.8136437601261528,0.0,0.006209657261419035,0.534,20/37,26.27%,GNG3;GNB2;PRKAR1A;KCNG2;PRKAR2B;AKAP5;PRKACB;GNG11;GNAS;GNG10;RAP1A;KCNB1;GNG7;ADCY5;KCNS3;GNB5;PRKAR2A;IQGAP1;GNG2;ADCY6
gsea,Signaling By Hippo R-HSA-2028269,-0.5613876603549559,-1.8080607318142936,0.004219409282700422,0.006587739622991402,0.553,7/20,19.71%,YWHAE;YWHAB;AMOTL1;WWC1;CASP3;YAP1;TJP1
gsea,Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.5389654801843919,-1.806608953517632,0.0,0.006684960724627298,0.556,16/26,26.27%,GNG3;GNB2;PRKAR1A;ADCY9;PRKAR2B;ADCY1;PRKACB;GNG11;GNAS;GNG10;ADCY2;GNG7;ADCY5;PRKAR2A;GNG2;ADCY6
gsea,RHO GTPases Activate PAKs R-HSA-5627123,-0.5908614718625852,-1.8057750791855165,0.008016032064128256,0.006754783410018149,0.557,9/19,26.22%,CALM1;MYL6;PKN2;MYL12B;MYH10;PPP1CB;PPP1R12B;PPP1R12A;MYH9
gsea,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.4073097422425177,-1.8055299538877863,0.002242152466367713,0.0067615514175534885,0.559,26/88,25.07%,SPARCL1;KTN1;CST3;PPP3CA;HSP90B1;APOE;TMEM132A;DMTF1;CHGB;VGF;MFGE8;SCG2;WFS1;DNAJC3;FAM20A;MIA3;RCN1;EVA1A;MBTPS1;CXXC1;PCSK9;PDIA6;SERPIND1;CKAP4;CSF1;APLP2
gsea,Regulation Of TP53 Degradation R-HSA-6804757,-0.49307699459866117,-1.8042770720274082,0.0021008403361344537,0.00684428611572832,0.563,11/34,21.96%,UBB;RPS27A;PPP2R1A;RICTOR;AKT1;UBC;CCNA1;CCNG1;MTOR;CCNA2;PPP2CA
gsea,Cellular Senescence R-HSA-2559583,-0.4012516588848761,-1.8037496246463045,0.0,0.006864197208236911,0.563,48/122,28.94%,UBB;RPS27A;CBX6;H2AZ1;MAP2K7;TNIK;SCMH1;TNRC6A;AGO3;JUN;ANAPC4;TNRC6C;CDK4;UBE2E1;CEBPB;MAP2K6;TERF1;CDC26;AGO4;UBC;MAPK1;CCNA1;NFKB1;CDKN1B;RB1;MAPK3;MINK1;KDM6B;MAPK8;ANAPC1;MAPK10;CCNA2;EHMT1;PHC3;MAPK9;TFDP2;RBBP7;H2AJ;CDKN2D;ANAPC16;TERF2IP;MAPK11;H2BC4;UBA52;ETS2;CBX8;E2F3;ANAPC7
gsea,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.4216175763627159,-1.8034218628547278,0.0,0.006875116927754395,0.564,14/86,5.56%,CALM1;SLC1A3;AHCYL2;SLC4A4;SLC6A15;SLC4A10;SLC7A6;SLC15A2;SLC25A22;SLC4A7;SLC7A10;SLC1A2;SLC17A7;SLC9A7
gsea,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.5407359233438751,-1.8008318096723182,0.007677543186180422,0.007068014570245054,0.574,11/26,22.80%,CALM1;CAMK2B;NEFL;CAMK2A;MAPK1;MAPK3;LRRC7;GRIN2B;HRAS;LLGL1;CAMK2G
gsea,TCR Signaling R-HSA-202403,-0.4055299850972283,-1.7993257936793565,0.0,0.0071625793271241885,0.578,30/100,19.23%,UBB;RPS27A;SKP1;PSMD2;PKN2;UBE2N;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;FBXW11;PTPRJ;UBC;PSMC1;NFKB1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;CUL1;ENAH;PSMA7;CHUK;PSMB2;PSMA2;IKBKG;PSMC5
gsea,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.4820579036388586,-1.79778162193742,0.004140786749482402,0.007221356801404658,0.579,15/40,22.16%,TPR;TOP1;SUMO2;RANBP2;TOP2B;PCNA;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;UBE2I;SEH1L
gsea,Presynaptic Function Of Kainate Receptors R-HSA-500657,-0.587405425389991,-1.7965213364192436,0.0,0.007297503968586421,0.581,10/18,25.76%,GNG3;GNB2;PLCB1;GNG11;GNG10;GNG7;GNB5;PLCB3;PLCB2;GNG2
gsea,MTOR Signaling R-HSA-165159,-0.48612996971321554,-1.7956477443022922,0.0,0.00734690893228476,0.581,17/40,23.77%,RPS6;YWHAB;STRADA;RPS6KB1;LAMTOR3;EIF4B;AKT1;CAB39;PRKAG2;EIF4G1;RRAGB;MTOR;LAMTOR5;LAMTOR1;RRAGA;LAMTOR4;LAMTOR2
gsea,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.5040455085572324,-1.7952072990519716,0.009671179883945842,0.007356585499781489,0.582,14/33,22.16%,TPR;NPM1;RANBP1;RANBP2;XPO1;NUP98;NUP88;RAN;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L
gsea,Hemostasis R-HSA-109582,-0.3498989761073949,-1.7914306283428119,0.0,0.007628984689107247,0.592,131/429,25.84%,TMSB4X;ATP1B1;CALM1;DGKH;PPIA;YWHAZ;KIF26B;TSPAN7;PFN1;PRKCE;GNG3;BSG;MAFG;DOCK11;GNB2;TUBA4A;CAPZA2;PTK2;DGKI;SDC4;KIF5B;SLC7A6;CDC37L1;PDE10A;PRKAR1A;KIF3A;TGFB3;CLU;SELENOP;KIFAP3;GNAQ;PPP2R1A;ATP1B2;DOCK3;SLC7A10;SOS1;RHOB;F3;ATP2B1;HSPA5;MANF;RAB27B;KIF21A;HDAC1;CD9;TMX3;VCL;CAPZB;SERPING1;PRKAR2B;GRB14;PHF21A;JMJD1C;GTPBP2;RAB5A;CAP1;PRKACB;ABCC4;CYRIB;KIF23;DOCK10;CDK5;SLC7A11;SDC3;AKT1;S100A10;RASGRP1;F2RL2;KIF2A;GNG11;ATP2B4;GNAS;MAPK1;GNG10;AAMP;CENPE;KIFC2;VTI1B;DOCK7;CD47;TGFB2;CAV1;MAPK3;ATP2A2;RAP1A;ADRA2A;ITGA4;PDE1B;DOCK4;ORAI2;GNG7;JCHAIN;RBSN;GNB5;PCYOX1L;DGKE;OLA1;CD99L2;KIF22;PRKCD;VAV3;SOD1;GUCY1A2;SPNS1;VEGFA;HRAS;C1QBP;DOCK1;FAM3C;PPP2CA;KDM1A;DGKB;SERPIND1;TIMP3;PRKAR2A;EHD3;PIK3R3;ENDOD1;DAGLA;TRPC6;MFN1;GNA13;APLP2;SCCPDH;CARMIL1;KIF1B;ACTN1;PPP2R5D;GNG2;HDAC2;ITPK1
gsea,RHOH GTPase Cycle R-HSA-9013407,-0.49593352660508355,-1.7861958973429524,0.0,0.007996284278768454,0.604,18/34,30.48%,RALGAPA1;PKN2;ROCK2;SLC4A7;WDR11;ROCK1;TMEM59;UACA;TUBA1B;CAV1;VAMP3;FAM91A1;LAMTOR1;TFRC;NSFL1C;DBT;NIPSNAP2;ARHGDIA
gsea,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.39936956718358696,-1.7860375620948516,0.0,0.007995713481141111,0.607,46/118,27.53%,UBB;RPS27A;MEF2A;SKP1;MAP2K7;UBE2N;PPP2R1A;PELI2;IRAK1;JUN;BIRC2;MAP2K6;PELI1;USP14;FBXW11;NDUFA2;UBC;MAPK1;NFKB1;PTPN4;MAPK3;IRAK2;UBE2D3;CUL1;HMGB1;NKIRAS1;TAB3;MAPK8;CHUK;IKBKG;S100B;MAP3K8;MAPK10;IKBKE;SARM1;DUSP6;PPP2CA;MAPK9;IKBKB;DUSP7;MAPK11;PPP2R5D;UBA52;S100A1;DUSP3;TAB2
gsea,Sema3A PAK Dependent Axon Repulsion R-HSA-399954,-0.6051877172377064,-1.7856781664600612,0.00984251968503937,0.007999495164700984,0.607,3/15,2.82%,HSP90AA1;HSP90AB1;PKN2
gsea,EPHB-mediated Forward Signaling R-HSA-3928662,-0.5304630693648349,-1.7851933563847118,0.005940594059405941,0.008007600052668791,0.607,15/31,27.84%,ACTG1;PTK2;ACTR2;ROCK2;TIAM1;ROCK1;ARPC5;ARPC2;LIMK2;GRIN2B;HRAS;ACTR3;ITSN1;ARPC1A;WASL
gsea,PKMTs Methylate Histone Lysines R-HSA-3214841,-0.47174538336352406,-1.7846389560987606,0.0,0.00802432958334393,0.609,25/44,33.95%,KMT2C;NSD1;KMT5A;PRDM16;NFKB1;SETD2;KMT2E;SETD3;ASH2L;ASH1L;DOT1L;DPY30;SETD6;MECOM;ATF7IP;EHMT1;RBBP7;NSD2;SUV39H1;KMT2A;NSD3;SETD7;EZH2;SUZ12;PRDM9
gsea,DNA Repair R-HSA-73894,-0.34860900283672425,-1.7844971158786844,0.0,0.008019380494093545,0.609,108/275,34.54%,UBB;RPS27A;ASCC3;EYA1;H2AZ1;USP32;BAZ1B;EYA4;UBE2N;POLR2G;PIAS1;SUMO2;POLR2E;CETN2;PCNA;COPS8;TCEA1;HERC2;PRPF19;CUL4B;CCNH;MNAT1;SEM1;TERF1;LRIF1;RPA3;TDP2;OGG1;PARG;BLM;BRCC3;XRCC4;UBC;SPIDR;USP1;CCNA1;COPS7A;RBX1;GTF2H5;POLR2K;UBXN1;FEN1;RAD17;GTF2H1;POLD3;RAD23B;CDK7;MDC1;POLR2A;ERCC3;MAPK8;FANCA;RUVBL1;MBD4;PARP2;FANCE;UBE2I;REV3L;POLR2L;WRN;POLR2D;CCNA2;MSH2;REV1;RAD52;POLR2B;TOPBP1;BABAM2;NSD2;H2AJ;FAAP24;ALKBH3;TERF2IP;SPRTN;H2BC4;USP45;UVSSA;UBA52;COPS6;FTO;FANCM;COPS5;POLR2C;AQR;RNF4;COPS2;POLR2H;YY1;ISG15;RMI2;EME2;RAD18;RCHY1;XAB2;ERCC8;POLG2;RFC5;APEX1;ATM;INO80E;RAD51D;NPLOC4;ACTL6A;POLE3;COPS3;H2AZ2;ACTR8;UBE2V2
gsea,Signaling By MET R-HSA-6806834,-0.4413080820229334,-1.784340352433234,0.004098360655737705,0.008010142286013412,0.609,17/59,15.17%,UBB;RPS27A;PTK2;SH3GL1;SOS1;USP8;STAM;LAMA2;RNMT;PTPRJ;UBC;SH3KBP1;DOCK7;LAMA5;LAMA1;RAP1A;STAM2
gsea,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.4647264259799783,-1.782394482251128,0.0,0.00812569105543287,0.615,19/45,23.30%,PSMD2;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5;PSMA1;PSMC3
gsea,PERK Regulates Gene Expression R-HSA-381042,-0.5311594688697096,-1.7798941259025292,0.002070393374741201,0.008296524005319961,0.621,11/26,24.90%,CEBPG;EIF2S2;HSPA5;CEBPB;EXOSC9;KHSRP;DIS3;DCP2;ATF4;NFYA;EIF2S1
gsea,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.4623466955032169,-1.779795530422996,0.0,0.00827816886371527,0.621,20/49,25.71%,LDHB;BSG;MDH2;IDH3B;PCDHB16;HAGH;PDHX;PDHB;MPC2;ADHFE1;GSTZ1;PLPP6;FAHD1;CS;PDPR;GLO1;NNT;IDH3A;ACO2;SUCLA2
gsea,Cristae Formation R-HSA-8949613,-0.6170633976987241,-1.778623499160141,0.00819672131147541,0.00836244906665049,0.623,5/15,12.28%,ATP5PB;HSPA9;MICOS10;MICOS13;DNAJC11
gsea,KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.5988211663555478,-1.7768594067081345,0.009596928982725527,0.008433566939178128,0.626,6/16,13.39%,YWHAZ;EXOSC9;AKT1;KHSRP;DIS3;DCP2
gsea,Late Endosomal Microautophagy R-HSA-9615710,-0.5178549611238855,-1.7766003878955978,0.0,0.00843630319352122,0.626,8/28,15.83%,UBB;RPS27A;HSPA8;CHMP2A;VPS28;UBC;TSG101;CHMP2B
gsea,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.4371957677773879,-1.7763990908989318,0.0,0.008443272430373898,0.626,25/67,21.75%,ARF5;KIF26B;KIF5B;KIF3A;KIFAP3;ARCN1;NSF;KIF21A;COPG2;RAB1B;NAPG;KIF23;TMED7;KIF2A;ARF4;COPA;CENPE;KIFC2;NBAS;TMED2;ARF3;COPB2;KIF22;SEC22B;COPZ1
gsea,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.5571210954858112,-1.7759825732196526,0.004310344827586207,0.008475625336208275,0.626,7/22,14.51%,UBB;RPS27A;ELOC;ELOB;CUL5;UBC;UBE2D3
gsea,Signaling By Interleukins R-HSA-449147,-0.3500884433515533,-1.775149978689056,0.0,0.008520516302714056,0.626,100/339,23.68%,HSP90AA1;UBB;HNRNPA2B1;RPS27A;HSPA8;HSP90B1;PPIA;YWHAZ;MEF2A;SKP1;VAMP2;S1PR1;IL31RA;HIF1A;PSMD2;SNAP25;PTK2B;IL1RAPL1;PKN2;MAP2K7;UBE2N;HNRNPDL;HSPA9;PPP2R1A;PSMA4;PELI2;NDN;SOS1;AURKAIP1;CANX;CEBPD;IRAK1;JUN;PTPRZ1;PSMC2;TCP1;PSMB3;MAP2K6;PSMD14;PELI1;IL1RAP;SEM1;PSMC6;USP14;FBXW11;AKT1;UBC;MAPK1;PSMC1;BCL6;NFKB1;PTPN4;SMAD3;PSME2;PSMB11;PSME4;RBX1;BCL2L1;LAMA5;MAPK3;PSMD6;IRAK2;PSMB6;CUL1;RALA;HMGB1;NKIRAS1;TAB3;CASP3;MAPK8;TNFRSF1A;SQSTM1;PSMA7;CCND1;CHUK;GSTO1;PSMB2;IL1R1;PSMA2;IKBKG;S100B;PSMC5;IL5RA;MAP3K8;MAPK10;SOD1;RPLP0;VEGFA;TYK2;PSMA1;DUSP6;RHOU;PPP2CA;CSF2RA;PTPN12;IL6ST;MAPK9;PSMC3;PIK3R3;COL1A2
gsea,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.40599637406146655,-1.7748164607739951,0.0,0.00851882204090472,0.626,29/91,25.80%,DYNLL1;RPS27;PDS5B;TAOK1;DYNLL2;HDAC8;PDS5A;PPP2R1A;SMC1A;RANBP2;AHCTF1;CKAP5;XPO1;ITGB3BP;KIF2A;NUP98;CENPE;RCC2;WAPL;KANSL1;ZWINT;NUP37;PPP2CA;SEH1L;DYNC1I2;CENPF;CENPT;PPP2R5D;SEC13
gsea,Lysosome Vesicle Biogenesis R-HSA-432720,-0.5070922015233603,-1.774659976530849,0.007984031936127744,0.00852555128689915,0.629,11/32,18.01%,HSPA8;VAMP2;CHMP2A;CLTC;M6PR;CLVS2;TXNDC5;AP1G1;AP1S1;BLOC1S1;CLTA
gsea,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.4540649495429116,-1.7738733628039827,0.008676789587852495,0.008578439707235529,0.631,21/50,25.79%,TAF1D;H2AZ1;BAZ1B;KAT2B;HDAC1;POLR2E;TBP;POLR1F;CBX3;SF3B1;MTA3;POLR2K;POLR1H;TTF1;CHD4;POLR2L;RBBP7;H2AJ;CHD3;H2BC4;HDAC2
gsea,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.5519166110116278,-1.7735780187711516,0.009861932938856016,0.008568251363856477,0.631,12/21,35.46%,CANX;HSPA5;SEC24A;PIK3C3;SEC23A;CALR;SEC13;ATG14;SEC24D;SEC24B;PDIA3;SAR1B
gsea,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.5035772426748817,-1.7734986782560904,0.009881422924901186,0.008558107030600016,0.631,16/33,25.76%,GNG3;GNB2;GNAQ;CCT7;TCP1;CCT5;GNG11;CCT8;GNG10;CSNK2B;CCT6A;GNG7;GNB5;CCT2;RGS7;GNG2
gsea,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.43051984392562465,-1.773496097852809,0.002036659877800407,0.008539662834413379,0.631,36/70,33.19%,CCNT2;PCF11;POLR2G;CDK9;POLR2E;TBP;TAF11;RPRD2;PHAX;GTF2F1;INTS13;POLR2K;INTS6;ICE1;CDK7;POLR2A;INTS2;SNAPC3;POLR2L;POLR2D;POLR2B;TAF5;INTS10;GTF2A1;SNAPC5;CCNK;ZC3H8;POLR2C;NCBP2;INTS5;GTF2A2;POLR2H;INTS8;SNAPC1;GTF2B;GTF2E1
gsea,G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,-0.5906005792885866,-1.771676457147901,0.0041841004184100415,0.008687810874172235,0.641,10/17,25.76%,GNG3;GNB2;PLCB1;GNG11;GNG10;GNG7;GNB5;PLCB3;PLCB2;GNG2
gsea,Formation Of Early Elongation Complex R-HSA-113418,-0.5005707795652998,-1.7714041634477262,0.006224066390041493,0.008685783061421284,0.641,15/31,22.74%,POLR2G;POLR2E;CCNH;MNAT1;GTF2F1;GTF2H5;POLR2K;GTF2H1;CDK7;POLR2A;ERCC3;NELFB;POLR2L;POLR2D;POLR2B
gsea,RHO GTPases Activate ROCKs R-HSA-5627117,-0.579181367053581,-1.7695843934246949,0.008016032064128256,0.008845418727074457,0.648,11/18,26.22%,MYL6;MYL12B;ROCK2;RHOB;ROCK1;MYH10;LIMK2;PPP1CB;PPP1R12B;PPP1R12A;MYH9
gsea,Surfactant Metabolism R-HSA-5683826,-0.6034969333804172,-1.7694582827479668,0.013100436681222707,0.008826518259708914,0.648,9/15,28.11%,CCDC59;LMCD1;TTF1;ADRA2A;ZDHHC2;ADORA2A;CSF2RA;CKAP4;NAPSA
gsea,Translesion Synthesis By REV1 R-HSA-110312,-0.5835330812552548,-1.7688431527984243,0.0042643923240938165,0.00886960817385848,0.652,5/16,10.83%,UBB;RPS27A;PCNA;RPA3;UBC
gsea,RHOG GTPase Cycle R-HSA-9013408,-0.43943491920340355,-1.7681144984909904,0.0,0.008904277652062488,0.654,25/68,22.49%,KTN1;CYFIP1;IQGAP2;ERBIN;NDUFA5;PKN2;ARHGAP5;DOCK3;ARHGAP32;ELMO2;ARHGAP21;LMAN1;YKT6;CAV1;VAMP3;LETM1;HSPE1;DOCK4;ARHGEF26;LAMTOR1;DSG2;VAV3;OPHN1;DOCK1;TFRC
gsea,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.3656468680193464,-1.7656707442992043,0.0,0.00910730142941497,0.659,64/209,25.76%,TMSB4X;CALM1;DGKH;PPIA;YWHAZ;PFN1;PRKCE;GNG3;GNB2;TUBA4A;PTK2;DGKI;CDC37L1;TGFB3;CLU;SELENOP;GNAQ;SOS1;RHOB;HSPA5;MANF;RAB27B;CD9;TMX3;VCL;SERPING1;GTPBP2;CAP1;ABCC4;CYRIB;AKT1;RASGRP1;F2RL2;GNG11;MAPK1;GNG10;AAMP;VTI1B;TGFB2;MAPK3;RAP1A;ADRA2A;GNG7;GNB5;PCYOX1L;DGKE;OLA1;PRKCD;VAV3;SOD1;SPNS1;VEGFA;FAM3C;DGKB;TIMP3;PIK3R3;ENDOD1;DAGLA;TRPC6;GNA13;APLP2;SCCPDH;ACTN1;GNG2
gsea,Translesion Synthesis By POLK R-HSA-5655862,-0.5815497942337999,-1.7646433319538415,0.004291845493562232,0.009174129102645444,0.661,5/17,10.83%,UBB;RPS27A;PCNA;RPA3;UBC
gsea,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.5275585600140812,-1.7631464645746897,0.008032128514056224,0.009285690776969292,0.666,12/26,25.76%,CALM1;GNG3;GNB2;PLCB1;GNG11;GNG10;GNG7;GNB5;PLCB3;LLGL1;PLCB2;GNG2
gsea,RND1 GTPase Cycle R-HSA-9696273,-0.4828520611906847,-1.7629695433965902,0.0039447731755424065,0.00929468718404615,0.667,10/39,15.63%,CCDC88A;ARHGAP5;RASAL2;FAM135A;TMEM59;KIF14;RRAS2;TXNL1;CAV1;PLEKHG5
gsea,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.47434479639437643,-1.7608851288754241,0.00199203187250996,0.009429976424197985,0.673,17/37,26.33%,UBB;RPS27A;BRAF;YWHAB;PPP2R1A;PEBP1;UBC;MAPK1;MAPK3;HRAS;DUSP6;PPP2CA;DUSP10;PTPN3;DUSP7;PPP2R5D;UBA52
gsea,Metabolism Of Cofactors R-HSA-8978934,-0.5764931122123162,-1.7603994458574055,0.006289308176100629,0.009475231516854948,0.675,7/18,20.98%,HSP90AA1;CALM1;AKT1;COQ2;TACR1;PDSS1;COQ3
gsea,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.47145322057843125,-1.7601600294894004,0.002136752136752137,0.009491890177820692,0.676,23/38,33.39%,POLR2E;TBP;GTF3C3;POLR3F;SSB;POLR3K;NFIA;POLR2K;GTF3C2;SNAPC3;POLR3H;GTF3A;POLR3A;POLR2L;BDP1;SNAPC5;GTF3C4;POLR3D;NFIX;POLR2H;NFIB;SNAPC1;POLR3E
gsea,Protein Methylation R-HSA-8876725,-0.5922329093389762,-1.7598721020291277,0.0020491803278688526,0.00950037992165663,0.677,7/17,18.74%,CALM1;EEF1A1;HSPA8;RPS2;EEF1AKMT2;EEF2;CAMKMT
gsea,Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.6014862267252222,-1.7561459851605434,0.007936507936507936,0.00986041457340132,0.691,7/16,20.07%,YWHAB;ZFP36L1;EXOSC9;AKT1;DIS3;DCP2;DCP1A
gsea,EPH-Ephrin Signaling R-HSA-2682334,-0.4325031933838416,-1.7547587505657856,0.002012072434607646,0.009960854076356133,0.691,40/82,32.13%,ACTG1;MYL6;EPHA7;AP2M1;PTK2;ACTR2;EFNB3;PKN2;MYL12B;ROCK2;TIAM1;CLTC;ROCK1;ARPC5;ARPC2;APH1B;MYH10;LIMK2;CLTA;GRIN2B;VAV3;HRAS;PSENEN;EPHA4;ACTR3;EPHA10;EFNA3;CLTB;ITSN1;ARPC1A;MYH9;EPHB2;EPHA6;WASL;EFNB1;SDCBP;AP2S1;GPRIN1;MMP2;APH1A
gsea,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.52691557088952,-1.7536385321402284,0.0,0.010040754199537155,0.696,13/25,26.27%,GNG3;GNB2;CACNA2D2;GNG11;GNG10;ADRA2A;GNG7;ADCY5;GNB5;CACNA1C;GNG2;CACNB3;ADCY6
gsea,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.4365484354842709,-1.7524241511313674,0.0,0.010112290784725484,0.697,20/56,20.11%,UBB;RPS27A;DHX36;POLR2E;TLR3;DHX9;UBC;TRIM32;NFKB1;POLR3F;POLR3K;POLR2K;NKIRAS1;CREBBP;CHUK;CTNNB1;POLR3H;IKBKG;POLR3A;POLR2L
gsea,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.40368906562254125,-1.7484050716351551,0.0,0.010423992336400454,0.706,29/89,22.16%,HSP90AA1;HSP90AB1;TPR;UBE2N;G3BP2;IRAK1;RANBP2;SEC24A;CNBP;SIKE1;NUP98;NUP88;PIK3C3;NUP153;NUP155;IRAK2;TAB3;SEC23A;CREBBP;CHUK;G3BP1;IKBKG;NDC1;NUP37;NUP54;MASP1;IKBKE;TYK2;SEH1L
gsea,Processing Of SMDT1 R-HSA-8949664,-0.6063165419358265,-1.7483991035322253,0.006369426751592357,0.010402455162151693,0.706,8/15,27.86%,MICU3;YME1L1;PMPCB;SMDT1;PMPCA;PHB2;AFG3L2;STOML2
gsea,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.5514367796625139,-1.7424706899735003,0.00980392156862745,0.010943760341530858,0.721,8/20,19.38%,PABPN1;PCF11;PAPOLA;CPSF6;FIP1L1;CSTF2T;CSTF2;CSTF3
gsea,Plasma Lipoprotein Clearance R-HSA-8964043,-0.5031385952181529,-1.7414389750413035,0.00904977375565611,0.011016833058509949,0.727,19/28,36.33%,UBB;RPS27A;APOE;AP2M1;CLTC;UBC;NCEH1;CLTA;VLDLR;PCSK9;NPC2;UBA52;SOAT1;AP2S1;APOA1;LDLRAP1;SCARB1;AP2B1;AP2A2
gsea,PIP3 Activates AKT Signaling R-HSA-1257604,-0.34827844927542256,-1.7407373639841042,0.0,0.011049857991578305,0.73,76/238,23.77%,UBB;RPS27A;CBX6;PSMD2;SCMH1;PPP2R1A;NRG2;TNKS;PSMA4;TNRC6A;SOS1;AGO3;IRAK1;JUN;TNRC6C;HDAC1;PSMC2;NEDD4;PSMB3;RICTOR;PSMD14;LAMTOR3;IL1RAP;SEM1;RNMT;PSMC6;SNAI2;AKT1;PHLPP1;AGO4;RPS6KB2;UBC;MAPK1;PSMC1;TGFA;CDKN1B;PIP5K1B;PSME2;PSMB11;PSME4;MTA3;PREX2;CNOT6L;MAPK3;PSMD6;PSMB6;CSNK2B;FGFR1;PSMA7;PDGFRA;IER3;HDAC3;CHUK;RRAGB;CHD4;PSMB2;PSMA2;MTOR;PSMC5;LAMTOR5;LAMTOR1;RRAGA;TRIB3;PSMA1;PPP2CA;MECOM;USP13;VAPA;KDM1A;FGFR3;PHC3;PSMC3;RBBP7;LAMTOR4;PIK3R3;LAMTOR2
gsea,Other Semaphorin Interactions R-HSA-416700,-0.5542222318832096,-1.7387542438537373,0.014373716632443531,0.011185879801682206,0.737,6/19,21.77%,SEMA5A;SEMA6D;PLXNC1;PLXNA2;SEMA6A;PLXNA4
gsea,Translesion Synthesis By POLI R-HSA-5656121,-0.5713228072422973,-1.738404412057094,0.00663716814159292,0.011226340989263455,0.737,5/17,10.83%,UBB;RPS27A;PCNA;RPA3;UBC
gsea,RAS Processing R-HSA-9648002,-0.5840462191878008,-1.737817025728351,0.016293279022403257,0.011278488330363089,0.738,6/17,21.39%,CALM1;BCL2L1;ARL2;ABHD17B;RCE1;HRAS
gsea,Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.5920468195640883,-1.736567038160916,0.018518518518518517,0.011385616691382478,0.74,11/16,33.66%,UBB;RPS27A;USP14;UBC;CHUK;IKBKG;IKBKB;UBA52;LRRC14;TRAF6;NLRX1
gsea,Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.501129136797611,-1.7358931300213776,0.006172839506172839,0.011433293945251674,0.741,6/27,10.83%,UBB;RPS27A;LCT;PPP1R3C;IDS;UBC
gsea,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.5307044976146476,-1.7342911927920948,0.006147540983606557,0.01165746553883655,0.743,6/23,10.83%,UBB;RPS27A;ANAPC4;UBE2E1;CDC26;UBC
gsea,Signaling By NOTCH2 R-HSA-1980145,-0.508105826259627,-1.734212334286268,0.010416666666666666,0.011645622769727915,0.743,13/28,27.29%,UBB;RPS27A;MAML2;CNTN1;UBC;APH1B;MIB1;MAML3;JAG2;PSENEN;HES5;UBA52;NOTCH2
gsea,Post-chaperonin Tubulin Folding Pathway R-HSA-389977,-0.5998952447595556,-1.7333674884867516,0.00625,0.011731591109436744,0.744,11/16,30.04%,TUBA1A;TUBB2A;TUBA4A;TUBB4B;TBCA;TUBA1B;ARL2;TBCD;TBCC;TUBB4A;TBCB
gsea,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.3749666804760984,-1.7315259833753334,0.0,0.011879655142390522,0.752,54/147,26.16%,DDX5;TPR;NPM1;TOP1;HNRNPK;PGR;NOP58;SCMH1;PIAS1;SUMO2;SMC1A;RANBP2;TOP2B;HDAC1;CETN2;PCNA;NSMCE3;SMC5;NSMCE4A;HERC2;SMC6;MITF;CTBP1;BLM;XRCC4;UHRF2;NUP98;NR3C2;NUP88;THRA;NUP153;NUP155;MDC1;PPARA;TOPORS;CREBBP;NCOA2;IKBKG;NDC1;NUP37;NUP54;UBE2I;WRN;IKBKE;CASP8AP2;SEH1L;RAD52;PHC3;ING3;TRIM28;CHD3;HDAC2;SEC13;NSMCE1
gsea,Metabolism Of Carbohydrates R-HSA-71387,-0.3464126247135351,-1.7296597047910964,0.0,0.012038807725713039,0.756,78/240,26.63%,CALM1;UBB;RPS27A;TPR;ALDOC;NDST4;SDC4;B4GALT6;MDH2;MDH1;B3GALT1;B4GAT1;CHPF;PGM2L1;PHKA1;PPP2R1A;RPE;CHST1;SLC25A11;CHORDC1;RANBP2;B3GNT2;BCAN;TPI1;PRKACB;UBL4A;PPP1R3C;IDS;DSEL;HS3ST1;MAP4K5;SDC3;PHKG1;XYLT1;CHST9;UBC;NUP98;NUP88;B3GALT2;PKM;PHKB;GLCE;NUP153;B3GAT2;NUP155;GNPDA1;HAS2;CEMIP;AKR1A1;AGRN;ENO2;ENO1;PFKM;B3GNT4;FUT9;GOT2;NDC1;NUP37;NUP54;UGP2;SLC25A13;NCAN;B4GALT7;PHGDH;B4GALT4;PPP2CA;SEH1L;PCK2;HOOK3;TKT;PGP;RBKS;CHST11;PPP2R5D;SEC13;UBA52;CSPG4;PGM1
gsea,RUNX2 Regulates Bone Development R-HSA-8941326,-0.5482133095096431,-1.7295851104144253,0.00808080808080808,0.012026294331884643,0.756,12/21,18.98%,GLI3;HEY1;SMAD4;CBFB;MAPK1;GLI2;RB1;MAPK3;YAP1;HDAC3;HEY2;RUNX2
gsea,Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.5392641991491749,-1.7289357476064715,0.0102880658436214,0.012060381293135086,0.757,11/21,27.86%,MICU3;VDAC2;YME1L1;PMPCB;SMDT1;PMPCA;LETM1;PHB2;AFG3L2;SLC8B1;STOML2
gsea,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.4411405545268727,-1.7285546834266747,0.0020491803278688526,0.0120865890564083,0.757,22/49,26.34%,PSMD2;OAZ1;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5;PSMA1;PSMC3;AZIN1;PSME3
gsea,VLDLR Internalisation And Degradation R-HSA-8866427,-0.5850626343733873,-1.7233030063787211,0.004424778761061947,0.012603381802060155,0.766,8/16,20.94%,UBB;RPS27A;AP2M1;CLTC;UBC;CLTA;VLDLR;PCSK9
gsea,Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.4755227956649176,-1.7205509025264647,0.002079002079002079,0.01290217955300584,0.772,23/38,34.70%,MAML2;H2AZ1;TNRC6A;AGO3;JUN;TNRC6C;KAT2B;AGO4;PRKCI;MAML3;CCND1;CREBBP;TFDP2;H2AJ;H2BC4;NOTCH2;E2F3;SNW1;MAMLD1;NOTCH4;KAT2A;H2AZ2;NOTCH1
gsea,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.5132646732543947,-1.7199952524461861,0.008421052631578947,0.012953495797753624,0.774,10/26,18.19%,UBB;RPS27A;PPP1R15A;PPP1CA;XPO1;UBC;ZFYVE9;SMAD3;UCHL5;PPP1CB
gsea,HDACs Deacetylate Histones R-HSA-3214815,-0.4708839942998243,-1.7189558073601707,0.004415011037527594,0.013019971204490957,0.775,17/37,25.79%,H2AC25;HDAC8;ARID4B;HDAC1;PHF21A;NCOR1;MTA3;BRMS1L;HDAC3;CHD4;KDM1A;SAP18;RBBP7;CHD3;TBL1XR1;H2BC4;HDAC2
gsea,SLC-mediated Transmembrane Transport R-HSA-425407,-0.3523761952788679,-1.715015199162978,0.0,0.01349632441365132,0.791,45/184,20.96%,CALM1;SLC1A3;SLC25A4;AHCYL2;SLC4A4;BSG;SLCO1C1;SLC6A15;SLC4A10;SLC7A6;SLC25A5;SLC15A2;SLC25A22;SLC4A7;SLC7A10;SLC1A2;SLC17A7;SLC9A7;APOD;SLC39A7;SLC35A1;SLC2A13;SLC39A14;SLC7A11;SLC27A1;SLC39A6;SLC32A1;SLC22A4;SLC14A2;SLC36A4;SLC14A1;SLC20A1;SLC39A10;SLC22A5;SLC35A3;SLC30A1;SLC12A5;SLC39A3;ARL2;SLC25A18;SLC24A5;SLC7A2;SLC29A1;SLC38A1;SLC30A3
gsea,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.4152301391517247,-1.7139872532425997,0.0071090047393364926,0.013618847070520045,0.794,20/61,26.33%,UBB;RPS27A;UBE2N;SUMO2;HERC2;RPA3;BLM;BRCC3;UBC;CCNA1;RAD17;MDC1;UBE2I;WRN;CCNA2;TOPBP1;BABAM2;NSD2;H2BC4;UBA52
gsea,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.5674297431960793,-1.713473464592369,0.013513513513513514,0.013649255040786982,0.794,9/19,22.80%,CALM1;CAMK2B;NEFL;CAMK2A;LRRC7;GRIN2B;HRAS;LLGL1;CAMK2G
gsea,Signaling By EGFR R-HSA-177929,-0.4513422170139172,-1.7117660548544393,0.0020876826722338203,0.013797667484644928,0.796,16/46,23.16%,UBB;RPS27A;SH3GL1;SOS1;STAM;PXDN;UBC;TGFA;AAMP;SH3KBP1;STAM2;SPRY1;EPS15;HRAS;PTPN12;PTPN3
gsea,EGFR Downregulation R-HSA-182971,-0.4953140570686765,-1.711490722727103,0.0125,0.013797180883950929,0.797,14/28,27.71%,UBB;RPS27A;SH3GL1;STAM;UBC;TGFA;SH3KBP1;STAM2;SPRY1;EPS15;PTPN12;PTPN3;UBA52;GRB2
gsea,Peroxisomal Protein Import R-HSA-9033241,-0.41952056875090205,-1.711140324815321,0.002288329519450801,0.013827060309660546,0.797,14/56,16.79%,UBB;RPS27A;AGPS;LONP2;ZFAND6;MPV17;UBC;DDO;USP9X;SYCP2;NUDT19;UBE2D3;PEX2;ACOX1
gsea,Deadenylation Of mRNA R-HSA-429947,-0.524341071307798,-1.7078886632680172,0.008403361344537815,0.014205326808148698,0.806,13/24,24.40%,EIF4A2;TUT4;CNOT4;EIF4A1;EIF4B;EIF4G1;CNOT6L;CNOT1;CNOT2;CNOT7;PAIP1;CNOT6;CNOT11
gsea,Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,-0.5811448809028212,-1.7065447756579748,0.013888888888888888,0.014340151636494996,0.811,7/15,18.87%,GNG3;GNB2;GNG11;GNAS;GNG10;GNG7;GNB5
gsea,Signaling By NTRK2 (TRKB) R-HSA-9006115,-0.5488887963916499,-1.705524730309343,0.0111731843575419,0.014398984456424466,0.812,8/21,21.39%,CDK5R1;DOCK3;SOS1;TIAM1;CDK5;NTRK2;GRIN2B;HRAS
gsea,Signaling By Insulin Receptor R-HSA-74752,-0.42217045555959987,-1.7053544312523388,0.004149377593360996,0.014389800756441707,0.813,24/60,28.31%,ATP6V0C;ATP6V1D;ATP6V1G1;ATP6V0E2;SOS1;ATP6V1F;ATP6V0A2;ATP6V1E1;ATP6V1H;ATP6V1A;MAPK1;PIK3C3;MAPK3;PDE3B;FGFR1;ATP6V1G2;ATP6AP1;TRIB3;HRAS;FGFR3;ATP6V1C2;ATP6V1B2;GRB2;PIK3CB
gsea,Olfactory Signaling Pathway R-HSA-381753,0.5652725235926346,1.7044878493777633,0.011945392491467578,0.4638558382803088,0.811,9/20,11.49%,ADCY8;LDB2;OR1L4;ANO2;REEP1;OR52E5;OR4K5;OR4K15;OR52B2
gsea,RMTs Methylate Histone Arginines R-HSA-3214858,-0.4698729885643643,-1.7030945592903828,0.002070393374741201,0.014576103307175318,0.815,13/37,17.37%,H2AZ1;H2AC25;RPS2;ACTL6B;SMARCC2;PBRM1;CDK4;SMARCA2;PRMT6;SMARCD2;CCND1;SMARCE1;ARID2
gsea,Post NMDA Receptor Activation Events R-HSA-438064,-0.4478340445625874,-1.702693056878943,0.013084112149532711,0.014600374377244358,0.815,16/57,15.21%,NRGN;CALM1;GRIA2;CAMK2B;NEFL;CAMKK1;PRKAR1A;CAMK2A;PRKAR2B;ADCY1;PRKACB;PRKAG2;MAPK1;MAPK3;LRRC7;GRIN2C
gsea,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.4605594646934236,-1.7022469418332746,0.002109704641350211,0.014632039805003869,0.815,11/35,21.96%,UBB;RPS27A;PPP2R1A;RICTOR;AKT1;UBC;CCNA1;CCNG1;MTOR;CCNA2;PPP2CA
gsea,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.486685814138625,-1.7016227626775842,0.019646365422396856,0.014730847114499887,0.816,13/31,22.16%,TPR;RANBP1;RANBP2;XPO1;NUP98;NUP88;RAN;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L
gsea,Activation Of GABAB Receptors R-HSA-991365,-0.474320336697469,-1.7000083794700909,0.021367521367521368,0.014877759719392336,0.819,14/34,18.87%,GNG3;GNB2;ADCY9;GNAL;ADCY1;KCNJ4;GNG11;GNG10;KCNJ10;GABBR2;ADCY2;GNG7;ADCY5;GNB5
gsea,FCERI Mediated MAPK Activation R-HSA-2871796,-0.5014037556089791,-1.699451707486503,0.021739130434782608,0.014904986504539383,0.82,12/27,23.17%,PKN2;MAP2K7;SOS1;JUN;MAPK1;MAPK3;MAPK8;MAPK10;VAV3;SPNS1;HRAS;MAPK9
gsea,E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.5477696801760081,-1.6972322794920092,0.02092050209205021,0.015106731591957802,0.824,8/19,23.39%,ORC4;PPP2R1A;ORC6;RB1;POLA1;PPP2CA;ORC5;TFDP2
gsea,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.6097604332439687,-1.6970048225697725,0.019157088122605363,0.01510004106246812,0.824,7/17,10.60%,HSPA8;VAMP2;RAB3A;SNAP25;GAD1;SLC32A1;GAD2
gsea,Phase II - Conjugation Of Compounds R-HSA-156580,-0.4172903958159089,-1.6960295431993384,0.0,0.015208112425107976,0.825,19/58,21.02%,PRNP;BPNT2;MGST3;MAT2B;GSTM1;GSTP1;COMT;ESD;SULT4A1;GSTM5;TRMT112;GSTZ1;GSTM4;AKR1A1;GSTO1;ABHD14B;UGP2;SLC38A1;CHAC2
gsea,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.45435676984850565,-1.6955211697792478,0.009881422924901186,0.015275136114868233,0.825,18/39,30.95%,TRMT10A;NSUN6;CDKAL1;ALKBH8;THADA;TRMT112;TRMT6;LAGE3;QTRT2;TRMT44;TRMT13;TYW5;PUS3;THG1L;CTU1;PUS7;TRDMT1;ADAT2
gsea,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.5332571996792022,-1.6931036831793924,0.020703933747412008,0.0155151968363888,0.828,6/21,10.83%,UBB;RPS27A;ANAPC4;UBE2E1;CDC26;UBC
gsea,SUMOylation R-HSA-2990846,-0.36654394025157533,-1.6928908999886216,0.00202020202020202,0.015522500882955684,0.828,58/153,28.21%,DDX5;TPR;NPM1;TOP1;HNRNPK;PGR;NOP58;SCMH1;PIAS1;SUMO2;SMC1A;RANBP2;TOP2B;HDAC1;CETN2;PCNA;NSMCE3;SMC5;NSMCE4A;HERC2;SMC6;MITF;CTBP1;BLM;XRCC4;UHRF2;NUP98;NR3C2;NUP88;THRA;NUP153;NUP155;MDC1;PPARA;TOPORS;CREBBP;NCOA2;IKBKG;NDC1;NUP37;NUP54;UBE2I;WRN;IKBKE;CASP8AP2;SEH1L;RAD52;PHC3;ING3;TRIM28;CHD3;HDAC2;SEC13;NSMCE1;SENP5;L3MBTL2;CBX8;NCOA1
gsea,RAC2 GTPase Cycle R-HSA-9013404,-0.4160090834825785,-1.6888559874150961,0.006578947368421052,0.016014623613147618,0.837,30/82,26.04%,CYFIP1;ERBIN;SYDE1;NCKAP1;PKN2;DOCK3;TIAM1;DOCK10;ARHGAP32;ARHGAP21;NHS;LMAN1;ABR;ABI1;CAV1;VAMP3;ARMCX3;SLITRK5;DOCK4;LAMTOR1;DSG2;VAV3;OPHN1;DOCK1;TFRC;ABI2;PIK3R3;IQGAP1;CYBA;TMPO
gsea,Mitotic Prophase R-HSA-68875,-0.3975173299341172,-1.6884685397443948,0.0,0.01602828635326795,0.838,40/84,29.55%,TPR;H2AZ1;PPP2R1A;SET;RANBP2;KMT5A;RAB1B;BANF1;USO1;RAB2A;MAPK1;BLZF1;NUP98;NUP88;VRK1;NUP153;RB1;MAPK3;NCAPG2;NUP155;NCAPH2;ARPP19;MCPH1;NDC1;NUP37;NUP54;PHF8;NEK7;RAB33B;PPP2CA;SEH1L;H2AJ;ENSA;H2BC4;SEC13;TMPO;SMC4;NUMA1;NEK6;CNEP1R1
gsea,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.5365142991316374,-1.6876889375089816,0.027131782945736434,0.016104103701293258,0.84,4/19,4.25%,HSP90AA1;ERBIN;NRG2;SOS1
gsea,RHOF GTPase Cycle R-HSA-9035034,-0.46185362869187147,-1.6871865918204714,0.018072289156626505,0.01616137350712736,0.84,19/39,28.68%,DIAPH2;SYDE1;ARHGAP5;SLC4A7;CAPZB;ARHGAP12;ARHGAP32;ARHGAP21;SRGAP2;MTMR1;CAV1;VAMP3;SOWAHC;DIAPH1;ACTN1;TMPO;TOR1AIP1;MYO9B;ESYT1
gsea,Fanconi Anemia Pathway R-HSA-6783310,-0.46252657562250626,-1.6846888165625167,0.0043859649122807015,0.01646267005515197,0.842,10/33,26.79%,UBB;RPS27A;RPA3;UBC;USP1;FANCA;FANCE;FAAP24;UBA52;FANCM
gsea,Regulation Of FZD By Ubiquitination R-HSA-4641263,-0.5569706168210073,-1.6843839188945622,0.010351966873706004,0.016453556530985035,0.842,6/17,15.30%,UBB;RPS27A;USP8;ZNRF3;UBC;LRP6
gsea,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.4638784404229726,-1.6819328405110359,0.008298755186721992,0.01684396759534457,0.846,10/36,14.28%,TAF1D;H2AZ1;BAZ1B;KAT2B;POLR2E;TBP;POLR1F;SF3B1;POLR2K;POLR1H
gsea,Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.49557994591102633,-1.678409201413605,0.008849557522123894,0.017272790674188958,0.848,6/25,15.01%,UBB;RPS27A;PCNA;RPA3;UBC;POLD3
gsea,G2/M DNA Damage Checkpoint R-HSA-69473,-0.41770478098088865,-1.6757615222486395,0.006564551422319475,0.017609556819418174,0.852,18/56,25.54%,YWHAH;YWHAZ;YWHAE;YWHAB;UBE2N;HERC2;RPA3;BLM;BRCC3;RAD17;MDC1;WRN;YWHAG;TOPBP1;BABAM2;NSD2;REXO2;H2BC4
gsea,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.4883800674624717,-1.675046058114454,0.016293279022403257,0.017706713711900707,0.853,15/28,32.05%,PABPN1;PCF11;PAPOLA;CPSF6;SNRPG;FIP1L1;CSTF2T;SNRPE;CSTF2;CSTF3;SNRPF;NCBP2;SNRPD3;SNRPB;LSM11
gsea,Gap Junction Trafficking And Regulation R-HSA-157858,-0.5585735840232691,-1.6730349592719853,0.018518518518518517,0.01800176608954743,0.857,7/16,19.71%,GJA1;AP2M1;GJB6;CLTC;CLTA;GJB1;TJP1
gsea,Interleukin-12 Family Signaling R-HSA-447115,-0.44172840000861274,-1.672981811832511,0.008146639511201629,0.017986295451212372,0.857,15/41,23.00%,HNRNPA2B1;PPIA;PKN2;HNRNPDL;HSPA9;AURKAIP1;CANX;TCP1;PSME2;RALA;GSTO1;SOD1;RPLP0;TYK2;IL6ST
gsea,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.508436140916102,-1.67094020894107,0.01904761904761905,0.018247412579708598,0.861,4/22,4.25%,HSP90AA1;ERBIN;NRG2;SOS1
gsea,SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.4784613855555214,-1.670898893170861,0.007920792079207921,0.018217205727770355,0.861,13/31,22.16%,TPR;SUMO2;RANBP2;NUP98;NUP88;NUP153;NUP155;TOPORS;NDC1;NUP37;NUP54;UBE2I;SEH1L
gsea,PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.5629582753981774,-1.669954753254845,0.014344262295081968,0.018305185432754036,0.861,11/17,26.27%,CALM1;PRKAR1A;ADCY9;PRKAR2B;ADCY1;PRKACB;ADCY2;ADCY5;PRKAR2A;NBEA;ADCY6
gsea,Stimuli-sensing Channels R-HSA-2672351,-0.3960326294377142,-1.6648683349039453,0.008333333333333333,0.019024982774160468,0.867,26/74,26.70%,CALM1;UBB;RPS27A;TTYH1;RYR2;CLCN2;WWP1;WNK3;TRPM3;CLCN4;UBC;CLCN3;TRPC4AP;UNC80;TRDN;TRPC1;FKBP1B;OSTM1;ANO3;TRPM7;BEST3;TRPC6;ANO5;UBA52;NALCN;WNK2
gsea,Pre-NOTCH Expression And Processing R-HSA-1912422,-0.4242593253556152,-1.6636903391153048,0.010638297872340425,0.01918244777233896,0.87,17/53,16.93%,MAML2;H2AZ1;TNRC6A;AGO3;JUN;TNRC6C;KAT2B;SEL1L;RAB6A;FURIN;AGO4;PRKCI;ATP2A2;TMED2;MAML3;CCND1;CREBBP
gsea,SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.4460348402337097,-1.6609908310071995,0.007692307692307693,0.01949945713447188,0.874,16/42,22.76%,TPR;HNRNPK;NOP58;SCMH1;SUMO2;RANBP2;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;UBE2I;SEH1L;PHC3
gsea,Intraflagellar Transport R-HSA-5620924,-0.4643826536801531,-1.6607531724380187,0.008298755186721992,0.019524058338008576,0.875,15/38,26.32%,DYNLL1;DYNLL2;KIF3A;KIFAP3;DYNC2H1;TRIP11;TTC30B;IFT43;DYNLRB1;DYNLT2B;IFT20;TTC21B;IFT46;TNPO1;WDR35
gsea,PKA Activation R-HSA-163615,-0.5814366685822883,-1.6593120637278718,0.01867219917012448,0.019757739829170347,0.879,11/15,26.27%,CALM1;PRKAR1A;ADCY9;PRKAR2B;ADCY1;PRKACB;ADCY2;ADCY5;PRKAR2A;NBEA;ADCY6
gsea,Kinesins R-HSA-983189,-0.46596266409696946,-1.6588819499599936,0.013539651837524178,0.0197711625634183,0.879,9/33,12.55%,KIF26B;KIF5B;KIF3A;KIFAP3;KIF21A;KIF23;KIF2A;CENPE;KIFC2
gsea,HATs Acetylate Histones R-HSA-3214847,-0.3813447951231681,-1.6578810911490005,0.00998003992015968,0.019908167584506583,0.881,47/79,39.66%,MORF4L2;H2AC25;CLOCK;KAT2B;ZZZ3;BRD8;MRGBP;KAT7;MBIP;KAT6B;KANSL1;ATXN7L3;CREBBP;RUVBL1;SAP130;NCOA2;KANSL3;TAF10;SGF29;ING3;RBBP7;HAT1;TADA1;H2BC4;MSL2;ING4;SUPT7L;TADA2B;NCOA1;EP400;ELP2;KAT6A;MORF4L1;JADE3;HCFC1;DR1;KDELR2;KANSL2;ACTL6A;KAT2A;ATXN7;ENY2;MSL3;MSL1;TAF9;H2AC21;KAT14
gsea,DNA Double-Strand Break Repair R-HSA-5693532,-0.3495303055423679,-1.6562105480437725,0.0,0.0201716054674307,0.885,33/127,23.71%,UBB;RPS27A;EYA1;BAZ1B;EYA4;UBE2N;SUMO2;PCNA;HERC2;SEM1;LRIF1;RPA3;TDP2;BLM;BRCC3;XRCC4;UBC;SPIDR;CCNA1;UBXN1;FEN1;RAD17;POLD3;MDC1;MAPK8;PARP2;UBE2I;WRN;CCNA2;RAD52;TOPBP1;BABAM2;NSD2
gsea,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.5573270888200218,-1.6557872361654493,0.02895752895752896,0.020180683026453084,0.885,11/21,22.80%,CALM1;CAMK2B;NEFL;CAMK2A;PPM1F;PPM1E;LRRC7;GRIN2C;GRIN2B;LLGL1;CAMK2G
gsea,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.38137057594087703,-1.6557540509914406,0.0021551724137931034,0.020144057467421407,0.885,34/79,33.76%,UBB;RPS27A;CDK5R1;PDZD2;TBP;TAF11;CDK5;RPA3;BLM;UBC;PRKAG2;CCNA1;RAD17;CSNK2B;SSRP1;TAF1;WRN;CCNA2;TAF10;TAF5;TOPBP1;TAF7L;MAPK11;UBA52;TAF15;DYRK2;NOC2L;RMI2;TAF2;RFC5;TAF3;ATM;AURKA;TAF7
gsea,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.4775899176415214,-1.655467165452513,0.008714596949891068,0.020170685670551133,0.886,12/31,16.21%,DDX5;SDC4;CHMP2A;SDC3;FURIN;CTSL;ISCU;PIK3C3;RB1;UVRAG;CHMP2B;AGRN
gsea,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,-0.3844569697585372,-1.6545797709036758,0.003952569169960474,0.020302229098971,0.887,24/97,13.13%,KIF26B;MAFG;DOCK11;CAPZA2;KIF5B;PRKAR1A;KIF3A;KIFAP3;DOCK3;KIF21A;HDAC1;CAPZB;PRKAR2B;PHF21A;JMJD1C;RAB5A;PRKACB;KIF23;DOCK10;CDK5;KIF2A;CENPE;KIFC2;DOCK7
gsea,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.4838958999772801,-1.6539649492359567,0.01609657947686117,0.020345945992764035,0.888,7/27,14.10%,UBB;RPS27A;BRAF;PPP2R1A;UBC;MAPK1;MAPK3
gsea,GPER1 Signaling R-HSA-9634597,-0.4468243046482837,-1.6529894605088369,0.014314928425357873,0.02048716291743637,0.89,14/36,18.87%,GNG3;GNB2;PRKAR1A;ADCY9;PRKAR2B;ADCY1;PRKACB;GNG11;GNAS;GNG10;ADCY2;GNG7;ADCY5;GNB5
gsea,Circadian Clock R-HSA-400253,-0.40456164091711017,-1.6510936617734855,0.00398406374501992,0.020711427804238246,0.891,19/61,18.22%,UBB;RPS27A;SKP1;HIF1A;CHD9;CLOCK;PPP1CA;UBC;CRTC2;NCOR1;BHLHE41;NOCT;CUL1;PPARA;CREBBP;HDAC3;MBD4;PPP1CB;NCOA2
gsea,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.5092995204785914,-1.6470151368729429,0.016563146997929608,0.021355392308143,0.899,7/23,14.10%,UBB;RPS27A;BRAF;PPP2R1A;UBC;MAPK1;MAPK3
gsea,G Alpha (I) Signaling Events R-HSA-418594,-0.3390763665434607,-1.6463283644219986,0.0,0.021466288807450006,0.9,62/182,26.27%,CALM1;PPP3CA;PPP3CB;CAMK2B;PPP3R1;GNG3;GNB2;RGS20;CAMKK1;PRKAR1A;ADCY9;GNAQ;GNAL;PPP2R1A;PLCB1;GPR37L1;CAMK2A;SST;GPR37;PRKAR2B;PPP1CA;ADCY1;PRKACB;CDK5;NPY2R;GRM2;GNG11;SSTR1;GNAS;MAPK1;GNG10;GABBR2;RGS14;GRK2;ADORA1;P2RY14;ADCY2;SSTR4;ADRA2A;PPP1R1B;ACKR3;PDE1B;GNG7;ADCY5;RGS5;GNB5;GPR17;PRKCD;PLCB3;OPRL1;AHCYL1;PPP2CA;CAMK2G;PRKAR2A;CNOT6;RGS7;PLCB2;RGS3;PPP2R5D;GNG2;NBEA;ADCY6
gsea,RHO GTPases Activate CIT R-HSA-5625900,-0.5500989105713128,-1.6454238068499574,0.014,0.021549086034372274,0.901,11/17,26.22%,MYL6;MYL12B;RHOB;KIF14;CDKN1B;MYH10;PPP1CB;PPP1R12B;LLGL1;PPP1R12A;MYH9
gsea,Signaling By FGFR4 R-HSA-5654743,-0.46953852744099656,-1.6453450210782121,0.008016032064128256,0.021524432041689873,0.901,8/32,14.10%,UBB;RPS27A;BRAF;PPP2R1A;SOS1;UBC;MAPK1;MAPK3
gsea,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.5559962279989598,-1.6441793376705964,0.02071563088512241,0.021668938872724336,0.903,4/17,5.31%,VAMP2;RAB3A;SNAP25;PPFIA2
gsea,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.48589727650397835,-1.6437546440097914,0.021484375,0.02169582428065202,0.907,8/26,16.40%,UBB;RPS27A;BRAF;PPP2R1A;UBC;MAPK1;MAPK3;FGFR1
gsea,Regulation Of TP53 Activity R-HSA-5633007,-0.35278143228796716,-1.6424581794770035,0.002109704641350211,0.02192203039213469,0.907,45/137,27.48%,UBB;RPS27A;CDK5R1;PPP2R1A;PDZD2;HDAC1;TBP;TAF11;KMT5A;MAP2K6;RICTOR;CDK5;RPA3;BRD7;AKT1;BLM;UBC;PRKAG2;CCNA1;CCNG1;RAD17;CSNK2B;SSRP1;CHD4;TAF1;MTOR;WRN;CCNA2;TAF10;PPP2CA;EHMT1;TAF5;TOPBP1;ING3;RBBP7;TAF7L;PPP1R13B;CHD3;MAPK11;TTC5;HDAC2;UBA52;TAF15;DYRK2;NOC2L
gsea,RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.5399617408043964,-1.6416904418654,0.02385685884691849,0.02201701400631393,0.908,10/17,18.98%,GLI3;HEY1;CBFB;MAPK1;RB1;MAPK3;YAP1;HDAC3;HEY2;RUNX2
gsea,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.48841242439861837,-1.6394831949680124,0.006109979633401222,0.022375466466187037,0.912,7/27,14.51%,UBB;RPS27A;ELOC;ELOB;CUL5;UBC;UBE2D3
gsea,HCMV Infection R-HSA-9609646,-0.37710117095370965,-1.639277846376302,0.004210526315789474,0.022353033773959297,0.912,32/91,26.22%,DYNLL1;TPR;HNRNPK;DYNLL2;H2AC25;CHMP2A;CEBPD;RANBP2;VPS36;VPS28;VPS4A;NCOR1;NFKB1;NUP98;NUP88;NUP153;TSG101;NUP155;CHMP2B;HDAC3;NDC1;NUP37;NUP54;CBX1;SEH1L;DYNC1I2;RBBP7;TRIM28;TBL1XR1;H2BC4;SEC13;VPS37D
gsea,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.41537903461747766,-1.6350328182572553,0.004081632653061225,0.02315685733990486,0.918,28/53,35.34%,KMT2C;H2AZ1;POLR2G;JUN;POLR2E;NCOR1;MAFB;POLR2K;POLR2A;ASH2L;CREBBP;HDAC3;POLR2L;POLR2D;POLR2B;MEIS1;RBBP7;H2AJ;CNOT6;H2BC4;POLR2C;POLR2H;YY1;EZH2;PAX6;SUZ12;H2AZ2;RARB
gsea,RHOQ GTPase Cycle R-HSA-9013406,-0.4084223972001842,-1.633605809298435,0.010351966873706004,0.02333078873469833,0.918,18/57,24.79%,GJA1;SYDE1;CDC42BPA;PKN2;ARHGAP5;SLC4A7;ARHGEF9;ARHGAP32;ARHGAP21;SRGAP2;CAV1;VAMP3;CDC42EP3;LAMTOR1;OPHN1;TFRC;IQGAP1;ITSN1
gsea,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.47113361955291205,-1.6334620320427067,0.013565891472868217,0.02331700123299316,0.919,13/31,22.34%,TPR;GNL3;RANBP2;PBRM1;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;BLOC1S6
gsea,COPII-mediated Vesicle Transport R-HSA-204005,-0.40411110376153614,-1.632847406106465,0.005813953488372093,0.023388161780989458,0.919,33/60,35.46%,NSF;TFG;SEC24A;CNIH2;RAB1B;NAPG;MCFD2;USO1;PREB;TRAPPC5;TGFA;LMAN1;YKT6;SEC23IP;LMAN2;SEC23A;TMED2;TRAPPC4;SEC22B;TRAPPC1;ANKRD28;SEC22A;SEC13;SEC24D;NAPSA;TRAPPC2L;SCFD1;TRAPPC6B;TRAPPC2;SEC24B;PPP6C;CNIH3;SAR1B
gsea,NCAM Signaling For Neurite Out-Growth R-HSA-375165,-0.42408931105885667,-1.6322309550192418,0.012195121951219513,0.023448902961743786,0.919,19/52,27.71%,PRNP;PTK2;CACNA1H;SOS1;ST8SIA4;SPTBN1;COL4A2;MAPK1;COL4A1;MAPK3;AGRN;FGFR1;NCAN;HRAS;ST8SIA2;COL4A5;CACNA1C;CACNB3;GRB2
gsea,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.38333934495879196,-1.6313319780599713,0.004464285714285714,0.023566961678687735,0.92,24/80,25.80%,DYNLL1;RPS27;TAOK1;DYNLL2;PPP2R1A;RANBP2;AHCTF1;CKAP5;XPO1;ITGB3BP;KIF2A;NUP98;CENPE;RCC2;KANSL1;ZWINT;NUP37;PPP2CA;SEH1L;DYNC1I2;CENPF;CENPT;PPP2R5D;SEC13
gsea,Metabolism Of Polyamines R-HSA-351202,-0.40440084364989487,-1.6305360294867866,0.006097560975609756,0.02370487756450508,0.921,23/56,26.34%,PSMD2;OAZ1;PSMA4;PSMC2;PSMB3;PSMD14;SEM1;PSMC6;PSMC1;PSME2;PSMB11;PSME4;PSMD6;PSMB6;PSMA7;PSMB2;PSMA2;PSMC5;SLC38A1;PSMA1;PSMC3;AZIN1;PSME3
gsea,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.4473780063818912,-1.6303801621189866,0.016632016632016633,0.02368044147583048,0.921,7/33,10.83%,UBB;RPS27A;OTUB1;OTUD7A;VCPIP1;ZRANB1;UBC
gsea,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.4013592126257448,-1.6302515642141862,0.006198347107438017,0.02365945683882615,0.921,25/63,26.74%,TUBA1A;TUBB2A;TUBA4A;CHMP2A;PPP2R1A;AHCTF1;BANF1;VPS4A;TUBB4B;NUP98;RAN;TUBA1B;VRK1;NUP155;CHMP2B;NDC1;NUP37;NUP54;UBE2I;PPP2CA;SEH1L;TNPO1;SEC13;TMPO;TUBB4A
gsea,Mitotic Spindle Checkpoint R-HSA-69618,-0.3705049880050617,-1.6299621235487256,0.004357298474945534,0.023665429961437213,0.921,29/96,25.80%,DYNLL1;RPS27;TAOK1;DYNLL2;PPP2R1A;RANBP2;ANAPC4;AHCTF1;UBE2E1;CKAP5;XPO1;ITGB3BP;CDC26;KIF2A;NUP98;CENPE;RCC2;KANSL1;ANAPC1;ZWINT;NUP37;PPP2CA;SEH1L;DYNC1I2;CENPF;CENPT;ANAPC16;PPP2R5D;SEC13
gsea,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.45668391306445666,-1.6287424700505784,0.008791208791208791,0.023882734008376483,0.922,10/32,26.33%,UBB;RPS27A;PCBP2;PDZD2;UBC;UBE2D3;IKBKE;ATG12;TAX1BP1;UBA52
gsea,Processive Synthesis On C-strand Of Telomere R-HSA-174414,-0.5244707190920157,-1.6276382157773865,0.022271714922048998,0.024059098334743834,0.926,8/18,25.29%,PCNA;TERF1;RPA3;BLM;FEN1;POLD3;WRN;TERF2IP
gsea,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.4734909068292825,-1.627586467568921,0.015151515151515152,0.02403091828603483,0.926,14/27,26.03%,POLR2E;TBP;GTF3C3;POLR3F;POLR3K;POLR2K;GTF3C2;POLR3H;GTF3A;POLR3A;POLR2L;BDP1;GTF3C4;POLR3D
gsea,Translesion Synthesis By POLH R-HSA-110320,-0.5155001689124282,-1.627409524863833,0.02391304347826087,0.024026197457720333,0.926,5/19,10.83%,UBB;RPS27A;PCNA;RPA3;UBC
gsea,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.4933247542299576,-1.6273716981588784,0.027944111776447105,0.023984844277930798,0.926,7/24,14.10%,UBB;RPS27A;BRAF;PPP2R1A;UBC;MAPK1;MAPK3
gsea,G-protein Beta:Gamma Signaling R-HSA-397795,-0.47011782151197523,-1.6249915118001865,0.01279317697228145,0.024382660790105374,0.926,11/29,25.76%,GNG3;GNB2;PLCB1;AKT1;GNG11;GNG10;GNG7;GNB5;PLCB3;PLCB2;GNG2
gsea,SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.5608251684566029,-1.624794922888806,0.02391304347826087,0.0243806811839417,0.926,7/15,28.32%,TAF1D;H2AZ1;TBP;H2AJ;H2BC4;SUV39H1;TAF1B
gsea,Signaling By FGFR3 R-HSA-5654741,-0.45541672745832584,-1.6239817823064855,0.011811023622047244,0.024491403949929172,0.927,8/34,14.10%,UBB;RPS27A;BRAF;PPP2R1A;SOS1;UBC;MAPK1;MAPK3
gsea,RNA Polymerase III Transcription Initiation R-HSA-76046,-0.44310443708774133,-1.6237272409322654,0.016632016632016633,0.024492554136219445,0.927,20/34,35.35%,POLR2E;TBP;GTF3C3;POLR3F;POLR3K;POLR2K;GTF3C2;SNAPC3;POLR3H;GTF3A;POLR3A;POLR2L;BDP1;SNAPC5;GTF3C4;POLR3D;POLR2H;SNAPC1;POLR3E;POLR3C
gsea,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.48764589466991093,-1.623350257147293,0.022813688212927757,0.02453333956145871,0.928,4/23,4.25%,HSP90AA1;ERBIN;NRG2;SOS1
gsea,Metabolism Of Non-Coding RNA R-HSA-194441,-0.41618700111113716,-1.6218117868756612,0.011673151750972763,0.02485428511354528,0.928,24/47,32.66%,TPR;RANBP2;SNRPG;PHAX;GEMIN6;NUP98;NUP88;NUP153;NUP155;SNRPE;SNRPD2;GEMIN5;NDC1;NUP37;NUP54;SEH1L;SNRPF;SEC13;NCBP2;SNRPD3;SNRPB;NUP93;WDR77;NUP205
gsea,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.5397225376280661,-1.6216221335603123,0.03469387755102041,0.0248416441742323,0.928,8/15,26.33%,UBB;RPS27A;VPS28;UBC;TSG101;SGIP1;VPS37D;UBA52
gsea,Signaling By NTRKs R-HSA-166520,-0.3600523190190191,-1.620305867945702,0.006048387096774193,0.02503280537231858,0.929,35/123,21.96%,CDK5R1;MEF2A;AP2M1;BRAF;YWHAB;BCL11B;JUND;PPP2R1A;DOCK3;SOS1;F3;TIAM1;CLTC;VGF;TCF12;CDK5;FURIN;NTRK3;ID2;MAPK1;NTRK2;MAPK3;RALA;RAP1A;PTPRU;NAB2;NELFB;ID3;CHD4;CLTA;GRIN2B;ADORA2A;HRAS;DUSP6;PPP2CA
gsea,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.3727928085939335,-1.618905424563913,0.008456659619450317,0.025302059415145874,0.93,35/89,28.32%,TAF1D;H2AZ1;BAZ1B;ARID4B;KAT2B;HDAC1;POLR2E;TBP;POLR1F;UBTF;CCNH;MNAT1;CBX3;MTF2;SF3B1;MTA3;GTF2H5;POLR2K;POLR1H;GTF2H1;TTF1;CDK7;ERCC3;CHD4;SAP130;POLR2L;SAP18;RBBP7;H2AJ;CHD3;H2BC4;HDAC2;SUV39H1;UHRF1;TAF1B
gsea,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.47118152484943254,-1.6169251283998112,0.015841584158415842,0.0256326333057607,0.931,17/31,32.66%,TPR;PSIP1;RANBP2;BANF1;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;SGIP1;SEC13;KPNA1;NUP93;NUP205
gsea,"Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",-0.5476158435207452,-1.6159028207239299,0.025390625,0.025795331373795888,0.933,3/15,8.09%,SCN2A;GRM1;SCN3A
gsea,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.3733676710099498,-1.614685289609031,0.00437636761487965,0.026016237585943996,0.936,25/84,25.80%,DYNLL1;RPS27;TAOK1;DYNLL2;PPP2R1A;RANBP2;AHCTF1;CKAP5;XPO1;ITGB3BP;KIF2A;NUP98;CENPE;RCC2;KANSL1;ZWINT;NUP37;NEK7;PPP2CA;SEH1L;DYNC1I2;CENPF;CENPT;PPP2R5D;SEC13
gsea,Nuclear Import Of Rev Protein R-HSA-180746,-0.46717627538466155,-1.6135650484750679,0.02912621359223301,0.026167965724660288,0.936,12/30,22.16%,TPR;NPM1;RANBP2;NUP98;NUP88;RAN;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L
gsea,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.5063442247750389,-1.6133100275833974,0.024439918533604887,0.02618254532108108,0.936,8/22,21.70%,CEBPG;CEBPB;EXOSC9;KHSRP;DIS3;DCP2;ATF4;NFYA
gsea,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.38027066965937645,-1.6127772085811467,0.015184381778741865,0.02621656303160505,0.936,13/83,9.72%,ATP1B1;PPIA;TSPAN7;BSG;SDC4;SLC7A6;SELENOP;ATP1B2;SLC7A10;SOS1;GRB14;SLC7A11;SDC3
gsea,RHOU GTPase Cycle R-HSA-9013420,-0.4470907750471762,-1.6120885920413197,0.009940357852882704,0.026312072371454043,0.936,14/38,24.15%,PTK2B;PKN2;SPTBN1;CLTC;STAM;ITSN2;SRGAP2;USP9X;TXNL1;STAM2;RHOU;PARD6A;NCK1;IQGAP1
gsea,Cargo Concentration In ER R-HSA-5694530,-0.48444379305426555,-1.6108136455650797,0.012448132780082987,0.026523793471353797,0.938,10/26,15.91%,SEC24A;CNIH2;MCFD2;PREB;TGFA;LMAN1;MIA3;LMAN2;SEC23A;TMED2
gsea,MET Activates PTK2 Signaling R-HSA-8874081,-0.5393069872474766,-1.6093225892996008,0.029288702928870293,0.026799439126280834,0.938,6/17,14.02%,PTK2;SOS1;LAMA2;RNMT;LAMA5;LAMA1
gsea,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.4755720994075314,-1.608774328662313,0.00819672131147541,0.02686768995883203,0.94,13/27,32.48%,AMT;PDHX;DDO;PDHB;GRHPR;NDUFAB1;GLDC;GOT2;LIPT2;DBT;PXMP2;LIAS;GCSH
gsea,Signaling By NOTCH3 R-HSA-9012852,-0.4303200675923945,-1.6078136052447842,0.01702127659574468,0.02700335087712215,0.941,16/44,23.36%,UBB;RPS27A;MAML2;FABP7;KAT2B;HEY1;WWC1;UBC;APH1B;MIB1;MAML3;CREBBP;HEY2;JAG2;PSENEN;HES5
gsea,Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.5528157243749358,-1.6077612986433973,0.02813852813852814,0.02696814122051426,0.941,10/15,38.75%,ORC4;H2AZ1;ORC6;ORC5;H2AJ;H2BC4;KPNA1;H2AZ2;H2AX;KPNB1
gsea,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.48325870565510887,-1.607417138982728,0.0371900826446281,0.02703898286225479,0.942,5/28,4.25%,CALM1;PPP3CA;PPP3CB;PPP3R1;SOS1
gsea,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.42991431249307693,-1.6065189388531176,0.0078125,0.027189710480887613,0.942,15/44,18.90%,SCOC;NSF;RHOBTB3;M6PR;TMF1;GCC2;NAPG;RAB6A;RIC1;VPS53;NAA38;VAMP3;RAB9B;COG3;STX16
gsea,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.3951804414754502,-1.6018977706349868,0.012371134020618556,0.02808862864083959,0.945,12/59,8.50%,PCLO;VAMP2;RAB3A;CAPZA2;SNAP25;CACNA2D2;EPB41L1;EZR;ATP2B1;SPTBN1;CAPZB;CTBP2
gsea,tRNA Aminoacylation R-HSA-379724,-0.4777073045856189,-1.600497572866649,0.01616161616161616,0.028355313788692316,0.946,9/26,21.81%,YARS2;MARS2;LARS2;AIMP1;MARS1;FARS2;DTD1;RARS2;DARS2
gsea,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.4221116741884542,-1.6000885340196132,0.016359918200409,0.02841383635838292,0.946,13/39,17.31%,KMT2C;H2AZ1;TNRC6A;AGO3;TNRC6C;KAT2B;HDAC1;CBFB;AGO4;KMT2E;PRMT6;ASH2L;DPY30
gsea,DNA Damage Bypass R-HSA-73893,-0.3988357138834039,-1.5990725103050731,0.006564551422319475,0.02863135330556277,0.946,10/48,15.01%,UBB;RPS27A;USP32;PCNA;CUL4B;RPA3;UBC;USP1;RBX1;POLD3
gsea,G Beta:Gamma Signaling Thru BTK R-HSA-8964315,-0.5464038386178103,-1.5985849558728893,0.020366598778004074,0.028654266807076223,0.946,6/15,18.87%,GNG3;GNB2;GNG11;GNG10;GNG7;GNB5
gsea,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.49666929270405924,-1.5960765617097628,0.022448979591836733,0.029232432548396168,0.949,7/22,18.87%,GNG3;GNB2;AKT1;GNG11;GNG10;GNG7;GNB5
gsea,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.45840561154517745,-1.5959827692120803,0.026859504132231406,0.02922260622736227,0.949,12/30,20.80%,DPH5;ARSJ;EIF5A2;DPH3;FN3KRP;FURIN;ARSA;EEF2;DPH7;DNAJC24;DOHH;SUMF1
gsea,RNA Polymerase III Transcription Termination R-HSA-73980,-0.4980599699923858,-1.5953907679610138,0.027253668763102725,0.029301374029804948,0.95,15/21,35.35%,POLR2E;POLR3F;SSB;POLR3K;NFIA;POLR2K;POLR3H;POLR3A;POLR2L;POLR3D;NFIX;POLR2H;NFIB;POLR3E;POLR3C
gsea,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.5374431300358664,-1.5946986483789192,0.03262955854126679,0.0293862003794927,0.952,10/17,27.53%,MAP2K7;UBE2N;IRAK1;IRAK2;TAB3;MAPK8;IKBKG;MAPK10;MAPK9;TAB2
gsea,Nuclear Receptor Transcription Pathway R-HSA-383280,0.4239678978265918,1.5932663557254114,0.01556420233463035,0.5939464307162589,0.958,8/44,3.74%,NR2F1;NR4A3;ESRRA;ESRRG;NR4A1;HNF4G;THRB;RXRA
gsea,HCMV Late Events R-HSA-9610379,-0.39065501785884776,-1.593067952694629,0.008676789587852495,0.02968828163485075,0.952,18/62,19.29%,TPR;HNRNPK;H2AC25;CHMP2A;CEBPD;RANBP2;VPS36;VPS28;VPS4A;NUP98;NUP88;NUP153;TSG101;NUP155;CHMP2B;NDC1;NUP37;NUP54
gsea,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.44088773874242204,-1.5916773464782634,0.017699115044247787,0.02993902051128257,0.953,6/32,10.83%,UBB;RPS27A;USP32;PCNA;RPA3;UBC
gsea,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.37625195738638245,-1.5916565972083616,0.011928429423459244,0.02989041820525776,0.953,32/83,31.19%,YWHAE;RAB3A;RIN1;GDI1;TRAPPC11;RAB27B;SBF2;RAB1B;RAB14;RAB5A;RAB6A;AKT1;TRAPPC5;RIC1;RAB39B;DENND5B;RAB9B;DENND4B;GAPVD1;DENND1B;TRAPPC4;GDI2;TRAPPC1;HPS1;RAB3GAP1;DENND6B;DENND1A;TRAPPC2L;TRAPPC6B;DENND2A;SBF1;TRAPPC2
gsea,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.5050728826702462,-1.5887910166114232,0.029288702928870293,0.03051649239715729,0.954,10/20,25.76%,GNG3;GNB2;GNAQ;GNG11;GNG10;AAMP;GNG7;GNB5;GNA13;GNG2
gsea,Inositol Phosphate Metabolism R-HSA-1483249,-0.4232892694964487,-1.5875565703758239,0.010416666666666666,0.030755277284930906,0.956,19/46,27.03%,CALM1;PLCB1;SYNJ1;MTMR9;PPIP5K2;NUDT11;IMPA1;MINPP1;INPP1;INPP4B;PLCB3;PPIP5K1;ITPKB;INPP5B;NUDT10;PLCB2;PLCE1;ITPK1;PLCD1
gsea,RHOC GTPase Cycle R-HSA-9013106,-0.3904729523193126,-1.5858008237517478,0.015873015873015872,0.03109961412157106,0.96,27/68,30.48%,ERBIN;PKN2;SLK;ROCK2;ARHGAP5;MACO1;ROCK1;ARHGAP32;ARHGAP21;ARHGEF12;LMAN1;ABR;CAV1;VAMP3;CCDC187;FMNL2;OPHN1;C1QBP;ABCD3;TFRC;IQGAP1;DIAPH1;TMPO;MYO9B;DAAM1;ACBD5;ARHGDIA
gsea,RHOB GTPase Cycle R-HSA-9013026,-0.4012403147031674,-1.5835340146021688,0.012244897959183673,0.03158957969269575,0.961,20/64,23.07%,ERBIN;PKN2;SLK;MYO9A;ROCK2;ARHGAP5;RHOB;PRPF38B;ROCK1;ARHGAP32;ARHGAP21;ARHGEF12;ABR;CAV1;VAMP3;STARD8;SOWAHC;OPHN1;TFRC;ARHGEF2
gsea,Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,-0.54397446958715,-1.5831259444794712,0.02973977695167286,0.03163222348705808,0.961,4/16,5.31%,VAMP2;RAB3A;SNAP25;PPFIA2
gsea,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.4550147687960641,-1.5830549274399586,0.0189873417721519,0.031587591978342745,0.961,10/29,18.87%,GNG3;GNB2;GNAQ;F2RL2;GNG11;MAPK1;GNG10;MAPK3;GNG7;GNB5
gsea,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,-0.5275118320780139,-1.579660351418759,0.048,0.03228569651845255,0.963,6/17,16.90%,TNRC6A;AGO3;TNRC6C;CBFB;AGO4;CCND1
gsea,Transcriptional Regulation By VENTX R-HSA-8853884,-0.44250077849587693,-1.5775558316622853,0.017964071856287425,0.03273649737396023,0.963,15/35,25.58%,TNRC6A;AGO3;ANAPC4;TNRC6C;UBE2E1;CEBPB;CDC26;AGO4;NFKB1;CCND1;ANAPC1;CTNNB1;EHMT1;ANAPC16;TCF7L2
gsea,G Alpha (12/13) Signaling Events R-HSA-416482,-0.38215995597254987,-1.5746831209492154,0.00998003992015968,0.03337787835000954,0.964,24/70,25.76%,FGD4;GNG3;GNB2;ROCK2;SOS1;RHOB;ARHGEF4;TIAM1;PRPF38B;ROCK1;ARHGEF9;ARHGEF12;GNG11;GNG10;ABR;PLEKHG5;GNG7;GNB5;ARHGEF26;VAV3;ARHGEF2;ITSN1;GNA13;GNG2
gsea,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.5174985464217463,-1.5723350327216545,0.0297029702970297,0.033874969328498594,0.966,4/17,10.83%,UBB;RPS27A;KMT5A;UBC
gsea,FOXO-mediated Transcription R-HSA-9614085,-0.39221721656251135,-1.5698269398682847,0.008113590263691683,0.034435307167015115,0.966,23/57,26.67%,YWHAZ;YWHAB;KAT2B;HDAC1;SMAD4;AKT1;BCL6;CDKN1B;SMAD3;ATXN3;CAV1;CREBBP;NFYA;PLXNA4;YWHAG;RBL2;CCNG2;TXNIP;REXO2;HDAC2;BBC3;CITED2;RETN
gsea,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.4857410475413865,-1.5668747087910078,0.020316027088036117,0.03512023662683467,0.971,11/22,25.79%,H2AZ1;HDAC1;CBX3;MTA3;TTF1;CHD4;RBBP7;H2AJ;CHD3;H2BC4;HDAC2
gsea,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.4592367742670014,-1.5644383828202488,0.025052192066805846,0.03569220025182165,0.972,16/26,35.35%,POLR2E;TBP;POLR3F;POLR3K;POLR2K;SNAPC3;POLR3H;POLR3A;POLR2L;BDP1;SNAPC5;POLR3D;POLR2H;SNAPC1;POLR3E;POLR3C
gsea,G Alpha (Z) Signaling Events R-HSA-418597,-0.4192967599999653,-1.5638428718631887,0.014989293361884369,0.03575844834875888,0.974,15/41,20.18%,PRKCE;GNG3;GNB2;RGS20;ADCY9;ADCY1;GNG11;GNAS;GNG10;ADCY2;ADRA2A;GNG7;ADCY5;GNB5;PRKCD
gsea,Apoptotic Factor-Mediated Response R-HSA-111471,-0.5053073806882183,-1.561245517526068,0.03296703296703297,0.036413482991105126,0.975,11/19,25.74%,CYCS;UACA;MAPK1;BAK1;MAPK3;CASP3;APIP;C1QBP;DIABLO;APAF1;CASP9
gsea,Leishmania Infection R-HSA-9658195,-0.32795268124303845,-1.560739160030988,0.004761904761904762,0.03650288286230075,0.975,59/184,26.36%,CALM1;ACTG1;HSP90AB1;WIPF3;CYFIP1;GNG3;GNB2;PTK2;ACTR2;MYO5A;CALCRL;NCKAP1;PRKAR1A;BAIAP2;ADCY9;JUN;ADRB3;PRKAR2B;ADCY1;WASF1;ARPC5;ARPC2;PRKACB;ELMO2;FURIN;GNG11;GNAS;MAPK1;NFKB1;GNG10;PTGER4;ABI1;MAPK3;ADCY2;ENTPD5;MAPK8;PLK2;HTR4;GNG7;RAMP2;ADCY5;GNB5;ADORA2A;VAV3;DOCK1;AHCYL1;ACTR3;PRKAR2A;ABI2;NCK1;TXNIP;FSHR;CYBA;ARPC1A;GPR83;GNG2;MYH9;ADCY6;WASF3
gsea,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.484198758876414,-1.559289715626087,0.03347280334728033,0.03687027805856082,0.975,11/23,25.76%,GNG3;GNB2;KCNJ4;GNG11;GNG10;KCNJ10;GABBR2;GNG7;GNB5;KCNJ6;GNG2
gsea,CDC42 GTPase Cycle R-HSA-9013148,-0.3500376617714097,-1.5583583948389408,0.01016260162601626,0.03707469603929324,0.975,51/140,30.48%,KTN1;WIPF3;IQGAP2;FGD4;DOCK11;SYDE1;CDC42BPA;PKN2;BAIAP2;ARHGAP5;ARHGEF4;TIAM1;ARHGAP44;FNBP1L;ARHGEF9;DOCK10;ARHGAP32;ARHGAP21;ARHGEF12;SRGAP2;REPS1;ABR;DOCK7;YKT6;PREX2;CAV1;VAMP3;CDC42EP3;FMNL2;SPATA13;STARD8;ARHGEF26;LAMTOR1;SRGAP1;VAV3;OPHN1;SH3PXD2A;TFRC;PARD6A;IQGAP1;ITSN1;GNA13;WDR91;TMPO;WASL;KCTD3;MYO9B;DAAM1;ARHGAP27;CDC42SE2;ARHGDIA
gsea,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.46119249746552915,-1.5581955093166737,0.021691973969631236,0.03705593945171914,0.975,13/26,26.03%,POLR2E;TBP;GTF3C3;POLR3F;POLR3K;POLR2K;GTF3C2;POLR3H;POLR3A;POLR2L;BDP1;GTF3C4;POLR3D
gsea,TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,-0.5401994343945105,-1.5581462829759507,0.02385685884691849,0.037006806115472995,0.975,6/15,15.11%,UBB;RPS27A;NDUFA2;UBC;IRAK2;TAB3
gsea,Removal Of Flap Intermediate From C-strand R-HSA-174437,-0.5174532056013708,-1.557739227450075,0.03404255319148936,0.03704595210439349,0.975,7/16,25.29%,PCNA;TERF1;RPA3;FEN1;POLD3;WRN;TERF2IP
gsea,Sensory Perception Of Taste R-HSA-9717189,-0.5102506796902843,-1.5526048138230804,0.02895752895752896,0.03836230292785815,0.975,3/17,8.09%,SCN2A;GRM1;SCN3A
gsea,ECM Proteoglycans R-HSA-3000178,-0.40801044037407924,-1.5523527743978942,0.01702127659574468,0.03837800012722993,0.975,13/45,16.58%,TGFB3;ITGA7;DMTF1;BCAN;LAMA2;VTN;LAMA5;TGFB2;LAMA1;MATN4;LRP4;AGRN;ITGA9
gsea,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.39428019526932395,-1.5491373898700345,0.020491803278688523,0.03924657160773195,0.977,12/46,16.90%,UBB;RPS27A;HIF1A;NRG2;CDK4;PXDN;ELMO2;AKT1;UBC;CDKN1B;KHDRBS1;CCND1
gsea,Azathioprine ADME R-HSA-9748787,-0.5119354799280807,-1.5488290092323143,0.03292181069958848,0.03929707830369978,0.977,9/16,30.76%,GSTM1;GUK1;GMPS;ABCC4;SLC29A1;VAV3;NME2;ABCC5;TPMT
gsea,Rab Regulation Of Trafficking R-HSA-9007101,-0.34691210121902727,-1.5486535551357279,0.005964214711729622,0.03928109482970002,0.977,45/114,33.12%,YWHAE;RAB3A;GABARAP;RIN1;GDI1;TRAPPC11;RAB27B;SBF2;RAB1B;RAB14;RAB5A;RAB6A;GABARAPL2;AKT1;TRAPPC5;RIC1;RABGAP1;RAB39B;DENND5B;RAB9B;DENND4B;GAPVD1;TBC1D24;DENND1B;TBC1D14;TRAPPC4;GDI2;TRAPPC1;RAB33B;HPS1;RAB3GAP1;DENND6B;RAB11A;RABEP1;DENND1A;TRAPPC2L;TRAPPC6B;TBC1D15;DENND2A;ARF6;SBF1;TRAPPC2;TBC1D10B;GGA3;DENND4C
gsea,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.4540591976083291,-1.5482863827675317,0.03557312252964427,0.03931031766198931,0.977,14/28,27.41%,MEF2A;PPP2R1A;JUN;MAPK1;MAPK3;MAPK8;MAPK10;DUSP6;PPP2CA;MAPK9;DUSP7;MAPK11;PPP2R5D;DUSP3
gsea,Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.48758650196397474,-1.5417311220285066,0.041044776119402986,0.04120903544753467,0.977,9/23,18.00%,VAMP2;RAB3A;SNAP25;PPFIA2;LIN7B;LIN7C;SYN2;CASK;CPLX1
gsea,Pyroptosis R-HSA-5620971,-0.49141686061763323,-1.5402752116771763,0.0340632603406326,0.0415232846626008,0.977,6/19,15.84%,CYCS;CHMP2A;BAK1;HMGB1;CHMP2B;CASP3
gsea,Biological Oxidations R-HSA-211859,-0.3355832897197473,-1.539193459096663,0.0064794816414686825,0.04178562116637885,0.977,28/109,21.02%,HSP90AB1;PRNP;BPNT2;CYP7B1;VDAC2;MGST3;MAT2B;GSTM1;AURKAIP1;GSTP1;COMT;ESD;MAOB;SULT4A1;PTGES3;GSTM5;TRMT112;GSTZ1;MIA3;GSTM4;AKR1A1;GSTO1;CYP26B1;NCOA2;ABHD14B;UGP2;SLC38A1;CHAC2
gsea,Growth Hormone Receptor Signaling R-HSA-982772,0.5081631319962692,1.534529615532738,0.03832116788321168,0.6126145144441978,0.981,6/19,9.61%,PRLR;SOCS2;PTPN1;GHR;LYN;ADAM17
gsea,Sensory Processing Of Sound R-HSA-9659379,-0.370223692829524,-1.53422833910373,0.01263157894736842,0.04314514751038006,0.979,12/65,8.50%,PCLO;VAMP2;RAB3A;CAPZA2;SNAP25;CACNA2D2;EPB41L1;EZR;ATP2B1;SPTBN1;CAPZB;CTBP2
gsea,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.4560855028442355,-1.5287107177547534,0.04771371769383698,0.04480218606603368,0.981,11/28,22.16%,TPR;RANBP2;MAP4K5;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L
gsea,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.44357709164885134,-1.522425406387319,0.025390625,0.04666290073910284,0.984,11/34,17.37%,CBX6;SCMH1;ACTL6B;SMARCC2;PBRM1;SMARCA2;CBFB;CSNK2B;SMARCD2;SMARCE1;ARID2
gsea,Protein-protein Interactions At Synapses R-HSA-6794362,-0.3766468233482221,-1.5223679520119673,0.03642987249544627,0.0466268478924222,0.984,30/86,18.76%,LRRTM1;GRM1;DLGAP1;RTN3;SLITRK4;EPB41L1;IL1RAPL1;GRIA3;SHARPIN;PPFIA2;LIN7B;SLITRK1;LRRTM2;IL1RAP;DLGAP2;SYT7;LIN7C;NTRK3;SLITRK2;CASK;PDLIM5;SIPA1L1;EPB41L5;SLITRK6;GRIN2C;EPB41;SLITRK5;NLGN3;HOMER3;GRIN2B
gsea,Signaling By NTRK3 (TRKC) R-HSA-9034015,-0.5181264889588045,-1.520925653403382,0.04024144869215292,0.0470488162988662,0.985,9/16,39.82%,SOS1;NTRK3;PTPRU;NELFB;HRAS;GRB2;SHC1;PIK3R1;PTPRS
gsea,NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.42274044168297414,-1.51684650622147,0.041916167664670656,0.048360155599641866,0.987,11/37,19.29%,PABPN1;TPR;GNL3;RANBP2;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54
gsea,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.3619228233641873,-1.5166134784098915,0.012106537530266344,0.04835427693602879,0.987,8/70,4.63%,HSP90AA1;HSPA8;HSP90B1;S1PR1;HIF1A;NDN;SOS1;CEBPD
gsea,Inwardly Rectifying K+ Channels R-HSA-1296065,-0.4542536732227499,-1.5158965118733394,0.04487179487179487,0.04850528592009044,0.987,11/27,25.76%,GNG3;GNB2;KCNJ4;GNG11;GNG10;KCNJ10;GABBR2;GNG7;GNB5;KCNJ6;GNG2
gsea,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.48712400047626003,-1.5155009571613673,0.04743083003952569,0.04853171178299707,0.987,6/18,18.87%,GNG3;GNB2;GNG11;GNG10;GNG7;GNB5
gsea,Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.3864520677899443,-1.5146087108047634,0.04225352112676056,0.04873510395727202,0.987,24/55,25.79%,CBX6;SCMH1;JUN;HDAC1;LAMTOR3;SNAI2;MAPK1;MTA3;MAPK3;HDAC3;RRAGB;CHD4;MTOR;LAMTOR5;LAMTOR1;RRAGA;MECOM;KDM1A;PHC3;RBBP7;LAMTOR4;LAMTOR2;CHD3;HDAC2
gsea,RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,-0.5204504981878707,-1.5109678005936815,0.04384133611691023,0.04992488412884615,0.989,7/15,24.66%,TLR3;DHX9;NFKB1;NKIRAS1;CHUK;IKBKG;IKBKB
gsea,G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,-0.49208451255944363,-1.5082411466608607,0.04435483870967742,0.05079627402476641,0.989,6/17,18.87%,GNG3;GNB2;GNG11;GNG10;GNG7;GNB5
gsea,Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.510463284272497,-1.5070040788488843,0.05172413793103448,0.0511039858120285,0.989,5/18,10.15%,VAMP2;RAB3A;SNAP25;PPFIA2;SYN2
gsea,Nicotinamide Salvaging R-HSA-197264,-0.4965602162770204,-1.5019510002367082,0.036281179138321996,0.05263378351248795,0.99,7/16,28.95%,PARP6;NUDT12;PARP16;NNMT;PTGIS;NAXE;NAXD
gsea,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,-0.4613135610998694,-1.499028575837592,0.05142857142857143,0.053628901086042347,0.99,11/24,22.80%,CAMK2B;NEFL;CAMK2A;LIN7B;LIN7C;CASK;LRRC7;GRIN2C;GRIN2B;LLGL1;CAMK2G
gsea,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.3683137823943094,-1.4968332536280635,0.03680981595092025,0.05438708929737367,0.99,21/55,27.47%,NRN1;PIGC;THY1;SPRN;PIGW;PIGG;MDGA2;LYPD1;PIGB;PIGN;LSAMP;PIGL;PIGP;PIGK;PIGH;OTOA;PIGS;PIGF;PIGO;DPM2;MDGA1
gsea,Potassium Channels R-HSA-1296071,-0.3587955595317712,-1.496352681605633,0.02702702702702703,0.054465636959546766,0.99,22/83,18.87%,KCNA1;KCNA2;GNG3;GNB2;KCNN3;KCNAB2;KCNG2;KCNF1;KCNJ4;KCNS1;GNG11;KCND3;GNG10;KCNJ10;GABBR2;KCNA3;HCN3;KCNB1;GNG7;KCNA4;KCNS3;GNB5
gsea,FLT3 Signaling R-HSA-9607240,-0.4051680474504322,-1.493763273180401,0.05128205128205128,0.055336890515796926,0.99,7/36,12.13%,UBB;RPS27A;SOS1;AKT1;PTPRJ;UBC;CDKN1B
gsea,Activation Of SMO R-HSA-5635838,-0.5107960517818677,-1.4908359871110606,0.04365904365904366,0.05628120575437339,0.99,6/16,17.89%,KIF3A;PTCH1;GRK2;EFCAB7;CSNK1A1;GAS8
gsea,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.43626292621366985,-1.4896307370988708,0.03913894324853229,0.05665301605757998,0.99,15/31,29.23%,APOE;TNRC6A;AGO3;ABCA1;TNRC6C;APOD;AGO4;NCOR1;HDAC3;PLTP;ARL4C;KDM1A;TBL1XR1;NCOA1;EEPD1
gsea,Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.48609396094663615,-1.4892804780074622,0.05168986083499006,0.056710282771316435,0.99,7/18,21.81%,YARS2;MARS2;LARS2;FARS2;DTD1;RARS2;DARS2
gsea,TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,-0.5105575669676017,-1.48785233601595,0.06431535269709543,0.05722812397506577,0.99,2/16,0.34%,UBB;RPS27A
gsea,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.4126137716306499,-1.4868646479864338,0.03667953667953668,0.05747532699050148,0.99,17/40,28.21%,DDX5;NPM1;SCMH1;PIAS1;SUMO2;CTBP1;UHRF2;TOPORS;CREBBP;NCOA2;UBE2I;CASP8AP2;PHC3;ING3;TRIM28;CBX8;NCOA1
gsea,Plasma Lipoprotein Remodeling R-HSA-8963899,-0.47676145433758554,-1.4856325380578077,0.057649667405764965,0.0578142440283655,0.99,13/19,42.08%,APOE;MBTPS2;FURIN;LPL;MBTPS1;PLTP;LCAT;APOA1;PCSK5;ABCG1;P4HB;LIPC;PCSK6
gsea,Signaling By FLT3 Fusion Proteins R-HSA-9703465,-0.4950505802371189,-1.4845875624827585,0.06395348837209303,0.058105993801543,0.99,5/18,7.59%,GOLGB1;SOS1;TRIP11;SPTBN1;ZMYM2
gsea,Signaling By FGFR In Disease R-HSA-1226099,-0.37652365304704327,-1.4834189284530004,0.03,0.05852073782974298,0.991,28/53,38.48%,POLR2G;SOS1;CPSF6;POLR2E;CEP43;ZMYM2;GTF2F1;POLR2K;BAG4;POLR2A;FGFR1;ERLIN2;POLR2L;POLR2D;HRAS;FGFR3;POLR2B;POLR2C;GRB2;NCBP2;POLR2H;FGFR1OP2;STAT5A;CNTRL;GTF2F2;PIGU;PIK3R1;FGF9
gsea,RAB Geranylgeranylation R-HSA-8873719,-0.372059671717799,-1.482954380549249,0.030737704918032786,0.05860060497548973,0.991,15/52,21.93%,RAB3A;RAB27B;RAB1B;RAB14;RAB5A;RABGGTB;RAB6A;RAB2B;RAB2A;RAB3C;RAB39B;RAB9B;RABGGTA;RAB15;RAB33B
gsea,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.38524250272339355,-1.4812997845699643,0.025793650793650792,0.05912826354685282,0.991,19/47,27.96%,TCP1;CCT5;TTC8;LZTFL1;ARF4;CCT8;EXOC3;NUDT19;EXOC1;EXOC2;ARL3;BBS7;BBS5;EXOC6;BBIP1;CCT2;EXOC8;RAB11A;EXOC5
gsea,mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.5092011002201675,-1.478516228081204,0.052525252525252523,0.06015334236059993,0.991,9/15,27.38%,EDC4;LSM4;LSM7;DCP2;LSM2;DCP1A;PATL1;LSM6;DDX6
gsea,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.3828215217244666,-1.4771386328408145,0.03260869565217391,0.060619873261565115,0.991,16/39,34.03%,UBB;RPS27A;USP32;PCNA;RPA3;UBC;POLD3;REV3L;REV1;SPRTN;UBA52;ISG15;RCHY1;RFC5;NPLOC4;POLE3
gsea,MAP2K And MAPK Activation R-HSA-5674135,-0.42090867349395017,-1.4761756340845413,0.043933054393305436,0.06088487840312717,0.992,11/32,24.15%,BRAF;YWHAB;VCL;LAMTOR3;PEBP1;MAPK1;MAPK3;RAP1A;HRAS;LAMTOR2;IQGAP1
gsea,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.4313533164276301,-1.4735444787049534,0.04842105263157895,0.061888555426368654,0.992,7/24,22.20%,UBB;RPS27A;UBC;APH1B;MIB1;JAG2;PSENEN
gsea,Notch-HLH Transcription Pathway R-HSA-350054,-0.4316916715472666,-1.473428265254341,0.046370967741935484,0.061834469575858156,0.992,17/28,34.70%,MAML2;HDAC8;KAT2B;HDAC1;NCOR1;MAML3;CREBBP;HDAC3;TBL1XR1;HDAC2;NOTCH2;SNW1;MAMLD1;HDAC11;NOTCH4;KAT2A;NOTCH1
gsea,Keratan Sulfate Biosynthesis R-HSA-2022854,-0.4629563045280699,-1.4713034778838507,0.06471816283924843,0.06259752735577177,0.992,4/22,6.81%,B4GALT6;B4GAT1;CHST1;B3GNT2
gsea,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.4715360986264753,-1.470264848111223,0.05928853754940711,0.0629490304802962,0.992,11/19,30.63%,POLR2G;POLR2E;GTF2F1;POLR2K;POLR2A;POLR2L;POLR2D;POLR2B;POLR2C;NCBP2;POLR2H
gsea,Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,-0.4910232375200112,-1.4683550918408301,0.06976744186046512,0.06373943747047281,0.992,4/16,10.83%,UBB;RPS27A;NDUFA2;UBC
gsea,HCMV Early Events R-HSA-9609690,-0.351602334554917,-1.46827938581406,0.03777335984095427,0.06368012431223885,0.992,23/68,25.80%,DYNLL1;TPR;DYNLL2;H2AC25;RANBP2;NCOR1;NFKB1;NUP98;NUP88;NUP153;NUP155;HDAC3;NDC1;NUP37;NUP54;CBX1;SEH1L;DYNC1I2;RBBP7;TRIM28;TBL1XR1;H2BC4;SEC13
gsea,G-protein Activation R-HSA-202040,-0.457151225557488,-1.467703875037242,0.05139186295503212,0.06379927389654741,0.992,7/21,18.87%,GNG3;GNB2;GNAQ;GNG11;GNG10;GNG7;GNB5
gsea,Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,-0.4659057234810152,-1.4642004932406805,0.08,0.06520666671575433,0.995,2/20,1.28%,PRNP;CYP7B1
gsea,RHOJ GTPase Cycle R-HSA-9013409,-0.37771573531243674,-1.4641641581444704,0.05084745762711865,0.06512854369604966,0.995,11/52,15.03%,GJA1;SYDE1;CDC42BPA;PKN2;ARHGAP5;SLC4A7;FNBP1L;ARHGAP32;ARHGAP21;CAV1;VAMP3
gsea,NRAGE Signals Death Thru JNK R-HSA-193648,-0.3831099585370824,-1.4631578077192107,0.05353728489483748,0.06541412251448729,0.995,17/51,24.97%,MAGED1;FGD4;SOS1;ARHGEF4;TIAM1;PRPF38B;ARHGEF9;ARHGEF12;ABR;AATF;PLEKHG5;MAPK8;ARHGEF26;VAV3;ARHGEF2;ITSN1;GNA13
gsea,Signaling By GPCR R-HSA-372790,-0.27718173024722037,-1.4618463894886264,0.0024449877750611247,0.06588456451540296,0.995,126/448,26.33%,CALM1;DGKH;PPP3CA;PLPPR4;PPP3CB;CAMK2B;PPP3R1;FGD4;PRKCE;PLPPR1;GNG3;S1PR1;GNB2;GRM1;DGKI;NTSR2;CALCRL;RGS20;CAMKK1;PDE10A;PRKAR1A;ADCY9;ROCK2;GNAQ;GNAL;PPP2R1A;PLCB1;GPR37L1;SOS1;RHOB;CAMK2A;FZD2;SST;GPR37;ARHGEF4;TIAM1;ADRB3;PRPF38B;PRKAR2B;HTR2A;PPP1CA;ROCK1;ADCY1;PRKACB;ARHGEF9;CDK5;PTCH1;ARHGEF12;AKT1;NTS;RASGRP1;NPY2R;F2RL2;GRM2;ACKR1;PDE7B;GNG11;SSTR1;GNAS;WNT7B;MAPK1;GNG10;GABBR2;PTGER4;ABR;RGS14;GRK2;ADORA1;CHRM1;MAPK3;P2RY14;ADCY2;SSTR4;PDE3B;ADGRE5;PLEKHG5;TACR1;ADRA2A;PPP1R1B;FZD1;ACKR3;PDE1B;HTR4;GNG7;RAMP2;ADCY5;RGS5;WNT4;GNB5;DGKE;ARHGEF26;EDNRB;GPR17;PRKCD;ADORA2A;PLCB3;VAV3;PDE7A;OPRL1;HRAS;AHCYL1;PPP2CA;DGKB;CAMK2G;ARHGEF2;PRKAR2A;PIK3R3;CNOT6;DAGLA;RGS7;PLCB2;TRPC6;CD55;ITSN1;GNA13;PLPPR5;FSHR;RGS3;PPP2R5D;GPR83;GNG2;GRK6;CHRM3;NBEA;ADCY6;GRK3
gsea,SLC Transporter Disorders R-HSA-5619102,-0.34728145085879747,-1.4616670578643347,0.020080321285140562,0.0658423206454649,0.995,22/69,25.95%,SLC1A3;TPR;SLC4A4;BSG;RANBP2;SLC9A7;SLC35A1;MAP4K5;NUP98;NUP88;NUP153;NUP155;SLC22A5;SLC35A3;NDC1;NUP37;NUP54;SLC24A5;SEH1L;SLC9A9;SEC13;SLC2A9
gsea,Activation Of Pre-Replicative Complex R-HSA-68962,-0.41142806521435565,-1.4613041911989006,0.05239179954441914,0.0658899713969728,0.995,8/28,22.83%,ORC4;ORC6;RPA3;MCM6;MCM7;MCM4;POLA1;ORC5
gsea,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.4525068607055083,-1.4593401225072098,0.06692913385826772,0.06660139721191269,0.995,9/23,23.49%,TCP1;CCT5;TTC8;LZTFL1;CCT8;BBS7;BBS5;BBIP1;CCT2
gsea,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.4541677764366915,-1.4583591558058489,0.05102040816326531,0.06695831055460535,0.995,7/22,18.87%,GNG3;GNB2;GNAQ;GNG11;GNG10;GNG7;GNB5
gsea,NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,-0.5079468288971271,-1.4560766006432304,0.08057851239669421,0.06783652897232875,0.995,14/17,34.70%,MAML2;KAT2B;HEY1;SMAD3;MAML3;CREBBP;HEY2;HES5;NOTCH2;SNW1;MAMLD1;NOTCH4;KAT2A;NOTCH1
gsea,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.3287955879432503,-1.4532286480365098,0.029940119760479042,0.06888793680323248,0.995,28/107,21.96%,CDK5R1;MEF2A;AP2M1;BRAF;YWHAB;BCL11B;JUND;PPP2R1A;SOS1;F3;CLTC;VGF;TCF12;CDK5;ID2;MAPK1;NTRK2;MAPK3;RALA;RAP1A;NAB2;ID3;CHD4;CLTA;ADORA2A;HRAS;DUSP6;PPP2CA
gsea,NOD1/2 Signaling Pathway R-HSA-168638,-0.42193471055154785,-1.452740275695358,0.06092436974789916,0.06898378132195299,0.995,13/31,27.53%,UBE2N;IRAK1;BIRC2;MAP2K6;AAMP;IRAK2;TAB3;CHUK;IKBKG;IKBKB;MAPK11;CASP9;TAB2
gsea,NGF-stimulated Transcription R-HSA-9031628,-0.41309516607852403,-1.4517147160087949,0.04487179487179487,0.06937693841538567,0.995,10/34,17.83%,CDK5R1;JUND;F3;VGF;TCF12;CDK5;ID2;NAB2;ID3;CHD4
gsea,Signaling By FGFR1 R-HSA-5654736,-0.3904290278240259,-1.4495963395178961,0.04563492063492063,0.07031052252425489,0.995,13/42,22.59%,UBB;RPS27A;BRAF;PPP2R1A;SOS1;UBC;FLRT3;MAPK1;MAPK3;FGFR1;HRAS;PPP2CA;FLRT1
gsea,"Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",-0.5038422403739692,-1.447739968786659,0.06692160611854685,0.07092805694193041,0.995,6/15,25.45%,YWHAB;EXOSC9;DIS3;DCP2;DCP1A;TNPO1
gsea,VEGFR2 Mediated Cell Proliferation R-HSA-5218921,-0.48301444863798015,-1.446939966841969,0.08447937131630648,0.07115612809284867,0.995,5/18,21.76%,CALM1;PRKCD;VEGFA;HRAS;AHCYL1
gsea,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.44952552200166107,-1.4469072891295274,0.05942622950819672,0.071082129517474,0.995,12/21,30.63%,POLR2G;POLR2E;GTF2F1;POLR2K;POLR2A;NELFB;POLR2L;POLR2D;POLR2B;POLR2C;NCBP2;POLR2H
gsea,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.3754841638701901,-1.4468831938340703,0.04752851711026616,0.07100281934735556,0.995,21/50,28.13%,TPR;SCMH1;PIAS1;SUMO2;RANBP2;HDAC1;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;UBE2I;SEH1L;PHC3;CHD3;HDAC2;SEC13;L3MBTL2;CBX8
gsea,Homology Directed Repair R-HSA-5693538,-0.3211274267385699,-1.4440848945378828,0.01650943396226415,0.07219215075208968,0.995,25/98,23.71%,UBB;RPS27A;UBE2N;SUMO2;PCNA;HERC2;SEM1;RPA3;BLM;BRCC3;UBC;SPIDR;CCNA1;FEN1;RAD17;POLD3;MDC1;PARP2;UBE2I;WRN;CCNA2;RAD52;TOPBP1;BABAM2;NSD2
gsea,NCAM1 Interactions R-HSA-419037,-0.40397543449538986,-1.443914516131247,0.04564315352697095,0.0721748178043979,0.995,11/33,26.03%,PRNP;CACNA1H;ST8SIA4;COL4A2;COL4A1;AGRN;NCAN;ST8SIA2;COL4A5;CACNA1C;CACNB3
gsea,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.42157959538396605,-1.4432912066983612,0.05979381443298969,0.07234450633134144,0.995,7/28,15.07%,BRAF;YWHAB;VCL;PEBP1;MAPK1;MAPK3;RAP1A
gsea,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.4101991297212632,-1.443107392591812,0.055201698513800426,0.07231053229871034,0.995,6/30,7.71%,CALM1;PRKAR1A;ADCY9;PRKAR2B;ADCY1;PRKACB
gsea,Extension Of Telomeres R-HSA-180786,-0.3678685078623603,-1.442265686810196,0.039473684210526314,0.07261115440927789,0.995,16/46,26.23%,NOP10;PCNA;DKC1;TERF1;RPA3;BLM;CCNA1;FEN1;POLD3;RUVBL1;WRN;CCNA2;POLA1;ANKRD28;TERF2IP;NHP2
gsea,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.4069128204277829,-1.4406787591903294,0.0546875,0.07327233212117837,0.996,12/35,22.16%,TPR;PIAS1;RANBP2;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;UBE2I;SEH1L
gsea,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.32361196665323005,-1.4370679432536284,0.023529411764705882,0.07503346717121191,0.996,23/93,23.71%,UBB;RPS27A;UBE2N;SUMO2;PCNA;HERC2;SEM1;RPA3;BLM;BRCC3;UBC;SPIDR;CCNA1;RAD17;POLD3;MDC1;UBE2I;WRN;CCNA2;RAD52;TOPBP1;BABAM2;NSD2
gsea,Arachidonic Acid Metabolism R-HSA-2142753,-0.41981628222322964,-1.434691342794864,0.06502242152466367,0.07606340080531702,0.996,6/30,12.87%,PTGDS;GPX4;GPX1;PTGR2;PTGES3;LTA4H
gsea,Signaling By NODAL R-HSA-1181150,-0.49277534367090525,-1.4337336581638742,0.09696969696969697,0.07641974972054853,0.996,6/16,14.10%,FURIN;SMAD4;ACVR2A;MAPK1;SMAD3;MAPK3
gsea,GPCR Downstream Signaling R-HSA-388396,-0.272848189599745,-1.4330453736191542,0.009195402298850575,0.07660357741578983,0.996,114/406,26.33%,CALM1;DGKH;PPP3CA;PPP3CB;CAMK2B;PPP3R1;FGD4;PRKCE;GNG3;GNB2;GRM1;DGKI;NTSR2;CALCRL;RGS20;CAMKK1;PDE10A;PRKAR1A;ADCY9;ROCK2;GNAQ;GNAL;PPP2R1A;PLCB1;GPR37L1;SOS1;RHOB;CAMK2A;SST;GPR37;ARHGEF4;TIAM1;ADRB3;PRPF38B;PRKAR2B;HTR2A;PPP1CA;ROCK1;ADCY1;PRKACB;ARHGEF9;CDK5;ARHGEF12;AKT1;NTS;RASGRP1;NPY2R;F2RL2;GRM2;PDE7B;GNG11;SSTR1;GNAS;MAPK1;GNG10;GABBR2;PTGER4;ABR;RGS14;GRK2;ADORA1;CHRM1;MAPK3;P2RY14;ADCY2;SSTR4;PDE3B;PLEKHG5;TACR1;ADRA2A;PPP1R1B;ACKR3;PDE1B;HTR4;GNG7;RAMP2;ADCY5;RGS5;GNB5;DGKE;ARHGEF26;EDNRB;GPR17;PRKCD;ADORA2A;PLCB3;VAV3;PDE7A;OPRL1;HRAS;AHCYL1;PPP2CA;DGKB;CAMK2G;ARHGEF2;PRKAR2A;PIK3R3;CNOT6;DAGLA;RGS7;PLCB2;TRPC6;ITSN1;GNA13;FSHR;RGS3;PPP2R5D;GPR83;GNG2;GRK6;CHRM3;NBEA;ADCY6;GRK3
gsea,Effects Of PIP2 Hydrolysis R-HSA-114508,-0.43963280860254617,-1.4312733685214971,0.0741444866920152,0.0773279095193006,0.996,14/27,35.30%,DGKH;PRKCE;DGKI;RASGRP1;DGKE;PRKCD;DGKB;DAGLA;TRPC6;ABHD6;ABHD12;ITPR1;ITPR2;MGLL
gsea,RAC3 GTPase Cycle R-HSA-9013423,-0.34829661203583556,-1.4292548636509603,0.046610169491525424,0.07817237963091875,0.996,20/86,15.03%,CYFIP1;ERBIN;SYDE1;NCKAP1;PKN2;BAIAP2;ARHGAP5;TIAM1;WASF1;DOCK10;ARHGAP32;ARHGAP21;SRGAP2;NHS;LMAN1;ABR;YKT6;ABI1;CAV1;VAMP3
gsea,Signal Amplification R-HSA-392518,-0.4127896687188979,-1.4286097696839228,0.061224489795918366,0.07834213594922959,0.996,10/28,25.76%,GNG3;GNB2;GNAQ;GNG11;GNG10;AAMP;GNG7;GNB5;GNA13;GNG2
gsea,Syndecan Interactions R-HSA-3000170,-0.46678930627544174,-1.4214300364152825,0.08280254777070063,0.0820444312088032,0.997,6/18,25.50%,SDC4;SDC3;VTN;CASK;TRAPPC4;ACTN1
gsea,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.38787218187291894,-1.4197423503610995,0.04044943820224719,0.08272467569694561,0.997,6/34,9.19%,SLC25A4;SLCO1C1;SLC25A5;APOD;SLC35A1;SLC27A1
gsea,Cholesterol Biosynthesis R-HSA-191273,0.45366207171292305,1.4188352751365725,0.07661290322580645,1.0,0.999,8/23,10.56%,MSMO1;SREBF2;HMGCR;FDFT1;PMVK;DHCR7;MVD;SREBF1
gsea,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.43367726453499894,-1.4188142231883916,0.05371900826446281,0.0831033517330021,0.997,11/24,27.53%,SHARPIN;BIRC2;RACK1;TAB3;TNFRSF1A;OTUD7B;CHUK;IKBKG;IKBKB;USP25;TAB2
gsea,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",-0.34083891745368167,-1.411852219233332,0.04883227176220807,0.08663526775736591,0.997,13/57,17.54%,BSG;SLC6A15;SLC39A7;SLC2A13;SLC39A14;SLC39A6;SLC22A4;SLC14A2;SLC14A1;SLC39A10;SLC22A5;SLC30A1;SLC39A3
gsea,Mitochondrial Biogenesis R-HSA-1592230,-0.34423675230274275,-1.4077958719983654,0.06666666666666667,0.08868471008544186,0.998,28/70,28.36%,CALM1;CYCS;ATP5PB;HSPA9;CHD9;MICOS10;MICOS13;PRKAG2;CRTC2;NCOR1;DNAJC11;PPARA;CREBBP;HDAC3;MBD4;NCOA2;POLRMT;TFAM;CRTC3;GLUD1;TBL1XR1;MAPK11;CHCHD3;SSBP1;APOOL;NCOA1;TWNK;SIRT5
gsea,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.3549543244689938,-1.402988714214209,0.06464646464646465,0.09102688186700837,0.998,19/55,25.62%,CDK5R1;MEF2A;JUND;PPP2R1A;F3;VGF;TCF12;CDK5;ID2;MAPK1;MAPK3;NAB2;ID3;CHD4;DUSP6;PPP2CA;DUSP7;MAPK11;PPP2R5D
gsea,L1CAM Interactions R-HSA-373760,-0.3300299352933569,-1.4026561359993317,0.03680981595092025,0.09106977092070544,0.998,18/90,18.01%,HSPA8;SCN2A;AP2M1;CNTN1;SCN3B;EZR;SPTBN1;CLTC;SCN3A;MAPK1;LAMA1;MAPK3;CNTNAP1;CSNK2B;SCN1A;FGFR1;ITGA9;CLTA
gsea,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.3829566294978156,-1.3982004616759642,0.07758620689655173,0.09342628066404357,0.998,10/36,17.49%,ATRX;ANAPC4;CDK4;UBE2E1;SKP2;CDC26;CDKN1B;RB1;CCND1;ANAPC1
gsea,MET Promotes Cell Motility R-HSA-8875878,-0.4265450780246704,-1.3961149799588797,0.09336099585062241,0.09448044201805074,0.998,8/26,15.07%,PTK2;SOS1;LAMA2;RNMT;DOCK7;LAMA5;LAMA1;RAP1A
gsea,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.39418721803721224,-1.3938533606399128,0.09477756286266925,0.09558783768212169,0.998,17/32,35.39%,TPR;RANBP2;ALYREF;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;SEC13;NCBP2;NUP93;NUP205;EIF4E;POM121
gsea,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,-0.4614397074256747,-1.3911032474402165,0.11798839458413926,0.09706063132996331,0.998,9/20,17.04%,SLITRK4;IL1RAPL1;PPFIA2;SLITRK1;IL1RAP;NTRK3;SLITRK2;SLITRK6;SLITRK5
gsea,RHOA GTPase Cycle R-HSA-8980692,-0.3136546660822919,-1.3893494003401075,0.04693877551020408,0.0979561194930901,0.998,35/136,23.07%,KTN1;ERBIN;PKN2;SLK;MYO9A;ROCK2;ARHGAP5;MACO1;ARHGEF4;TIAM1;ARHGAP44;PRPF38B;ROCK1;TMEM87A;ARHGAP32;ARHGAP21;ARHGEF12;CCDC115;LMAN1;ABR;YKT6;PREX2;CAV1;VAMP3;PLEKHG5;STARD8;SOWAHC;ATP6AP1;SRGAP1;VAV3;OPHN1;C1QBP;ABCD3;TFRC;ARHGEF2
gsea,Drug ADME R-HSA-9748784,-0.3683468794494168,-1.3875882929191614,0.06512605042016807,0.09886511975920467,0.998,6/39,7.81%,BSG;GSTM1;GSTP1;GUK1;GMPS;ABCC4
gsea,Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.3986776081623167,-1.3875048165107065,0.09375,0.098766541264292,0.998,17/31,35.39%,TPR;RANBP2;ALYREF;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;SEC13;NCBP2;NUP93;NUP205;EIF4E;POM121
gsea,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.4478432720346388,-1.3806339055472414,0.09034907597535935,0.10268569969599825,0.998,7/19,17.55%,CDK5R1;YWHAE;PRDX2;JUN;CDK5;CAPN2;PRDX1
gsea,Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.44130423851170997,-1.3800173850362283,0.09663865546218488,0.10289505360650171,0.999,8/19,23.59%,LMBRD1;MMACHC;MMUT;ACACA;PCCA;MCCC2;PCCB;MMAB
gsea,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,-0.4000398188735376,-1.3777236430060162,0.08893280632411067,0.10425572932830317,1.0,17/31,35.39%,TPR;RANBP2;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;NEK7;SEH1L;SEC13;NEK6;NUP93;NUP205;NEK9;POM121
gsea,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.3339928195780567,-1.3710052992446593,0.04504504504504504,0.10820950389712432,1.0,10/61,15.01%,UBB;RPS27A;PCNA;SEM1;RPA3;BLM;UBC;SPIDR;RAD17;POLD3
gsea,Nicotinate Metabolism R-HSA-196807,-0.40046775516337957,-1.3709410619923832,0.08552631578947369,0.10811997616428684,1.0,10/25,29.95%,CD38;PARP6;NUDT12;NADK2;PARP16;NNMT;PTGIS;NAXE;NAXD;NT5E
gsea,RNA Polymerase III Chain Elongation R-HSA-73780,-0.45540168573076,-1.3685463049569602,0.11403508771929824,0.10941259069682754,1.0,11/17,35.35%,POLR2E;POLR3F;POLR3K;POLR2K;POLR3H;POLR3A;POLR2L;POLR3D;POLR2H;POLR3E;POLR3C
gsea,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.3808304760295869,-1.3683625789066904,0.08043478260869565,0.10938487666393475,1.0,10/34,25.54%,UBE2N;HERC2;LRIF1;TDP2;BRCC3;XRCC4;MDC1;BABAM2;NSD2;H2BC4
gsea,Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.3731655939913411,-1.3683454843517129,0.060240963855421686,0.1092494061286105,1.0,15/33,34.43%,NPM1;H2AZ1;RSF1;HJURP;ITGB3BP;MIS18A;RUVBL1;RBBP7;H2AJ;CENPT;H2BC4;CENPK;CENPH;CENPP;H2AZ2
gsea,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.3820948569719377,-1.368179921737821,0.08061420345489444,0.10921148281824386,1.0,15/36,29.23%,APOE;TNRC6A;AGO3;ABCA1;TNRC6C;APOD;AGO4;NCOR1;HDAC3;PLTP;ARL4C;KDM1A;TBL1XR1;NCOA1;EEPD1
gsea,Glucagon-type Ligand Receptors R-HSA-420092,-0.4195926262959824,-1.3679903470140726,0.08898305084745763,0.10917103936436459,1.0,7/23,18.87%,GNG3;GNB2;GNG11;GNAS;GNG10;GNG7;GNB5
gsea,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.4445238837591887,-1.3679437148824813,0.12424849699398798,0.10904426623973681,1.0,11/20,31.35%,PXMP4;ABCD2;PEX2;ATAD1;PEX19;ABCD3;PEX3;SLC25A17;ACBD5;FIS1;PXMP2
gsea,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.3864653346083516,-1.3642304156122431,0.07352941176470588,0.11127469654555998,1.0,6/30,13.88%,UBB;RPS27A;CNTN1;UBC;APH1B;MIB1
gsea,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,-0.44943081624365755,-1.3631164436098602,0.10097087378640776,0.11179327645368015,1.0,10/18,31.41%,GRIA2;FKBP5;HDAC1;RNMT;PTPN4;GRIN2B;MECP2;HDAC2;GRIN2A;GPRIN1
gsea,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.3999985867819685,-1.3606303531811177,0.10505050505050505,0.11321570419084959,1.0,11/28,23.77%,STRADA;LAMTOR3;CAB39;PRKAG2;RRAGB;MTOR;LAMTOR5;LAMTOR1;RRAGA;LAMTOR4;LAMTOR2
gsea,Telomere Extension By Telomerase R-HSA-171319,-0.4232497078407632,-1.360255625888755,0.12179487179487179,0.11330301219737775,1.0,10/21,29.24%,NOP10;DKC1;TERF1;CCNA1;RUVBL1;CCNA2;ANKRD28;TERF2IP;NHP2;GAR1
gsea,RND2 GTPase Cycle R-HSA-9696270,-0.36699235054799345,-1.357096023667589,0.09551656920077972,0.11531278921723397,1.0,20/39,42.36%,KTN1;ARHGAP5;KIF14;TXNL1;CAV1;PKP4;KCTD13;TFRC;CKAP4;ANKRD26;PTPN13;ARHGAP1;WDR6;TNFAIP1;PIK3R1;UBXN11;SCRIB;NISCH;PLXND1;KIDINS220
gsea,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.4392085983108651,-1.3569763097562964,0.11491935483870967,0.11522556201809606,1.0,10/20,24.40%,NPM1;CNOT4;RGCC;CNOT6L;CNOT1;CNOT2;PLK2;CNOT7;CNOT6;CNOT11
gsea,Sensory Perception R-HSA-9709957,-0.28079811132003923,-1.3546076422173985,0.018867924528301886,0.11659424525520919,1.0,23/161,9.72%,CALM1;APOE;PCLO;SCN2A;VAMP2;RAB3A;GRM1;CAPZA2;SDC4;SNAP25;CACNA2D2;EPB41L1;GNAL;EZR;ATP2B1;SPTBN1;CAPZB;GUCY2F;NMT1;SCN3A;CTBP2;METAP2;SDC3
gsea,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.437804031772582,-1.353995085835077,0.12190082644628099,0.11679317212505338,1.0,11/19,37.02%,ANAPC4;UBE2E1;SKP2;CDC26;RB1;ANAPC1;ANAPC16;ANAPC7;CDC27;CDC23;ANAPC10
gsea,Activation Of Matrix Metalloproteinases R-HSA-1592389,-0.454878574357703,-1.346836534655777,0.11286681715575621,0.12149960351207097,1.0,4/16,11.76%,SPOCK3;MMP16;FURIN;MMP14
gsea,Platelet Homeostasis R-HSA-418346,-0.32462102347193417,-1.3467935329122902,0.07782101167315175,0.12137873808752737,1.0,20/73,25.76%,CALM1;GNG3;GNB2;PDE10A;PPP2R1A;ATP2B1;GNG11;ATP2B4;GNAS;GNG10;ATP2A2;PDE1B;ORAI2;GNG7;GNB5;GUCY1A2;PPP2CA;TRPC6;PPP2R5D;GNG2
gsea,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.4403775331482147,-1.3459331831508434,0.12016293279022404,0.12174857547915703,1.0,8/21,18.09%,MAML2;FABP7;KAT2B;HEY1;WWC1;MAML3;CREBBP;HEY2
gsea,RHOV GTPase Cycle R-HSA-9013424,-0.3803841539724914,-1.344627799666868,0.09513742071881606,0.12241641950068193,1.0,7/34,11.90%,PKN2;MYO9A;SPTBN1;CLTC;ARHGAP12;USP9X;TXNL1
gsea,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.400868818019812,-1.3417528782434045,0.11262135922330097,0.12424340004396973,1.0,14/26,35.39%,AHCTF1;NUP98;RAN;NUP155;NDC1;NUP37;NUP54;UBE2I;SEH1L;TNPO1;SEC13;NUP93;NUP205;POM121
gsea,Signaling To ERKs R-HSA-187687,-0.3860165782172424,-1.3375634320884793,0.11332007952286283,0.12718376835723527,1.0,8/32,15.07%,BRAF;YWHAB;BCL11B;SOS1;MAPK1;MAPK3;RALA;RAP1A
gsea,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.40281131490475525,-1.3340499230101626,0.11691022964509394,0.12952073342872927,1.0,10/26,27.03%,CALM1;PLCB1;SYNJ1;PLCB3;ITPKB;INPP5B;PLCB2;PLCE1;ITPK1;PLCD1
gsea,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.43799617397630497,-1.332292211574003,0.12981744421906694,0.13069777191741705,1.0,8/18,27.96%,ARF4;EXOC3;EXOC1;EXOC2;EXOC6;EXOC8;RAB11A;EXOC5
gsea,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.36185349677446077,-1.332143300156673,0.10763209393346379,0.1306298703855889,1.0,19/38,35.64%,TPR;RANBP2;ALYREF;FIP1L1;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;SEC13;NCBP2;NUP93;NUP205;EIF4E;POM121;CPSF2
gsea,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.35812256987082114,-1.3317276849909434,0.10526315789473684,0.13075137246077512,1.0,19/39,35.64%,TPR;RANBP2;ALYREF;FIP1L1;NUP98;NUP88;NUP153;NUP155;NDC1;NUP37;NUP54;SEH1L;SEC13;NCBP2;NUP93;NUP205;EIF4E;POM121;CPSF2
gsea,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.3838992200040691,-1.3309738844196972,0.12064965197215777,0.13109217305006762,1.0,14/27,34.59%,PRDX2;CYCS;GSTP1;GPX1;PRDX5;PRDX1;SOD1;ATOX1;CYBA;ERO1A;SOD3;PRDX3;TXN2;NCF2
gsea,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.368821045190455,-1.328651891886955,0.10629067245119306,0.1325669795366352,1.0,16/36,28.85%,H2AZ1;HDAC1;TLE4;PYGO1;PYGO2;ASH2L;CREBBP;RUVBL1;CTNNB1;TLE1;H2AJ;H2BC4;TCF7L2;CDC73;TCF7;AXIN2
gsea,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.4184883843392874,-1.3284164476502702,0.10526315789473684,0.13262177841615955,1.0,7/21,17.55%,CDK5R1;YWHAE;PRDX2;JUN;CDK5;CAPN2;PRDX1
gsea,Neurexins And Neuroligins R-HSA-6794361,-0.3513413649584008,-1.327482861476532,0.10507246376811594,0.13317244371642908,1.0,19/55,18.76%,LRRTM1;GRM1;DLGAP1;EPB41L1;SHARPIN;LIN7B;LRRTM2;DLGAP2;SYT7;LIN7C;CASK;PDLIM5;SIPA1L1;EPB41L5;GRIN2C;EPB41;NLGN3;HOMER3;GRIN2B
gsea,Fatty Acid Metabolism R-HSA-8978868,-0.2886168757802617,-1.3272240055902245,0.04194260485651214,0.13316279656542154,1.0,42/129,29.69%,PTGDS;GPX4;GPX1;PTGR2;ACSL3;ACOT11;ACOT1;PRKAG2;PTGES3;SYCP2;LTA4H;MMUT;NUDT19;NDUFAB1;ACACA;ACSBG1;ACSL1;SLC22A5;ACADVL;ACOX1;ACSL4;HSD17B8;PCCA;ACBD6;HADHA;TECR;DBI;ACSL6;ACOT13;PCCB;PPT1;ACLY;SLC25A17;MCEE;PTGIS;ECI2;AMACR;PON2;MUSK;HPGDS;ACBD5;PTGR1
gsea,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.3185040194241815,-1.327102238737358,0.08993576017130621,0.13309989821009927,1.0,30/71,30.52%,MED28;THRAP3;CHD9;CEBPD;NR2F2;CDK4;CEBPB;MED13;MED19;NCOR1;NFKB1;MED23;MED8;PPARA;CREBBP;LPL;HDAC3;MBD4;CDK8;NCOA2;MED12;MED30;TBL1XR1;MED4;MED7;MED17;NCOA1;MED24;MED11;MED10
gsea,Signaling By PDGFR In Disease R-HSA-9671555,-0.42891350398823486,-1.3214675217376106,0.15810276679841898,0.13710114736751802,1.0,8/19,32.06%,SOS1;FIP1L1;KANK1;PDGFRA;HRAS;GRB2;PIK3CB;GOLGA4
gsea,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.3458707026500924,-1.3214445483978021,0.1,0.13694217292686042,1.0,17/45,24.51%,NPM1;CNOT4;PCNA;RGCC;CCNA1;CDKN1B;CNOT6L;CNOT1;CNOT2;PLK2;CNOT7;CCNA2;TFDP2;RBL2;CNOT6;CNOT11;REXO2
gsea,RHOD GTPase Cycle R-HSA-9013405,-0.3460928099097433,-1.3213117937699097,0.12323232323232323,0.13685437067916223,1.0,11/48,15.03%,DIAPH2;ARHGAP5;ANKFY1;SLC4A7;CAPZB;ARHGAP12;ARHGAP32;ARHGAP21;LMAN1;CAV1;VAMP3
gsea,Voltage Gated Potassium Channels R-HSA-1296072,-0.3631027311177057,-1.3208317899938118,0.11218568665377177,0.1369863632096536,1.0,13/39,23.13%,KCNA1;KCNA2;KCNAB2;KCNG2;KCNF1;KCNS1;KCND3;KCNA3;KCNB1;KCNA4;KCNS3;KCNV1;KCNC3
gsea,RAC1 GTPase Cycle R-HSA-9013149,-0.29392128736078893,-1.3176154098401873,0.08541666666666667,0.1392276362155457,1.0,30/165,14.00%,KTN1;WIPF3;CYFIP1;IQGAP2;DOCK11;ERBIN;CDC42BPA;NCKAP1;PKN2;BAIAP2;ARHGAP5;DOCK3;SOS1;ARHGEF4;TIAM1;ARHGAP44;ARHGAP12;WASF1;DOCK10;ARHGAP32;ARHGAP21;SRGAP2;NHS;REPS1;ABR;DOCK7;YKT6;ABI1;PREX2;CAV1
gsea,Metal Ion SLC Transporters R-HSA-425410,-0.3965975211698299,-1.3136853361462197,0.12915851272015655,0.14212258170212588,1.0,7/22,20.96%,SLC39A7;SLC39A14;SLC39A6;SLC39A10;SLC30A1;SLC39A3;SLC30A3
gsea,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.41113111164133864,-1.3100518524608487,0.13882863340563992,0.14467817141554157,1.0,8/21,25.71%,MDH2;IDH3B;FAHD1;CS;NNT;IDH3A;ACO2;SUCLA2
gsea,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.41664444289740543,-1.3060635346994391,0.12447257383966245,0.14774683676438652,1.0,4/20,7.99%,PRNP;VAMP2;SEC61B;UBL4A
gsea,Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,-0.4393905767936338,-1.2996651104679628,0.15022421524663676,0.15254016536406667,1.0,7/16,28.21%,CYP7B1;SYCP2;NCOA2;HSD3B7;PTGIS;AMACR;NCOA1
gsea,Platelet Calcium Homeostasis R-HSA-418360,-0.40569207744699937,-1.2983402739504835,0.144,0.15349223766330228,1.0,5/23,17.62%,CALM1;ATP2B1;ATP2B4;ATP2A2;ORAI2
gsea,WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,-0.4482973989145985,-1.296440526579585,0.16098484848484848,0.1549070210562719,1.0,10/15,36.33%,AP2M1;CLTC;CLTA;CLTB;AP2S1;FZD4;WNT5A;DVL2;AP2B1;AP2A2
gsea,RHO GTPases Activate NADPH Oxidases R-HSA-5668599,-0.43581145935647003,-1.296275599402273,0.18398268398268397,0.15487198880611128,1.0,7/17,25.48%,PDZD2;MAPK1;PIK3C3;MAPK3;PRKCD;MAPK11;CYBA
gsea,Striated Muscle Contraction R-HSA-390522,0.41106938143950245,1.2917963958241552,0.152753108348135,1.0,1.0,7/23,12.99%,TTR;DMD;TCAP;NEB;ACTN2;ACTN3;MYBPC1
gsea,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.377566141006717,-1.2894286860847177,0.12050739957716702,0.16030992480598608,1.0,11/26,30.63%,POLR2G;POLR2E;GTF2F1;POLR2K;POLR2A;POLR2L;POLR2D;POLR2B;POLR2C;NCBP2;POLR2H
gsea,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.33514287167797097,-1.2872080431870176,0.11752136752136752,0.16182506951066616,1.0,19/49,29.88%,HSP90AB1;UBE2N;IRAK1;BIRC2;MAP2K6;NFKB1;AAMP;BCL2L1;IRAK2;TAB3;CHUK;IKBKG;TXNIP;IKBKB;MAPK11;CASP9;TAB2;HMOX1;PSTPIP1
gsea,Signaling By FGFR2 In Disease R-HSA-5655253,-0.358166215011662,-1.2871402031742267,0.13263157894736843,0.16168424582028296,1.0,18/35,38.48%,POLR2G;SOS1;POLR2E;GTF2F1;POLR2K;POLR2A;POLR2L;POLR2D;HRAS;POLR2B;POLR2C;GRB2;NCBP2;POLR2H;GTF2F2;PIGU;PIK3R1;FGF9
gsea,Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,-0.3863979075636562,-1.2867006674368746,0.12205567451820129,0.16188918039623573,1.0,9/23,21.96%,PPP2R1A;XPO1;CCNH;MNAT1;CCNA1;PPME1;CDK7;CCNA2;PPP2CA
gsea,ERK/MAPK Targets R-HSA-198753,-0.40232881710647245,-1.2862962283235766,0.15057915057915058,0.16202162069961082,1.0,10/21,27.41%,MEF2A;PPP2R1A;MAPK1;MAPK3;DUSP6;PPP2CA;DUSP7;MAPK11;PPP2R5D;DUSP3
gsea,Meiotic Synapsis R-HSA-1221632,-0.35546827409300596,-1.2850021427056946,0.12359550561797752,0.1628700098396655,1.0,11/34,28.07%,H2AZ1;SMC1A;TERF1;SYNE1;SYCP2;HSPA2;UBE2I;H2AJ;TERF2IP;H2BC4;SMC1B
gsea,Signaling By ALK R-HSA-201556,-0.38506253698987836,-1.2842279047975647,0.16985138004246284,0.16333750282135973,1.0,7/25,17.25%,HIF1A;PTPRZ1;HDAC1;MYCN;CD274;PTN;HDAC3
gsea,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.26580011662526903,-1.2789241779559444,0.0585480093676815,0.16763567197198767,1.0,41/152,25.87%,HSP90AA1;CALM1;APOE;GPHN;SDC4;CD38;LMBRD1;PARP6;NUDT12;NADK2;SDC3;AKT1;MMACHC;AOX1;MMUT;AASDHPPT;RFK;PNPO;COQ2;ACACA;THTPA;TACR1;AGRN;LPL;TTPA;GSTO1;PCCA;PARP16;PDSS1;MCCC2;C1D;COQ3;PCCB;MTHFD1;FLAD1;MMAB;LRP12;UBIAD1;PANK3;NNMT;PTGIS
gsea,Peptide Hormone Metabolism R-HSA-2980736,-0.31920206801563394,-1.2782754825670408,0.10482180293501048,0.16801441602295927,1.0,16/59,19.13%,PLA2G7;VAMP2;MYO5A;KIF5B;ATP6AP2;CPE;SEC11A;SPCS2;EXOC3;SPCS3;EXOC1;SPCS1;EXOC2;CTNNB1;EXOC6;ENPEP
gsea,TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.40617218966241453,-1.2782697044074751,0.14376321353065538,0.16780038491974528,1.0,14/21,44.78%,NFKB1;HMGB1;NKIRAS1;CHUK;IKBKG;S100B;IKBKB;TRAF6;APP;TANK;TRIM25;RIGI;NKIRAS2;NFKBIA
gsea,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.36010151033457966,-1.2753529877853207,0.15350877192982457,0.17020971502507104,1.0,9/30,25.29%,PCNA;TERF1;RPA3;BLM;FEN1;POLD3;WRN;POLA1;TERF2IP
gsea,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.39033356320021484,-1.2718090947744114,0.1607843137254902,0.1730925461262487,1.0,10/27,25.79%,PDZD2;HDAC1;MAP2K6;BRD7;AKT1;CHD4;ING3;RBBP7;CHD3;HDAC2
gsea,Paracetamol ADME R-HSA-9753281,-0.4262165696158444,-1.2701945568152906,0.15071283095723015,0.17428536612673293,1.0,3/16,7.81%,GSTM1;GSTP1;ABCC4
gsea,IRE1alpha Activates Chaperones R-HSA-381070,-0.32949524184274775,-1.2658352000852424,0.1384928716904277,0.17792117694528672,1.0,15/46,22.55%,HSPA5;HDGF;DNAJB9;PREB;SYVN1;WFS1;DNAJC3;ACADVL;DNAJB11;TSPYL2;CXXC1;PDIA6;SSR1;MYDGF;FKBP14
gsea,Chemokine Receptors Bind Chemokines R-HSA-380108,0.46168855790535385,1.2637851193390552,0.18681318681318682,1.0,1.0,7/15,13.76%,CXCR5;CCL25;CX3CR1;ACKR4;CXCR4;CCR5;CCL5
gsea,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.3513010314517489,-1.2606886758456464,0.15966386554621848,0.18236862330426717,1.0,11/32,21.90%,ACOT11;ACOT1;MMUT;NDUFAB1;ACADVL;PCCA;ACBD6;HADHA;DBI;ACOT13;PCCB
gsea,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,-0.4249003344614382,-1.2595138618855897,0.1776061776061776,0.183187905293366,1.0,8/18,27.53%,UBE2N;IRAK1;MAP2K6;IRAK2;TAB3;IKBKG;MAPK11;TAB2
gsea,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.3657630147581307,-1.2508320927117156,0.162426614481409,0.19120049426900756,1.0,10/29,23.51%,ACSL3;ACACA;ACSBG1;ACSL1;ACSL4;HSD17B8;TECR;ACSL6;PPT1;ACLY
gsea,"Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.39321171570706964,-1.2456696956143727,0.18823529411764706,0.19610745169391094,1.0,4/20,8.78%,CALM1;GUCY2F;NMT1;METAP2
gsea,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.33752652036789405,-1.242890687015906,0.15950920245398773,0.19866895469943713,1.0,20/43,33.31%,EPHA7;AP2M1;EFNB3;TIAM1;CLTC;APH1B;CLTA;VAV3;PSENEN;EPHA4;EPHA10;EFNA3;CLTB;EPHB2;EPHA6;EFNB1;AP2S1;MMP2;APH1A;EPHB6
gsea,N-Glycan Antennae Elongation R-HSA-975577,-0.4306266395959009,-1.241850243898347,0.1821705426356589,0.19946604581203475,1.0,5/15,22.48%,B4GALT6;ST6GAL1;ST8SIA3;B4GALT4;ST8SIA2
gsea,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.3458932794811961,-1.2385698392703997,0.17467248908296942,0.20229898230211554,1.0,14/34,30.77%,ANAPC4;CDK4;UBE2E1;SKP2;CDC26;CDKN1B;RB1;CCND1;ANAPC1;TFDP2;ANAPC16;E2F3;ANAPC7;CDC27
gsea,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.2957300794712906,-1.2378337660354934,0.10023310023310024,0.20274706503706083,1.0,15/62,18.87%,GNG3;GNB2;CALCRL;FZD2;PTCH1;GNG11;GNAS;WNT7B;GNG10;ADGRE5;FZD1;GNG7;RAMP2;WNT4;GNB5
gsea,Integrin Cell Surface Interactions R-HSA-216083,-0.310612726017878,-1.2375155203183235,0.12529002320185614,0.20277680350990618,1.0,11/53,16.89%,BSG;ITGA7;COL4A2;VTN;ITGB8;COL4A1;CD47;ICAM5;AGRN;ITGA9;ITGA4
gsea,Apoptotic Execution Phase R-HSA-75153,-0.3428578222446924,-1.2370261203191355,0.1322314049586777,0.20305115711278046,1.0,12/40,20.18%,PTK2;PKN2;DNM1L;BIRC2;ROCK1;ACIN1;HMGB1;CASP3;CTNNB1;TJP1;DSG2;PRKCD
gsea,HS-GAG Degradation R-HSA-2024096,0.3974534892107384,1.236596257595018,0.18703703703703703,1.0,1.0,8/20,13.51%,GPC6;GPC3;GLB1;GLB1L;GPC1;HPSE;GUSB;GPC5
gsea,Polo-like Kinase Mediated Events R-HSA-156711,0.4272009236127576,1.2362207489434534,0.20255474452554745,1.0,1.0,9/16,19.79%,CDC25C;CCNB2;EP300;MYBL2;CDC25A;RBBP4;PKMYT1;LIN37;PLK1
gsea,Integrin Signaling R-HSA-354192,-0.37922301188467233,-1.2341266498006285,0.17543859649122806,0.20576382262329942,1.0,5/24,15.07%,PTK2;SOS1;AKT1;RASGRP1;RAP1A
gsea,FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,-0.4070178268289472,-1.23372891309266,0.21074380165289255,0.20589359813224553,1.0,9/16,34.90%,SMAD4;CDKN1B;SMAD3;CAV1;RBL2;CCNG2;KLF4;GADD45A;FOXO1
gsea,Processive Synthesis On Lagging Strand R-HSA-69183,-0.4318329276783768,-1.2332731475873289,0.2052980132450331,0.20608580378438565,1.0,5/15,21.84%,PCNA;RPA3;FEN1;POLD3;POLA1
gsea,Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,-0.40825392220948975,-1.227028077649689,0.19573643410852712,0.21214011213775924,1.0,4/16,15.33%,AP2M1;ATP6V1H;AP1G1;AP1S1
gsea,Insulin Processing R-HSA-264876,-0.3864266419707665,-1.2245593949572746,0.2099236641221374,0.21429589694321274,1.0,8/24,18.78%,VAMP2;MYO5A;KIF5B;CPE;EXOC3;EXOC1;EXOC2;EXOC6
gsea,Tie2 Signaling R-HSA-210993,-0.4122302379102111,-1.2236909132304814,0.20118343195266272,0.2148833280640724,1.0,11/16,44.75%,SOS1;GRB14;HRAS;ANGPT2;GRB2;PIK3CB;SHC1;PIK3R1;GRB7;NRAS;PTPN11
gsea,Ephrin Signaling R-HSA-3928664,-0.40271572065709416,-1.2236796159754557,0.2037735849056604,0.2146335348378532,1.0,2/16,2.82%,EFNB3;PKN2
gsea,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.33657011567887335,-1.223434529885524,0.16872427983539096,0.2145762528744556,1.0,15/31,33.91%,APOE;STMN1;PGR;NRG2;APH1B;NCOR1;YAP1;S100B;PSENEN;TAB2;GFAP;CXCL12;COPS2;APH1A;STAT5A
gsea,Phototransduction Cascade R-HSA-2514856,-0.38424033353382825,-1.222780374853519,0.18813905930470348,0.21504616314026506,1.0,4/21,8.78%,CALM1;GUCY2F;NMT1;METAP2
gsea,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.32046245898885656,-1.2219600176641805,0.1882591093117409,0.21568958044486508,1.0,14/44,22.55%,HDGF;DNAJB9;PREB;SYVN1;WFS1;DNAJC3;ACADVL;DNAJB11;TSPYL2;CXXC1;PDIA6;SSR1;MYDGF;FKBP14
gsea,Signal Transduction By L1 R-HSA-445144,-0.3862408561981735,-1.2218513950186467,0.2055888223552894,0.2155117184489123,1.0,5/19,16.58%,MAPK1;MAPK3;CSNK2B;FGFR1;ITGA9
gsea,Degradation Of Extracellular Matrix R-HSA-1474228,-0.27569384487038817,-1.21914365546675,0.13304721030042918,0.2179574123072402,1.0,20/82,22.61%,SPOCK3;MMP16;BSG;HTRA1;BCAN;FURIN;ADAMTS5;CTSL;COL19A1;MMP14;ADAMTS18;LAMA5;CAPN2;CASP3;CTSB;COL12A1;CXXC1;MMP15;CAPN7;COL16A1
gsea,PI-3K cascade:FGFR2 R-HSA-5654695,0.4106869095913078,1.2090618446139005,0.2,1.0,1.0,6/16,16.34%,FGF1;FRS2;FGF23;FGFR2;FGF22;FGF13
gsea,Reproduction R-HSA-1474165,-0.2851488359854107,-1.2031949579218912,0.16587677725118483,0.23520337606101235,1.0,13/70,16.87%,H2AZ1;SMC1A;CD9;CDK4;ADAM2;TERF1;RPA3;SYNE1;BLM;ADAM21;SYCP2;HSPA2;CATSPER3
gsea,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.3636606324046617,-1.2011584510244941,0.21153846153846154,0.2373974041002713,1.0,8/23,18.22%,CHD9;CLOCK;BHLHE41;NOCT;PPARA;CREBBP;MBD4;NCOA2
gsea,SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.35429348114797937,-1.196893294954063,0.19915254237288135,0.24196406663213282,1.0,7/25,19.97%,PGR;PIAS1;SUMO2;NR3C2;THRA;PPARA;UBE2I
gsea,Chondroitin Sulfate Biosynthesis R-HSA-2022870,-0.4036676275591479,-1.1959760462008544,0.2450199203187251,0.24271935078613546,1.0,8/18,32.46%,CHPF;BCAN;CHST9;NCAN;CHST11;CSPG4;VCAN;CSPG5
gsea,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.3123448413394084,-1.1879615110464612,0.20718816067653276,0.2517659835274659,1.0,19/47,28.36%,CALM1;CYCS;CHD9;CRTC2;NCOR1;PPARA;CREBBP;HDAC3;MBD4;NCOA2;POLRMT;TFAM;CRTC3;GLUD1;TBL1XR1;SSBP1;NCOA1;TWNK;SIRT5
gsea,DNA Strand Elongation R-HSA-69190,-0.3349565287622141,-1.1873551457913096,0.21610169491525424,0.252168612384736,1.0,8/30,21.84%,PCNA;RPA3;MCM6;FEN1;MCM7;POLD3;MCM4;POLA1
gsea,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.3814597687330834,-1.1837910657595256,0.23742454728370221,0.25603466164626154,1.0,11/25,34.50%,CALM1;SOS1;SH3KBP1;TRPC1;ORAI2;AHCYL1;NCK1;GRB2;CLSTN1;ITPR1;ITPR2
gsea,ABC Transporters In Lipid Homeostasis R-HSA-1369062,-0.4052834572428915,-1.1765867759822366,0.27865612648221344,0.2645142904146694,1.0,11/15,38.83%,ABCD2;ABCA5;ABCG4;PEX19;ABCD3;PEX3;ABCA2;APOA1;ABCG1;ABCA7;ABCD1
gsea,Extracellular Matrix Organization R-HSA-1474244,-0.23319790910425003,-1.1757452375931972,0.11508951406649616,0.26518317452865636,1.0,53/232,22.61%,SPOCK3;MMP16;BSG;SDC4;TGFB3;PPIB;P3H2;ITGA7;DMTF1;HTRA1;BCAN;PLOD2;LAMA2;COL4A2;P3H3;PXDN;COLGALT2;SDC3;FURIN;ADAMTS5;CTSL;COL19A1;VTN;MMP14;COL2A1;ITGB8;ADAMTS18;COL4A1;LAMA5;CD47;TGFB2;LAMA1;MATN4;CASK;LRP4;ICAM5;CAPN2;CASP3;AGRN;ITGA9;ITGA4;COL11A2;CTSB;COL12A1;CXXC1;MMP15;P4HA2;NCAN;TRAPPC4;MFAP3;SH3PXD2A;CAPN7;COL16A1
gsea,G Alpha (Q) Signaling Events R-HSA-416476,-0.24762615892657358,-1.1729514970704398,0.1613588110403397,0.26831427767896077,1.0,38/145,26.10%,DGKH;PRKCE;GNG3;GNB2;GRM1;DGKI;NTSR2;GNAQ;PLCB1;SOS1;HTR2A;NTS;RASGRP1;F2RL2;GNG11;MAPK1;GNG10;GRK2;CHRM1;MAPK3;TACR1;GNG7;RGS5;GNB5;DGKE;EDNRB;GPR17;PRKCD;PLCB3;HRAS;DGKB;PIK3R3;DAGLA;PLCB2;TRPC6;RGS3;GNG2;CHRM3
gsea,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.3350845550240871,-1.1707563183049516,0.24229979466119098,0.27073836278958324,1.0,6/31,14.99%,TUBA1A;TUBB2A;TTLL11;TUBB4B;TUBA1B;AGBL2
gsea,Amino Acid Transport Across Plasma Membrane R-HSA-352230,-0.35458001005644035,-1.1699449620359714,0.2548596112311015,0.2713831339024581,1.0,8/24,23.92%,SLC6A15;SLC7A6;SLC7A10;SLC7A11;SLC36A4;SLC7A2;SLC38A1;SLC25A29
gsea,Intra-Golgi Traffic R-HSA-6811438,-0.3342001362327729,-1.1683527095847897,0.23062015503875968,0.2730482271144278,1.0,12/35,24.84%,MAN1A2;NSF;TRIP11;NAPG;RIC1;YKT6;COG3;MAN2A2;STX16;RAB33B;MAN1C1;COG6
gsea,Recycling Pathway Of L1 R-HSA-437239,-0.35618331787030205,-1.164923943291605,0.2440944881889764,0.2769218618200324,1.0,4/25,11.48%,AP2M1;EZR;CLTC;MAPK1
gsea,Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.39702738328751347,-1.1627791451859575,0.2554112554112554,0.2791738046465155,1.0,6/15,23.70%,HDAC1;LIN52;LIN54;CCNA2;TFDP2;RBL2
gsea,Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.32244556574135697,-1.162134917440114,0.24299065420560748,0.279643752674639,1.0,6/32,14.99%,ORC4;ORC6;RPA3;MCM6;RAD17;MCM7
gsea,Peptide Ligand-Binding Receptors R-HSA-375276,0.275646172799984,1.1609004441528104,0.20853080568720378,1.0,1.0,34/90,19.03%,NMUR2;MC1R;CXCR5;QRFPR;NPFFR1;TACR3;MRLN;CD200R1;CCKBR;OXTR;CCL25;RXFP2;CX3CR1;FPR3;ACKR4;C5AR2;GHRL;TTF2;NLRP3;CXCR4;OPRK1;CCR5;POMC;ECE1;CCL5;NPSR1;NMUR1;GRPR;HCRT;RXFP1;NPFF;CORT;C3AR1;F2R
gsea,mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,-0.39697831241771747,-1.1596536311284629,0.2651072124756335,0.28253220622891934,1.0,4/15,18.39%,SKIC3;EXOSC9;DIS3;SKIC2
gsea,Pre-NOTCH Processing In Golgi R-HSA-1912420,-0.37746890279535983,-1.159341301477528,0.259656652360515,0.2825533199037021,1.0,9/17,34.70%,SEL1L;RAB6A;FURIN;ATP2A2;TMED2;NOTCH2;NOTCH4;ST3GAL6;NOTCH1
gsea,Meiotic Recombination R-HSA-912446,-0.32133548893239816,-1.1579563733404865,0.24726477024070023,0.28399235043721877,1.0,14/30,40.54%,H2AZ1;CDK4;RPA3;BLM;H2AJ;H2BC4;ATM;PSMC3IP;PRDM9;H2AZ2;MSH4;H2AX;BRCA2;RAD50
gsea,Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.3699696584875454,-1.156061185113869,0.24885844748858446,0.28591941620949357,1.0,7/20,25.54%,H2AZ1;TERF1;OGG1;MBD4;H2AJ;TERF2IP;H2BC4
gsea,Nephrin Family Interactions R-HSA-373753,-0.3848538982912406,-1.1516363011329633,0.27218934911242604,0.29121073392446317,1.0,9/20,29.63%,SPTBN1;CASK;CD2AP;NCK1;IQGAP1;ACTN1;WASL;PIK3CB;MAGI2
gsea,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.3061637612700546,-1.1504998297160722,0.24952380952380954,0.2923065351989374,1.0,9/50,12.26%,PLEKHA2;PLEKHA5;SYNJ1;SBF2;RAB14;RAB5A;MTMR9;MTMR1;PIP5K1B
gsea,Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.34177412136315055,-1.149219738468016,0.2545045045045045,0.2936039564978242,1.0,6/25,18.31%,PCNA;RPA3;PARG;FEN1;POLD3;PARP2
gsea,Signaling By WNT In Cancer R-HSA-4791275,-0.33929011533509384,-1.1480888565534815,0.26229508196721313,0.29464558437311694,1.0,10/28,25.62%,PPP2R1A;TNKS;CTBP2;CTBP1;CSNK1A1;LRP6;CTNNB1;PPP2CA;TCF7L2;PPP2R5D
gsea,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.3504304356818793,-1.1469655067274944,0.26095617529880477,0.29579817715076523,1.0,5/22,15.33%,AP2M1;PKN2;ATP6V1H;AP1G1;AP1S1
gsea,G Alpha (S) Signaling Events R-HSA-418555,-0.24819493499583362,-1.1430808625481317,0.19457013574660634,0.3004239727380067,1.0,33/108,26.33%,GNG3;GNB2;CALCRL;PDE10A;PRKAR1A;ADCY9;ADRB3;PRKAR2B;ADCY1;PRKACB;PDE7B;GNG11;GNAS;GNG10;PTGER4;GRK2;ADCY2;PDE3B;PDE1B;HTR4;GNG7;RAMP2;ADCY5;GNB5;ADORA2A;PDE7A;PRKAR2A;FSHR;GPR83;GNG2;GRK6;ADCY6;GRK3
gsea,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.37651630061897134,-1.142300683055541,0.28286852589641437,0.30108414607254147,1.0,9/18,37.02%,ANAPC4;UBE2E1;CDC26;ANAPC1;ANAPC16;ANAPC7;CDC27;CDC23;ANAPC10
gsea,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,-0.35512667098333867,-1.1397317939614906,0.27720739219712526,0.3040983624935866,1.0,6/21,23.68%,RICTOR;AKT1;MTOR;MAP3K8;TRIB3;PIK3R3
gsea,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.32898512172099637,1.1362237767863705,0.2819047619047619,1.0,1.0,10/33,14.96%,GPC6;HEXB;GPC3;EXT1;PAPSS2;GPC1;DCN;SLC26A2;GPC5;ST3GAL3
gsea,Diseases Of Metabolism R-HSA-5668914,-0.2328747447437421,-1.1360979687088744,0.17995444191343962,0.30860327500230444,1.0,65/189,34.74%,UBB;RPS27A;PRNP;SEMA5A;CYP7B1;SDC4;B4GAT1;LCT;NUS1;LMBRD1;ADAMTS17;BCAN;PPP1R3C;IDS;ALG2;SPON1;POMGNT1;SDC3;ADAMTS5;UBC;MMACHC;ADAMTS19;ADAMTS18;MMUT;ACACA;AGRN;PCCA;CYP26B1;CTSA;MPDU1;MCCC2;NCAN;B4GALT7;PCCB;ALG6;CSF2RA;RFT1;ADAMTSL2;MMAB;ADAMTS6;ADAMTS20;UBA52;CSPG4;PGM1;NOTCH2;DPM2;DOLK;GFPT1;VCAN;APRT;TPMT;GALNT12;C1GALT1C1;CSPG5;ADAMTS14;ADAMTSL5;SLPI;NOTCH4;GBE1;ALG13;ADAMTS16;CD320;NOTCH1;GPC2;ADAMTS15
gsea,"Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.38572231446922695,-1.1345889122483495,0.2809734513274336,0.3103078386226956,1.0,6/15,35.54%,LMBRD1;MMACHC;MMUT;MMAB;CD320;LDLRAP1
gsea,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,-0.3817682268034619,-1.1336261555698055,0.3057692307692308,0.3112428043799648,1.0,3/17,7.59%,CPSF6;CEP43;ZMYM2
gsea,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.3418709324980207,1.1330144275650562,0.2655038759689923,1.0,1.0,10/26,16.85%,ADGRG6;SREBF2;HMGCR;DAG1;PRX;LAMC1;SMARCA4;EGR2;ADGRV1;DRP2
gsea,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.24517980355081093,-1.131608825285295,0.20437956204379562,0.3135785416985429,1.0,30/110,26.27%,CALM1;GNG3;GNB2;CALCRL;PRKAR1A;ADCY9;ADRB3;PRKAR2B;ADCY1;PRKACB;FURIN;GNG11;GNAS;GNG10;PTGER4;ADCY2;PLK2;HTR4;GNG7;RAMP2;ADCY5;GNB5;ADORA2A;AHCYL1;PRKAR2A;FSHR;GPR83;GNG2;MYH9;ADCY6
gsea,Meiosis R-HSA-1500620,-0.27483310001220634,-1.1261336971081974,0.25054945054945055,0.32050720810970645,1.0,9/56,14.61%,H2AZ1;SMC1A;CDK4;TERF1;RPA3;SYNE1;BLM;SYCP2;HSPA2
gsea,TBC/RABGAPs R-HSA-8854214,-0.2979670985393815,-1.1233389289378273,0.2698412698412698,0.3238000364912222,1.0,21/42,42.42%,GABARAP;RAB5A;RAB6A;GABARAPL2;RABGAP1;TBC1D24;TBC1D14;RAB33B;RAB11A;RABEP1;TBC1D15;ARF6;TBC1D10B;GGA3;RAB5C;RAB6B;TBC1D16;ULK1;TBC1D7;RAB4A;TSC2
gsea,Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.3275340220556597,-1.121609176604798,0.2973568281938326,0.32587239997996803,1.0,9/28,28.21%,CYP7B1;STARD5;SYCP2;OSBP;NCOA2;HSD3B7;PTGIS;AMACR;NCOA1
gsea,Acyl Chain Remodelling Of PC R-HSA-1482788,0.3852384858150069,1.1213794879212957,0.29558541266794625,1.0,1.0,7/17,21.56%,LPCAT1;LPCAT3;TMEM86B;PLA2G4B;PLA2G6;PLA2G4E;PLA2G4C
gsea,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.2428635686137955,1.120601996798818,0.2246153846153846,1.0,1.0,57/169,18.53%,FFAR1;NMUR2;HRH4;MC1R;CXCR5;PTGER3;QRFPR;HTR7;GPR39;NPFFR1;OPN3;TACR3;MRLN;HTR5A;CD200R1;CCKBR;ADRA1A;OXTR;HTR1D;CCL25;RXFP2;CX3CR1;GNRH1;FPR3;OPN5;ACKR4;C5AR2;TSHR;GHRL;S1PR2;TTF2;ADRB1;P2RY6;NLRP3;CXCR4;OPRK1;CCR5;POMC;CHRM2;ECE1;CCL5;NPSR1;ADRA1B;NMUR1;HRH2;GPR35;GRPR;ADRA1D;HCRT;ADRA2C;RXFP1;LHCGR;NPFF;CORT;S1PR5;C3AR1;DRD2
gsea,Retinoid Metabolism And Transport R-HSA-975634,0.32408991007600485,1.1142383277501757,0.29444444444444445,1.0,1.0,6/31,8.76%,TTR;GPC6;GPC3;BCO2;GPC1;BCO1
gsea,Triglyceride Metabolism R-HSA-8979227,-0.3405808432915394,-1.1094736255387683,0.32079646017699115,0.34290679021253123,1.0,8/24,19.49%,FABP7;PPP1CA;PRKACB;GPD2;CAV1;FABP3;PPP1CB;AGMO
gsea,Regulation Of Beta-Cell Development R-HSA-186712,-0.3349950636091141,-1.10720534157304,0.3192771084337349,0.34564110382425395,1.0,7/25,16.93%,MAML2;KAT2B;NEUROD1;PDHX;AKT1;MAML3;CREBBP
gsea,Interleukin-6 Family Signaling R-HSA-6783589,-0.36515076788508893,-1.1045758741341838,0.31736526946107785,0.3491715330831059,1.0,3/16,23.00%,IL31RA;TYK2;IL6ST
gsea,Glycosaminoglycan Metabolism R-HSA-1630316,-0.24966074001000893,-1.1030143597074145,0.2697768762677485,0.3511018165547524,1.0,20/106,16.21%,NDST4;SDC4;B4GALT6;B4GAT1;CHPF;CHST1;CHORDC1;B3GNT2;BCAN;IDS;DSEL;HS3ST1;SDC3;XYLT1;CHST9;GLCE;B3GAT2;HAS2;CEMIP;AGRN
gsea,Generation Of Second Messenger Molecules R-HSA-202433,0.371075419413261,1.1023562534031244,0.3290441176470588,1.0,1.0,7/18,11.21%,PLCG2;CD247;LCP2;ITK;CD101;ZAP70;LCK
gsea,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.3621982645201244,-1.1009327847180252,0.32857142857142857,0.353719051898439,1.0,9/19,37.02%,ANAPC4;UBE2E1;CDC26;ANAPC1;ANAPC16;ANAPC7;CDC27;CDC23;ANAPC10
gsea,Beta-catenin Phosphorylation Cascade R-HSA-196299,-0.37900571918520864,-1.0999889140600556,0.3125,0.3546375310122959,1.0,6/16,25.62%,PPP2R1A;CSNK1A1;CTNNB1;FRAT1;PPP2CA;PPP2R5D
gsea,Cleavage Of Damaged Purine R-HSA-110331,-0.3625867438768903,-1.0978127666344297,0.32134831460674157,0.35747141473600674,1.0,6/16,25.54%,H2AZ1;TERF1;OGG1;H2AJ;TERF2IP;H2BC4
gsea,Interaction Between L1 And Ankyrins R-HSA-445095,-0.3413932400902815,-1.0970004221459577,0.32838589981447125,0.35827681678883444,1.0,4/25,8.09%,SCN2A;SCN3B;SPTBN1;SCN3A
gsea,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,0.30449648608247337,1.096342704494542,0.3319838056680162,1.0,1.0,10/40,10.56%,SREBF2;HMGCR;FDFT1;ELOVL6;PMVK;RXRA;ACACB;DHCR7;MVD;SREBF1
gsea,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,-0.24098980333255657,-1.0925017026440296,0.27896995708154504,0.36447995403141115,1.0,30/101,30.01%,GPHN;CD38;LMBRD1;PARP6;NUDT12;NADK2;MMACHC;AOX1;MMUT;AASDHPPT;RFK;PNPO;ACACA;THTPA;GSTO1;PCCA;PARP16;MCCC2;PCCB;MTHFD1;FLAD1;MMAB;PANK3;NNMT;PTGIS;PDXK;NAXE;NAXD;NT5E;SLC5A6
gsea,SHC1 Events In ERBB2 Signaling R-HSA-1250196,-0.35348576813650634,-1.0920318462613288,0.3373493975903614,0.3646941207286351,1.0,3/19,4.25%,PRKCE;NRG2;SOS1
gsea,Diseases Of Programmed Cell Death R-HSA-9645723,-0.2791611961278608,-1.0913911588269616,0.3111111111111111,0.3652782156896011,1.0,5/46,4.71%,CDK5R1;YWHAE;H2AZ1;PRDX2;JUN
gsea,HDMs Demethylate Histones R-HSA-3214842,-0.36002027514083645,-1.090076464815359,0.3534971644612476,0.36682203716474004,1.0,8/19,29.60%,KDM5A;KDM4C;KDM6B;KDM7A;PHF8;KDM1A;KDM4D;RIOX2
gsea,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.2443695515807411,-1.0899989937056889,0.3069544364508393,0.366536970636705,1.0,19/87,18.87%,GNG3;GNB2;CALCRL;PRKAR1A;ADCY9;ADRB3;PRKAR2B;ADCY1;PRKACB;GNG11;GNAS;GNG10;PTGER4;ADCY2;HTR4;GNG7;RAMP2;ADCY5;GNB5
gsea,Interleukin Receptor SHC Signaling R-HSA-912526,-0.35517422516572694,-1.0875377847783503,0.35294117647058826,0.3697120904997917,1.0,12/20,40.85%,SOS1;IL5RA;CSF2RA;PIK3R3;GRB2;PIK3CB;CLSTN1;INPPL1;SHC1;PIK3R1;JAK1;JAK3
gsea,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.3410249224038188,-1.086011226577529,0.3393574297188755,0.37162982777506676,1.0,10/21,41.43%,ALDH6A1;MCCC2;HIBADH;SOAT1;DBT;SLC25A44;MCCC1;ACAD8;IVD;PPM1K
gsea,G1/S-Specific Transcription R-HSA-69205,-0.31600735558057425,-1.0857214430375806,0.29694323144104806,0.37167252559026387,1.0,9/26,26.65%,HDAC1;PCNA;LIN52;CCNA1;LIN54;POLA1;TFDP2;RBL2;E2F6
gsea,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,-0.31343351303647204,-1.0835388807898283,0.3286004056795132,0.37453458059946154,1.0,9/32,20.18%,PTK2;BIRC2;ROCK1;ACIN1;CASP3;CTNNB1;TJP1;DSG2;PRKCD
gsea,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.32574230738937343,-1.0828563089712286,0.33617021276595743,0.3752414591859506,1.0,10/25,25.62%,PPP2R1A;FZD2;CAV1;CSNK1A1;LRP6;FZD1;CTNNB1;FRAT1;PPP2CA;PPP2R5D
gsea,HS-GAG Biosynthesis R-HSA-2022928,0.3300219001317168,1.0805821437717318,0.3515625,1.0,1.0,10/28,14.44%,GPC6;HS6ST3;GPC3;EXT1;HS3ST2;GPC1;HS2ST1;HS6ST1;GPC5;NDST2
gsea,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.3182354558087538,-1.0785586230490694,0.34063745019920316,0.38159048025937253,1.0,7/27,21.21%,APOE;NPM1;HSPD1;TGFA;CREBBP;UBE2I;VEGFA
gsea,G0 And Early G1 R-HSA-1538133,-0.30794645485532735,-1.0762522894294844,0.3416856492027335,0.38468151411846124,1.0,8/26,23.70%,HDAC1;PCNA;LIN52;CCNA1;LIN54;CCNA2;TFDP2;RBL2
gsea,PI Metabolism R-HSA-1483255,-0.2596698157585361,-1.072655538002544,0.3246753246753247,0.38977257508193297,1.0,17/78,21.25%,PLEKHA2;PLEKHA5;SYNJ1;SBF2;RAB14;RAB5A;MTMR9;MTMR1;PIP5K1B;TNFAIP8L3;PIK3C3;ARF3;INPP4B;MTM1;GDPD1;MTMR12;MTMR2
gsea,Diseases Associated With TLR Signaling Cascade R-HSA-5602358,-0.3264764847072029,-1.0696057307820217,0.3576158940397351,0.39392419072780255,1.0,9/23,30.27%,TLR3;NDUFA2;NFKB1;HMGB1;CHUK;IKBKG;IKBKB;S100A1;IRAK4
gsea,Defective B3GALTL Causes PpS R-HSA-5083635,-0.29066674990827823,-1.068685928026545,0.34647302904564314,0.39492099702042893,1.0,6/34,12.47%,SEMA5A;ADAMTS17;SPON1;ADAMTS5;ADAMTS19;ADAMTS18
gsea,Base Excision Repair R-HSA-73884,-0.27090438658295,-1.068647205390898,0.3581395348837209,0.3945449383326549,1.0,22/50,39.59%,H2AZ1;PCNA;TERF1;RPA3;OGG1;PARG;FEN1;POLD3;MBD4;PARP2;H2AJ;TERF2IP;H2BC4;POLG2;RFC5;APEX1;POLE3;H2AZ2;H2AX;TDG;PNKP;POLD4
gsea,Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,-0.33487369619757645,-1.0668841995415772,0.34130434782608693,0.3968677397281263,1.0,6/19,23.70%,HDAC1;PCNA;LIN52;LIN54;TFDP2;RBL2
gsea,"Base-Excision Repair, AP Site Formation R-HSA-73929",-0.3285074279854726,-1.0640214512764279,0.3333333333333333,0.4007590899574814,1.0,7/22,25.54%,H2AZ1;TERF1;OGG1;MBD4;H2AJ;TERF2IP;H2BC4
gsea,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.3037061322854175,-1.0620219032782114,0.3479212253829322,0.4034596985137801,1.0,13/28,34.23%,PRELID3A;RABGGTB;BCL6;CREBBP;PRELID1;BNIP3L;RABGGTA;PPP1R13B;APAF1;BBC3;CASP6;ATM;STEAP3
gsea,Phosphorylation Of APC/C R-HSA-176412,-0.3425505315745843,-1.0610455984827403,0.37573385518590996,0.4045439864423386,1.0,9/18,37.02%,ANAPC4;UBE2E1;CDC26;ANAPC1;ANAPC16;ANAPC7;CDC27;CDC23;ANAPC10
gsea,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.29576803604263513,1.0591101539546035,0.36813186813186816,1.0,1.0,6/35,8.76%,TTR;GPC6;GPC3;BCO2;GPC1;BCO1
gsea,Signaling By FGFR1 In Disease R-HSA-5655302,-0.30757224807118744,-1.058979447324469,0.37358490566037733,0.40741992498627083,1.0,15/31,38.48%,SOS1;CPSF6;CEP43;ZMYM2;BAG4;FGFR1;ERLIN2;HRAS;GRB2;FGFR1OP2;STAT5A;CNTRL;PIGU;PIK3R1;FGF9
gsea,Elastic Fibre Formation R-HSA-1566948,-0.2870609572364434,-1.0585383392057237,0.3528138528138528,0.40758018380118965,1.0,5/33,13.97%,TGFB3;FURIN;VTN;ITGB8;TGFB2
gsea,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.2858451933917755,-1.0579967477283536,0.35920177383592017,0.40804908484757735,1.0,8/37,18.31%,PCNA;RPA3;OGG1;PARG;FEN1;POLD3;MBD4;PARP2
gsea,Visual Phototransduction R-HSA-2187338,-0.2512809885494258,-1.0555537597412061,0.34151785714285715,0.4117269376548286,1.0,16/63,21.49%,CALM1;APOE;SDC4;GUCY2F;NMT1;METAP2;SDC3;NAPEPLD;AGRN;STRA6;LPL;CAMKMT;GNB5;C1D;RDH10;RDH5
gsea,O-linked Glycosylation R-HSA-5173105,-0.24582431474758132,-1.054277416337035,0.3494736842105263,0.4131854376875591,1.0,14/81,14.95%,SEMA5A;B4GALT6;B4GAT1;ADAMTS17;B3GNT2;ST6GAL1;SPON1;POMGNT1;ADAMTS5;ST6GALNAC2;ADAMTS19;ADAMTS18;B3GALNT2;B3GNTL1
gsea,Costimulation By CD28 Family R-HSA-388841,-0.27299270241270723,-1.052084378634708,0.37579617834394907,0.4163937625939043,1.0,12/47,27.71%,PKN2;PPP2R1A;RICTOR;AKT1;CD274;MTOR;MAP3K8;TRIB3;PPP2CA;PIK3R3;PPP2R5D;GRB2
gsea,Phase I - Functionalization Of Compounds R-HSA-211945,-0.26116883557862136,-1.051979219456781,0.3530701754385965,0.41611887084064814,1.0,9/50,18.22%,HSP90AB1;CYP7B1;VDAC2;AURKAIP1;MAOB;PTGES3;MIA3;CYP26B1;NCOA2
gsea,Molecules Associated With Elastic Fibres R-HSA-2129379,-0.30462628718068974,-1.0487789291504233,0.40350877192982454,0.4209604141192087,1.0,6/25,25.92%,TGFB3;VTN;ITGB8;TGFB2;MFAP3;EFEMP1
gsea,Metabolism Of Steroids R-HSA-8957322,-0.22931103261092686,-1.0475407776594832,0.3426124197002141,0.42250926798832034,1.0,33/113,28.21%,CYP7B1;SUMO2;STARD5;CHD9;SEC24A;MBTPS2;SH3D19;SYCP2;RAN;PLPP6;ACACA;SEC23A;OSBP;PPARA;CREBBP;MBD4;MBTPS1;NCOA2;GGPS1;STARD6;UBE2I;NFYA;LMBR1;TSPOAP1;TBL1XR1;HSD3B7;PTGIS;AMACR;SCAP;SEC24D;TM7SF2;ARV1;NCOA1
gsea,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.2766882362755481,1.0475099560634094,0.3502722323049002,1.0,1.0,18/45,23.77%,CDH23;PCDH15;TWF2;RIPOR2;CHRNA9;KCNMA1;STRC;XIRP2;TMC2;KCNN2;MYO7A;OTOGL;EPB41L3;WHRN;MYO3B;ESPN;TMIE;TRIOBP
gsea,Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,0.30149233569756295,1.0451111478521034,0.3833634719710669,1.0,1.0,10/36,12.35%,PVR;CD160;OSCAR;CXADR;CD247;CD200R1;RAET1E;ICAM1;COLEC12;FCGR2B
gsea,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,-0.28198202958077206,-1.0446802080449376,0.37267080745341613,0.42662753873368053,1.0,6/35,12.47%,SEMA5A;ADAMTS17;SPON1;ADAMTS5;ADAMTS19;ADAMTS18
gsea,Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,-0.3193695422255134,-1.0379017595766833,0.38155136268343814,0.4372544951366898,1.0,6/22,17.32%,MAGED1;NDUFA2;APPL1;DAPK1;CASP3;UNC5A
gsea,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,-0.30548960161798183,-1.0348595316064315,0.41358024691358025,0.4417510108594501,1.0,4/27,6.81%,B4GALT6;B4GAT1;CHST1;B3GNT2
gsea,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.2983623421785383,-1.031653605360311,0.4134419551934827,0.4465429118394624,1.0,6/30,16.25%,PTK2;SOS1;AKT1;RASGRP1;RAP1A;ADRA2A
gsea,Phospholipid Metabolism R-HSA-1483257,-0.21648003501159502,-1.0303706633522345,0.3789868667917448,0.44821118523032427,1.0,56/184,33.13%,PLEKHA2;CHKA;CDIPT;CHPT1;CPNE6;PLEKHA5;DDHD1;SYNJ1;SBF2;RAB14;RAB5A;MTMR9;DDHD2;SELENOI;MTMR1;AGPAT3;PIP5K1B;TNFAIP8L3;GPCPD1;GPD2;PIK3C3;CDS2;PCYT2;CSNK2B;ARF3;CRLS1;PLAAT3;HADHA;INPP4B;MTM1;MFSD2A;GDPD1;MTMR12;MTMR2;LPGAT1;GPAT3;AGK;PIK3R3;CEPT1;PCYT1B;BCHE;CHKB;PNPLA8;PIK3CB;OSBPL10;GPAT4;LPCAT2;PIK3C2A;SBF1;OSBPL8;PI4KB;GPAT2;PLD3;LPIN2;CLSTN1;PTPN13
gsea,Miscellaneous Transport And Binding Events R-HSA-5223345,-0.3264997930260019,-1.028595822338317,0.4074803149606299,0.4507771509067923,1.0,7/20,25.54%,NIPAL2;NIPA2;MAGT1;ADD2;MMGT1;TUSC3;MRS2
gsea,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,-0.25397537278354726,-1.0267238544410064,0.42398286937901497,0.45332865053664795,1.0,8/51,12.47%,SEMA5A;B4GAT1;ADAMTS17;SPON1;POMGNT1;ADAMTS5;ADAMTS19;ADAMTS18
gsea,Laminin Interactions R-HSA-3000157,-0.3250652112546612,-1.0235345959913464,0.41517857142857145,0.4583337119938445,1.0,4/21,14.02%,ITGA7;LAMA2;LAMA5;LAMA1
gsea,Regulation Of Complement Cascade R-HSA-977606,-0.3168985863211708,-1.0215685287255272,0.4266666666666667,0.4610207549022137,1.0,7/23,24.62%,CD81;CLU;SERPING1;VTN;PSMA7;CR2;CD55
gsea,FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.3137353867541636,-1.0200966616100329,0.42448979591836733,0.4630363108750115,1.0,6/25,17.42%,CPSF6;CEP43;ZMYM2;BAG4;FGFR1;ERLIN2
gsea,Downstream Signal Transduction R-HSA-186763,-0.2990916825230029,-1.0197341288717412,0.4342857142857143,0.4631766020373989,1.0,13/28,44.75%,SOS1;PDGFRA;HRAS;NCK1;GRB2;PIK3CB;PDGFA;STAT5A;PDGFB;PIK3R1;GRB7;NRAS;PTPN11
gsea,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,-0.27119510205940994,-1.0182854501254748,0.43564356435643564,0.46523715258194265,1.0,12/45,20.90%,SDC4;CHPF;BCAN;IDS;DSEL;SDC3;XYLT1;CHST9;B3GAT2;AGRN;NCAN;B4GALT7
gsea,Lagging Strand Synthesis R-HSA-69186,-0.3215654293973621,-1.0179287542328512,0.4313304721030043,0.4653249852484684,1.0,5/20,21.84%,PCNA;RPA3;FEN1;POLD3;POLA1
gsea,PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.3134785017738779,-1.016810570342843,0.39869281045751637,0.46678078456006117,1.0,8/21,34.03%,PCNA;RPA3;FEN1;POLD3;POLG2;RFC5;APEX1;POLE3
gsea,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.27014479264589153,1.0145634350088042,0.4389763779527559,1.0,1.0,17/50,16.65%,GPC6;HS6ST3;GPC3;EXT1;GLB1;HS3ST2;GLB1L;GPC1;DCN;HS2ST1;HS6ST1;HPSE;GUSB;GPC5;NDST2;HS3ST4;HPSE2
gsea,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.23100711381532157,-1.0143713037328126,0.40372670807453415,0.4702983890031077,1.0,29/91,32.89%,PPP2R1A;NRG2;SOS1;IRAK1;IL1RAP;RNMT;AKT1;PHLPP1;MAPK1;TGFA;PIP5K1B;MAPK3;FGFR1;PDGFRA;IER3;TRIB3;PPP2CA;FGFR3;PIK3R3;PPP2R5D;GRB2;PIK3CB;IRAK4;IRS2;PDGFA;INSR;TRAF6;IL33;CLSTN1
gsea,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.2403568101337929,-1.0139931789369718,0.40725806451612906,0.4704147496630798,1.0,25/76,30.05%,NUS1;ST8SIA4;SLC35A1;ST6GAL1;ALG2;ST8SIA3;ST6GALNAC2;GNPNAT1;FUOM;UAP1;CTSA;MPDU1;PMM1;ALG6;ST8SIA2;RFT1;FPGT;GMPPA;ALG5;DPM2;NEU4;DOLK;GFPT1;NANP;ALG10B
gsea,CRMPs In Sema3A Signaling R-HSA-399956,-0.3408921932264344,-1.013262540171803,0.40847784200385356,0.4712320098391147,1.0,3/16,13.64%,CDK5R1;CDK5;PLXNA2
gsea,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,-0.3195950771712589,-1.0132562130311185,0.4277456647398844,0.470717593457642,1.0,7/22,22.48%,B4GALT6;ST6GAL1;FUT8;ST8SIA3;MAN2A2;B4GALT4;ST8SIA2
gsea,ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,-0.33745065205167657,-1.0125277475345908,0.4085106382978723,0.47146832509693826,1.0,7/18,24.66%,TLR3;DHX9;NFKB1;NKIRAS1;CHUK;IKBKG;IKBKB
gsea,CD28 Co-Stimulation R-HSA-389356,-0.2873468381845511,-1.0084571299820786,0.44565217391304346,0.4778851945813334,1.0,9/31,30.66%,PKN2;RICTOR;AKT1;MTOR;MAP3K8;TRIB3;PIK3R3;GRB2;MAPKAP1
gsea,Insulin Receptor Signaling Cascade R-HSA-74751,-0.2670152306252749,-1.00840232087553,0.4282744282744283,0.477440070238643,1.0,18/41,38.56%,SOS1;MAPK1;PIK3C3;MAPK3;PDE3B;FGFR1;TRIB3;HRAS;FGFR3;GRB2;PIK3CB;IRS2;INSR;SHC1;PIGU;PIK3R1;FGF9;KL
gsea,CD209 (DC-SIGN) Signaling R-HSA-5621575,-0.3544613262594314,-1.0082730363099137,0.4266666666666667,0.4771392364908699,1.0,5/15,21.39%,PKN2;PRKACB;NFKB1;CREBBP;HRAS
gsea,Cell-cell Junction Organization R-HSA-421270,0.27228585907235175,1.007452590827861,0.4348697394789579,1.0,1.0,9/44,8.87%,PVR;CADM1;SDK1;PALS1;CLDN16;NECTIN3;PATJ;PARD6B;CADM3
gsea,Other Interleukin Signaling R-HSA-449836,-0.3389835300656294,-1.0049267276994858,0.4457831325301205,0.48227658162182296,1.0,3/17,5.06%,VAMP2;SNAP25;PTPRZ1
gsea,Signaling By BMP R-HSA-201451,-0.3099794738164129,-1.003323080303284,0.44047619047619047,0.4846665638446821,1.0,12/22,39.51%,SMAD4;ACVR2A;UBE2D3;SKI;GREM2;BMPR1B;SMAD1;BMPR1A;BMPR2;BMP2;SMAD9;FSTL1
gsea,Adherens Junctions Interactions R-HSA-418990,-0.2981216705263362,-1.000490731565642,0.4500978473581213,0.48909785010640594,1.0,3/26,4.01%,CDH9;AFDN;CDH13
gsea,Nuclear Envelope Breakdown R-HSA-2980766,-0.2590118495729804,-0.9998946534618586,0.42524271844660194,0.489628796026635,1.0,22/48,35.39%,TPR;RANBP2;BANF1;NUP98;NUP88;VRK1;NUP153;NUP155;NDC1;NUP37;NUP54;NEK7;SEH1L;SEC13;TMPO;NEK6;CNEP1R1;NUP93;LPIN2;NUP205;NEK9;POM121
gsea,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.29979225211558896,-0.9997750275933394,0.45374449339207046,0.4892545334651172,1.0,10/25,34.38%,CYP7B1;SYCP2;OSBP;NCOA2;HSD3B7;PTGIS;AMACR;NCOA1;HSD17B4;OSBPL1A
gsea,"Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",0.3400804238232561,0.9967568793949425,0.4714828897338403,1.0,1.0,2/16,1.25%,FFAR1;PCSK1
gsea,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.2300062462122265,-0.9939843602605719,0.4214876033057851,0.4988571302535729,1.0,27/84,32.89%,PPP2R1A;NRG2;SOS1;IRAK1;IL1RAP;RNMT;AKT1;MAPK1;TGFA;PIP5K1B;MAPK3;FGFR1;PDGFRA;IER3;PPP2CA;FGFR3;PIK3R3;PPP2R5D;GRB2;PIK3CB;IRAK4;IRS2;PDGFA;INSR;TRAF6;IL33;CLSTN1
gsea,PPARA Activates Gene Expression R-HSA-1989781,-0.22499614944141721,-0.9893751211880253,0.46595744680851064,0.5065305485762445,1.0,36/103,30.52%,MED28;THRAP3;CHD9;CLOCK;ABCA1;PCDHB16;MED13;SLC27A1;G0S2;MED19;NCOR1;MED23;MED8;MIA3;ACSL1;PPARA;ACOX1;CREBBP;HDAC3;MBD4;CDK8;NCOA2;MED12;TRIB3;NFYA;PLIN2;MED30;TBL1XR1;MED4;MED7;MED17;NCOA1;MUSK;MED24;MED11;MED10
gsea,Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.3429163847303561,0.9890481611484256,0.46990291262135925,1.0,1.0,10/15,19.67%,PAPSS2;SULT2B1;PODXL2;SLC26A2;TPST2;SLC35B2;SULT1A1;SLC26A1;TPST1;BPNT1
gsea,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.31219793907545906,-0.9866740215164128,0.47769516728624534,0.5108351735238792,1.0,6/20,21.56%,ACSL3;ACSBG1;ACSL1;ACSL4;TECR;ACSL6
gsea,Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.2558361958930668,-0.9854981943653212,0.44889779559118237,0.5124385951023556,1.0,7/43,12.34%,PLPP3;DEGS1;PRKD1;ACER3;CERS2;CERT1;CERS4
gsea,Complement Cascade R-HSA-166658,-0.284324474749859,-0.984380446557083,0.4737991266375546,0.5139052333663625,1.0,8/28,24.62%,CD81;CLU;SERPING1;VTN;PSMA7;MASP1;CR2;CD55
gsea,Amine Ligand-Binding Receptors R-HSA-375280,0.2882324407275332,0.9823205775319279,0.48741007194244607,1.0,1.0,12/29,18.53%,HRH4;HTR7;HTR5A;ADRA1A;HTR1D;ADRB1;CHRM2;ADRA1B;HRH2;ADRA1D;ADRA2C;DRD2
gsea,Mismatch Repair R-HSA-5358508,-0.33070100851690454,-0.9767448711031596,0.4606986899563319,0.5271245305221471,1.0,4/15,21.30%,PCNA;RPA3;POLD3;MSH2
gsea,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.2738946948581175,-0.9735504803910976,0.498812351543943,0.5324623781498142,1.0,13/31,34.43%,H2AZ1;TERF1;CCNA1;CDKN1B;RB1;CCNA2;H2AJ;TERF2IP;H2BC4;EP400;CABIN1;ATM;H2AZ2
gsea,Signaling By PDGF R-HSA-186797,-0.24746186657871339,-0.9707053106677,0.5150862068965517,0.5371328158722131,1.0,24/51,44.75%,SOS1;COL4A2;FURIN;COL4A1;THBS4;PDGFRA;CXXC1;HRAS;PTPN12;NCK1;COL4A5;GRB2;PIK3CB;PDGFA;STAT5A;COL6A1;PDGFB;PIK3R1;COL9A3;GRB7;NRAS;PDGFD;COL6A2;PTPN11
gsea,Interferon Alpha/Beta Signaling R-HSA-909733,0.28549225029366665,0.9658642106797254,0.49710982658959535,1.0,1.0,6/31,6.47%,PTPN1;ADAR;IRF2;EGR1;IRF7;IRF8
gsea,Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.28577520559760383,-0.9657230342633222,0.5173160173160173,0.545818276200953,1.0,5/25,18.22%,CYP7B1;VDAC2;MIA3;CYP26B1;NCOA2
gsea,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,-0.2310466776342227,-0.9572706212299418,0.51338199513382,0.560773816791269,1.0,15/63,24.36%,PPIB;P3H2;PLOD2;COL4A2;P3H3;COLGALT2;COL19A1;COL2A1;COL4A1;COL11A2;COL12A1;P4HA2;COL16A1;COL1A2;COL4A5
gsea,Glycerophospholipid Biosynthesis R-HSA-1483206,-0.21105138717771987,-0.949280571904652,0.5632411067193676,0.575013811611309,1.0,36/107,35.31%,CHKA;CDIPT;CHPT1;CPNE6;DDHD1;DDHD2;SELENOI;AGPAT3;GPCPD1;GPD2;CDS2;PCYT2;CSNK2B;CRLS1;PLAAT3;HADHA;MFSD2A;LPGAT1;GPAT3;AGK;CEPT1;PCYT1B;BCHE;CHKB;PNPLA8;OSBPL10;GPAT4;LPCAT2;OSBPL8;GPAT2;PLD3;LPIN2;GPAM;DGAT2;MGLL;ABHD3
gsea,IGF1R Signaling Cascade R-HSA-2428924,-0.2512420888160506,-0.9452436307079538,0.556989247311828,0.5814184180006585,1.0,17/40,38.56%,SOS1;IGF1R;PIK3C3;PDE3B;FGFR1;TRIB3;HRAS;FGFR3;GRB2;PIK3CB;IRS2;IGF1;SHC1;PIGU;PIK3R1;FGF9;KL
gsea,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.2512420888160506,-0.9452436307079538,0.556989247311828,0.5814184180006585,1.0,17/40,38.56%,SOS1;IGF1R;PIK3C3;PDE3B;FGFR1;TRIB3;HRAS;FGFR3;GRB2;PIK3CB;IRS2;IGF1;SHC1;PIGU;PIK3R1;FGF9;KL
gsea,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.2137712526062505,-0.9447134908515251,0.5546218487394958,0.581807311802677,1.0,36/105,30.52%,MED28;THRAP3;CHD9;CLOCK;ABCA1;PCDHB16;MED13;SLC27A1;G0S2;MED19;NCOR1;MED23;MED8;MIA3;ACSL1;PPARA;ACOX1;CREBBP;HDAC3;MBD4;CDK8;NCOA2;MED12;TRIB3;NFYA;PLIN2;MED30;TBL1XR1;MED4;MED7;MED17;NCOA1;MUSK;MED24;MED11;MED10
gsea,Interleukin-37 Signaling R-HSA-9008059,0.31633703599437163,0.9445283316895314,0.5481927710843374,1.0,1.0,4/17,8.11%,PTPN9;PTPN5;PTPN2;PTPN23
gsea,RAF-independent MAPK1/3 Activation R-HSA-112409,-0.30930189627697824,-0.9394969360954806,0.5232323232323233,0.5908945615098999,1.0,7/17,25.35%,MAPK1;MAPK3;TYK2;DUSP6;DUSP10;IL6ST;DUSP7
gsea,Netrin-1 Signaling R-HSA-373752,-0.2498467883976998,-0.9361101327321437,0.5366336633663367,0.5967387839758828,1.0,15/46,27.84%,DSCAML1;PTK2;EZR;MAPK8;ABLIM3;TRPC1;UNC5A;RGMA;RGMB;DOCK1;NCK1;TRPC6;MAPK11;NEO1;WASL
gsea,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.2293815667395875,-0.9311534655103634,0.5883534136546185,0.6053664267620721,1.0,20/62,29.06%,NUS1;ST8SIA4;SLC35A1;ST6GAL1;ST8SIA3;ST6GALNAC2;GNPNAT1;FUOM;UAP1;CTSA;PMM1;ST8SIA2;FPGT;GMPPA;ALG5;DPM2;NEU4;DOLK;GFPT1;NANP
gsea,Synaptic Adhesion-Like Molecules R-HSA-8849932,-0.30004355701076835,-0.9276570795247511,0.58,0.6113117848604528,1.0,10/21,34.40%,RTN3;GRIA3;GRIN2C;GRIN2B;LLGL1;GRIA4;GRIN2A;GPRIN1;PTPRF;LRFN4
gsea,Interferon Gamma Signaling R-HSA-877300,-0.23893937099818907,-0.927204551976938,0.5690721649484536,0.6115476394264605,1.0,4/50,4.85%,CAMK2B;BCL11B;PIAS1;CAMK2A
gsea,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,-0.2878225292706985,-0.9269190841108021,0.5515873015873016,0.6114749379021192,1.0,8/24,20.90%,SDC4;BCAN;SDC3;XYLT1;B3GAT2;AGRN;NCAN;B4GALT7
gsea,Cell Junction Organization R-HSA-446728,0.2241565098320329,0.9221099329199272,0.5553470919324578,1.0,1.0,11/69,8.87%,PVR;CADM1;SDK1;PALS1;CLDN16;NECTIN3;LIMS2;PLEC;PATJ;PARD6B;CADM3
gsea,WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.30033071929033883,-0.9186075509871259,0.5871369294605809,0.6267092837154951,1.0,4/19,11.32%,VPS35;VPS29;WLS;WNT7B
gsea,Heme Signaling R-HSA-9707616,-0.24861744923960405,-0.9175647604525069,0.5948616600790514,0.6280514852963426,1.0,10/39,18.22%,CHD9;CLOCK;XPO1;CRTC2;NCOR1;PPARA;CREBBP;HDAC3;MBD4;NCOA2
gsea,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.22968057611183607,0.9172748232747215,0.6027131782945736,1.0,1.0,21/58,20.81%,NRG3;NRG1;ERBB4;FGF1;FRS2;CD86;TRAT1;EGF;LCK;GAB2;NRG4;FGF23;FGFR2;FGF22;FGF13;ESR1;KIT;FLT3;ESR2;KLB;PIK3AP1
gsea,GPCR Ligand Binding R-HSA-500792,0.18891440025089662,0.9147077507469384,0.6883509833585476,1.0,1.0,76/242,19.76%,FFAR1;WNT8B;GRM7;NMUR2;CRHR1;HRH4;MC1R;CXCR5;PTGER3;QRFPR;HTR7;GPR39;NPFFR1;OPN3;TACR3;MRLN;HTR5A;CD200R1;CCKBR;ADRA1A;VIPR1;OXTR;ADCYAP1;HTR1D;CCL25;RXFP2;WNT7A;CX3CR1;GNG4;GNRH1;WNT2B;FPR3;OPN5;PTH2R;ACKR4;C5AR2;TSHR;PTCH2;GHRL;S1PR2;TTF2;ADRB1;P2RY6;NLRP3;CXCR4;OPRK1;CCR5;POMC;GRM8;CHRM2;ECE1;CCL5;NPSR1;ADRA1B;NMUR1;HRH2;GRM3;GPR35;GRPR;ADRA1D;HCRT;CRHR2;ADRA2C;RXFP1;LHCGR;NPFF;CORT;S1PR5;C3AR1;DRD2;F2R;GRM4;RAMP3;TAS1R3;P2RY13;EDNRA
gsea,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.23019088353821465,-0.9117917052872169,0.6016096579476862,0.6384428073258142,1.0,19/53,28.21%,CHD9;SEC24A;MBTPS2;RAN;ACACA;SEC23A;PPARA;CREBBP;MBD4;MBTPS1;NCOA2;GGPS1;NFYA;LMBR1;TBL1XR1;SCAP;SEC24D;TM7SF2;NCOA1
gsea,IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.24351369649125493,-0.9107360950147204,0.6157112526539278,0.6397944421225338,1.0,16/39,38.56%,SOS1;IGF1R;PIK3C3;PDE3B;FGFR1;TRIB3;HRAS;FGFR3;GRB2;PIK3CB;IRS2;IGF1;PIGU;PIK3R1;FGF9;KL
gsea,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.2987575099778047,0.9093911561634859,0.592,1.0,1.0,3/18,6.51%,VRK2;LMNB1;CCNB2
gsea,Tight Junction Interactions R-HSA-420029,0.30945947774548177,0.9023490410617835,0.5877862595419847,1.0,1.0,4/16,7.71%,PALS1;CLDN16;PATJ;PARD6B
gsea,Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.30439345708418836,0.896230401205818,0.5805168986083499,1.0,1.0,6/19,12.14%,PRKG1;PDE5A;PDE1A;KCNMA1;PDE11A;GUCY1A1
gsea,Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.27404015822103056,-0.8958123949178702,0.6030701754385965,0.667417119151803,1.0,5/22,25.29%,PCNA;TERF1;POLD3;POLA1;TERF2IP
gsea,Regulation Of KIT Signaling R-HSA-1433559,0.313718191496895,0.8917691291181588,0.6027944111776448,1.0,1.0,5/15,17.55%,SH2B2;LYN;LCK;CBL;KIT
gsea,Interleukin-2 Family Signaling R-HSA-451927,-0.25421644670659255,-0.8872324762254129,0.6075949367088608,0.6831307383087694,1.0,18/34,46.58%,PTK2B;SOS1;IL5RA;CSF2RA;PIK3R3;GRB2;PIK3CB;CLSTN1;STAT5A;INPPL1;SHC1;PIK3R1;JAK1;JAK3;IL15RA;SOS2;IL3RA;HAVCR2
gsea,Collagen Formation R-HSA-1474290,-0.2038252928951908,-0.8850586665269176,0.683046683046683,0.6867585792841253,1.0,18/81,24.36%,PPIB;P3H2;PLOD2;COL4A2;P3H3;PXDN;COLGALT2;CTSL;COL19A1;COL2A1;COL4A1;COL11A2;CTSB;COL12A1;P4HA2;COL16A1;COL1A2;COL4A5
gsea,Cell-Cell Communication R-HSA-1500931,-0.20466196415234755,-0.8828892876894255,0.670020120724346,0.6903250298460377,1.0,25/98,28.31%,PTK2;CDH9;PTK2B;CLDN10;AFDN;CDH13;SPTBN1;PXDN;PRKCI;CD47;CASK;CD2AP;CADM2;CLDN5;CTNNB1;TESK1;PARD6A;NCK1;IQGAP1;CLDN12;ACTN1;LAMC2;GRB2;WASL;PIK3CB
gsea,Sphingolipid Metabolism R-HSA-428157,-0.20455166695012095,-0.8794325442805053,0.6787878787878788,0.6961020169196065,1.0,18/77,22.21%,PLPP3;DEGS1;PRKD1;ARSJ;ACER3;CERS2;UGCG;CERT1;ARSA;ESYT2;CERS4;GALC;OSBP;SMPD4;CTSA;SUMF1;GM2A;VAPA
gsea,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.25924700629818886,-0.8779690887928454,0.625,0.6982259255542478,1.0,7/26,23.87%,GUK1;DTYMK;CTPS2;NME4;NME2;AK2;RRM2B
gsea,Regulation Of Signaling By CBL R-HSA-912631,0.29501329454329794,0.8765170222732446,0.6198019801980198,1.0,1.0,9/18,25.00%,HCK;CRKL;LYN;CBL;SYK;CRK;PIK3R2;RAPGEF1;VAV1
gsea,NLRP3 Inflammasome R-HSA-844456,-0.300948496307265,-0.8702358712736361,0.6189473684210526,0.7121447324591824,1.0,7/15,35.04%,HSP90AB1;NFKB1;TXNIP;HMOX1;PSTPIP1;TXN2;APP
gsea,Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.29836209119893564,-0.8688405405576356,0.6423841059602649,0.7140724350448653,1.0,6/16,28.40%,CDK4;CDKN1B;RB1;CCND1;TFDP2;E2F3
gsea,RORA Activates Gene Expression R-HSA-1368082,-0.28638269975657304,-0.8685577317223232,0.6673640167364017,0.7138509594733733,1.0,7/18,28.21%,CHD9;PPARA;CREBBP;MBD4;NCOA2;TBL1XR1;NCOA1
gsea,Diseases Of Glycosylation R-HSA-3781865,0.19375373468050108,0.8674864182827573,0.7148148148148148,1.0,1.0,15/117,7.19%,GPC6;HEXB;MUC15;B3GLCT;GPC3;EXT1;GLB1;ADAMTS10;DAG1;PAPSS2;ADAMTSL1;DHDDS;THSD4;ADAMTS12;GPC1
gsea,TNFs Bind Their Physiological Receptors R-HSA-5669034,0.3099007781930107,0.8622424480823296,0.6516666666666666,1.0,1.0,6/16,22.20%,TNFRSF9;TNFRSF8;TNFRSF13B;EDA2R;TNFRSF18;TNFRSF1B
gsea,PI-3K cascade:FGFR1 R-HSA-5654689,0.2945968474172052,0.8615777551335375,0.666023166023166,1.0,1.0,5/15,16.34%,FGF1;FRS2;FGF23;FGF22;FGF13
gsea,Signaling By SCF-KIT R-HSA-1433557,0.24070119184656133,0.8541184116165994,0.6939163498098859,1.0,1.0,7/38,12.34%,TEC;SH2B2;LYN;LCK;FES;GAB2;CBL
gsea,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.24813605939714856,-0.8500345512961565,0.6991869918699187,0.7473839404249696,1.0,12/26,38.63%,RICTOR;AKT1;RPS6KB2;CDKN1B;CHUK;MTOR;CASP9;BAD;MAPKAP1;FOXO1;AKT3;GSK3B
gsea,Non-integrin membrane-ECM Interactions R-HSA-3000171,0.2332341883450405,0.8491461974384835,0.7018867924528301,1.0,1.0,4/39,3.82%,TTR;NRXN1;DAG1;DMD
gsea,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,-0.2871098882213416,-0.848572815995665,0.6615384615384615,0.749151475888846,1.0,5/16,21.25%,PIK3C3;INPP4B;MTM1;MTMR12;MTMR2
gsea,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.2740856714690748,-0.8438040863732935,0.6673267326732674,0.7573669675322164,1.0,5/19,22.50%,ALG2;CTSA;MPDU1;ALG6;RFT1
gsea,Metabolism Of Porphyrins R-HSA-189445,0.2644509104297186,0.8432421155657807,0.6994219653179191,1.0,1.0,7/21,17.52%,ALAS1;GUSB;HMOX2;ABCC1;ABCC2;ALAS2;SLCO2B1
gsea,Nucleotide Salvage R-HSA-8956321,0.28174847843410117,0.8428619124652257,0.6925996204933587,1.0,1.0,4/18,5.30%,AMPD1;UPP2;DCK;TK2
gsea,SUMOylation Of DNA Methylation Proteins R-HSA-4655427,0.2921406074872158,0.8425219147898972,0.6864754098360656,1.0,1.0,4/15,10.50%,DNMT3A;DNMT3B;RNF2;PHC2
gsea,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.23733115413780848,-0.8359068816327222,0.7063829787234043,0.7707917368564107,1.0,9/31,33.23%,SEM1;RPA3;BLM;RAD17;WRN;TOPBP1;RMI2;RFC5;ATM
gsea,FRS-mediated FGFR2 Signaling R-HSA-5654700,0.2772916651425624,0.834763934531317,0.695906432748538,1.0,1.0,6/17,16.34%,FGF1;FRS2;FGF23;FGFR2;FGF22;FGF13
gsea,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.22914788508505146,-0.8291536852657369,0.7213114754098361,0.781964564738466,1.0,4/33,9.90%,H2AZ1;CDK4;CEBPB;CBFB
gsea,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.25422031712806087,-0.8275800897239736,0.7069672131147541,0.7836739329168837,1.0,7/23,26.67%,HDAC1;SMAD4;SMAD3;ATXN3;PLXNA4;HDAC2;RETN
gsea,TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,-0.282173974388409,-0.8177980888146678,0.7338877338877339,0.7998669825412791,1.0,9/15,41.23%,PCNA;TFDP2;RBL2;REXO2;AURKA;E2F4;GADD45A;CARM1;CCNB1
gsea,Sialic Acid Metabolism R-HSA-4085001,-0.2303107519260424,-0.8143278503766628,0.7471910112359551,0.8048554301881079,1.0,5/32,11.22%,ST8SIA4;SLC35A1;ST6GAL1;ST8SIA3;ST6GALNAC2
gsea,Collagen Chain Trimerization R-HSA-8948216,0.22933618619109009,0.8098914166552494,0.7688356164383562,1.0,1.0,12/40,18.12%,COL13A1;COL26A1;COL8A1;COL6A6;COL28A1;COL24A1;COL6A3;COL8A2;COL14A1;COL7A1;COL4A4;COL23A1
gsea,Interleukin-10 Signaling R-HSA-6783783,0.27814889047263147,0.8017994515717266,0.7212230215827338,1.0,1.0,6/20,13.76%,IL10RA;CD86;ICAM1;CCR5;IL10RB;CCL5
gsea,Metabolism Of Nucleotides R-HSA-15869,-0.1853096494667335,-0.7993041964057027,0.8530020703933747,0.8290176917573103,1.0,17/77,23.87%,ADK;AMPD2;NT5C;GUK1;GMPS;DTYMK;GDA;SAMHD1;GMPR2;ENTPD5;CTPS2;NME4;SCO2;UCKL1;NME2;AK2;RRM2B
gsea,Platelet Sensitization By LDL R-HSA-432142,-0.27482769014508923,-0.7978590224851777,0.7381443298969073,0.8304267702151621,1.0,3/16,25.62%,PPP2R1A;PPP2CA;PPP2R5D
gsea,Peroxisomal Lipid Metabolism R-HSA-390918,-0.237335068786533,-0.7953299784122296,0.7621052631578947,0.8334175817247977,1.0,11/26,38.83%,SYCP2;NUDT19;ACOX1;SLC25A17;ECI2;AMACR;ACBD5;HSD17B4;PECR;MLYCD;ABCD1
gsea,Collagen Degradation R-HSA-1442490,-0.22763720431985757,-0.7941743222405084,0.8036117381489842,0.8343893941052765,1.0,8/30,22.61%,FURIN;CTSL;COL19A1;MMP14;CTSB;COL12A1;MMP15;COL16A1
gsea,Inflammasomes R-HSA-622312,-0.2514218760914451,-0.7931758217397902,0.7752577319587629,0.835205288308691,1.0,3/19,13.20%,HSP90AB1;NFKB1;BCL2L1
gsea,Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,-0.24915678857115053,-0.792271902816662,0.7703862660944206,0.8358273220324323,1.0,2/19,6.59%,F3;SERPING1
gsea,Metabolism Of Steroid Hormones R-HSA-196071,0.2599218874994166,0.7885183221062746,0.7532228360957642,1.0,1.0,6/19,23.85%,HSD17B2;POMC;STARD4;HSD3B2;CYP11A1;SRD5A1
gsea,Role Of Phospholipids In Phagocytosis R-HSA-2029485,-0.2513164042925814,-0.7838210117551909,0.7470355731225297,0.8484502830828037,1.0,8/21,38.10%,PRKCE;PRKCD;AHCYL1;PIK3CB;PLD3;ITPR1;ITPR2;PIK3R1
gsea,Glycosphingolipid Metabolism R-HSA-1660662,0.21632189411207842,0.7776231793553038,0.8222222222222222,1.0,1.0,8/34,14.11%,HEXB;GLB1;GLB1L;B3GALNT1;CERK;ARSG;NEU2;GLTP
gsea,Myogenesis R-HSA-525793,-0.23702845404224393,-0.7768994734587682,0.7957198443579766,0.8578335149624474,1.0,8/24,26.94%,MEF2A;MAP2K6;TCF12;CTNNB1;BNIP2;MAPK11;TCF7L2;NEO1
gsea,Synthesis Of PA R-HSA-1483166,0.2255843628092232,0.7758657629120197,0.8065764023210832,1.0,1.0,3/28,2.68%,MIGA2;AGPAT4;LPCAT1
gsea,Transcriptional Regulation By E2F6 R-HSA-8953750,-0.21422888596557116,-0.7733939359049751,0.8336594911937377,0.8619627091342003,1.0,13/32,33.91%,CBX3;EHMT1;PHC3;TFDP2;RBBP7;APAF1;UXT;E2F6;L3MBTL2;MGA;EZH2;PCGF6;SUZ12
gsea,Endogenous Sterols R-HSA-211976,-0.24008068238673758,-0.7706354450519861,0.8126272912423625,0.8649996330342277,1.0,5/19,28.21%,CYP7B1;MIA3;NCOA2;PTGIS;NCOA1
gsea,IRS-mediated Signaling R-HSA-112399,-0.21026113399647148,-0.7704631589112807,0.8256302521008403,0.8643841817183511,1.0,14/36,38.56%,SOS1;PIK3C3;PDE3B;FGFR1;TRIB3;HRAS;FGFR3;GRB2;PIK3CB;IRS2;PIGU;PIK3R1;FGF9;KL
gsea,Nucleotide Catabolism R-HSA-8956319,0.2253511046797926,0.7597052694517168,0.822,1.0,1.0,6/25,11.11%,ENTPD1;UPP2;ENTPD6;ENTPD7;NT5C2;NUDT1
gsea,PRC2 Methylates Histones And DNA R-HSA-212300,0.2468604276238631,0.7582638121551799,0.8078358208955224,1.0,1.0,6/19,13.11%,DNMT3A;DNMT3B;PHF1;EED;JARID2;RBBP4
gsea,RET Signaling R-HSA-8853659,-0.21436607521714693,-0.7580785129809859,0.8336755646817249,0.8804215585711936,1.0,3/35,7.71%,SOS1;DOK6;PRKACB
gsea,Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,-0.24566901589614015,-0.7578769371838291,0.8034934497816594,0.879779338273882,1.0,9/21,34.58%,HSP90AB1;NFKB1;ENTPD5;TXNIP;HMOX1;PSTPIP1;NT5E;TXN2;IL1A
gsea,Acyl Chain Remodelling Of PE R-HSA-1482839,0.262019851987728,0.7552293896536286,0.806390977443609,1.0,1.0,7/16,26.71%,LPCAT3;PLA2G4B;PLA2G6;PLA2G4E;PLA2G4C;MBOAT1;PLA2G3
gsea,PI3K/AKT Signaling In Cancer R-HSA-2219528,0.17637089130709024,0.7533883466262945,0.89272030651341,1.0,1.0,24/85,18.14%,NR4A1;NRG3;NRG1;ERBB4;FGF1;FRS2;CDKN1A;CD86;TRAT1;EGF;LCK;GAB2;FOXO6;AKT1S1;NRG4;FGF23;FOXO3;FGFR2;FGF22;FGF13;ESR1;KIT;FLT3;MDM2
gsea,Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.25269838039045334,-0.7317436729708309,0.796,0.9117426681868337,1.0,6/15,33.06%,NUS1;PGM1;DPM2;DOLK;GFPT1;SLPI
gsea,Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.24700761131831192,0.7298552132010927,0.8137254901960784,1.0,1.0,4/18,9.37%,GPC6;GPC3;GPC1;DCN
gsea,Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.24565101577043652,0.7269065873931988,0.8412698412698413,1.0,1.0,4/18,9.37%,GPC6;GPC3;GPC1;DCN
gsea,Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,0.2555004891005979,0.7248207372422849,0.7954545454545454,1.0,1.0,5/15,18.88%,PI4K2B;FIG4;SACM1L;PI4KA;VAC14
gsea,FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,-0.2480278851274006,-0.7241481708414311,0.8137651821862348,0.9192069612722586,1.0,8/15,40.79%,BCL6;CREBBP;NFYA;BBC3;CITED2;FOXO1;PINK1;NFYB
gsea,Synthesis Of PC R-HSA-1483191,-0.21470364924597052,-0.7224765094640727,0.8778467908902692,0.9199999278234692,1.0,13/25,38.47%,CHKA;CHPT1;CSNK2B;MFSD2A;CEPT1;PCYT1B;BCHE;CHKB;LPIN2;ABHD3;STARD10;CSNK2A2;PCTP
gsea,Signaling By KIT In Disease R-HSA-9669938,-0.234559295636355,-0.7219434088505781,0.836,0.9195934338990559,1.0,7/19,39.20%,SOS1;HRAS;PIK3R3;GRB2;STAT5A;PIK3R1;YES1
gsea,"Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",-0.2380422856091932,-0.7176186774586341,0.8201581027667985,0.9233528570223959,1.0,8/18,28.51%,SDC4;BCAN;SDC3;AGRN;NCAN;B4GALT7;CSPG4;VCAN
gsea,Defective Pyroptosis R-HSA-9710421,-0.22641826082278424,-0.7092280403292566,0.9084668192219679,0.9306706300945259,1.0,10/20,38.83%,H2AZ1;POLA1;RBBP7;H2AJ;H2BC4;EZH2;SUZ12;H2AZ2;H2AX;GSDME
gsea,DAP12 Signaling R-HSA-2424491,-0.2199829595110034,-0.7058602864118364,0.8685258964143426,0.9319280877128087,1.0,6/23,28.31%,SOS1;VAV3;SPNS1;HRAS;GRB2;PIK3CB
gsea,DAP12 Interactions R-HSA-2172127,-0.2199829595110034,-0.7058602864118364,0.8685258964143426,0.9319280877128087,1.0,6/23,28.31%,SOS1;VAV3;SPNS1;HRAS;GRB2;PIK3CB
gsea,Signaling To RAS R-HSA-167044,-0.2324225914129588,-0.7018456460847889,0.8810020876826722,0.9348675869569463,1.0,5/18,27.71%,SOS1;RALA;HRAS;MAPK11;GRB2
gsea,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.21534409541232485,0.6919955180999037,0.8765182186234818,1.0,1.0,6/22,16.34%,FGF1;FRS2;FGF23;FGFR2;FGF22;FGF13
gsea,Formation Of Cornified Envelope R-HSA-6809371,0.22815240279543952,0.6880930209253225,0.891459074733096,1.0,1.0,6/20,16.57%,PKP3;EVPL;PERP;CAPN1;ST14;JUP
gsea,CTLA4 Inhibitory Signaling R-HSA-389513,-0.21817637943056162,-0.6830837906987762,0.875751503006012,0.9499539066745498,1.0,2/21,9.88%,PPP2R1A;AKT1
gsea,O-linked Glycosylation Of Mucins R-HSA-913709,-0.19044006596149227,-0.6723206937542141,0.9270833333333334,0.9571214996913625,1.0,6/36,18.12%,B4GALT6;B3GNT2;ST6GAL1;ST6GALNAC2;B3GNTL1;B3GNT4
gsea,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.18510305171442054,-0.6705447130384923,0.9336188436830836,0.9573466961262062,1.0,10/36,33.62%,SEM1;RPA3;BLM;RAD17;WRN;TOPBP1;RMI2;RFC5;ATM;RAD51D
gsea,Sulfur Amino Acid Metabolism R-HSA-1614635,-0.20235638004113649,-0.6663145712961716,0.9369565217391305,0.9593625105109104,1.0,4/22,19.89%,ADO;GOT2;APIP;MRI1
gsea,Signaling By Retinoic Acid R-HSA-5362517,-0.19335608769110985,-0.6642723693216191,0.9316239316239316,0.95981256945865,1.0,6/29,21.49%,PDHX;PDHB;RDH14;CYP26B1;RDH10;RDH5
gsea,Signaling By Erythropoietin R-HSA-9006335,-0.2152161317750081,-0.6628752747811966,0.8947368421052632,0.9598128767588928,1.0,10/22,38.10%,SOS1;HRAS;GRB2;PIK3CB;IRS2;CLSTN1;STAT5A;SHC1;PIGU;PIK3R1
gsea,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.1980185293838045,-0.6520952110306466,0.9429133858267716,0.965491931934583,1.0,11/24,38.56%,SOS1;FLRT3;FGFR1;HRAS;FLRT1;GRB2;SHC1;PIGU;PIK3R1;FGF9;KL
gsea,TRP Channels R-HSA-3295583,-0.19844060773085406,-0.6427200348236881,0.9465020576131687,0.970103745198411,1.0,5/19,24.55%,TRPM3;TRPC4AP;TRPC1;TRPM7;TRPC6
gsea,GPVI-mediated Activation Cascade R-HSA-114604,0.19716814549405753,0.6369408606424172,0.9309021113243762,1.0,1.0,6/28,14.67%,PLCG2;LCP2;LYN;LCK;CDC42;PIK3R5
gsea,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.17695815130875947,-0.628106324950828,0.9680851063829787,0.976734524419457,1.0,9/33,33.23%,RPA3;BLM;RAD17;WRN;RAD52;TOPBP1;RMI2;RFC5;ATM
gsea,Downstream Signaling Of Activated FGFR3 R-HSA-5654708,-0.20163706782571977,-0.626950603143541,0.9404761904761905,0.9762942402865674,1.0,10/19,44.75%,SOS1;HRAS;FGFR3;GRB2;SHC1;PIGU;PIK3R1;FGF9;NRAS;PTPN11
gsea,SHC-mediated cascade:FGFR2 R-HSA-5654699,0.2110168331419753,0.6126195824248555,0.9416195856873822,1.0,1.0,5/15,16.34%,FGF1;FGF23;FGFR2;FGF22;FGF13
gsea,Signaling By FGFR3 In Disease R-HSA-5655332,-0.20635804158799836,-0.6092985049126267,0.9362549800796812,0.9829839386618736,1.0,7/16,38.48%,SOS1;HRAS;FGFR3;GRB2;PIGU;PIK3R1;FGF9
gsea,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.17176196470562277,-0.6050909008583893,0.9711934156378601,0.983552242164599,1.0,2/37,4.25%,YWHAZ;SOS1
gsea,Diseases Of DNA Repair R-HSA-9675135,0.15426466925182797,0.5875896607734313,0.9828897338403042,1.0,1.0,10/47,16.75%,NEIL3;RAD51B;PALB2;POLR1B;RFC2;NTHL1;RAD9B;MUTYH;MSH3;EXO1
gsea,Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,-0.16868260874416446,-0.5809648795094732,0.9767441860465116,0.9903761027016527,1.0,8/29,33.62%,SEM1;BLM;SPIDR;WRN;RMI2;EME2;ATM;RAD51D
gsea,Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.155421967208661,0.5738674642103053,0.9918032786885246,1.0,1.0,16/49,22.98%,PLEC;COL8A1;COL6A6;CTSS;COL24A1;COL6A3;COL8A2;LAMB3;LOXL3;COL7A1;LOXL2;COL4A4;LOXL4;LOXL1;CD151;COL9A2
gsea,FRS-mediated FGFR1 Signaling R-HSA-5654693,0.19467972883344892,0.5738528592348292,0.9615384615384616,1.0,1.0,5/16,16.34%,FGF1;FRS2;FGF23;FGF22;FGF13
gsea,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.1545484346917032,-0.5648189521480368,0.9872068230277186,0.9935049478935973,1.0,10/37,33.62%,SEM1;RPA3;BLM;RAD17;WRN;TOPBP1;RMI2;RFC5;ATM;RAD51D
gsea,PI3K Cascade R-HSA-109704,-0.15422445546902486,-0.5589375915302625,0.9786324786324786,0.9938238109750277,1.0,12/33,38.56%,PIK3C3;PDE3B;FGFR1;TRIB3;FGFR3;GRB2;PIK3CB;IRS2;PIGU;PIK3R1;FGF9;KL
gsea,Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,0.19307475339073218,0.5579899080885562,0.9761904761904762,1.0,1.0,3/15,11.71%,NOX4;CDKN1A;GAB2
gsea,Cell-extracellular Matrix Interactions R-HSA-446353,-0.18573814808410904,-0.5550897204888967,0.9755102040816327,0.9935548565781159,1.0,6/16,37.26%,PXDN;TESK1;ACTN1;FERMT2;ARHGEF6;ITGB1
gsea,Resolution Of D-Loop Structures R-HSA-5693537,-0.1576113837633772,-0.5482039695639264,0.9830148619957537,0.9938749803440772,1.0,3/30,11.44%,SEM1;BLM;SPIDR
gsea,Keratinization R-HSA-6805567,0.16698026077298195,0.5465426993228438,0.9861351819757366,1.0,1.0,4/28,8.78%,PKP3;EVPL;PERP;CAPN1
gsea,Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,-0.18422488306512014,-0.5370119806401727,0.9882121807465619,0.9947550528985906,1.0,8/15,47.57%,AASDHPPT;PANK3;SLC5A6;PDZD11;ENPP1;SLC25A16;PPCS;PANK2
gsea,Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.16713067650100905,0.5316411776292235,0.9904942965779467,1.0,1.0,2/22,5.61%,RAD51B;PALB2
gsea,Interleukin-7 Signaling R-HSA-1266695,0.17570395527856958,0.5313687487000055,0.9798165137614679,1.0,1.0,3/19,13.00%,SOCS2;CRLF2;SMARCA4
gsea,Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,-0.1515518385705648,-0.4881670898033669,0.99375,0.9989876755531204,1.0,13/23,50.10%,SEM1;BLM;WRN;RMI2;ATM;RAD51D;BRCA2;RAD50;RAD51AP1;RBBP8;XRCC2;BRIP1;BARD1
gsea,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.13231568864118629,-0.4869057270219791,0.9955947136563876,0.9980674174221046,1.0,10/39,33.62%,SEM1;RPA3;BLM;RAD17;WRN;TOPBP1;RMI2;RFC5;ATM;RAD51D
gsea,Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.15781132515122745,-0.4783831273832705,0.9979959919839679,0.9976124913827686,1.0,9/18,44.75%,SOS1;HRAS;GRB2;SHC1;PIGU;PIK3R1;FGF9;NRAS;PTPN11
gsea,Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.1263749067008493,0.413917821340709,0.99812382739212,0.9995632345394126,1.0,7/25,23.01%,RAD51B;PALB2;XRCC3;EXO1;RTEL1;KAT5;TOP3A
